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  Abstract	  Network	  and	  Algebraic	  Topology	  of	  Influenza	  Evolution	  Joseph	  Chan	  Evolution	   is	   a	   force	   that	   has	   molded	   human	   existence	   since	   its	   divergence	   from	  chimpanzees	  about	  5.4	  million	  years	  ago.	  In	  that	  same	  amount	  of	  time,	  an	  influenza	  virus,	  which	   replicates	   every	   six	   hours,	   would	   have	   undergone	   an	   equivalent	   number	   of	  generations	  over	  only	  a	  hundred	  years.	  The	  fast	  replication	  times	  of	  influenza,	  coupled	  with	  its	   high	  mutation	   rate,	  make	   the	   virus	   a	   perfect	  model	   to	   study	   real-­‐time	   evolution	   at	   a	  mega-­‐Darwin	  scale,	  more	   than	  a	  million	   times	   faster	   than	  human	  evolution.	  While	  recent	  developments	   in	   high-­‐throughput	   sequencing	   provide	   an	   optimal	   opportunity	   to	   dissect	  their	  genetic	  evolution,	  a	  concurrent	  growth	  in	  computational	  tools	  is	  necessary	  to	  analyze	  the	   large	   influx	   of	   complex	   genomic	   data.	   In	   my	   thesis,	   I	   present	   novel	   computational	  methods	   to	   examine	   different	   aspects	   of	   influenza	   evolution.	   I	   first	   focus	   on	   seasonal	  influenza,	   particularly	   the	   problems	   that	   hamper	   public	   health	   initiatives	   to	   combat	   the	  virus.	   I	   introduce	   two	   new	   approaches:	   1.	   The	   q2-­‐coefficient,	   a	   method	   of	   quantifying	  pathogen	   surveillance,	   and	   2.	   FluGraph,	   a	   technique	   that	   employs	   network	   topology	   to	  track	  the	  spread	  of	  seasonal	  influenza	  around	  the	  world.	  The	  second	  chapter	  of	  my	  thesis	  examines	   how	   mutations	   and	   reassortment	   combine	   to	   alter	   the	   course	   of	   influenza	  evolution	   towards	   pandemic	   formation.	   I	   highlight	   inherent	   deficiencies	   in	   the	   current	  phylogenetic	   paradigm	   for	   analyzing	   evolution	   and	   offer	   a	   novel	   methodology	   based	   on	  algebraic	   topology	   that	   comprehensively	   reconstructs	   both	   vertical	   and	   horizontal	  evolutionary	  events.	  I	  apply	  this	  method	  to	  viruses,	  with	  emphasis	  on	  influenza,	  but	  foresee	  broader	  application	  to	  cancer	  cells,	  bacteria,	  eukaryotes,	  and	  other	  taxa.	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Introduction	  Defined	  as	  the	  transfer	  of	  genomic	  information	  across	  generations	  of	  organisms,	  evolution	  is	  a	  force	  that	  can	  shape	  a	  species	  over	  the	  timescale	  of	  eons.	  An	  extreme	  example	  of	  near	  evolutionary	  stasis	  is	  the	  coelacanth,	  popularly	  believed	  to	  be	  a	  living	  fossil	  that	  evolved	  to	  roughly	  its	  current	  form	  at	  least	  400	  million	  years	  ago1.	  Molecular	  time	  estimates	  of	  human	  evolution	  since	   the	  divergence	   from	  our	  chimpanzee	  relatives	  date	   to	  roughly	  5.4	  million	  years	   ago2.	   Elucidating	   macroscopic	   principles	   that	   govern	   the	   evolution	   of	   such	   slowly	  changing	  organisms	  over	  many	  different	  generations	  is	  a	  continuing	  challenge.	  	  
However,	  evolution	  does	  not	  always	  occur	  at	  a	  slow	  pace.	  It	  tends	  to	  be	  particularly	  fast	  in	  many	  parasites,	  since	  they	  generally	  undergo	  shorter	  generation	  cycles	  than	  their	  hosts3.	  Of	  all	  parasites,	  viruses	  and	  in	  particular	  influenza	  display	  the	  fastest	  evolution.	  Consider	  that	  100,000	  years	   is	  equivalent	  to	  only	  3,000	  generations	  of	  humans,	  a	  mere	  snapshot	   in	  the	  entire	   course	   of	   the	   human	   evolution.	   In	   the	   same	   amount	   of	   time,	   influenza	   with	   a	  replication	   time	   of	   six	   hours	   would	   have	   evolved	   over	   150	   million	   generations.	   Short	  generations	   combined	   with	   the	   virus’s	   high	   evolutionary	   rate	   of	   roughly	   5*10-­‐3	  substitutions	   per	   site	   per	   generation	   lead	   to	   an	   exceedingly	   high	   genetic	   diversity.	   In	  addition,	   this	   virus	   undergoes	   a	   form	   of	   sexual	   evolution	   called	   reassortment,	   in	   which	  segments	   of	   the	   genome	   are	   swapped	   between	   parental	   strains	   to	   form	   new	   hybrid	  progeny.	  	  
The	  study	  of	  influenza	  has	  especially	  benefitted	  from	  the	  development	  of	  high-­‐throughput	  sequencing.	  Since	  2010,	  Illumina	  machines,	  one	  of	  the	  most	  widely	  used	  deep	  sequencing	  platforms,	  could	  sequence	  18	  gigabases	  in	  four	  days	  for	  a	  single	  run4,	  and	  new	  methods	  will	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promise	  greater	  coverage	  at	   lower	  cost.	  These	  technologies	   facilitate	  consensus	  sequence	  determination	  and	  capture	  the	  full	  genetic	  variability	  of	  a	  species	  at	  unprecedented	  detail	  and	  high	  depth	  of	  reads	  (confidence).	  With	  great	  amounts	  of	  data	  come	  great	  complexity,	  demanding	  a	   concurrent	   growth	   in	   the	  development	  of	   computational	   tools	   to	  overcome	  statistical	   hurdles	   of	   sensitivity	   and	   specificity.	   Combined	   with	   such	   novel	   and	   proper	  computational	   analysis,	   influenza	   genomics	   promise	   the	   perfect	   opportunity	   to	   study	  evolution	  in	  real	  time.	  	  
While	  modern	  molecular	   research	  of	   influenza	  began	  with	   its	   first	   successful	   isolation	   in	  1933,	   recordings	   of	   historical	   pandemics	   suggest	   that	   it	   has	  most	   likely	   co-­‐evolved	  with	  humans	   for	   at	   least	   a	  millennium.	  We	  now	  recognize	   that	   in	   regards	   to	  human	   infection,	  influenza	   assumes	   two	   forms—seasonal	   and	   pandemic	   influenza—both	   of	   which	   exist	  primarily	  due	  to	  the	  virus’s	  fast	  evolution.	  	  
For	  example,	  seasonal	  influenza	  refers	  to	  strains	  that	  are	  already	  adapted	  to	  human	  hosts.	  Due	  to	  its	  fast	  evolution,	  these	  strains	  readily	  evade	  the	  immune	  system,	  facilitating	  global	  seasonal	   epidemics	  each	  year.	  Vaccines	  offer	   the	  major	  defense	  against	   influenza	   spread,	  but	  they	  must	  be	  updated	  nearly	  every	  two	  years	  to	  match	  the	  constantly	  shifting	  dominant	  epitope	  of	   the	  virus.	   Pandemic	   influenza,	   on	   the	  other	  hand,	   refers	   to	   strains	   endemic	   in	  animals	  like	  avian	  or	  swine	  but	  acquire	  the	  necessary	  mutations	  for	  infecting	  and	  adapting	  to	  human	  hosts,	   thereby	  spreading	  on	  a	  global	  scale.	   In	  this	  case,	   fast	  evolution	  increases	  the	  chance	  of	  developing	  a	  novel	  pandemic	  strain	  adapted	  to	  switching	  from	  their	  original	  reservoirs	  to	  human	  hosts.	  Reassortment	  can	  expedite	  this	  process	  when	  a	  virus	   from	  an	  animal	  host	  swaps	  genomic	  segments	  with	  a	  virus	  that	  already	  adapted	  to	  human	  hosts.	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Figure	  1.	  Different	  aspects	  of	  influenza	  evolution.	  This	  thesis	  will	  examine	  evolution	  in	  two	  different	  ways.	  We	  
will	  first	  consider	  the	  evolution	  of	  seasonal	  influenza	  as	  an	  epidemiological	  process	  across	  space	  and	  time.	  We	  
will	  then	  consider	  evolution	  in	  biological	  terms,	  as	  influenced	  by	  antigenic	  drift	  and	  shift	  towards	  reaching	  
pandemic	  potential.	  	  To	  study	  seasonal	  and	  pandemic	  influenza,	  I	  will	  frame	  the	  discussion	  of	  evolution	  in	  two	  different	  ways.	  We	  can	  think	  of	  evolution	  as	  an	  epidemiological	  process,	  occurring	  across	  space	  and	   time.	  Alternatively,	  we	   can	   think	  of	   evolution	   in	  biological	   terms,	  mediated	  by	  mutation	  and	  reassortment	  (Figure	  1).	  In	  my	  thesis,	  I	  will	  present	  two	  vignettes.	  The	  first	  part	   will	   feature	   seasonal	   influenza,	   particularly	   the	   systematic	   and	   statistical	   problems	  that	  hamper	  public	  health	  initiatives.	  I	  will	  show	  how	  we	  can	  overcome	  these	  problems	  by	  harnessing	  spatial	  and	   temporal	   information	   to	  construct	  a	  network	   that	   represents	  how	  seasonal	   flu	  spreads	  around	  the	  world.	   In	   the	  second	  part,	   I	  will	   focus	  on	  how	  mutations	  and	  reassortment	  combine	  to	  altering	  the	  course	  of	   influenza	  evolution	  towards	  reaching	  pandemic	   status.	   I	  will	   examine	  how	   the	  current	  phylogenetic	  paradigm	   for	   representing	  this	   process	   is	   inadequate,	   and	   I	   will	   offer	   an	   alternative	   strategy	   based	   on	   algebraic	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Chapter	  1:	  Overcoming	  Gaps	  in	  
Genomic	  Surveillance	  in	  Modeling	  
the	  Global	  Spread	  of	  Seasonal	  
Influenza	  	  	  
Section	  1.1:	  Introduction	  Seasonal	   influenza	   refers	   to	   strains	   that	   are	   already	  adapted	   to	  human	  hosts	   and	   spread	  around	  the	  world	  in	  seasonal	  epidemics	  annually.	  This	  virus	  includes	  subtypes	  like	  H3N2	  A,	  2009	  H1N1	  A,	  and	  B	  that	  have	  adapted	  to	  human	  host	  populations	  (i.e.	  capable	  of	  spreading	  from	  human	  to	  human).	  These	  viruses	  display	  a	  very	  characteristic	  pattern	  of	  infection	  that	  peaks	   during	   the	   wintertime	   in	   temperate	   regions.	   Due	   to	   their	   high	   evolutionary	   rate,	  seasonal	   influenza	   is	  capable	  of	  evading	  previously	  acquired	  host	   immunity	  annually	   in	  a	  process	   known	   as	   antigenic	   drift.	   As	   a	   result,	   the	   virus	   produces	   symptomatic	   upper	  respiratory	  infection	  in	  5-­‐15%	  of	  the	  global	  population	  and	  kills	  half	  a	  million	  people	  each	  year5,	  thus	  molding	  their	  reputation	  as	  ubiquitous	  and	  household	  viruses.	  	  
The	  most	  effective	  means	  of	  combatting	  seasonal	  influenza	  is	  the	  use	  of	  vaccines,	  which	  are	  based	  on	  strain	  selection	  and	  is	  complicated	  by	  the	  virus’s	  fast	  evolutionary	  rate	  and	  ability	  to	  reassort,	  necessitating	  a	  vaccine	  update	  generally	  every	  two	  years.	  However,	  the	  biggest	  obstacle	   to	   effective	   vaccine	  design	   is	   simply	  our	   lack	  of	   knowledge	  of	   how	   the	   seasonal	  influenza	   spreads	   around	   the	   world.	   Currently	   the	   WHO	   offers	   only	   two	   vaccine	  formulations	   to	   represent	   the	   entire	   global	   diversity	   of	   the	   virus.	   What	   would	   be	   more	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optimal	  is	  if	  for	  a	  given	  region,	  we	  could	  predict	  the	  most	  likely	  source	  of	  viruses	  seeding	  into	  it.	  If	  we	  could	  accomplish	  this	  goal,	  then	  we	  could	  cater	  our	  vaccine	  design	  to	  localized	  regions.	  	  
	  
Figure	  2.	  Paradigmatic	  models	  for	  how	  seasonal	  influenza	  spreads	  around	  the	  world.	  	  There	  are	   several	   theories	   for	  how	   influenza	   spreads	   around	   the	  world	   (Figure	  2).	   Local	  persistence,	  for	  example,	  postulates	  that	  in	  a	  local	  region,	  viruses	  from	  one	  season	  persist	  through	   the	  period	  of	   the	  off-­‐season	  only	   to	  become	   the	  predominant	  viral	   strains	  of	   the	  next	   season.	   While	   there	   is	   evidence	   of	   a	   certain	   amount	   of	   viral	   diversity	   during	   the	  seasonal	   ebb,	  most	   phylogenetic	   analysis	   demonstrates	   that	   few	  viruses	   of	   a	   season	   in	   a	  local	  region	  are	  closely	  related	  to	  viruses	  of	  the	  previous	  season.	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Another	  theory	  is	  that	  of	  northern	  to	  southern	  hemispheric	  oscillations,	  which	  is	  what	  the	  WHO	  bases	  its	  current	  vaccine	  design	  on.	  At	  first	  blush,	  this	  theory	  makes	  intuitive	  sense	  due	   to	   the	   fact	   that	   northern	   and	   southern	   winters	   are	   offset	   from	   each	   other	   by	   six	  months.	  As	  a	  result,	  a	  possible	  scenario	  might	  involve	  predominant	  viruses	  of	  the	  northern	  seasonal	   peak	   seeding	   into	   the	   southern	   seasonal	   ebb,	   and	   vice	   versa.	   A	   theory	   that	   is	  gaining	  even	  more	  popularity,	  however,	   is	   the	   idea	   that	  a	   reservoir	  of	   seasonal	   influenza	  exists	   within	   the	   tropics.	   Certain	   epidemiological	   characteristics	   make	   this	   plausible.	   In	  particular,	   influenza	   infection	   in	   the	   tropics	  exists	  at	  a	   low	  constant	   level	   throughout	   the	  year	  in	  stark	  contrast	  to	  the	  seasonal	  peaks	  of	  the	  temperate	  zones.	  Yet,	  the	  tropics	  share	  the	  same	  annual	  burden	  of	   infection	  as	   the	   temperate	  zones,	  creating	  a	  possible	  scenario	  where	  new	  seasonal	   variants	   are	   created	  within	   the	   tropical	   reservoir	   and	   spread	   to	   the	  rest	  of	  the	  world.	  One	  particular	  study	  conducted	  in	  Brazil	  noted	  that	  hospitalizations	  due	  to	  influenza	  appeared	  to	  occur	  in	  a	  traveling	  wave	  from	  the	  north	  in	  the	  tropics	  downward	  to	  the	  south	  each	  season	  6.	  A	  more	  recent	  theory	  based	  on	  antigenic	  assays	  conducted	  by	  Russell,	  et	  al.	  5	  asserts	  that	  an	  influenza	  epicenter	  exists	  in	  E-­‐SE	  Asia.	  They	  found	  that	  viral	  strains	  most	  closely	  related	  to	  a	  reference	  viral	  strain	  in	  the	  past	  tended	  to	  appear	  first	  in	  Asian	   countries	   and	   last	   in	   South	   American	   countries	   each	   year.	   In	   reality,	   influenza	  dynamics	  is	  most	  likely	  the	  result	  of	  a	  mixture	  of	  all	  of	  these	  paradigms.	  	  
A	  problem	  that	   is	  common	  to	  a	   lot	  of	  these	  studies	  on	  the	  seasonal	   influenza	  dynamics	   is	  that	  they	  do	  not	  properly	  take	  into	  account	  sampling	  bias.	  Most	  of	  these	  studies	  draw	  their	  data	   from	   public	   databases	   of	   viral	   sequences,	   collected	   by	   such	   organizations	   as	   NCBI,	  GISAID,	  WHO,	   and	   USAID	   as	   part	   of	   a	   global	   effort	   towards	   the	   genomic	   surveillance	   of	  influenza.	   The	   collection	   of	   viral	   isolates	   is	   far	   from	  uniform	   among	  different	   places	   and	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seasons,	   and	   if	   these	   discrepancies	   are	   not	   properly	   accounted	   for,	   they	   can	   confound	  evolutionary	   analysis.	   In	   addition,	   genomic	   surveillance	   through	   sequencing	   is	   growing	  rapidly	   as	   a	   warning	   system	   against	   emerging	   infectious	   diseases	   that	   have	   pandemic	  potential,	   like	   avian	   H5N1	   or	   H7N9.	   Such	   systems	   would	   depend	   on	   identifying	   host-­‐determinant	   markers	   that	   could	   herald	   a	   zoonotic	   jump	   into	   human	   hosts.	   Pandemic	  influenza	  will	  be	  addressed	  in	  more	  depth	  in	  the	  next	  chapter.	  	  
It	   is	   therefore	   imperative	   to	   identify	   the	   source	   of	   data	   bias	   and	   to	   quantify	   genomic	  surveillance.	  One	  might	   think	   that	  a	  natural	  measure	   is	   simply	   the	  number	  of	   sequences.	  However,	   this	  measure	  of	  surveillance	   is	  rudimentary,	  since	   it	  does	  not	   take	   into	  account	  either	   the	   timing	   of	   isolate	   collection	   or	   the	   biodiversity	   of	   the	   viral	   population.	   For	  example,	   one	   could	   imagine	   that	   a	  highly	  homogenous	  population	  of	   viruses	  would	  need	  few	  sequences	  to	  represent	  its	  low	  diversity,	  and	  vice	  versa.	  	  
To	   address	   these	   issues,	   we	   can	   consider	   a	   particular	   schema	   for	   quantifying	   genomic	  surveillance.	   We	   can	   imagine	   that	   influenza	   viruses	   traverse	   a	   hypothetical	   mutational	  landscape	  assuming	  a	  constant	  evolutionary	  rate.	  These	  viruses	  are	  represented	  in	  Figure	  3	  as	  small	  nodes	  or	  circles.	  However,	  we	  do	  not	  observe	  all	  these	  viruses.	  Instead,	  we	  observe	  a	  sample	  of	  these	  viruses	  colored	  in	  red.	  We	  would	  expect	  surveillance	  to	  be	  adequate	  if	  a	  large	   proportion	   of	   sampled	   viruses	  would	   have	   a	   closest	   ancestor	   in	   the	   sample	  within	  some	  threshold	  of	  genetic	  distance	  R,	  as	  represented	  by	  the	  orange	  dome.	  In	  Figure	  3	  for	  example,	  we	  can	  see	  that	  the	  current	  sampled	  virus	  in	  cyan	  has	  a	  closest	  ancestor	  colored	  in	  red	  falling	  within	  the	  orange	  dome.	  We	  encapsulate	  this	  idea	  with	  q2-­‐coefficient,	  a	  new	  measure	   of	   genomic	   surveillance	   given	   a	   set	   of	   viral	   sequences	   with	   known	   time	   of	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collection.	   In	   short,	   the	   q2-­‐coefficient	   is	   the	   proportion	   of	   viruses	   that	   have	   a	   closest	  sampled	  ancestral	   virus	  within	   genetic	  distance	  R.	  We	  define	  R	   to	  be	  μ*t,	  where	  μ	   is	   the	  evolutionary	   rate,	   and	   time	   t	   is	   set	   to	   two,	   the	   median	   time	   for	   updating	   the	   influenza	  vaccine.	  With	  this	  measure,	  we	  can	  track	  how	  surveillance	  of	  different	  viral	  strains	  changes	  over	  time,	  as	  well	  as	  which	  regions	  are	  deficient	   in	  the	  sampling	  of	  the	  virus.	   I	  will	  detail	  the	  method	  of	   q2-­‐coefficient	   in	  more	  depth	   in	   the	   first	   part	   to	   this	   chapter,	   "Quantifying	  Pathogen	  Surveillance	  Using	  Temporal	  Genomic	  Data,”	  published	  in	  mBio	   journal.	  We	  will	  see	  that	  although	  some	  viral	  strains	  are	  well	  sampled,	  other	  strains	  from	  particular	  hosts	  or	  geographic	   regions	   are	   not.	   Such	   gaps	   in	   surveillance	   can	   overlook	   potential	   emerging	  pathogens.	  	  
	  
Figure	  3.	  Measuring	  pathogen	   surveillance.	  A)	  An	  ancestral	  pathogen	   (maroon	  node)	   traverses	   the	  mutational	  
landscape	  by	  mutating	  into	  its	  descendants	  with	  an	  average	  rate	  of	  μ.	  This	  process	  can	  be	  discretized	  as	  
transmission	  (green	  arrow)	  between	  hosts.	  Each	  host	  harbors	  a	  dominant	  viral	  genotype	  (nodes)	  that	  can	  be	  
sampled	  and	  sequenced	  (red	  nodes)	  by	  the	  surveillance	  network.	  To	  quantify	  the	  effectiveness	  of	  surveillance,	  
we	  first	  define	  the	  R-­‐threshold	  as	  the	  expected	  proportion	  of	  mutations	  that	  have	  accumulated	  over	  two	  years.	  
We	  assume	  that	  in	  a	  sufficiently	  sampled	  viral	  population,	  the	  closest	  ancestor	  of	  each	  virus	  should	  be	  within	  an	  
editing	  distance	  of	  R	  (yellow-­‐orange	  sphere).	  B)	  We	  can	  define	  the	  q2-­‐coefficient	  as	  the	  proportion	  of	  all	  sampled	  
pathogens	  with	  a	  closest	  ancestor	  of	  less	  than	  R	  Hamming	  distance.	  	  
Given	  the	  identification	  of	  data	  bias	  with	  q2-­‐coefficient,	  it	  would	  be	  instructive	  to	  develop	  a	  computational	   tool	   that	   accounts	   for	   these	   biases	   to	   elucidate	   how	   seasonal	   influenza	  spreads	   around	   the	   world.	   Towards	   this	   end,	   I	   designed	   a	   novel	   methodology	   called	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FluGraph	   that	   counters	   sampling	   bias	   by	   spatiotemporally	   clustering	   sequences	   and	  modeling	  transmission	  as	  a	  binomial	  or	  multinomial	  process.	  It	  then	  constructs	  a	  network	  that	   represents	   the	   seeding	   pattern	   of	   seasonal	   influenza	   between	   different	   parts	   of	   the	  world	  each	  year.	  In	  particular,	  FluGraph	  can	  predict	  the	  most	  likely	  source	  of	  the	  dominant	  influenza	   strain	   in	   a	   given	   region.	   The	   resulting	   network	   can	   describe	   transmission	  between	   different	   countries	   at	   a	   resolution	   not	   assessed	   by	   prior	   studies.	   Analyzing	   the	  network	  topology	  can	  dissect	  the	  dynamics	  of	  influenza	  movement	  in	  the	  world.	  We	  show	  that	  while	  local	  persistence	  does	  not	  play	  a	  large	  role	  in	  the	  spread	  of	  flu,	  there	  does	  exist	  a	  continuous	  circulation	  of	  virus	  across	  tropical	  and	  Asian	  countries.	  We	  also	  show	  that	  new	  seasonal	   variants	   originate	   in	   the	   tropics	   and	   in	   SE	   Asia,	   but	   that	   these	   two	   theoretical	  reservoirs	   are	   potentially	   independent	   of	   each	   other.	   This	   work	   also	   offers	   different	  strategies	  for	  vaccine	  implementation.	  One	  might	  consider	  increasing	  vaccines	  in	  areas	  like	  the	   tropics	   and	   E-­‐SE	   Asia,	   where	   new	   seasonal	   variants	   begin.	   Alternatively,	   one	   could	  increase	   vaccines	   in	   regions	   of	   high	   eigenvector	   centrality,	   hubs	   that	   heavily	   seed	   other	  hubs.	  Or	  one	  could	  increase	  vaccines	  in	  areas	  of	  high	  betweenness,	  where	  viral	  flow	  to	  the	  rest	   of	   the	   world	   would	   be	   disrupted	   maximally.	   Finally,	   one	   could	   harness	   the	   high-­‐resolution	  network	  of	  transmission	  between	  countries	  to	  design	  localized	  vaccines,	  rather	  than	  depending	  on	  only	  two	  Northern	  and	  Southern	  Hemispheric	  vaccine	  formulations	  to	  represent	  the	  entire	  global	  diversity	  of	  influenza.	  I	  will	  detail	  the	  methodology	  of	  FluGraph	  in	  the	  second	  part	  of	  this	  chapter,	  “Network	  Analysis	  of	  Global	  Influenza	  Spread,”	  published	  in	  PLoS	  Computational	  Biology.	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Section	  1.2:	  Quantifying	  Pathogen	  Surveillance	  
Using	  Temporal	  Genomic	  Data	  
	  
Summary	  
With	  the	  advent	  of	  deep	  sequencing,	  genomic	  surveillance	  has	  become	  a	  popular	  method	  for	  detection	  of	   infectious	  disease,	  supplementing	   information	  gathered	  by	  classic	  clinical	  or	   serological	   techniques	   to	   identify	   host-­‐determinant	   markers	   and	   trace	   origin	   of	  transmission.	  However,	  two	  main	  factors	  complicate	  genomic	  surveillance.	  First,	  pathogens	  exhibiting	   high	   genetic	   diversity	   demand	   higher	   levels	   of	   scrutiny	   to	   obtain	   an	   accurate	  representation	   of	   the	   entire	   population.	   Second,	   current	   systems	   of	   detection	   are	   non-­‐uniform,	   with	   significant	   gaps	   in	   certain	   geographic	   locations	   and	   animal	   reservoirs.	  Despite	  past	  unforeseen	  pandemics	  like	  the	  2009	  swine-­‐origin	  H1N1	  influenza,	  there	  is	  no	  standardized	  way	  of	  evaluating	  surveillance.	  A	  more	  complete	  surveillance	  system	  should	  capture	  a	  greater	  proportion	  of	  pathogen	  diversity.	  Here	  we	  present	  a	  novel	  quantitative	  method	   of	   assessing	   completeness	   of	   genomic	   surveillance	   that	   incorporates	   time	   of	  sequence	   collection,	   as	   well	   as	   the	   pathogen’s	   evolutionary	   rate.	   We	   propose	   the	   q2-­‐coefficient,	  which	  measures	  the	  proportion	  of	  sequenced	  isolates	  whose	  closest	  neighbor	  in	  the	   past	   is	   within	   a	   genetic	   distance	   equivalent	   to	   two	   years	   of	   evolution,	   roughly	   the	  median	  time	  of	  changing	  strain	  selection	  for	  influenza	  A	  vaccines.	  Easily	  interpretable	  and	  significantly	  faster	  than	  other	  methods,	  q2	  requires	  no	  full	  phylogenetic	  characterization	  or	  use	  of	  arbitrary	  clade	  definitions.	  Application	  of	  q2	  to	  influenza	  A	  confirmed	  poor	  sampling	  in	   swine	   and	   avian,	   as	   well	   as	   identified	   regions	   with	   deficient	   surveillance.	   We	  demonstrate	   that	   q2	   can	   be	   applied	   not	   only	   to	   other	   pathogens,	   including	   dengue	   and	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West	   Nile	   virus,	   but	   also	   to	   describe	   surveillance	   dynamics,	   particularly	   the	   effects	   of	  different	  public	  health	  policies.	  	  
Introduction	  Despite	  many	  therapeutic	  and	  epidemiological	  advances,	  infectious	  diseases—the	  number	  one	   cause	   of	   mortality	   in	   children—remain	   directly	   responsible	   for	   roughly	   15	   million	  (>25%)	  of	  annual	  deaths	  worldwide7.	  Of	  particular	  concern	  are	  emerging	   infections	  (EIs)	  that	   include	   novel	   entities,	   like	   HIV/AIDS	   and	   SARS,	   and	   previously	   existing	   but	   rapidly	  spreading	   diseases,	   like	   cholera	   and	   the	   plague8,9.	   Zoonosis	   is	   a	   rich	   source	   for	   such	   EI	  transmission	  into	  human	  hosts10,	  suggesting	  that	  pathogen	  surveillance	  in	  animals,	  as	  well	  as	   humans,	   is	   an	   important	   method	   for	   early	   detection	   of	   potential	   outbreaks	   and	   for	  capturing	  the	  entire	  biodiversity	  of	  a	  pathogen	  population	  at	  any	  given	  place	  and	  time.	  	  
Clinical,	  serologic,	  and	  genomic	  surveillance	  systems	  serve	  as	  invaluable	  tools	  for	  detecting	  early	   outbreaks,	   determining	   the	   genetic	   variation	   of	   a	   population,	   improving	   vaccine	  design,	   and	   evading	   antibiotic	   resistance.	   In	   the	   case	   of	   influenza	   A,	   coordinated	   global	  efforts	   like	   the	   World	   Health	   Organization	   (WHO)	   identify	   cases	   of	   influenza-­‐like	  symptoms,	   conduct	   serology	   studies,	   and	   sequence	   viral	   isolates11.	   Despite	   such	   efforts,	  there	  remain	  areas	  of	  sparse	  data,	  particularly	  in	  potential	  tropical	  influenza	  hotspots	  like	  India,	   Africa,	   or	   South	   America.	   Such	   sampling	   bias	   in	   strain	   selection	   can	   skew	   the	  predicted	  dominant	  virus	  used	  in	  annual	  vaccine	  design12,13.	  	  
Similarly,	   influenza	   surveillance	   has	   historically	   centered	   on	   human	   cases	   but	   ignored	  animal	  hosts,	  despite	  the	  importance	  of	  zoonosis	  in	  influenza	  transmission.	  One	  particular	  animal	  host	  that	  deserves	  special	  attention	  is	  poultry,	  which	  has	  played	  a	  crucial	  role	  in	  the	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transmission	   of	   highly	   pathogenic	   avian	   influenza	   (HPAI)	   H5N1	   into	   humans.	   First	  reported	  in	  Hong	  Kong	  in	  1997	  and	  2003,	  this	  virus	  has	  spread	  quickly	  from	  waterfowl	  to	  chickens,	  crows,	  pigeons	  and	  other	  birds	  in	  Europe,	  Africa,	  and	  particularly	  Asia,	  leading	  to	  the	   death	   by	   infection	   and	   forced	   culling	   of	   millions	   of	   birds,	   resulting	   in	   appreciable	  economic	   losses14.	   Concurrently,	   sporadic	   infections	   among	   humans	   and	   other	  mammals	  have	   claimed	  as	   of	   January	  2012	  a	  high	   rate	   of	   340	  deaths	  out	   of	   578	   confirmed	  human	  infections	  since	  200315.	  	  
At	   present,	   no	   human-­‐to-­‐human	   transmission	   of	   HPAI	   has	   been	   documented.	   However,	  scientists	  have	  recently	  discovered	  the	  set	  of	  mutations	  that	  enable	  transmission	  of	  avian	  flu	  between	  ferrets15,	  the	  animal	  model	  most	  closely	  mimicking	  human	  pathogenesis	  due	  to	  shared	  host	  cellular	  receptors	  for	  viral	  attachment16.	  These	  developments,	  combined	  with	  the	  virus’s	  atypically	  high	  rate	  of	  mortality	  and	  apparent	  resistance	  to	  oseltamavir17,	  have	  raised	  worldwide	  concerns	  about	  whether	  our	  current	  avian	  flu	  surveillance	  is	  sufficient	  to	  identify	  wild	  strains	  that	  have	  the	  potential	  for	  mammalian	  adaptation.	  	  
Swine	  is	  another	  animal	  that	  demands	  adequate	  surveillance18.	  Researchers	  have	  observed	  that	  epithelial	  cells	  in	  pig	  trachea	  contain	  sialyloligosaccharides	  SAα2,3	  and	  SAα2,6,	  which	  are	   unique	   host	   determinants	   for	   birds	   and	   humans,	   respectively19.	   This	   feature	   confers	  tropism	   in	   pigs	   to	   both	   avian	   and	  human	   influenza	   viruses20,	   allowing	   swine	   to	   serve	   as	  mixing	   vessels	   for	   antigenic	   shift,	   in	  which	   different	   strains	   infecting	   the	   same	   host	   can	  reassort	   RNA	   segments	   to	   create	   a	   novel	   viral	   strain21.	   Such	   reassortments	   have	  engendered	  at	  least	  two	  major	  human	  pandemics	  in	  the	  20th	  century	  in	  1957	  and	  196822.	  The	   most	   recent	   2009	   pandemic	   of	   swine-­‐origin	   influenza	   (S-­‐OIV)	   in	   particular	   was	   a	  reassortant	  between	  a	  Eurasian	  and	  North	  American	  swine	  lineage,	  and	  although	  the	  virus	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most	   likely	  came	  from	  a	  pig,	  a	  definitive	  geographic	  origin	  has	  yet	   to	  be	  determined	  18,23.	  Interestingly,	   the	   closest	   ancestors	   of	   the	   2009	   pandemic	   virus	   were	   related	   to	   viruses	  isolated	  in	  swine	  more	  than	  a	  decade	  prior18,24,	  suggesting	  that	  relevant	  strains	  circulating	  in	  swine	  herds	  have	  escaped	  detection	  due	  to	  inadequate	  sampling23.	  	  
In	  response	  to	  the	  dearth	  of	  avian	  and	  swine	  isolates,	  invaluable	  programs	  like	  the	  Global	  Initiative	  on	  Sharing	  Avian	  Influenza	  Data	  and	  the	  PREDICT	  program	  sponsored	  by	  the	  U.S.	  Agency	   for	   International	   Development’s	   (USAID)	   Emerging	   Pandemic	   Threats	   were	  established	   to	   focus	  monitoring	   of	   circulating	   strains	   in	  wildlife	   as	  well	   as	   to	   collect	   and	  make	   public	   clinical,	   epidemiological,	   and	  molecular	   data	   for	   influenza25,26.	   Despite	   such	  initiatives,	   many	   countries	   with	   the	   greatest	   number	   of	   poultry	   or	   pig	   stock	   do	   not	  proportionately	  contribute	  avian	  and	  swine	  sequences	  to	  public	  repositories13.	  	  
Currently,	   there	   is	   no	   standard	   quantitative	   measurement	   for	   the	   appropriate	   level	   of	  genomic	  surveillance	  for	  a	  given	  pathogen.	  One	  immediate	  approach	  might	  be	  to	  consider	  the	   absolute	   number	   of	   sequenced	   isolates,	   but	   this	   method	   fails	   to	   account	   for	   the	  diversity	  and	  time	  information	  of	  the	  sampled	  population.	  A	  comparatively	  large	  number	  of	  sequences	  may	  be	   insufficient	   to	  capture	  high	  genetic	  diversity	   in	  a	  pathogen	  population.	  Another	  possible	   strategy	  appeals	   to	   clustering	   techniques.	  After	   representing	   sequences	  as	   points	   in	   a	   mutational	   landscape,	   highly	   clustered	   structure	   could	   potentially	   reflect	  highly	  biased	   sampling.	  Once	   again,	   this	  method	   ignores	   time	  and	   can	  be	   confounded	  by	  evolutionary	   processes	   like	   bottlenecks.	   A	   final	   tactic	   might	   be	   to	   measure	   the	   genetic	  diversity	  within	  a	  sample	  of	  the	  pathogen.	  Phylogenetic	  reconstruction	  and	  tallying	  species	  richness	  is	  one	  method	  that	  characterized	  the	  subclades	  of	  avian	  H5N114,	  but	  such	  analyses	  are	   cumbersome	   with	   arbitrary	   boundaries	   for	   classifying	   clades.	   Techniques	   more	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grounded	  in	  information	  theory	  include	  Shannon’s	  entropy	  and	  Rao’s	  quadratic	  entropy27,	  but	  high	  diversity	  in	  a	  sample	  does	  not	  necessarily	  correlate	  with	  high	  surveillance	  either.	  	  	  
In	   this	   paper,	   we	   propose	   a	   readily	   interpretable	   and	   computable	   quantitative	  measurement	   for	   genomic	   surveillance	   of	   a	   pathogen	   that	   directly	   accounts	   for	   both	   the	  number	  of	   isolates,	   the	  evolutionary	  rate,	  and	  time	  of	  sample	  collection	  without	  the	  need	  for	  defining	  arbitrary	  clades	  or	  species	  or	  a	  full	  phylogenetic	  reconstruction.	  This	  measure	  ranks	  a	  surveillance	  system	  as	  more	  complete	  if	  it	  is	  able	  to	  capture	  a	  greater	  proportion	  of	  the	   pathogen	   diversity.	  We	   apply	   this	  measure	   to	   influenza	   and	   compare	   surveillance	   of	  different	   flu	   strains	   in	  different	  hosts	   and	  geographic	   regions.	  We	   find	   that,	   compared	   to	  human	  seasonal	  strains,	  sampling	  is	  indeed	  substantially	  lower	  for	  swine	  H1N1	  and	  avian	  non-­‐H5N1,	   historically	   overlooked	   strains	  despite	   their	   pandemic	  potential.	  We	   also	   find	  that	   avian	  H5N1	  surveillance	   in	   the	  WHO	   transmission	   zones	  of	  N-­‐W	  Africa,	  E-­‐SE-­‐S	  Asia,	  and	  E-­‐SW-­‐N	  Europe	  is	  high	  and	  may	  potentially	  serve	  as	  an	  effective	  early	  warning	  system	  given	  a	  list	  of	  genetic	  determinants	  for	  mammalian	  adaptation.	  Avian	  H5N1	  surveillance	  in	  North	  America,	  however,	  is	  much	  less	  comprehensive.	  We	  similarly	  apply	  our	  methodology	  to	  other	  RNA	  viruses	  and	  show	  inadequate	  surveillance	  in	  both	  dengue	  and	  West	  Nile	  virus.	  	  Finally,	   we	   perform	   a	   comparative	   analysis	   between	   q2-­‐coefficient	   and	   other	   methods,	  particularly	   phylogenetic	   and	   clustering	   alternatives,	   and	   find	   that	   q2	   produces	   similar	  results	  with	  negligible	  computation	  time.	  	  
Results	  
Measurement	  of	  surveillance:	  the	  q2-­‐coefficient	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We	   propose	   a	   quantitative	   measure	   of	   pathogen	   surveillance	   that	   reflects	   both	   the	  evolutionary	   rate	   and	   the	   biodiversity	   of	   a	   given	   population.	   For	   each	   host	   and	   subtype,	  sequences	   were	   first	   temporally	   ordered	   from	   oldest	   to	   newest	   sequence.	   For	   each	  sequence,	   we	   identified	   the	   sequence	   from	   the	   past	   with	   the	   highest	   homology	   and	  recorded	   its	   genetic	   distance,	   such	   that	   for	   N	   sequences,	   we	   compiled	   a	   vector	   of	   N	  distances.	   We	   defined	   the	   surveillance	   measurement	   q2-­‐coefficient,	   a	   measurement	  between	  0	  and	  1,	   to	  be	  the	  proportion	  of	  sequences	  within	  R	  genetic	  distance	  away	  from	  their	  most	  related	  ancestor	  in	  the	  past.	  	  	  
𝑞2 =   𝐺𝑒𝑛𝑒𝑡𝑖𝑐  𝐷𝑖𝑠𝑡𝑎𝑛𝑐𝑒 < 𝑅𝑁 	  Given	   a	   viral	   evolutionary	   rate	   μ	   substitutions/site/year,	   R	   =	   t*μ	   is	   thus	   the	   expected	  proportion	  of	  mutations	  that	  have	  accumulated	  over	  the	  span	  of	  t	  years.	  In	  this	  manuscript,	  we	  examine	   short	   time	  periods	  on	   the	  order	  of	   a	  decade,	   and	  do	  not	   expect	   true	  genetic	  distance	   to	  diverge	  greatly	   from	  Hamming	  distance.	  However,	  we	  calculate	  q2-­‐coefficient	  using	  a	  number	  of	  distance	  methods,	   including	  Hamming	  distance,	   Jukes-­‐Cantor,	  Kimura,	  Tamura,	   Tajima-­‐Nei,	   Hasegawa,	   and	   Nei-­‐Tamura,	   and	   find	   little	   significant	   change	   (see	  Results).	   We	   show	   results	   based	   on	   Hamming	   and	   Nei-­‐Tamura	   in	   Appendix	   B.	   If	  surveillance	  of	  a	  pathogen	  in	  a	  given	  time	  and	  place	  is	  sufficient,	  we	  would	  therefore	  expect	  a	  maximal	  number	  of	  viral	  isolates	  to	  have	  a	  closest	  ancestor	  in	  the	  sequence	  database	  with	  a	  sequence	  identity	  greater	  than	  1-­‐R.	  For	  the	  q	  coefficient,	  we	  choose	  to	  use	  t=2	  years	  since	  antigenic	   variant	   strains	   of	   influenza	   emerge	   and	   become	   predominant	   over	   a	   period	   of	  roughly	   2-­‐5	   years28;	   however,	   any	   value	   of	   t	   can	   be	   used.	   One	   consideration	   is	   that	  substitution	   rates	   can	   vary	   over	   time	   and	   across	   different	   lineages.	   To	   incorporate	   such	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variability	   into	   our	   calculation	   of	   q2,	   we	   used	   the	   95%	   highest	   posterior	   density	   (HPD)	  interval	  of	  evolutionary	  rate	  collected	  from	  literature	  (Table	  1)29-­‐31.	  	  	  
Table	  1.	  Evolutionary	  rates	  of	  viral	  genes	  used	  for	  the	  calculation	  of	  q2-­‐coefficient.	  95%	  HPD	  intervals	  are	  also	  
provided.	  
Viral	  Gene	   Evolutionary	  Rate	   Source	  Influenza	  PB2	   3.78E-­‐3	  (3.4E-­‐3-­‐4.17E-­‐3)	   Rambaut,	  et	  al.	  Nature	  (2008).	  Influenza	  PB1	   4.58E-­‐3	  (4.11E-­‐3-­‐5.06E-­‐3)	   Rambaut,	  et	  al.	  Nature	  (2008).	  Influenza	  PA	   4.45E-­‐3	  (3.96E-­‐3-­‐4.9E-­‐3)	   Rambaut,	  et	  al.	  Nature	  (2008).	  Influenza	  HA	   5.72E-­‐3	  (5.17E-­‐3-­‐6.28E-­‐3)	   Rambaut,	  et	  al.	  Nature	  (2008).	  Influenza	  NP	   4.55E-­‐3	  (3.98E-­‐3-­‐5.04E-­‐3)	   Rambaut,	  et	  al.	  Nature	  (2008).	  Influenza	  NA	   5.41E-­‐3	  (4.81E-­‐3-­‐5.99E-­‐3)	   Rambaut,	  et	  al.	  Nature	  (2008).	  Influenza	  M1	   5.2E-­‐3	  (4.36E-­‐3-­‐6.07E-­‐3)	   Rambaut,	  et	  al.	  Nature	  (2008).	  Influenza	  NS1	   5.39E-­‐3	  (4.48E-­‐3-­‐6.35E-­‐3)	   Rambaut,	  et	  al.	  Nature	  (2008).	  Dengue	  ENV	   8.7E-­‐4	  (7.7E-­‐4-­‐9.7E-­‐4)	   Araujo,	  et	  al.	  Infect	  Genet	  Evol	  (2009).	  WNV	  ENV	   0.85E-­‐3	  (0.66E-­‐3-­‐1.06E-­‐3)	   Bertolotti,	  et	  al.	  Virology	  (2007).	  	  
A	   major	   motivation	   behind	   the	   q2-­‐coefficient	   is	   the	   ability	   to	   evaluate	   surveillance	   for	  different	  strains,	  hosts,	  and	  geographic	  regions.	  Sampling	  during	  variable	  windows	  of	  time,	  however,	  can	  compromise	  an	  appropriate	  comparison.	  For	  example,	  a	  high	  q2	  derived	  from	  a	   local	   weeklong	   outbreak	   should	   not	   be	   extrapolated	   to	   surveillance	   during	   an	   entire	  season.	   For	   any	   comparisons	   of	   surveillance	   over	   a	   span	   of	   years,	   we	   therefore	   exclude	  from	  analysis	  any	  groups	  not	  sampled	  for	  more	  than	  a	  month.	  
	  
Influenza	  surveillance	  
Complete	   coding	   sequences	   of	   hemagglutinin	   (HA),	   the	   major	   antigenic	   segment	   of	  influenza,	   were	   collected	   from	   NCBI	   and	   GISAID	   databases	   and	   multiply	   aligned.	   To	  compare	   the	   level	   of	   surveillance	   between	   different	   strains,	   we	   considered	   separately	  sequences	   for	   humans	   (H3N2,	   seasonal	   H1N1	   pre-­‐2009,	   S-­‐OIV	   H1N1	   post-­‐2009,	   and	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H5N1),	   avian	   (H5N1	   and	   non-­‐H5N1),	   and	   swine	   H1N1.	   Figure	   4A-­‐B	   depict	   the	   absolute	  number	  of	  sequences	  isolated	  across	  time	  as	  a	  first	  measure	  of	  surveillance.	  However,	  we	  wanted	  a	  measure	  of	  surveillance	  that	  would	  take	  into	  account	  the	  evolutionary	  rate	  of	  the	  virus	  as	  well	  as	  the	  biodiversity	  of	  the	  viral	  pool.	  Calculation	  of	  Shannon’s	  entropy	  in	  Figure	  
4C	  is	  an	  effective	  measure	  of	  genetic	  diversity	  but,	  by	  itself,	  is	  no	  measure	  of	  surveillance.	  	  
	  
	  
Figure	  4.	  Surveillance	  of	  Influenza	  A.	  A)	  Number	  of	  human	  H3N2	  and	  H1N1	  sequences	  over	  time.	  B)	  Number	  of	  
H5N1	  and	  swine	  H1N1pdm	  sequences	  over	  time.	  C)	  Measurement	  of	  influenza	  A	  genetic	  diversity	  by	  entropy.	  D)	  
Measurement	  of	  influenza	  A	  surveillance	  by	  q2-­‐coefficient	  over	  time.	  The	  width	  of	  each	  plotted	  line	  denotes	  the	  
interval	  of	  q2	  based	  on	  the	  95%	  HPD	  of	  evolutionary	  rate.	  N	  =	  7,083	  H3N2	  human	  (dark	  blue),	  2,567	  H1N1	  human	  
(blue),	  11,626	  H1N1pdm	  human	  (cyan),	  878	  H1N1	  swine	  (green),	  1,193	  H5N1	  avian	  (yellow),	  158	  H5N1	  human	  
(orange),	  and	  3,418	  non-­‐H5N1	  avian	  (red)	  sequences.	  
	  Towards	   a	  measure	   that	   synthesizes	   both	   absolute	   number	   of	   isolates	   and	   evolutionary	  rate,	  we	  calculated	  the	  q2-­‐coefficient	  as	  a	  function	  of	  time	  for	  each	  influenza	  strain	  in	  Figure	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4D	  as	  a	  representation	  of	  surveillance	  history.	  We	  also	  tabulated	  their	  final	  q2-­‐coefficients	  in	   Supplementary	  Table	  B-­‐1	   and	  Supplementary	  Table	  B-­‐2	   and	  mapped	   these	  values	  per	  WHO	  transmission	  zone32	  in	  Figure	  5	  and	  Supplementary	  Figure	  A-­‐2	  to	  denote	  the	  present	  state	   of	   surveillance	   around	   the	   world.	   We	   showed	   that	   our	   q2	   calculations	   did	   not	  drastically	  change	  for	  different	  genetic	  distances	  (<0.035	  difference	  in	  q2).	  
	  
	  
Figure	  5.	  Global	  map	  of	  influenza	  A	  surveillance	  by	  transmission	  zone	  in	  animal	  hosts.	  Depicted	  strains	  include	  A)	  
swine	  H1N1	  and	  B)	   avian	  non-­‐H5N1.	  Each	   zone	   is	   colored	  on	   the	   spectrum	   from	  blue	   to	   red	  by	  q2-­‐coefficient.	  
Gray	  areas	  denote	  regions	  with	  viruses	  isolated	  over	  the	  span	  of	  no	  more	  than	  one	  month.	  Analysis	  of	  each	  strain	  reflects	  a	  different	  state	  of	  geographic	  and	  host	  surveillance.	  Overall,	  surveillance	  for	  human	  seasonal	  strains	  was	  high;	  q2	  values	  for	  both	  human	  seasonal	  H3N2	  and	   seasonal	   H1N1	   viruses,	   which	   had	   been	   sampled	   and	   sequenced	   long	   before	   2003,	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approached	   one	   from	   2003	   to	   present	   (Figure	   4D).	   Clustering	   sequences	   by	   transmission	  zone	  began	  to	  uncover	  weakness	  in	  surveillance	  for	  seasonal	  H3N2	  particularly	  in	  Central	  Asia	  (Supplementary	  Figure	  A-­‐1A,	  Supplementary	  Figure	  A-­‐2A).	  In	  addition	  to	  Central	  Asia,	  several	   parts	   of	   Europe,	   Western	   Asia,	   and	   especially	   Middle	   Africa	   yielded	   lower	   q2-­‐coefficients	  for	  seasonal	  H1N1	  (Supplementary	  Figure	  A-­‐1B,	  Supplementary	  Figure	  A-­‐2B).	  As	  a	  testament	  to	  the	  global	  response	  to	  the	  pandemic,	  human	  S-­‐OIV	  H1N1	  shot	  up	  to	  a	  q2	  of	   1	   shortly	   after	   its	   arrival	   in	   March	   2009	   in	   all	   transmission	   zones	   except	   Middle-­‐Southern	   Africa	   and	   Central	   Asia	   (Figure	   4D,	   Supplementary	   Figure	   A-­‐1C,	   Supplementary	  Figure	  A-­‐2C).	  
In	   contrast,	   despite	   a	   moderate	   increase	   in	   number	   of	   sequences	   following	   H1N1pdm’s	  arrival	   (Figure	   4B),	   the	   q2-­‐coefficient	   of	   classical	   H1N1	   swine	   isolates	   has	   lagged	   much	  further	   behind	   (Figure	   4D)	   and	   is	   consistently	   high	   only	   in	   Eastern	   Asian	   (q2	   =	   0.753,	  Hamming	   distance)	   and	   North	   American	   (q2	   =	   0.877,	   Hamming	   distance)	   transmission	  zones	  (Figure	  5A,	  Supplementary	  Figure	  A-­‐1D).	  These	  findings	  suggest	  that	  surveillance	  in	  pigs	  is	  still	  not	  enough	  to	  capture	  the	  high	  biodiversity	  of	  swine	  flu,	  as	  indicated	  by	  entropy	  (Figure	  4C).	  	  
Analysis	  of	  H5N1	  influenza	  describes	  the	  effects	  of	  implementing	  international	  sequencing	  initiatives	  like	  GISAID.	  Immediately	  following	  the	  second	  outbreak	  of	  HPAI	  among	  humans	  in	  2003,	  the	  q2-­‐coefficient	  of	  H5N1	  in	  both	  human	  and	  avian	  hosts	  rose	  to	  approximately	  0.7-­‐0.85.	   With	   the	   establishment	   of	   GISAID	   in	   2006,	   both	   human	   and	   avian	   H5N1	   q2-­‐coefficients	   increased	   further	   to	  high	   levels	  around	  0.9,	   affirming	   the	  effectiveness	  of	   the	  global	   consortium.	   Beyond	   2007	   however,	   surveillance	   in	   human	   H5N1	   has	   waned	  compared	  to	  avian	  H5N1	  (Figure	  4D).	  This	  discrepancy	  most	  likely	  draws	  from	  the	  fact	  that	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human	  HPAI	  cases	  represent	  a	  subsampling	  of	  avian	  H5N1	  genotypes,	  as	  reflected	  by	  the	  slight	  drop	  in	  human	  H5N1	  entropy	  compared	  to	  that	  in	  birds	  (Figure	  4C).	  
Within	   H5N1,	   there	   is	   biased	   sampling	   in	   different	   transmission	   zones.	   Following	  particularly	   large	   outbreaks,	   H5N1	   human	   surveillance	   is	   high	   with	   q2-­‐coefficients	   of	  roughly	  0.9	  in	  Northern	  Africa	  and	  E-­‐SE	  Asia.	  Over	  time,	  q2	  has	  decreased	  in	  E-­‐SE	  Asia	  most	  likely	   due	   to	   a	   decline	   in	   sporadic	   introductions	   into	   the	   local	   human	   populations	  compared	   to	   in	   North	   Africa,	   specifically	   Egypt	   (Supplementary	   Figure	   A-­‐1E,	  Supplementary	  Figure	  A-­‐2D).	  H5N1	  avian	  surveillance	   is	  high	   in	  N-­‐W	  Africa,	  E-­‐SE-­‐S	  Asia,	  and	  E-­‐SW-­‐N	  Europe.	  On	  the	  other	  hand,	  q2	  indicates	  less	  avian	  H5N1	  surveillance	  in	  North	  America.	  In	  the	  United	  States	  for	  example,	  only	  until	  2006	  has	  reporting	  and	  tracking	  of	  H5	  in	  birds	  been	  mandated	  by	  the	  USDA33.	  The	  smaller	  push	  for	  reporting	  stems	  from	  the	  low	  pathogenicity	  displayed	  by	  North	  American	  avian	  H5N1	  strains,	  which	  have	  antigenic	  and	  genetic	   differences	   from	   the	   Asian	   HPAI	   lineage	   (Supplementary	   Figure	   A-­‐1F,	  Supplementary	  Figure	  A-­‐2E)	  34.	  
These	  results	   indicate	  that	  H5N1	  surveillance	  in	  avian	  hosts	   is	  much	  more	  complete	  than	  H1N1	   in	   swine.	   However,	   potential	   zoonotic	   transmission	   is	   possible	   from	   other	   avian	  strains,	  as	  well.	  Performing	  the	  same	  analysis	  on	  non-­‐H5N1	  avian	  strains	  yielded	  a	  low	  q2-­‐coefficient	   beginning	   at	   0.5	   in	   2003	   and	   plateauing	   at	   a	   level	   just	   below	   0.7	   in	   spite	   of	  GISAID	  (Figure	  4D)	  and	  the	  resulting	  increase	  in	  sequenced	  isolates	  (Figure	  4B).	  This	  finding	  potentially	   reflects	   the	   extremely	   high	   genetic	   diversity	   of	   influenza	   A	   in	   its	   natural	  reservoir	   (Figure	   4C)	   that	   is	   not	   fully	   captured	   by	   current	   surveillance	   systems.	  Transmission	  zone	  analysis	  of	  non-­‐H5N1	  avian	  strains	  indicates	  non-­‐H5N1	  surveillance	  is	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concentrated	  in	  SW	  Europe,	  Central	  America-­‐Caribbean,	  North	  America,	  N	  Africa,	  and	  E-­‐SE	  Asia	  (Figure	  5B,	  Supplementary	  Figure	  A-­‐1G).	  	  
Calculation	   of	   q2	   for	   other	   complete	   coding	   segments	   of	   influenza	   was	   also	   performed.	  Since	   observed	   differences	   in	   sequences	   should	   reflect	   the	   evolutionary	   rates	   of	   each	  segment,	   any	   differences	   in	   q2	   should	   reflect	   differences	   in	   sampling	   alone.	   For	   H3N2,	  H1N1pdm,	   and	   seasonal	   H1N1,	   q2-­‐coefficient	   exhibited	   little	   change	   among	   different	  segments	   (<0.02	   difference	   in	   q2),	   and	   moderate	   change	   for	   other	   strains.	   The	   largest	  change	   in	   q2	   was	   0.186	   between	   swine	   H1N1	   HA	   and	   PB2.	   Despite	   such	   differences	  between	  segments,	  results	  showed	  that	  generally	  surveillance	  of	  human	  H3N2,	  H1N1pdm,	  and	  seasonal	  H1N1	  across	  all	  segments	  surpassed	  that	  of	  human	  H5N1,	  avian	  H5N1,	  swine	  H1N1,	  and	  avian	  non-­‐H5N1	  (Supplementary	  Table	  B-­‐1,	  Supplementary	  Table	  B-­‐2).	  	  
Dengue	  and	  West	  Nile	  virus	  surveillance	  
As	  a	  proof	  of	  concept,	  we	  have	  also	  shown	  that	  the	  q2-­‐coefficient	  can	  be	  used	  to	  monitor	  surveillance	  efforts	  for	  other	  RNA	  viruses,	  such	  as	  dengue	  virus	  and	  West	  Nile	  virus.	  Here,	  we	   focus	  on	   the	  ENV	  gene	  of	   these	  viruses,	   as	   it	   is	   the	   longest	  of	   the	   structural	  proteins,	  prevalently	   sequenced	   for	   subtyping,	   and	   has	   the	   most	   well-­‐documented	   evolutionary	  rates	  of	  all	  flavivirus	  proteins30,31,35,36.	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Figure	  6.	  Dengue	  virus	  surveillance	  by	  q2-­‐coefficient	  in	  different	  countries.	  Depicted	  strains	  include	  A)	  DENV-­‐1,	  
B)	  DENV-­‐2,	  and	  C)	  DENV-­‐3.	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Figure	  7.	  Global	  map	  of	  dengue	  virus	  surveillance	  in	  different	  countries.	  Depicted	  strains	  include	  A)	  DENV-­‐1,	  B)	  
DENV-­‐2,	   and	   C)	   DENV-­‐3.	   Each	   zone	   is	   colored	   on	   the	   spectrum	   from	   blue	   to	   red	   by	   q2-­‐coefficient.	   Gray	   areas	  
denote	  regions	  with	  viruses	  isolated	  over	  the	  span	  of	  no	  more	  than	  one	  month.	  Calculation	  of	  q2-­‐coefficient	   for	  dengue	   subtypes	  1,	  2,	   and	  3	  depicts	  poor	   surveillance	   in	  general	  (Figure	  6,	  Figure	  7,	  Supplementary	  Table	  B-­‐3).	  These	  sampling	  gaps	  may	  reflect	  the	  current	   limited	   funding	   and	   staff	   in	   many	   tropical	   countries	   around	   the	   world37.	  Incorporation	   of	   other	   genetic	   distances	   besides	   Hamming	   distance	   produced	   less	   than	  0.118	  change	  in	  q2	  for	  dengue.	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Figure	  8.	  West	  Nile	  virus	  surveillance	  by	  q2-­‐coefficient	  in	  the	  United	  States	  in	  mosquito	  and	  bird	  hosts.	  	  
The	  q2-­‐coefficient	  for	  West	  Nile	  virus	  in	  the	  United	  States,	  on	  the	  other	  hand,	  was	  higher	  in	  the	   first	   few	  years	   of	   its	   introduction	   to	   the	   States	   (Figure	   8,	   Supplementary	  Table	  B-­‐4).	  However,	   despite	   the	   implementation	   of	   early	   warning	   systems	   for	   West	   Nile	   virus,	   by	  sampling	   dead	   birds38	   and	   mosquito	   populations39,	   the	   q2-­‐coefficient	   beyond	   2003	  dropped	   over	   time	   even	  with	   the	   addition	   of	  multiple	   isolates	  within	   a	   short	  window	  of	  time.	  This	  decline	  in	  q2	  coincided	  with	  a	  rapid	  population	  growth	  of	  West	  Nile	  Virus	  in	  the	  United	  States	  during	  2002-­‐2003	  spurred	  by	  the	  establishment	  of	  the	  WN02	  strain	  marked	  by	  a	  V159A	  mutation	  in	  its	  E	  protein40.	  This	  analysis	  suggests	  that	  current	  surveillance	  is	  
	  	   26	  
being	   outpaced	   by	   the	   growing	   diversity	   of	   the	   virus	   in	   the	   New	   World.	   Other	   genetic	  distances	  besides	  Hamming	  distance	  produced	  less	  than	  0.094	  change	  in	  q2	  for	  WNV.	  	  
Comparison	  to	  phylogenetic	  methods	  
One	  may	  wonder	   if	   other	   alternative	  methods	   that	   account	   for	   pathogen	   evolution	  may	  suffice	  to	  characterize	  the	  genetic	  surveillance	  of	  a	  pathogen.	  Phylogenetics	  has	  been	  used	  in	  many	   studies	   to	   characterize	   pathogen	   surveillance	   qualitatively	  without	   producing	   a	  quantitative	  measure	  of	  sampling	  completeness41.	  A	  possible	  phylogenetic	  analogue	  to	  the	  q2-­‐coefficient	   might	   entail	   reconstructing	   a	   tree	   based	   on	   available	   sequences	   and	  measuring	  the	  distribution	  of	  branch	  lengths.	  The	  true	  distance	  between	  two	  isolates	  A	  and	  B	   is	   represented	  by	   the	   sum	  of	   their	   patristic	   distances	  dA	   and	  dB,	  which	   are	   the	  branch	  lengths	  from	  each	  respective	  sequence	  to	  their	  common	  ancestral	  node.	  Sequences	  are	  time	  ordered,	  however,	   and	   if	  we	  assume	  an	  approximate	  molecular	   clock,	   then	  dA	  <	  dB	  given	  that	   sequence	   A	   occurs	   before	   sequence	   B.	   An	   estimate	   for	   distance	   then	   is	   the	   larger	  patristic	   distance.	   A	   parallel	   to	   our	   q2-­‐coefficient	   would	   predict	   high	   surveillance	   to	  correspond	   to	   a	  maximal	   number	   of	   patristic	   distances	  d	   to	   their	   closest	   ancestor	   in	   the	  past	  less	  than	  two	  years:	  
𝑝2 =   #  𝑏𝑟𝑎𝑛𝑐ℎ  𝑙𝑒𝑛𝑔𝑡ℎ𝑠  𝑑 < 2  𝑦𝑒𝑎𝑟𝑠𝑇𝑜𝑡𝑎𝑙  #  𝑏𝑟𝑎𝑛𝑐ℎ  𝑙𝑒𝑛𝑔𝑡ℎ𝑠  𝑑 	  
Moreover,	   homogeneity	   of	   surveillance	   can	   be	   confirmed	   if	   branch	   lengths	   d	   have	   low	  variance.	  	  
Phylogenies	  can	  be	  divided	   into	   those	   that	  are	  distance-­‐based	  and	  character-­‐based.	  Since	  the	  q2-­‐coefficient	  readily	   incorporates	  different	  genetic	  distance	  methods,	   it	   is	  equivalent	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to	   any	  p2-­‐coefficient	   calculated	   from	  distance-­‐based	   trees.	  On	   the	  other	  hand,	   character-­‐based	   trees,	   including	  maximum	   likelihood	  and	  Bayesian	   inference	  methods,	   incorporate	  site	   heterogeneity	   by	   considering	   one	   character	   (a	   site	   in	   the	   alignment)	   at	   a	   time	   to	  reconstruct	  a	  tree42;	  moreover,	  Markov	  Chain	  Monte	  Carlo	  (MCMC)	  methods	  like	  BEAST43	  can	  incorporate	  relaxed	  clock	  rates.	  q2-­‐coefficient	  does	  not	  take	  into	  account	  either	  site	  or	  clock	  rate	  heterogeneity.	  	  
To	   determine	   the	   impact	   of	   site	   and	   rate	   heterogeneity	   in	   quantifying	   surveillance	  completeness,	   we	   calculated	   the	   p2-­‐coefficient	   for	   the	   human	   H5N1	   HA	   dataset	   of	   158	  sequences	   using	   BEAST	   (see	   Methods).	   We	   accounted	   for	   site	   heterogeneity	   using	   the	  gamma	  model44,	  and	  reconstructed	  trees	  under	  both	  a	  strict	  and	  relaxed	  molecular	  clock.	  We	   calculated	   the	   p2-­‐coefficient	   to	   be	   0.848	   (0.740-­‐0.917)	   and	   0.860	   (0.721-­‐0.911)	   for	  strict	   and	   relaxed	   clocks,	   respectively.	  Given	  our	  q2-­‐coefficent	  of	  0.821	   (0.795-­‐0.848)	   for	  human	   H5N1	   HA,	   we	   concluded	   that	   incorporating	   site	   heterogeneity	   and	   relaxed	  molecular	  clock	  did	  not	  make	  a	  significant	  difference.	  	  
While	   these	   phylogenetic	   techniques	   can	   examine	   the	   fit	   of	   a	   number	   of	   evolutionary	  models,	  they	  suffer	  from	  problems	  of	  robustness.	  For	  example,	  tree	  topology	  can	  be	  highly	  unstable;	   an	   addition	   or	   deletion	   of	   a	   single	   sequence	   can	   radically	   restructure	   the	   tree.	  Moreover,	   different	   methods	   of	   phylogenetic	   inference,	   such	   as	   maximum	   likelihood	   or	  Bayesian	   inference,	   can	   lead	   to	   variable	   results,	   rendering	   interpretation	   of	   surveillance	  complicated.	  Finally,	   computation	   time	  particularly	   for	  BEAST	  can	  be	  very	  expensive;	   for	  datasets	  of	  more	  than	  a	  thousand	  sequences,	  several	  weeks	  may	  be	  needed	  for	  the	  MCMC	  to	  converge	  to	  a	  stable	  tree	  solution.	  In	  our	  analysis	  of	  158	  human	  H5N1	  HA	  sequences,	  p2-­‐
	  	   28	  
coefficents	  needed	  days	  of	  computation	  to	  complete,	  whereas	  q2	  analysis	  was	  finished	  on	  the	  order	  of	  seconds.	  	  
Comparison	  to	  clustering	  methods	  
Another	  possible	  surveillance	  measurement	  characterizes	  the	  cluster	  structure	  of	  isolates.	  In	  an	  ideal	  situation,	  a	  well-­‐sampled	  population	  of	  sequences	  separated	  by	  genetic	  distance	  would	   be	   represented	   by	   points	   densely	   and	   homogenously	   spread	   across	   a	   continuum.	  Therefore,	   clustering	   techniques,	   such	   as	   hierarchical,	   k-­‐means,	   or	   expectation-­‐maximization	  clustering,	  can	  be	  used	  to	  ascertain	  how	  poorly	  sampled	  a	  pathogen	  is	  based	  on	   the	  number	  of	   clusters	   in	  a	  dataset.	  Barcoding	   is	  an	  alternative	   strategy	  based	  on	   the	  field	  of	  persistent	  homology	  that	  identifies	  topologically	  invariant	  clusters	  in	  cloud	  data;	  in	  particular,	  it	  calculates	  the	  b!	  Betti	  number:	  the	  number	  of	  connected	  components	  in	  a	  set	  of	   simplicial	   complexes	   constructed	   from	   sequences	   at	   different	   filtration	   Hamming	  distances	  (see	  Methods)	  45.	  A	  lower	  b0	  would	  indicate	  better	  sampling.	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Figure	  9.	  Persistence	  homology	  analysis	  of	  influenza.	  A)	  Barcoding	  plots	  for	  Betti	  number	  of	  dimension	  0	  (b0)	  for	  
each	  strain	  of	  influenza.	  b0,	  or	  the	  number	  of	  simplicial	  complexes,	  can	  be	  determined	  by	  counting	  the	  number	  of	  
bars	  present	  at	  each	  filtration	  Hamming	  distance.	  A	  smaller	  b0	  indicates	  better	  surveillance,	  though	  this	  number	  
may	   be	   higher	   in	   the	   setting	   of	   bottleneck	   effects.	   B)	   Comparison	   of	   persistence	   homology	   and	   q2-­‐coefficient	  
applied	  to	  influenza.	  The	  top	  bar	  plot	  displays	  b0	  at	  Hamming	  distance	  of	  17,	  roughly	  1%	  of	  the	  length	  of	  HA.	  The	  
bottom	  bar	  plot	  displays	  q2-­‐coefficient,	  with	  a	  threshold	  of	  two	  years	  of	  influenza	  evolution,	  or	  2*(5x10-­‐3)	  =	  1%.	  As	  a	  comparison	  to	  the	  q2-­‐coefficient,	  we	  applied	  barcoding	  to	  determine	  the	  b0	  of	  different	  influenza	  strains	  at	  filtration	  Hamming	  distance	  ε	  from	  0	  to	  200	  (Figure	  9A).	  This	  threshold	  
ε	   is	   analogous	   to	   the	  R	   threshold	   of	   the	   q2-­‐coefficient:	   	   two	   years	   of	   influenza	   evolution	  equivalent	   to	   2*(5x10-­‐3)	   =	   1%	   genetic	   distance.	  We	   therefore	   considered	   b0	  at	  Hamming	  distance	   of	   1%	   of	   the	   length	   of	   HA,	   or	   roughly	   17	   nucleotides,	   to	   be	   appropriate	   for	  comparison	  to	  q2	  (Figure	  9B).	  For	   the	  most	  part,	  q2	  and	  b0	  are	   inversely	  correlated.	  For	  example,	  the	  low	  b0	  and	  high	  q2	  for	  human	  H3N2,	  seasonal	  H1N1	  and	  H1N1pdm	  indicate	  good	  surveillance.	  Avian	  non-­‐H5N1	  has	  an	  extremely	  high	  b0	  and	  low	  q2.	  It	  should	  be	  noted	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that	  the	  avian	  non-­‐H5N1	  dataset	  contains	  15	  different	  HA	  subtypes,	  as	  opposed	  to	  all	   the	  other	  single-­‐subtype	  HA	  datasets	  considered.	  Thus,	  b0	  may	  need	   to	  be	  normalized	  by	   the	  expected	  number	  of	  HA	  subtypes.	  Nevertheless,	  avian	  non-­‐H5N1	  remains	  high	  for	  b0	  even	  with	   normalization.	   However,	   as	   with	   p2,	   calculating	   b0	  demands	   substantial	   computing	  power	  and	  time	  on	  the	  order	  of	  hours.	  
Comparison	  to	  diversity	  metrics	  
Other	  alternative	  methods	  may	  exist	  to	  gauge	  sampling	  bias.	  For	  instance,	  there	  are	  many	  diversity	  metrics	  in	  ecology,	  including	  Chao’s	  estimate	  of	  asymptotic	  species	  richness46,	  and	  in	  information	  theory	  techniques	  like	  Shannon’s	  entropy,	  which	  was	  applied	  in	  Figure	  4C.	  In	  particular,	   it	   is	   well	   known	   that	   the	   empirical	   Shannon’s	   entropy	   of	   a	   sample	  underestimates	  the	  entropy	  of	  the	  true	  distribution.	  Bootstrapping	  techniques	  can	  be	  used	  to	  estimate	  the	  bias	  produced	  from	  a	  low	  number	  of	  sequences.	  This	  method	  is	  attractive	  for	   its	   ability	   to	   measure	   surveillance	   by	   assaying	   the	   diversity	   of	   a	   pathogen	   directly.	  However,	   like	   the	  phylogenetic	  and	  barcoding	  methods	  considered,	   implementation	   for	  a	  large	  number	  of	  trials	  is	  substantially	  more	  difficult,	  computationally	  expensive,	  and	  time-­‐consuming.	  
Discussion	  In	  this	  paper,	  we	  offer	  a	  quantitative	  method	  for	  measuring	  the	  quality	  of	  surveillance	  for	  a	  particular	   pathogen	   that	   reflects	   its	   evolutionary	   rate	   and	   genetic	   diversity.	   The	   q2-­‐coefficient	  represents	  an	  easily	  interpretable	  quantitative	  measure	  of	  genomic	  surveillance	  that	  does	  not	  rely	  on	  a	  full	  phylogenetic	  reconstruction.	  A	  number	  between	  0	  and	  1,	  the	  q2-­‐coefficient	  reflects	  the	  fraction	  of	  isolates	  with	  a	  closest	  isolate	  in	  the	  past	  within	  two	  years	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of	  evolution.	  However,	  in	  its	  simplicity,	  the	  q2-­‐coefficient	  does	  not	  capture	  the	  complexity	  of	   evolutionary	   processes	   such	   as	   variable	   evolutionary	   rates,	   recombination,	  reassortment,	   and	   population	   genetic	   effects.	  We	   decided	   on	   q2	   instead	   of	   other	   equally	  valid	  metrics	  (q1,	  q5	  or	  q100)	  as	   two	  years	   in	   influenza	  A	  represents	   the	  median	  time	  of	  vaccine	   update.	   However,	   different	  metrics	  may	   be	   applicable	   depending	   on	   the	   specific	  aim	  of	  the	  surveillance	  program.	  
We	  applied	  this	  measure	  to	  multiple	  influenza	  strains	  and	  found	  that	  current	  surveillance	  is	   generally	   complete	   for	   humans,	   particularly	  H1N1pdm,	  H3N2	   and	   seasonal	  H1N1,	   but	  poor	   for	   other	   hosts,	   particularly	   swine.	   Indeed,	   the	   calculated	   q2-­‐coefficient	   of	   swine	  H1N1	   is	   most	   likely	   an	   overestimate	   considering	   that	   influenza	   evolves	   more	   slowly	   in	  swine	  than	  in	  humans	  due	  to	  a	  lesser	  degree	  of	  immune	  selection47.	  This	  finding	  reaffirms	  the	  need	  for	  increased	  surveillance	  in	  swine	  that	  can	  serve	  as	  mixing	  vessels	  for	  pandemic	  strain	  selection.	  
Compared	  to	  the	  cases	  of	  human	  H3N2	  and	  H1N1,	  human	  and	  avian	  H5N1	  surveillance	  is	  lower	  at	  q2	  of	  0.838	  and	  0.923	  respectively.	  Although	  these	  q2	  values	  are	  already	  high,	  the	  difference	   in	  q2	  may	   suggest	   that	   there	   are	   strains	   of	  H5N1	   circulating	   in	  bird	   and	   even	  possibly	   human	   hosts	   that	   remain	   undetected.	   Given	   the	   recent	   discovery	   of	   molecular	  determinants	   that	   enable	   ferret-­‐to-­‐ferret	   transmission	   of	   H5N115,	   it	   is	   all	   the	   more	  important	   to	   increase	  viral	   isolation	   to	  match	  or	  exceed	   the	  surveillance	   levels	  of	  human	  H3N2	  and	  H1N1.	  	  	  	  
In	  our	  analysis,	  we	  also	  noted	  geographic	  disparities;	  for	  H5N1	  avian,	  a	  preponderance	  of	  isolated	  viruses	  derived	  from	  N-­‐W	  Africa,	  E-­‐SE-­‐S	  Asia,	  and	  E-­‐SW-­‐N	  Europe.	  Although	  North	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America’s	  surveillance	  of	  non-­‐H5N1	  avian	  sequences	  is	  trending	  upwards,	  it	  is	  particularly	  deficient	   in	   sampling	   H5N1	   avian.	   Even	   though	   only	   LPAI	   has	   been	   discovered	   in	   North	  America,	   it	   is	   clear	   that	   current	   surveillance	   is	   not	   sufficient	   to	   capture	   the	   complete	  diversity	  of	  even	  this	  H5N1	  population.	  	  
One	  may	  wonder	  whether	  factors	  beyond	  the	  completeness	  of	  surveillance,	  such	  as	  natural	  selection,	  may	  influence	  the	  q2-­‐coefficient.	  For	  instance,	  bottlenecks	  and	  selective	  sweeps	  can	   reduce	   the	   diversity	   of	   a	   pathogen	   population,	   thus	   increasing	   the	   q2-­‐coefficient.	  However,	  it	  is	  important	  to	  note	  that	  in	  such	  cases,	  q2	  behaves	  appropriately,	  for	  it	  simply	  reflects	   surveillance	   completeness.	   If	   only	   a	   few	   sequences	   are	   enough	   to	   capture	   the	  reduced	  biodiversity	  following	  a	  bottleneck,	  q2	  will	  be	  close	  to	  one.	  	  	  
Another	   possible	   confounding	   effect	   stems	   from	   selection	   bias	   in	   the	   submission	   of	  sequences	   to	   public	   databases.	  We	   account	   for	   any	   possible	   duplication	   of	   sequences	   by	  considering	  only	  unique	  sequences	  from	  each	  date	  and	  location.	  Beyond	  this	  safeguard,	  we	  acknowledge	  that	  q2	  may	  fall	  prey	  to	  selection	  bias.	  However,	  without	  prior	  knowledge	  of	  such	   biases,	   it	   would	   be	   difficult	   for	   any	   method	   to	   address	   these	   confounders	  satisfactorily.	  	  	  
We	  compared	  q2-­‐coefficient	  to	  other	  possible	  quantitative	  methods,	  including	  those	  based	  on	   phylogenetics	   and	   clustering.	   A	   drawback	   common	   to	   many	   of	   these	   surveillance	  methods	  is	  that	  they	  are	  slow,	  computationally	  expensive	  techniques	  that	  are	  not	  explicitly	  designed	   to	   capture	  pathogen	  diversity.	   For	   this	   reason,	  we	  developed	   the	  q2-­‐coefficient	  that	  is	  readily	  computable	  and	  captures	  surveillance	  at	  any	  given	  time	  point.	  Applying	  the	  q2-­‐coefficient	  revealed	  deficient	  sampling	  of	  swine	  H1N1	  and	  non-­‐avian	  H5N1,	  dengue,	  and	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West	  Nile	  virus.	  These	  results	  bear	  great	  potential	  to	  guide	  the	  future	  allocation	  of	  energy	  and	  resources	  for	  gathering	  viral	  isolates.	  We	  also	  foresee	  further	  ecological	  applications	  of	  q2	   as	   an	   effective	   measure	   of	   asymptotic	   species	   richness	   without	   relying	   on	   arbitrary	  criteria	  for	  defining	  species,	  unlike	  classic	  techniques	  like	  Chao’s	  estimate.	  This	  feature	  can	  be	   particularly	   valuable	   for	   assessing	   the	   number	   of	   additional	   samples	   needed	   to	  represent	  all	   species	  of	  an	  organism	   in	  metagenomic	  studies.	   In	  conclusion,	   the	  scientific	  community	  as	  a	  whole	  must	  improve	  their	  surveillance	  networks	  and	  share	  information	  for	  the	  advancement	  of	  scientific	  inquiry	  and	  public	  health	  interventions,	  and	  we	  offer	  the	  q2-­‐coefficient	  as	  a	  means	  of	  evaluating	  the	  effectiveness	  of	  such	  efforts.	  
Methods	  
Sequence	  collection,	  annotation,	  and	  alignment	  
Complete	   coding	   sequences	   of	   all	   influenza	   coding	   segments	   were	   collected	   from	   the	  Influenza	   Virus	   Resource	   at	   the	   National	   Collaboration	   of	   Biotechnology	   Information	  (NCBI)48	  and	  the	  Global	  Initiative	  on	  Sharing	  Avian	  Influenza	  Data	  (GISAID)25	  downloaded	  as	  of	  October	  2012	  for	  human,	  avian,	  and	  swine	  hosts.	  Complete	  coding	  sequences	  for	  the	  envelope	  (ENV)	  gene	  of	  dengue	  viral	  subtypes	  1,	  2,	  and	  3,	  as	  well	  as	  West	  Nile	  virus	  (WNV),	  were	   collected	   from	   the	  Virus	  Pathogen	  Resource	   and	  Broad	   Institute,	   downloaded	  as	   of	  May	   2012.	   All	   sequences	   were	   filtered	   for	   year	   and	   month	   information.	   If	   no	   day	  information	   was	   provided,	   isolation	   was	   assumed	   to	   have	   occurred	   on	   the	   15th	   of	   the	  month.	  To	  avoid	  the	  effect	  of	  depositing	  duplicated	  sequences,	  only	  unique	  sequences	  were	  considered	   for	   each	   date	   and	   location.	   Sequences	   were	   then	   aligned	   using	   ClustalW2	   v.	  2.0.12,	   using	   default	   parameters,	   and	   then	   manually	   curated.	   Influenza	   sequences	   were	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annotated	  by	  transmission	  zone,	  defined	  by	  the	  WHO	  as	  geographically	  contiguous	  regions	  with	  similar	  peaks	  in	  flu	  season32.	  All	  alignments	  and	  code	  used	  are	  available	  upon	  request.	  
Shannon’s	  entropy	  as	  a	  measurement	  of	  genetic	  diversity	  
Our	  measure	  of	  pathogen	  surveillance	  incorporates	  evolutionary	  rate,	  which	  contributes	  to	  population	  diversity.	  To	  measure	  genetic	  diversity	  directly,	  we	  chose	  to	  employ	  Shannon’s	  entropy,	   a	   popular	   and	   intuitive	   measure	   that	   avoids	   cumbersome	   phylogenetic	  reconstruction,	   and	   applied	   it	   to	   the	   distribution	   of	   alleles	   at	   each	   nucleotide	   position	  within	  an	  alignment.	  This	  calculation	  recovers	  the	  number	  of	  bits	  of	  information	  per	  base.	  Assuming	  independence	  of	  each	  position,	  the	  total	  entropy	  of	  a	  population	  is	  the	  sum	  of	  the	  entropies	   of	   each	   base	   position	   of	   the	   alignment.	   To	   correct	   for	   bias	   stemming	   from	   a	  variable	  number	  of	  n	   isolates,	  we	  estimate	  Shannon’s	  entropy	  H	  for	  a	  given	  base	  position	  based	  on	  the	  algorithm	  below	  by	  Miller,	  et	  al.	  where	  m	  is	  the	  number	  of	  alleles	  49.	  
𝐻 =   𝑚 − 12𝑛 −    𝑝!𝑙𝑜𝑔!𝑝!!!!! 	  
	  
Phylogeny	  as	  a	  measurement	  of	  surveillance	  
Sequences	  were	  analyzed	  using	  BEAST	  v1.7.4,	  a	  Bayesian	  Markov	  chain	  Monte	  Carlo	  (MCMC)	  approach	  to	  sample	  time-­‐structured	  evolutionary	  trees	  from	  their	  joint	  posterior	  probability	  distribution.	  Due	  to	  computational	  and	  time	  limits,	  we	  restricted	  our	  phylogenetic	  analysis	  to	  human	  H5N1,	  as	  BEAST	  analysis	  for	  datasets	  of	  over	  a	  thousand	  sequences	  can	  take	  weeks	  to	  converge	  to	  a	  stationary	  condition.	  This	  dataset	  was	  analyzed	  using	  an	  exponential-­‐growth	  coalescent	  as	  a	  tree	  prior	  with	  a	  HKY+	  Γ	  model	  of	  nucleotide	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substitution.	  Relaxed	  and	  strict	  molecular	  clocks	  were	  employed.	  	  For	  strict	  (relaxed)	  clock,	  twenty	  independent	  runs	  of	  750,000	  (1,500,000)	  steps	  each	  were	  performed,	  compared	  for	  convergence,	  and	  combined,	  with	  a	  burn-­‐in	  of	  150,000	  (500,000)	  steps	  from	  each.	  Each	  run	  finished	  after	  an	  average	  of	  32.47	  (19.14)	  hours	  using	  one	  Intel	  Xeon	  CPU	  3.00	  GHz	  with	  12	  GB	  of	  RAM.	  A	  single	  maximum	  clade	  credibility	  (MCC)	  tree	  was	  created	  from	  each	  set	  of	  simulations	  with	  the	  average	  length	  determined	  for	  each	  branch.	  We	  found	  the	  corresponding	  evolutionary	  rates	  to	  be	  5.11*10-­‐3	  (4.58*10-­‐3-­‐5.62*10-­‐3)	  and	  5.39*10-­‐3	  (4.39*10-­‐3-­‐5.80*10-­‐3)	  similar	  to	  the	  evolutionary	  rate	  we	  used	  for	  influenza	  HA	  analysis.	  The	  95%	  HPD	  of	  each	  branch	  length	  of	  the	  MCC	  tree	  was	  used	  to	  set	  a	  confidence	  interval	  for	  each	  p2-­‐coefficent.	  
	  
Persistence	  homology	  as	  a	  measurement	  of	  surveillance	  
Another	   possible	   surveillance	   measure	   can	   be	   derived	   from	   employing	   persistence	  homology	   techniques	   like	   barcoding45:	   a	   method	   of	   identifying	   topological	   invariants	   in	  cloud	  data.	  First,	   sequenced	   isolates	  can	  be	   transformed	   in	  high-­‐dimensional	   space	  using	  distance	  measures,	  such	  as	  pairwise	  genetic	  distance.	  From	  this	  cloud	  data,	  points	  can	  be	  linked	  together	  based	  on	  certain	  criteria	  to	  form	  a	  simplicial	  complex:	  a	  network	  of	  points,	  line	   segments,	   triangles,	   and	   even	   n-­‐dimensional	   counterparts.	   When	   this	   criteria	   is	   a	  distance	  less	  than	  some	  ε,	  a	  filtered	  simplicial	  complex	  or	  Vietoris-­‐Rips	  stream	  is	  created.	  
An	  objective	  in	  the	  study	  of	  topology	  is	  to	  identify	  features	  of	  filtered	  simplicial	  complexes	  that	   persist	   across	   all	   values	   of	   ε.	   A	   useful	   characteristic	   is	   the	   Betti	   number,	   which	   in	  dimension	   0	   is	  𝑏!	  number	   of	   connected	   components	   in	   a	   particular	   simplicial	   complex.	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Trivially,	  with	  a	   large	  enough	  ε,	  𝑏!	  is	  1,	  but	  what	   is	   interesting	   is	  the	  minimum	  value	  of	  ε	  that	  yields	  𝑏!	  =	  1.	  Low	  values	  would	  indicate	  a	  higher	  degree	  of	  surveillance.	  	  	  Calculating	   Vietoris-­‐Rips	   streams	   for	   large	   point	   cloud	   data	   can	   be	   computationally	  expensive,	  and	  an	  alternative	  method	  called	  witness	  streams50	  can	  be	  used	  to	  estimate	  ε.	  Suppose	   a	   landmark	   subset	   of	   points	   L	   is	   pre-­‐selected	   from	   point	   cloud	   data	   either	   at	  random	  or	  using	  a	  max-­‐min	  scheme.	  Let	  d(L,p)	  be	  a	  vector	  of	  distances	  between	  a	  point	  p	  and	  all	  points	  in	  L.	  In	  dimension	  0,	  a	  pair	  of	  points	  a	  and	  b	  is	  then	  linked	  if	  there	  exists	  a	  witness	  point	  z	  such	  that	  the	  maximum	  of	  d(a,z)	  and	  d(b,z)	  is	  less	  than	  the	  sum	  of	  ε	  and	  the	  smallest	  element	  in	  d(L,z).	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Chapter	  1.3:	  Network	  Analysis	  of	  Global	  Influenza	  
Spread	  
Summary	  Although	  vaccines	  pose	   the	  best	  means	  of	  preventing	   influenza	   infection,	   strain	   selection	  and	   optimal	   implementation	   remain	   difficult	   due	   to	   antigenic	   drift	   and	   a	   lack	   of	  understanding	   global	   spread.	   Detecting	   viral	   movement	   by	   sequence	   analysis	   is	  complicated	  by	  skewed	  geographic	  and	  seasonal	  distributions	  in	  viral	  isolates.	  We	  propose	  a	  probabilistic	  method	  that	  accounts	   for	  sampling	  bias	  through	  spatiotemporal	  clustering	  and	  modeling	  regional	  and	  seasonal	  transmission	  as	  a	  binomial	  process.	  Analysis	  of	  H3N2	  not	   only	   confirmed	   East-­‐Southeast	   Asia	   as	   a	   source	   of	   new	   seasonal	   variants,	   but	   also	  increased	  the	  resolution	  of	  observed	  transmission	  to	  a	  country	   level.	  H1N1	  data	  revealed	  similar	  viral	  spread	  from	  the	  tropics.	  Network	  analysis	  suggested	  China	  and	  Hong	  Kong	  as	  the	  origins	  of	  new	  seasonal	  H3N2	  strains	  and	  USA	  as	  a	  region	  where	  increased	  vaccination	  would	  maximally	  disrupt	  global	  spread	  of	  the	  virus.	  	  
From	  a	  global	  health	  viewpoint,	  how	  to	  optimally	  implement	  a	  limited	  stockpile	  of	  vaccines	  is	  a	   fundamental	  question	   that	   remains	  unanswered.	  Here,	  we	  show	  that	   it	   is	  possible	   to	  counter	  this	  data	  bias	  through	  probabilistic	  modeling	  and	  represent	  the	  global	  viral	  spread	  as	  a	  network	  of	  seeding	  events	  between	  different	  regions	  of	  the	  world.	  On	  a	  local	  scale,	  our	  technique	  can	  output	  the	  most	  likely	  origins	  of	  a	  virus	  circulating	  in	  a	  given	  location.	  On	  a	  global	   scale,	   we	   can	   pinpoint	   regions	   of	   the	   world	   that	   would	   maximally	   disrupt	   viral	  transmission	  with	  an	  increase	  in	  vaccine	  implementation.	  We	  demonstrate	  our	  method	  on	  seasonal	  H3N2	  and	  H1N1	  and	  foresee	  similar	  application	  to	  any	  seasonal	  viruses,	  including	  swine-­‐origin	  H1N1,	  once	  more	  seasonal	  data	  is	  collected.	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Introduction	  Influenza,	   a	   negative-­‐sense	   RNA	   orthomyxovirus,	   is	   one	   of	   the	   few	   diseases	   that	   is	   truly	  global	  in	  scale.	  It	  is	  responsible	  for	  approximately	  three	  to	  five	  million	  cases	  of	  severe	  acute	  respiratory	   illness	   and	   250,000	   to	   500,000	   deaths	   each	   year	   throughout	   the	  world52.	   In	  2009,	   the	   swift	   isolation	   of	   swine-­‐origin	   H1N1	   strain	   (S-­‐OIV)	   from	   all	   continents	  within	  several	   weeks	   of	   onset	   reinforced	   the	   idea	   that	   influenza	   is	   a	   highly	   infectious	   agent	  circulating	  worldwide53,54.	  	  
Although	   vaccination	   remains	   one	   of	   the	   most	   powerful	   ways	   of	   combating	   influenza,	  choosing	  a	  representative	  strain	  for	  vaccine	  composition	  poses	  a	  challenging	  problem.	  Due	  to	  the	  virus’s	  high	  evolutionary	  rate,	  significant	  resources	  must	  be	  spent	  to	  update	  vaccines	  each	  year	   in	  order	  to	  match	  the	  dominant	  epitope	  of	   the	  season.	  Even	  with	  annual	  strain	  selection,	   major	   antigenic	   reassortment	   can	   obviate	   otherwise	   promising	   vaccine	  candidates,	   as	   occurred	   with	   the	   'Fujian/411/2002'-­‐like	   H3N2	   strain	   in	   200355,56.	   To	  prevent	  such	  vaccine	  failures,	  a	  solid	  understanding	  of	  the	  global	  spread	  of	  influenza	  must	  inform	  the	  design	  process.	  If	  reservoirs	  for	  new	  viral	  strains	  can	  be	  identified,	  surveillance	  in	  these	  areas	  can	  better	  optimize	  prediction	  of	  seasonal	  variants	  in	  seeded	  regions.	  	  
Previous	  papers	  investigating	  the	  global	  circulation	  of	  H3N2,	  the	  major	  seasonal	  influenza	  subtype	   prior	   to	   pandemic	   H1N1,	   focused	   on	   transmission	   within	   and	   between	   climate	  zones.	   Important	   motivating	   factors	   for	   such	   analysis	   include	   increased	   aerosol	  transmission	   in	   cold	   and	   dry	   conditions,	   as	   well	   as	   increased	   indoor	   crowding	   and	  decreased	  host	  immunity	  in	  cold	  and	  wet	  conditions57,58.	  In	  the	  temperate	  zones,	  influenza	  exhibits	  distinct	  seasonality	  with	  flu-­‐related	  cases	  spiking	  in	  the	  winter.	  However,	  several	  papers	   have	   confirmed	   the	   presence	   of	   viral	   diversity	   even	   between	   these	   epidemic	  
	  	   39	  
peaks59-­‐61,	  suggesting	  two	  possible	  scenarios	  during	  the	  inter-­‐epidemic	  period:	  either	  viral	  infections	   locally	   persist	   at	   a	   low	   level	   only	   to	   reemerge	   as	   the	   dominant	   strains	   of	   the	  epidemic	   season,	   or	   an	   outside	   source	   introduces	   new	   genetic	   diversity	   into	   temperate	  populations	   each	   year.	   Although	   a	   degree	   of	   local	   persistence	   may	   occur,	   phylogenetic	  analysis	   supports	   the	   latter	   scenario,	   with	   few	   direct	   links	   between	   strains	   of	   the	   same	  region	  but	  successive	  seasons59-­‐61.	  	  
For	   a	   given	   temperate	   zone,	   these	   conclusions	   suggest	   the	   tropics	   or	   the	   opposite	  temperate	   zone	   as	   plausible	   external	   seeding	   regions.	   At	   first	   blush,	   northern-­‐southern	  temperate	  oscillations	  seem	  credible.	  Each	  year,	  northern	  and	  southern	  temperate	  climates	  have	  alternating	  seasonal	  influenza	  epidemics,	  lasting	  from	  November	  to	  April,	  and	  May	  to	  September	  respectively62.	  A	  possible	  mechanism	  of	  viral	  spread	  could	  involve	  transmission	  from	   the	   seasonal	   peak	   of	   one	   temperate	   zone	   into	   the	   season	   ebb	   of	   the	   other.	   On	   the	  other	  hand,	  specific	  epidemiological	  characteristics	  suggest	  a	  tropical	  origin	  for	  influenza.	  For	   example,	   although	   both	   climates	   share	   a	   similar	   yearly	   burden	   of	   mortality	   from	  influenza,	  the	  tropics	  do	  not	  possess	  the	  same	  consistent	  seasonal	  peaks	  during	  the	  winter	  months60,63,64.	   With	   a	   constant,	   low-­‐level	   circulation	   of	   viruses	   year-­‐round,	   the	   tropics	  represent	  an	  ideal	  epicenter	  for	  the	  extended	  transmission	  of	  new	  viruses	  to	  the	  rest	  of	  the	  world6,29,65.	  	  
Several	  papers	  tracking	  H3N2	  across	  continents	  have	  asserted	  that	  this	  tropical	  reservoir	  of	  influenza	  strains	  lies	  within	  East-­‐Southeast	  Asia63,65,66.	  Russell,	  et	  al.	  analyzed	  H3N2	  data	  to	   identify	   regions	   of	   the	  world	   that	   are	   antigenically	   and	   genetically	   leading	   or	   trailing.	  They	  found	  that	  newly	  emerging	  strains	  appeared	  in	  E-­‐SE	  Asia	  roughly	  6-­‐9	  months	  earlier	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than	  in	  other	  parts	  of	  the	  world,	  while	  South	  America	  experienced	  delayed	  transmission	  of	  roughly	  6-­‐9	  months	  following	  other	  parts	  of	  the	  world	  59.	  	  
However,	   such	   studies	   have	   been	   limited	   by	   several	   drawbacks.	   Most	   papers	   focus	   on	  H3N2	  as	   a	   single	   entity,	  when	   in	   reality,	   it	   co-­‐circulates	  with	   several	   other	   subtypes,	   the	  most	   important	   of	   which	   is	   seasonal	   H1N162.	   Although	   they	   possess	   different	   surface	  antigens,	  H3N2	  and	  H1N1	  share	  enough	  genetic	  similarity	  to	  display	  cross-­‐immunity.	  As	  a	  result,	   seasonal	   H1N1	  may	   demonstrate	   transmission	   patterns	   distinct	   from	  H3N2’s67,68.	  Such	   codependence	   between	   different	   subtypes	   is	   exemplified	   by	   the	   pandemic	   years	   of	  1957	   and	   1968,	   when	   H2N2	   replaced	   preexisting	   H1N1	   and	   H3N2	   replaced	   preexisting	  H2N2,	  respectively69,70.	  Similarly,	  the	  antigenically	  different	  pandemic	  H1N1	  strain	  of	  2009	  has	   largely	   overtaken	   previously	   circulating	   H1N1	   and	   H3N271.	   During	   the	   years	   our	  dataset	   took	  place,	  evidence	  that	  H3N2	  and	  H1N1	  rarely	  co-­‐dominate	   in	  a	  season	   further	  supports	  the	  idea	  of	  codependent	  dynamics58.	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Figure	  10.	  Number	  of	  H3N2	  and	  H1N1	  sequences	  from	  the	  NCBI	  Influenza	  Virus	  Resource	  sampled	  from	  (A)	  each	  
climate	  zone	  and	  (B)	  each	  continent	  for	  complete	  coding	  segments	  and	  the	  HA1	  domain.	  HA,	  HA1,	  and	  NA	  possess	  
the	  greatest	  geographic	  coverage	  of	  sequences.	  	  
	  A	  second	  shortcoming	  stems	  from	  biases	  in	  the	  number	  of	  sequences	  from	  different	  regions	  and	   different	   seasons59.	   Most	   isolates	   of	   H3N2	   and	   H1N1	   were	   sampled	   from	   North	  America,	  whereas	  Africa	  and	  South	  America	  have	  been	  largely	  neglected18.	  Many	  sequences	  were	  obtained	  within	  the	  last	  15	  years,	  making	  reliable	  tracking	  over	  long	  periods	  of	  time	  problematic.	  On	  the	  level	  of	  climate	  zones,	  the	  number	  of	  temperate	  isolates	  far	  outstrips	  the	  tropics.	  Although	  hemagglutinin	  (HA),	  the	  HA1	  domain,	  and	  neuraminidase	  (NA)	  have	  the	   most	   globally	   representative	   distributions	   of	   sequences,	   even	   these	   remain	   skewed	  (Figure	  10).	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In	   this	  paper,	  we	  present	  a	  novel	  probabilistic	  model	   for	   tracking	  the	  spread	  of	   influenza	  that	  employs	  two	  strategies	  to	  eliminate	  regional	  and	  seasonal	  data	  bias.	  The	  first	  involves	  clustering	  isolates	  of	  high	  sequence	  similarity	  by	  region	  and	  season.	  Since	  we	  would	  expect	  highly	   similar	   sequences	   from	   the	   same	   time	   and	   location	   to	   be	   related,	   we	   considered	  seeding	   events	   between	   clusters	   to	   be	   of	   greater	   significance.	   Consideration	   of	   clusters	  rather	   than	   individual	   sequences	   nullifies	   the	   over-­‐representation	   of	   a	   high	   number	   of	  isolates	  from	  a	  single	  region	  and	  season	  (Figure	  11).	  As	  a	  second	  strategy	  for	  eliminating	  bias,	   we	   determined	   statistical	   significance	   of	   inter-­‐cluster	   seeding	   events	   by	   modeling	  transmission	  as	  a	  binomial	  distribution	  with	  prior	  probabilities	  based	  on	  the	  proportion	  of	  sequences	   isolated	   before	   a	   given	   time	   point.	   To	   illustrate	   our	   methodology,	   Figure	   12	  depicts	   the	  2003-­‐2004	   flu	   season,	  which	  was	  marked	  by	   failure	   to	  predict	   the	  dominant,	  tropically-­‐derived	   Fujian/411/2002-­‐like	   H3N2	   strain.	   We	   identified	   a	   strong	   seeding	  pattern	   from	   the	   tropics	   to	   all	   three	   climate	   zones,	   supporting	   the	   effectiveness	   of	   our	  methodology.	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Figure	  11.	  Methodology	  for	  spatiotemporal	  clustering.	  (A)	  We	  first	  ordered	  sequences	  from	  NCBI	  from	  earliest	  to	  
latest.	  Starting	  with	  the	  most	  recent	  virus	  “Seq	  1,”	  we	  worked	  backwards,	  tracing	  the	  most	  parsimonious	  
evolutionary	  path	  of	  the	  virus	  until	  we	  reached	  the	  oldest	  sequence	  “Seq	  10.”	  To	  accomplish	  this	  goal,	  we	  defined	  
each	  virus’s	  most	  likely	  ancestor	  to	  have	  the	  highest	  sequence	  similarity	  among	  all	  older	  viruses.	  (B)	  Contiguous	  
sequences	  along	  the	  evolutionary	  path	  were	  clustered	  (grouped)	  together	  by	  common	  geography	  and	  season.	  (C)	  
The	  process	  was	  repeated	  starting	  with	  the	  next	  most	  recent	  virus	  not	  yet	  included	  in	  the	  evolutionary	  path.	  (D)	  
The	  cycle	  continued	  until	  all	  sequences	  were	  connected	  in	  a	  tree	  of	  clustered	  evolutionary	  paths.	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Figure	   12.	   Methodology	   for	   determining	   significant	   seasons.	   As	   an	   example,	   consider	   the	   2003-­‐04	   flu	   season.	  
After	  clustering,	  there	  were	  a	  total	  of	  10	  observed	  seeding	  events	  into	  the	  northern	  temperate	  zone:	  1	  from	  the	  
north,	   4	   from	   the	   tropics,	   and	   5	   from	   the	   south.	   Up	   until	   that	   year,	   the	   skewed	   regional	   distribution	   of	   HA	  
sequences	   included	   541	   (48.3%)	   northern	   temperate,	   240	   (21.4%)	   tropical,	   and	   339	   (30.2%)	   southern	  
temperate	  isolates.	  Multiplying	  these	  percentages	  with	  the	  10	  observed	  seeding	  events	  yielded	  expected	  counts	  
of	  4.8,	  2.1,	  and	  3.0.	  Therefore,	  the	  number	  of	  seeding	  events	  from	  the	  north	  was	  less	  than	  expected,	  and	  from	  the	  
tropics	   and	   the	   south,	   more	   than	   expected.	   Corresponding	   binomial	   p-­‐values—0.986,	   0.043,	   and	   0.049,	  
respectively—indicated	   that	   there	   were	   two	   statistically	   significant	   events,	   the	  most	   significant	   of	   which	   was	  
transmission	   from	   the	   tropics	   into	   the	   northern	   temperate	   zone.	   Similar	   analysis	   for	   transmission	   into	   the	  
tropics	  and	  the	  southern	  temperate	  showed	  that	  only	  the	  tropical	  zone	  was	  a	  significant	  seeder.	  We	   applied	   this	   model	   to	   the	   H3N2	   and	   H1N1	   coding	   regions	   of	   HA	   and	   NA,	   the	   most	  antigenic	   proteins	   of	   the	   eight	   viral	   segments.	   Clustering	   H3N2	   sequences	   confirmed	  previous	  findings	  that	  this	  strain	  originates	  in	  the	  tropics,	  specifically	  E-­‐SE	  Asia,	  and	  seeds	  South	  America	  by	  way	  of	  North	  America	   last.	  Clustering	  H1N1	  NA	  also	  revealed	  a	  similar	  pattern	   of	   circulation	   beginning	   in	   the	   tropics.	   However,	   similar	   H1N1	   analysis	   by	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continent	  and	  country	  was	  not	  possible	  due	  to	  the	  absence	  of	  a	  larger	  number	  of	  countries	  in	  the	  dataset.	  	  
Applying	   the	   same	   methodology	   to	   the	   H3N2	   HA1	   domain	   increased	   the	   geographic	  diversity	  enough	  to	  enable	  reconstruction	  of	  the	  global	  influenza	  network	  prior	  to	  the	  2009	  pandemic	   strain	   at	   a	   country	   level.	   Our	   results	   suggest	   a	   possible	   flu	   seeding	   hierarchy	  beginning	   in	   China	   and	   spreading	   throughout	   a	   highly	   interconnected	   E-­‐SE	   Asian	  subnetwork.	   From	   there,	   viruses	   transmit	   to	   an	   Oceanic	   subnetwork	   dominated	   by	  interchange	   between	   Australia	   and	   New	   Zealand.	   Both	   subnetworks	   seed	   into	   the	   USA,	  which	  in	  turn	  seeds	  many	  countries,	  particularly	  in	  South	  America.	  	  
Expanding	   upon	   the	   sink-­‐source	   hypothesis	   of	   global	   influenza	   dynamics	   proposed	   by	  Rambaut,	  et	  al.29,	  we	  applied	  techniques	  of	  graph	  theory	  to	  identify	  important	  source	  and	  sink	  regions	  in	  the	  global	  flu	  network.	  These	  techniques	  better	  describe	  the	  dynamic	  nature	  of	  influenza	  movement	  across	  the	  globe,	  as	  well	  as	  suggest	  different	  vaccination	  strategies	  to	  disrupt	  maximally	  viral	  flow	  around	  the	  world.	  
	  
Results	  
Emergent	  Strains	  from	  the	  Tropics	  and	  Asia	  Spatiotemporally	  clustering	  the	  complete	  H3N2	  and	  H1N1	  coding	  sequences	  for	  HA	  and	  NA	  allowed	   the	   determination	   of	   multiple	   statistically	   significant	   seeding	   seasons	   between	  1988	  and	  2009.	  For	  our	  initial	  analysis,	  we	  clustered	  sequences	  into	  three	  climate	  zones—northern	  temperate,	  tropical,	  and	  southern	  temperate.	  To	  determine	  seasonal	  boundaries,	  we	   defined	   the	   northern	   temperate	   season	   to	   last	   from	   1st	   July	   to	   the	   30th	   June	   of	   the	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following	   year	   and	   the	   southern	   temperate	   season	   to	   last	   from	   1st	   January	   to	   the	   31st	  December	   of	   the	   same	   year62.	   Although	   the	   tropics	   do	   not	   have	   a	   well-­‐defined	   seasonal	  pattern,	  we	  determined	  a	  consensus	  tropical	  flu	  season	  from	  1st	  October	  to	  30th	  September	  of	  the	  next	  year	  (Appendix	  C.	  Supplementary	  Text	  to	  “Network	  Analysis	  of	  Global	  Influenza	  Spread”,	  Supplementary	  Table	  D-­‐1).	  
	  
Figure	   13.	   Clustering	   the	   complete	   HA	   coding	   sequences	   of	   H3N2	   by	   (A)	   climate	   zone,	   (B)	   continent,	   and	   (C)	  
country.	  Top	  H3N2	  seeders	  were	  located	  in	  the	  E-­‐SE	  Asian	  tropics,	  particularly	  in	  Hong	  Kong.	  (D)	  Clustering	  the	  
H3N2	  HA1	  domain	  by	  country	  increased	  the	  total	  number	  of	  sequences	  and	  countries	  under	  consideration.	  This	  
analysis	   identified	  USA,	  Hong	  Kong,	  Australia,	  and	  China	  as	  the	  top	  H3N2	  seeders	   in	  that	  order.	  For	  all	  country	  
heat	  maps,	   only	   countries	   transmitting	  or	   receiving	   at	   least	   one	   significant	   seeding	   season	  were	   included.	   For	  
each	  entry,	  there	  was	  a	  maximum	  number	  of	  22	  seeding	  seasons,	  the	  range	  in	  the	  date	  of	  isolation	  for	  all	  datasets.	  Results	   for	   H3N2	   HA	   (Figure	   13A)	   and	   NA	   (not	   shown)	   showed	   that	   the	   overwhelming	  majority	   of	   statistically	   significant	   seeding	   seasons	   came	   from	   the	   tropics,	   confirming	  previous	   findings.	   Clustering	   H3N2	   by	   the	   six	   major	   continents	   rendered	   an	   even	  more	  detailed	  picture.	  For	  HA,	  Asia	  was	  the	  primary	  seeder	  of	  Asia,	  North	  America,	  and	  Oceania.	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Prominent	   transmission	   from	   North	   America	   to	   Europe	   and	   South	   America	   was	   also	  observed	  (Figure	  13B).	  Interestingly,	  this	  hierarchical	  seeding	  structure	  reflects	  the	  findings	  of	   Russell,	   et	   al.,	  which	   identified	  Asia	   and	   South	  America	   as	   antigenically	   advanced	   and	  lagging	  continents	  respectively59.	  This	  network	  of	  hierarchical	  seeding	  can	  be	  visualized	  as	  a	   directed	   graph	   plotted	   against	   the	   world	   map	   (Figure	   14A).	   Analysis	   of	   NA	   produced	  similar	  findings	  with	  the	  exception	  of	  North	  America	  being	  its	  own	  primary	  seeder	  (Figure	  
13B).	   No	   complete	   HA	   and	   NA	   isolates	   existed	   in	   the	   NCBI	   Influenza	   Virus	   Resource	  database72	  	  for	  Africa.	  	  
The	   complete	   dataset	   of	   HA	   and	   NA	   represented	   only	   17	   and	   21	   countries	   respectively.	  Despite	   the	   sparse	   number	   of	   countries	   for	   analysis,	   both	   HA	   (Figure	   13C)	   and	   NA	   (not	  shown)	   consistently	   identified	   Hong	   Kong	   (considered	   a	   country	   by	   NCBI	   sequence	  annotation)	   as	   the	   primary	   external	   seeder	   of	   USA	   and	  New	   Zealand	   among	   others,	   and	  New	  Zealand	  as	  the	  primary	  external	  seeder	  of	  Australia.	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Figure	  14.	  Global	  network	  of	  statistically	  significant	  seeding	  seasons	  for	  H3N2	  after	  clustering	  by	  (A)	  continent	  
and	   (B)	   country.	   (A)	   Seasonal	   variants	   emerge	   from	   Asia	   and	   make	   their	   way	   to	   North	   America.	   A	   smaller	  
connection	  from	  North	  America	  to	  South	  America	  is	  consistent	  with	  the	  finding	  that	  South	  American	  isolates	  are	  
antigenically	  delayed57.	   (B)	  Clustering	  by	  country	  showed	   tropic-­‐centric	  movement	  patterns.	   (C)	  H3N2	  seeding	  
events	   in	   the	   South-­‐East	   Asian/Oceanic	   subnetwork	   showing	   China,	   Hong	   Kong,	   and	   Australia	   as	  major	   hubs.	  
Arrows	  signify	   the	  direction	  of	   the	  seeding	  event.	  Each	  edge	   is	  color-­‐coded	  according	  to	  weight:	   the	  number	  of	  
seeding	   events	   represented.	   For	   visual	   simplicity,	   arrowheads	   were	   omitted	   for	   edges	   of	   unit	   weight.	   Edges	  
connect	   between	   the	   centroids	   of	   two	   continents	   or	   countries.	   World	   map	   image	   taken	   from:	  
onearth.jpl.nasa.gov.	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Due	   to	   fewer	   available	   sequences,	   clustering	   H1N1	   did	   not	   yield	   as	   many	   significant	  seeding	   events	   as	  H3N2;	   however,	   our	   tests	   suggest	   that	  H1N1	   adopts	   a	   similar	   seeding	  pattern	  with	  the	  tropics	  as	  a	  source.	  Of	  the	  two	  segments,	  NA	  sequences	  display	  a	  broader	  geographical	   profile	   than	   HA.	   In	   particular,	   our	   HA	   dataset	   for	   H1N1	   contained	   no	  sequences	   from	  Hong	   Kong	   and	   only	   1	   (0.091%)	   China	   sequence,	  while	   NA	   contained	   9	  (0.69%)	  Hong	  Kong	  and	  3	  (0.23%)	  China	  sequences.	  Consequently,	  we	  considered	  NA	  to	  be	  more	  suitable	  for	  comparison	  between	  H3N2	  and	  H1N1	  and	  HA	  to	  be	  a	  background	  signal	  to	  assess	  the	  effect	  of	  Hong	  Kong	  and	  China	  on	  global	  influenza	  transmission.	  Even	  so,	  the	  number	  of	  these	  H1N1	  Hong	  Kong	  and	  China	  sequences	  remained	  vastly	  disproportionate	  to	  the	  361	  (7.42%)	  Hong	  Kong	  and	  133	  (2.73%)	  China	  sequences	  of	  H3N2.	  
Clustering	  H1N1	  NA	  by	  climate	  zone	  supported	  the	  theory	  of	  global	  viral	  spread	  from	  the	  tropics	   (Figure	   15B).	   Unlike	   H3N2,	   H1N1	   analysis	   by	   continent	   and	   country	   was	  inconclusive	   due	   to	   low	   (typically	   fewer	   than	   3	   seeding	   events),	   homogeneous	   counts.	  Although	  inconclusive,	  the	  fact	  that	  a	  tropical	  signal	  could	  be	  detected	  at	  all	  from	  such	  few	  tropical	   countries,	   including	   Hong	   Kong	   and	   China,	   suggests	   that	   H1N1	   adopts	   a	   similar	  seeding	  pattern	  out	  of	  the	  tropics.	  Due	  to	   insufficient	  sampling,	  however,	  a	  more	  detailed	  transmission	  pattern	  could	  not	  be	  discerned.	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Figure	   15.	   Clustering	   the	   H1N1	   (A)	   HA	   and	   (B)	   NA	   segments	   by	   climate.	   HA	   counts	   were	   noticeably	   low	   and	  
homogeneous,	  compared	  to	  NA	  counts	  that	  reflected	  a	  strong	  signal	  from	  the	  tropics.	  One	  explanation	  is	  the	  lack	  
of	  Hong	  Kong	  and	  China	  sequences	  in	  HA	  compared	  to	  NA.	  The	  difference	  between	  HA	  and	  NA	  counts	  may	  reflect	  
the	  impact	  of	  including	  even	  a	  marginal	  number	  of	  Hong	  Kong	  and	  China	  sequences.	  If	  H1N1	  sequences	  were	  
more	  evenly	  distributed	  by	  region,	  one	  may	  anticipate	  seeding	  counts	  more	  aligned	  with	  those	  of	  H3N2.	  For	  each	  
entry,	  there	  was	  a	  maximum	  number	  of	  22	  seeding	  seasons,	  the	  range	  in	  the	  date	  of	  isolation	  for	  all	  datasets.	  
	  
The	  Global	  Seeding	  Network	  of	  H3N2	  by	  Country	  Although	   using	   the	   complete	   HA	   and	   NA	   coding	   genomes	   facilitated	   differentiation	   of	  isolates	   by	   Hamming	   distance,	   the	   absence	   of	   data	   from	   certain	   countries	   limited	   the	  information	   gained	   from	  clustering	   at	   this	   geographic	  detail,	   a	   problem	   that	  has	  plagued	  previous	  studies59.	  To	  increase	  the	  amount	  of	  data	  from	  different	  geographical	  regions,	  we	  clustered	   H3N2	   sequences	   of	   the	   HA1	   epitope,	   expanding	   the	   number	   of	   isolates	   in	   the	  dataset	   from	   2,251	   to	   4,864,	   and	   the	   number	   of	   countries	   from	   17	   to	   81.	   A	   necessary	  consequence	   of	   expanding	   geographic	   coverage	   was	   an	   increase	   in	   the	   number	   of	   non-­‐unique	  solutions	  (Appendix	  C).	  
Importantly,	   clustering	  HA1	  by	  climate	  and	  continent	  was	  corroborated	  by	   findings	   from	  the	  complete	  HA	  and	  NA	  sequences,	  lending	  credence	  to	  the	  validity	  of	  the	  dataset.	  Due	  to	  the	  inclusion	  of	  isolates	  from	  Africa,	  which	  was	  hitherto	  not	  present	  in	  our	  datasets,	  H3N2	  HA1	  analysis	  also	  revealed	  Europe	  and	  North	  America	  tied	  for	  being	  the	  primary	  seeders	  of	  Africa.	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Country	  clustering	  of	  the	  HA1	  data	  produced	  a	  highly	  detailed	  global	  network	  of	  influenza	  variants.	  USA,	  Hong	  Kong,	  Australia,	  and	  China	  were	  identified	  as	  the	  four	  most	  prominent	  seeding	   countries	   in	   that	   order	   (Figure	  13D,	   Supplementary	  Table	  D-­‐2).	   From	   the	  data,	   an	  inferred	   seeding	   hierarchy	   would	   begin	   with	   China	   at	   the	   epicenter	   of	   an	   E-­‐SE	   Asian	  influenza	  subnetwork.	  Our	  analysis	  supports	  China	  as	  the	  most	  predictive	  seeder	  of	  many	  Asian	  countries,	  including	  Hong	  Kong.	  Both	  China	  and	  Hong	  Kong	  then	  serve	  as	  a	  launching	  pad	  for	  the	  dispersal	  of	  new	  seasonal	  variants	  to	  the	  rest	  of	  the	  world65,66,	  in	  particular	  USA	  and	   an	   Oceanic	   subnetwork	   dominated	   by	   interchange	   between	   Australia	   and	   New	  Zealand.	  Viruses	  from	  USA,	  the	  largest	  seeder	  of	  the	  entire	  world,	  then	  spread	  to	  a	  number	  of	   South	   American,	   European,	   and	   African	   countries.	   Interestingly,	   Australia	   and	   Hong	  Kong	  are	  equally	  probable	  seeders	  of	  the	  USA	  (Figure	  13D).	  Detailed	  transmission	  events	  are	  enumerated	  in	  Supplementary	  Table	  D-­‐2.	  An	  inset	  of	  the	  Asian	  subnetwork	  is	  depicted	  in	  Figure	  14C,	  a	  demonstration	  of	  this	  study’s	  high	  geographic	  resolution.	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Figure	  16.	  Rankings	  of	   significant	   seeding	  and	   seeded	  climate	   zones	   for	  H3N2	  and	  H1N1	  using	  different	  graph	  
theory	  metrics.	  (A)	  The	  indegree	  and	  outdegree	  of	  a	  node	  represent	  the	  total	  number	  of	  seeding	  events	  into	  and	  
out	  of	  a	  region,	  respectively.	  Local	  seeding	  events	  depicted	  in	  gray	  play	  little	  role	  in	  overall	  seeding	  except	  in	  the	  
tropics.	  (B)	  Degree	  flow	  measures	  the	  difference	  between	  seeding	  events	  out	  of	  and	  into	  a	  node	  and	  determines	  
whether	   it	   is	  a	   terminal	  sink	  or	  source.	   (C)	  PageRank	  uses	  an	  algorithm	  similar	   to	   that	  employed	  by	  Google	   to	  
categorize	  nodes	  based	  on	  the	  number	  and	  quality	  of	  links	  pointing	  to	  that	  node.	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Figure	  17.	  Rankings	  of	  significant	  seeding	  and	  seeded	  continents	  for	  H3N2	  using	  different	  graph	  theory	  metrics.	  
(A)	  The	  indegree	  and	  outdegree	  of	  a	  node	  represent	  the	  total	  number	  of	  seeding	  events	  into	  and	  out	  of	  a	  region,	  
respectively.	  Local	  seeding	  events	  depicted	   in	  gray	  play	   little	  role	   in	  overall	  seeding	  except	   in	  Asia.	   (B)	  Degree	  
flow	  measures	   the	   difference	   between	   seeding	   events	   out	   of	   and	   into	   a	   node	   and	   determines	   whether	   it	   is	   a	  
terminal	  sink	  or	  source.	  (C)	  PageRank	  uses	  an	  algorithm	  similar	  to	  that	  employed	  by	  Google	  to	  categorize	  nodes	  
based	   on	   the	   number	   and	   quality	   of	   links	   pointing	   to	   that	   node.	   (D)	   Betweenness	   measures	   the	   number	   of	  
shortest	  paths	  in	  a	  network	  passing	  through	  a	  given	  node.	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Figure	   18.	   Graph	   theory	   metrics	   of	   significant	   seeding	   (left)	   continents	   and	   (right)	   countries	   for	   H3N2.	   (A)	  
Indegree	  and	  outdegree	  represent	  the	  total	  number	  of	  seeding	  events	  into	  and	  out	  of	  a	  region,	  respectively.	  
Internal	  seeding	  events	  (gray	  bars)	  play	  a	  minor	  role	  in	  overall	  seeding	  except	  in	  Asia.	  (B)	  Terminal	  
sinks/sources:	  Degree	  flow	  measures	  the	  difference	  between	  seeding	  events	  out	  of	  and	  into	  a	  node.	  (C)	  Waypoint	  
sinks/sources:	  PageRank	  categorizes	  nodes	  based	  on	  the	  number	  and	  quality	  of	  links	  pointing	  into	  and	  out	  of	  
that	  node.	  (D)	  Betweenness	  measures	  the	  number	  of	  shortest	  paths	  in	  a	  network	  passing	  through	  a	  given	  node.	  
	  
High	  Circulation	  between	  Tropical	  and	  Asian	  Countries	  with	  Minimal	  Local	  
Persistence	  
As	  can	  be	  seen	  with	  the	  world	  map	  plots	  (Figure	  14A,B),	  a	  natural	  representation	  of	  the	  global	  influenza	  network	  is	  a	  directed	  graph	  with	  each	  node	  representing	  a	  clustered	  region	  (climate,	  continent,	  and	  country)	  and	  each	  edge	  representing	  a	  seeding	  event	  with	  a	  weight	  equal	  to	  the	  number	  of	  significant	  seeding	  seasons.	  To	  quantify	  observed	  patterns,	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we	  employed	  principles	  of	  graph	  theory	  to	  measure	  the	  importance	  of	  nodes	  using	  four	  different	  metrics.	  	  
By	  counting	  the	  number	  of	  indegrees	  and	  outdegrees	  of	  each	  node	  for	  H3N2,	  we	  identified	  that	  the	  tropics	  and	  the	  northern	  temperate	  zone	  (Figure	  16A),	  specifically	  Asia	  and	  North	  America	  (Figure	  17A),	  transmit	  and	  receive	  the	  most	  seeding	  events	  to	  and	  from	  the	  rest	  of	  the	  world,	  respectively.	  In	  a	  similar	  manner,	  we	  identified	  USA,	  Hong	  Kong,	  Australia,	  and	  China	  as	  the	  greatest	  seeders,	  and	  USA,	  Japan,	  Australia,	  and	  Hong	  Kong	  as	  the	  most	  seeded	  (Figure	  18A).	  	  	  
In	  this	  analysis,	  we	  differentiated	  between	  internal	  (self-­‐seeding)	  and	  external	  (seeding	  between	  nodes)	  transmission	  events.	  Importantly,	  we	  can	  accurately	  detect	  internal	  events	  in	  temperate	  countries	  since	  their	  flu	  seasons	  are	  discrete.	  	  On	  the	  other	  hand,	  the	  specificity	  for	  internal	  events	  in	  the	  tropics	  is	  much	  lower	  due	  to	  unpronounced	  seasonal	  peaks.	  To	  minimize	  the	  number	  of	  local	  false	  positives,	  we	  demarcated	  seasons	  within	  the	  tropics	  on	  a	  per	  country	  basis.	  We	  found	  that	  for	  all	  climate	  zones	  except	  the	  tropics	  (Figure	  
16A)	  and	  all	  continents	  except	  Asia	  (Figure	  17A),	  the	  number	  of	  internal	  seeding	  events	  paled	  in	  comparison	  to	  the	  proportion	  of	  external	  seeding	  events.	  The	  more	  numerous	  internal	  events	  in	  the	  tropics	  and	  Asia	  indicate	  a	  high	  level	  of	  circulation	  between	  tropical	  countries	  and	  between	  Asian	  countries.	  This	  pattern	  is	  supported	  by	  the	  highly	  interconnected	  E-­‐SE	  Asian	  subnetwork	  depicted	  in	  Figure	  14C.	  The	  small	  proportion	  of	  internal	  events	  for	  countries	  supports	  the	  notion	  that	  local	  persistence	  often	  plays	  only	  a	  minor	  role	  in	  influenza	  transmission59-­‐61	  (Figure	  18A).	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Sinks	  and	  Sources	  within	  the	  Global	  Flu	  Network	  
Beyond	  the	  absolute	  number	  of	  seeding	  events,	  a	  region’s	  influence	  on	  global	  viral	  spread	  is	  also	  dependent	  on	  the	  topological	  structure	  of	  the	  graph	  itself.	  As	  an	  analogy,	  consider	  the	  influenza	  network	  as	  a	  system	  of	  connected	  train	  stations	  each	  representing	  a	  single	  region	  seeding	  influenza.	  In	  such	  systems,	  trains	  begin	  and	  end	  their	  routes	  at	  terminal	  stations.	  Similarly,	  influenza	  commuters	  begin	  their	  journeys	  at	  terminal	  sources	  and	  end	  at	  terminal	  sinks	  in	  each	  season.	  These	  start	  and	  end	  terminals	  can	  represent	  regions	  where	  new	  influenza	  variants	  respectively	  originate	  and	  ultimately	  spread	  to.	  To	  quantify	  the	  terminal	  characteristic,	  we	  calculated	  the	  outdegree	  minus	  the	  indegree	  of	  each	  node,	  which	  we	  term	  “degree	  flow.”	  Positive	  degree	  flow	  indicates	  terminal	  sources,	  while	  negative	  indicates	  terminal	  sinks.	  Countries	  were	  also	  ranked	  by	  calculating	  the	  proportion	  of	  nodes	  in	  a	  1,000	  randomized	  networks	  with	  a	  greater,	  or	  lesser,	  degree	  flow	  (Appendix	  C.	  Supplementary	  Text	  to	  “Network	  Analysis	  of	  Global	  Influenza	  Spread”).	  
For	  analysis	  by	  climate	  zone,	  the	  tropics	  was	  identified	  as	  the	  only	  terminal	  source,	  suggesting	  that	  flu	  spreads	  from	  the	  tropical	  belt	  outward	  to	  both	  temperate	  zones	  (Figure	  
16B).	  As	  for	  continental	  clustering,	  Asia	  was	  the	  only	  terminal	  source,	  indicating	  that	  global	  circulation	  begins	  in	  Asia	  and	  ends	  in	  terminal	  sink	  continents,	  of	  which	  North	  America	  was	  the	  most	  prominent	  (Figure	  17B).	  On	  a	  country	  level,	  Hong	  Kong	  and	  China	  were	  the	  greatest	  terminal	  sources,	  corroborating	  our	  observations	  (Figure	  13D).	  Australia	  was	  also	  a	  conspicuous	  terminal	  source,	  especially	  within	  the	  Oceanic	  subnetwork	  where	  it	  seeded	  the	  greatest	  terminal	  sink,	  New	  Zealand.	  Several	  South	  American	  countries,	  including	  Chile	  and	  Argentina	  ,	  figure	  as	  terminal	  sinks	  too,	  correlating	  with	  such	  countries	  as	  antigenically	  delayed	  59	  (Figure	  18B).	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Trains	  also	  stop	  at	  waypoint	  stations,	  which	  can	  be	  the	  junction	  of	  a	  large	  number	  of	  routes.	  Correspondingly,	  certain	  regions	  act	  as	  waypoint	  sources:	  important	  intermediate	  launch	  pads	  to	  other	  destinations.	  Others	  act	  as	  waypoint	  sinks:	  important	  points	  of	  convergence	  for	  multiple	  routes.	  Eigenvector	  centrality	  can	  gauge	  this	  property	  on	  the	  principle	  that	  connections	  to	  high-­‐scoring	  nodes	  contribute	  more	  to	  the	  score	  of	  the	  node	  in	  question	  than	  equivalent	  connections	  to	  low-­‐scoring	  nodes.	  We	  used	  a	  method	  akin	  to	  PageRank,	  Google’s	  method	  of	  assigning	  importance	  to	  web	  pages73.	  
Using	  this	  method,	  the	  northern	  temperate	  zone	  was	  the	  most	  important	  waypoint	  source	  and	  sink	  (Figure	  16C).	  Similarly,	  the	  predominantly	  northern	  temperate	  continents	  of	  North	  America	  and	  Europe	  were	  identified	  as	  prominent	  waypoint	  sources	  and	  sinks.	  Asia,	  however,	  was	  the	  greatest	  waypoint	  source	  but	  a	  poor	  waypoint	  sink,	  correlating	  with	  its	  role	  as	  a	  greater	  terminal	  source	  than	  North	  America	  or	  Europe	  (Figure	  17C).	  Interestingly,	  USA	  was	  both	  the	  greatest	  waypoint	  source	  and	  sink	  (Figure	  18C).	  	  
H1N1	  NA	  clustering	  by	  climate	  zone	  produced	  results	  similar	  to	  that	  of	  H3N2	  NA.	  The	  tropics	  consistently	  scored	  highest	  by	  seeding	  outdegree,	  positive	  degree	  flow,	  and	  PageRank	  source.	  In	  addition,	  the	  tropics	  possessed	  a	  large	  amount	  of	  internal	  seeding	  events.	  These	  results	  emphasize	  that	  similar	  to	  H3N2,	  H1N1	  circulates	  within	  the	  tropics	  across	  seasons	  only	  to	  spread	  eventually	  to	  the	  temperate	  zones.	  
	  
Disrupting	  the	  Global	  Flow	  of	  Influenza	  
Betweenness	  measures	  the	  number	  of	  shortest	  paths	  between	  any	  two	  vertices	  in	  a	  network	  that	  lie	  on	  a	  given	  node.	  In	  the	  context	  of	  influenza,	  increasing	  vaccinations	  in	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regions	  of	  high	  betweenness	  would	  hypothetically	  have	  the	  greatest	  effect	  on	  diminishing	  the	  spread	  of	  infection	  worldwide.	  This	  novel	  strategy	  contrasts	  with	  previous	  studies	  simulating	  containment	  only	  at	  the	  source	  of	  influenza74,75.	  For	  H3N2,	  this	  criteria	  highlighted	  Europe	  and	  North	  America	  as	  promising	  candidates	  for	  vaccination	  programs	  (Figure	  17D).	  Clustering	  by	  country	  revealed	  USA,	  Japan,	  and	  Australia	  as	  sites	  in	  the	  influenza	  network	  vulnerable	  to	  disruption	  (Figure	  18D).	  	  
Discussion	  Using	  statistical	  and	  network	  theory	  analysis,	  we	  analyzed	  H3N2	  and	  H1N1	  sequence	  data	  to	  determine	  the	  global	  spread	  of	  influenza.	  Our	  novel	  method	  employs	  two	  main	  strategies	  to	  eliminate	  geographic	  and	  seasonal	  bias:	  1)	  Spatiotemporal	  clustering	  of	  sequence	  data	  to	  count	  seeding	  events	  between	  clusters	  and	  2)	  Use	  of	  binomial	  prior	  probabilities	  based	  on	  the	  regional	  proportion	  of	  viral	  isolates	  to	  screen	  for	  significant	  seeding	  events.	  	  
Applying	   these	   techniques	   to	   coding	  HA	   and	  NA	   segments	   of	  H3N2	   by	   climate	   zone	   and	  continent	   revealed	   a	   seeding	   pattern	   stemming	   from	   the	   tropics,	   particularly	   Asia.	   HA1	  analysis	  produced	  a	  more	  detailed	  picture:	  each	  year,	  a	  wave	  of	  seasonal	  flu	  originates	  in	  China	  to	  feed	  an	  E-­‐SE	  Asian	  subnetwork.	  From	  there,	  China	  and	  Hong	  Kong	  seed	  two	  major	  subnetworks,	  each	  dominated	  by	  Australia	  and	  USA.	  	  
	  Similar	   clustering	   of	   H1N1	   NA	   sequences	   by	   climate	   zone	   reproduced	   tropical	  transmission	   to	   the	   rest	   of	   the	  world.	   However,	   due	   to	   inadequate	   geographic	   coverage,	  clustering	  H1N1	  by	  continent	  and	  country	  proved	  inconclusive	  with	  few	  significant	  seeding	  events	  detected.	  One	  explanation	  for	  these	  results	  is	  that	  important	  seeding	  countries,	  such	  as	  China	  and	  Hong	  Kong,	  were	   too	  underrepresented	   in	   the	  dataset.	  Alternatively,	   global	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patterns	  may	  be	  weaker	   for	  H1N1	  due	   to	   cross-­‐reactivity	   between	   the	   two	   strains67,68,	   a	  conclusion	  reflected	  by	  the	  smaller	  number	  of	  seeding	  events	  for	  the	  strain.	  	  
In	   our	   analysis,	   the	   total	   number	   of	   seeding	   seasons	   for	   each	   region	   did	   not	   necessarily	  correspond	   to	   the	   total	   number	   of	   isolates	   from	   each	   region,	   indicating	   that	   our	  methodology	   counters	   data	   bias.	   However,	   certain	   confounders	  may	   affect	   results.	   First,	  selection	   bias	   in	   sampling	   remarkable	   variants,	   such	   as	   patients	   suffering	   severe	   rather	  than	   mild	   or	   non-­‐symptomatic	   influenza,	   would	   poorly	   represent	   flu	   in	   the	   general	  population.	  Moreover,	  many	  sequences	  had	   to	  be	  excluded	   from	  our	  dataset	  due	   to	  poor	  annotation	   and	   lack	   of	   date	   information.	   Finally,	   although	   our	   probabilistic	  methodology	  accepts	  regional	  and	  temporal	  variability,	   it	  has	  low	  sensitivity	  for	  detecting	  anything	  but	  particularly	   significant	   seeding	   events	   for	   regions	   with	   very	   few	   sequences.	   This	   issue	  becomes	   important	   in	  analyses	  with	  regions	   that	  have	  no	  sequences	  whatsoever,	  as	  with	  near-­‐absent	  sequences	   from	  Hong	  Kong	  and	  China	   for	  H1N1	  HA.	  The	  persistence	  of	  such	  bias	   highlights	   the	   continuing	   need	   to	   sequence	   viruses	   in	   underrepresented	   areas,	  especially	  the	  tropics.	  	   	  
Each	   year,	   the	   current	   influenza	   vaccine	   is	   formulated	   separately	   for	   the	   Northern	   and	  Southern	   Hemisphere;	   one	   can	   surmise	   that	   two	   viral	   strains	   may	   not	   be	   enough	   to	  represent	  the	  entire	  pool	  of	   influenza	  strains	  around	  the	  world.	  Although	  there	  are	  many	  other	  economic	  and	  political	  concerns	  to	  consider,	  our	  methodology	  suggests	  several	  ways	  of	   guiding	   vaccine	   strain	   selection	   based	   on	   biological	   and	   epidemiological	   principles.	  Graph	   theory	  metrics—terminal	   and	  waypoint	   sinks	   and	   sources,	   as	  well	   as	   degree	   and	  betweenness	   centralities—pinpoint	   potential	   regions	   in	   which	   increased	   vaccinations	  could	   stem	   the	   transmission	   of	   influenza	   globally	   as	  well	   as	   locally.	   Increased	   analytical	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resolution	   could	   optimize	   vaccine	   design	   by	   choosing	   the	   dominant	   antigenic	   strain	   of	   a	  country’s	  most	  predictive	   seeder.	  Vaccines	   could	  be	   catered	   to	   each	   country,	   rather	   than	  each	  hemisphere.	  At	   the	  very	   least,	  our	  analysis	  advises	  strain	  selection	   from	  the	  tropics,	  from	   which	   seasonal	   strains	   are	   dispersed	   each	   year.	   On	   the	   other	   hand,	   local	   strain	  selection	  within	  a	  country	  should	  prove	  comparatively	  ineffective,	  as	  few	  viruses	  persist	  in	  the	  inter-­‐epidemic	  period	  to	  seed	  the	  following	  flu	  season.	  
Our	  analysis	  of	  terminal	  sources	  resonates	  with	  an	  old	  hypothesis	  that	  in	  southern	  China,	  zoonotic	  infection	  from	  live-­‐animals	  markets76	  selling	  in	  particular	  duck—a	  natural	  host	  of	  influenza77—combined	  with	  a	  dense	  population	  for	  sustained	  viral	  circulation,	  could	  be	  the	  main	  ingredients	  for	  the	  creation	  of	  new	  seasonal	  influenza	  variants.	  In	  support,	  two	  major	  acute	  respiratory	  infections—SARS78	  and	  H5N1/9779,80—have	  been	  definitively	  traced	  back	  to	  southern	  China,	  with	  Hong	  Kong	  serving	  as	  an	  important	  sentinel	  post	  for	  the	  rest	  of	  the	  world.	  Other	  influenza	  pandemics,	  1968	  H3N2	  (Hong	  Kong)76	  and	  even	  as	  early	  as	  1889	  pandemic	  influenza81,	  have	  suspected	  origins	  in	  southern	  China.	  	  
It	  would	  be	  interesting	  to	  dissect	  the	  factors	  that	  govern	  waypoint	  sources	  and	  sinks.	  For	  example,	  air	  travel	  and	  other	  transportation	  may	  play	  a	  major	  role	  in	  the	  dispersal	  of	  virus	  worldwide59,68,82,83.	  Many	  important	  hubs	  of	  the	  global	  flu	  network,	  including	  USA,	  Australia,	  Hong	  Kong,	  and	  China,	  have	  several	  of	  the	  world’s	  busiest	  airports84.	  Understanding	  the	  reasons	  for	  these	  seeding	  patterns	  may	  offer	  other	  strategies	  for	  arresting	  the	  movement	  of	  flu.	  	  
The	  advent	  of	  2009	  pandemic	  S-­‐OIV	  has	  largely	  depleted	  the	  number	  of	  seasonal	  H3N2	  and	  H1N1	   infections,	   most	   likely	   via	   cross-­‐reactivity	   between	   novel	   and	   seasonal	   strains71.	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Consequently,	  the	  conclusions	  of	  this	  paper	  may	  not	  necessarily	  apply	  to	  current	  dynamics	  of	   seasonal	   H3N2	   and	   H1N1.	   However,	   the	   fact	   that	   H1N1	   shares	   a	   tropic-­‐centric	  movement	   pattern	   with	   H3N2	   despite	   cross-­‐reactivity	   suggests	   that	   these	   patterns	  may	  still	   persist	   even	   in	   the	   presence	   of	   the	   cross-­‐reactive	   S-­‐OIV.	   Moreover,	   this	   paper	  demonstrates	  that	  when	  more	  sequence	  data	  is	  deposited	  in	  NCBI,	  a	  similar	  methodology	  can	  be	  applied	  to	  predict	  global	  circulation	  of	  S-­‐OIV	  as	  well.	  
Methods	  
Data	  All	   sequence	   data	   used	   in	   this	   study	  was	   publicly	   available	   from	   the	  National	   Center	   for	  Biotechnology	   Information	   database	   (NCBI)72.	   For	   each	   segment,	   only	   protein	   coding	  regions	  were	  considered.	  Furthermore,	  we	  only	  used	  sequences	  with	  full	  date	  (year,	  month	  and	  day)	  and	   location	   information	   to	  build	  hierarchies.	  Geographical	   coordinates	  of	   each	  isolate	  were	   obtained	   using	   geolocation	   information	   from	  Google	  Maps.	   Sequences	  were	  then	  aligned	  using	  the	  ClustalW	  v.	  1.83	  multiple	  sequence	  alignment	  package	  using	  default	  parameters	   for	  H3N2	  and	  H1N1,	   respectively.	  For	  each	  segment,	   sequences	  were	  aligned	  and	  those	  that	  were	  poorly	  aligned	  compared	  to	  the	  rest	  of	  the	  dataset	  were	  removed	  until	  all	   sequences	   aligned	   with	   a	   Hamming	   distance	   no	   greater	   than	   0.15.	   Given	   estimated	  mutation	   rates	   of	   6.7	   x	   10–3	   nucleotide	   substitutions	   per	   site	   per	   year63,68,	   Hamming	  distances	  over	  the	  20-­‐year	  span	  of	  our	  dataset	  are	  expected	  to	  be	  no	  more	  than	  0.15	  of	  the	  sequence	   length.	   Outlying	   sequences	   were	   most	   likely	   incorrectly	   sequenced	   and	   were	  discarded	  from	  analysis.	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Spatiotemporal	  clustering	  	  
Our	  methodology	  aimed	  to	  minimize	  data	  bias	  from	  geospatial	  and	  temporal	  variability	  	  	  in	  sequences	   from	   NCBI.	   First,	   we	   determined	   the	   most	   parsimonious	   evolutionary	   paths	  traversed	  by	   the	   flu	  virus.	  To	   this	  end,	  we	  sorted	  sequences	   from	  earliest	   to	  most	   recent	  viral	   isolates.	   Working	   backwards	   from	   newest	   to	   oldest,	   we	   calculated	   the	   sequence	  similarity	  of	  each	  virus	  to	  all	  earlier	  isolates	  regardless	  of	  geography.	  We	  defined	  a	  virus’s	  most	  likely	  ancestor	  to	  be	  the	  sequence	  with	  minimum	  Hamming	  distance.	  From	  this	  data	  we	   built	   evolutionary	   paths	   for	   each	   virus.	   Related	   sequences	  were	   clustered	   (grouped)	  together	  by	  common	  geography	  and	  season	  to	  simplify	  the	  paths.	  For	  example,	  a	  chain	  of	  related	  viruses	   in	   the	   same	   region	  and	   season	  would	  be	   collapsed	   into	  a	   single	  umbrella	  node	   representing	  all	   of	   them.	  Our	  analysis	  was	   then	  based	  on	   looking	  at	   the	   transitions	  between	  clusters	  rather	  than	  individual	  viruses.	  We	  counted	  these	  “seeding	  events,”	  where	  the	  closest	  ancestor	  of	  a	  given	  cluster	  of	  sequences	   is	   from	  a	  different	  region	  or	  season59	  (Figure	   11).	   When	   tallying	   seeding	   events,	   non-­‐unique	   solutions	   were	   not	   considered	  where	  a	  given	  viral	  isolate	  possessed	  multiple	  closest	  ancestors	  from	  different	  geographical	  zones	   or	   seasons	   (Appendix	   C.	   Supplementary	   Text	   to	   “Network	   Analysis	   of	   Global	  Influenza	  Spread”,	  Figure	  19).	  
Modeling	  transmission	  as	  a	  binomial	  process	  
The	  observed	  frequencies	  of	  seeding	  events	  between	  clusters	  were	  compared	  to	  expected	  frequencies	  based	  on	  the	  prior	  probability	  of	  randomly	  choosing	  a	  sequence	  from	  a	  given	  geographical	  zone	  in	  the	  past.	  Using	  the	  binomial	  distribution	  with	  the	  proportion	  of	  prior	  NCBI	   sequences	   as	   a	   binomial	   probability,	   a	   p-­‐value	   was	   calculated	   for	   observing	   more	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seeding	  events	  than	  expected.	  The	  best	  predictor	  of	  a	  seeding	  region	  for	  each	  season	  had	  the	  greatest	  ratio	  of	  observed	  to	  expected	  seeding	  events	  with	  a	  p-­‐value	  smaller	  than	  0.05	  (Figure	  12).	  	  
	  
Figure	  19.	  Non-­‐unique	  solutions	  per	  segment	  for	  H3N2	  and	  H1N1	  clustering	  by	  (A)	  climate	  zone,	  (B)	  continent,	  
and	   (C)	   country.	  The	  number	  of	   these	  non-­‐unique	  solutions	   increases	  with	   sequence	   length,	   conservation,	  and	  
geographic	  coverage.	  Due	  to	  greater	  genetic	  diversity,	  H1N1	  has	  fewer	  non-­‐unique	  solutions	  in	  all	  segments	  apart	  
from	  M1	  and	  M2.	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Chapter	  2:	  Algebraic	  topology	  of	  
pandemic	  influenza	  evolution	  	  
Section	  2.1:	  Introduction	  Pandemic	   influenza	   refers	   to	   strains	   endemic	   to	   animal	   hosts	   like	   avian	   and	   swine	   that	  obtain	   the	   requisite	   host-­‐determinant	   mutations	   to	   infect	   and	   adapt	   to	   human	   hosts,	  thereby	   spreading	   on	   a	   global	   scale.	   A	   calamitous	   example	   of	   a	   confirmed	   influenza	  pandemic	  was	   the	  Spanish	   flu	  epidemic	  of	  1918	   that	  claimed	   the	   lives	  of	  over	  60	  million	  people	  worldwide.	   In	  2009,	   a	   swine-­‐origin	  H1N1	  virus	  marked	   the	   first	   pandemic	   of	   the	  twenty-­‐first	   century.	   Such	   pandemics	   are	   often	   the	   result	   of	   reassortments	   that	   rapidly	  acquire	  the	  necessary	  functional	  alleles	  conferring	  heightened	  host	  infectivity	  or	  specificity.	  	  	  	  
However,	   despite	   the	   tremendous	   impact	   influenza	   bears	   on	   humans,	   the	   evolution	   of	  influenza	   is	  by	  no	  means	  human-­‐centric.	   In	   fact,	  waterfowl	  represents	   the	  virus’s	  natural	  reservoir	   perpetuating	   the	   vast	   biodiversity	   of	   influenza,	   including	   all	   different	   subtypes	  (H1	  to	  H14	  and	  N1	  to	  N9).	  In	  contrast	  to	  mammals,	  the	  wild	  duck	  shows	  no	  clinical	  signs	  upon	  infection	  of	  the	  virus,	  which	  replicates	  in	  the	  waterfowl	  gut	  and	  sheds	  through	  fecal	  matter	  in	  the	  water	  supply85.	  	  
In	  both	  humans	  and	  waterfowl,	  one	   important	   factor	  governing	  the	  replication	  cycle,	  and	  clinical	   symptoms,	   is	   viral	   attachment	   determined	   by	   hemagglutinin	   specificity	   for	   sialic	  acid	  residues	  on	  the	  surface	  of	  epithelial	  cells.	  Avian	  influenza	  recognizes	  sugars	  with	  an	  α-­‐2,3	  linkage,	  prevalent	  in	  the	  intestinal	  tract	  of	  birds.	  In	  contrast,	  human	  influenza	  binds	  α-­‐
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2,6-­‐sialic	  acid	  predominant	  in	  the	  human	  upper	  respiratory	  tract,	  begetting	  the	  classic	  flu-­‐like	  symptoms	  of	  cough,	  sore	  throat,	  and	  rhinorrea.	  Interestingly,	  pig	  trachea	  contains	  both	  types	  of	  sialic	  acids.	  This	  unique	  feature	  supports	  the	  mixing	  vessel	  theory	  that	  swine	  hosts	  provide	  a	  bridge	  for	  the	  adaptation	  of	  influenza	  virions	  from	  avian	  to	  human	  host	  through	  reassortment19.	  	  	  
However,	   host	   switching	   from	  waterfowl	   to	  human	  does	  not	  necessarily	   require	   a	   swine	  intermediate.	   In	   Hong	   Kong	   in	   1997,	   H5N1	   avian	   virus	  made	   its	   first	   introduction	   from	  poultry	   to	   human	   hosts.	   Since	   2003,	   a	   number	   of	   sporadic	   H5N1	   outbreaks	   with	   a	  suspected	   poultry	   intermediary	   have	   taken	   place	   among	   humans	   and	   other	   mammals,	  claiming	   as	   of	   January	   2012	   a	   high	   mortality	   rate	   of	   340	   deaths	   out	   of	   578	   confirmed	  human	  infections.	  As	  such,	  avian	  H5N1	  has	  displayed	  a	  high	  pathogenicity	  and	  productive	  infectivity	   in	   humans,	   but	   an	   inability	   for	   sustained	   transmission	   between	   humans.	   This	  characteristic	   epidemiology	   most	   likely	   derives	   from	   its	   specificity	   for	   α-­‐2,3-­‐sialic	   acids	  present	   at	   a	   low	   concentration	   in	   the	   human	   lower	   respiratory	   tract,	   leading	   to	   more	  flagrant	   symptoms	  of	  viral	  pneumonia.	  Recently,	   teams	   led	  by	  Kawaoka86	  and	  Fouchier87	  evolved	  H5N1	  within	  the	  laboratory	  through	  site-­‐directed	  mutagenesis	  and	  serial	  passage	  to	  create	  strains	  that	  were	  capable	  of	  transmission	  between	  ferrets,	  which	  display	  similar	  sialic	  acid	  distributions	  to	  humans.	  These	  findings	  demonstrate	  the	  pandemic	  potential	  of	  non-­‐seasonal	   strains	   like	   H5N1	   influenza.	   Most	   recently,	   a	   new	   H7N9	   avian	   influenza	  outbreak	  began	  in	  the	  Jiangsu	  province	  of	  China	  in	  April	  201388,	  resulting	  in	  32	  deaths	  out	  of	   131	   positive	   cases	   as	   of	  May	   8th,	   2013.	   Similar	   to	   the	  H5N1	   ferret	   studies,	   Zhu,	   et	   al.	  demonstrated	   that	   the	   current	   H7N9	   strain	   infects	   and	   transmits	   between	   ferrets,	  suggesting	  that	  human	  to	  human	  transmission	  has	  most	  likely	  already	  occurred89.	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In	  light	  of	  the	  potential	  damage	  that	  pandemic	  influenza	  can	  cause,	  it	  would	  be	  important	  to	   understand	   how	   these	   viral	   strains	   form.	   In	   particular,	   can	  we	   develop	   tools	   that	   can	  effectively	  detect	  reassortment?	  Beyond	  simple	  detection,	  is	  it	  possible	  to	  characterize	  the	  broad,	  global	  patterns	  of	  reassortment?	  More	  generally,	  can	  we	  understand	  how	  mutations	  and	   reassortment	   combine	   to	   alter	   the	   course	   of	   influenza	   evolution	   towards	   reaching	  pandemic	  status?	  All	  of	  these	  questions	  relate	  to	  a	  more	  fundamental	  notion	  of	  what	  is	  the	  topology	  of	  evolution.	  
	  
Figure	  20.	  Examples	  of	  a	  phylogenetic	  tree	  (top)	  and	  a	  reticulate	  tree	  (bottom)	  capturing	  vertical	  and	  horizontal	  evolution,	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structure	  called	  a	  phylogenetic	  tree.	  Figure	  20	  at	  top	  depicts	  a	  rooted	  tree	  where	  the	  root	  node	  at	   the	  apex	  represents	  an	  ancestral	  virus	   that	  propagates	  and	  diversifies	  over	   time,	  creating	  new	  clades	  or	  lineages	  in	  a	  branching	  pattern.	  
Phylogenetic	   trees,	  however,	  are	  not	  able	  to	  capture	  horizontal	  or	  reticulate	  evolutionary	  events,	  which	  occur	  when	  distinct	  clades	  merge	  together	  to	  form	  a	  new	  hybrid	  lineage.	  In	  the	  context	  of	   influenza,	  horizontal	  evolution	  occurs	   through	  reassortment.	  The	  resulting	  evolutionary	  representation	  is	  no	  longer	  a	  phylogenetic	  tree	  but	  a	  different	  structure	  called	  a	  “reticulate	  tree.”	  This	  structure	  is	  not	  a	  tree	  in	  the	  mathematical	  sense,	  which	  precludes	  the	   existence	   of	   cycles.	   A	   cycle	   in	   the	   reticulate	   tree	   corresponds	   to	   a	   single	   horizontal	  evolutionary	  event	  (Figure	  20,	  bottom).	  
To	   place	   these	   notions	   into	  more	   concrete	   terms,	  we	   can	   consider	   the	   example	   of	   triple	  reassortment	   in	   Figure	   21.	   Here,	   we	   consider	   three	   parental	   viruses	   with	   genomes	  comprised	   of	   three	   different	   genes	   and	   a	   unique	   phylogenetic	   history.	   All	   three	   can	  undergo	  a	  reassortment	  where	  each	  parental	  virus	  donates	  a	  different	  gene.	  The	  resulting	  reticulate	   tree	   is	   a	  merging	   of	   the	   three	   parental	   phylogenies.	   Here,	   we	   can	   see	   that	   no	  single	  phylogenetic	  tree	  can	  faithfully	  represent	  the	  evolutionary	  history	  of	  the	  reassortant.	  Yet,	  a	  number	  of	  influenza	  papers	  still	  persist	  in	  presenting	  the	  evolution	  of	  influenza	  as	  a	  phylogenetic	  tree,	  despite	  the	  high	  frequency	  of	  reassortment.	  However,	  this	  inconsistency	  may	  simply	  follow	  from	  the	  fact	  that	  there	  still	  exists	  no	  agreed	  upon	  way	  of	  constructing	  the	  reticulate	  tree.	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Figure	  21.	  Reticulate	  tree	  representing	  the	  reassortment	  of	  three	  parental	  strains.	  The	  reticulate	  tree	  (right)	  results	  from	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Figure	  22.	  Idealized,	  simplistic	  phylogenetic	  trees	  contrast	  with	  more	  realistic,	  complex	  reticulate	  trees.	  Figures	  
from	  Doolittle,	  1999	  90.	  	  To	  address	  these	  concerns,	  I	  propose	  a	  new	  mathematical	  structure	  that	  can	  capture	  both	  vertical	  and	  horizontal	  evolutionary	  events	  at	  the	  same	  time.	  This	  structure	  is	  based	  on	  the	  mathematical	   field	   of	   algebraic	   topology,	   which	   characterizes	   the	   global	   properties	   of	   a	  geometric	  object	  that	  are	  invariant	  to	  continuous	  deformation,	  that	  is	  stretching	  a	  bending	  an	   object	  without	   tearing	   or	   gluing	   any	   single	   part	   of	   it.	   These	   global	   properties	   include	  such	  notions	  as	  connectedness	  (the	  number	  of	  distinct	  connected	  components),	  as	  well	  as	  the	  number	  of	  holes.	  As	  an	  example,	  we	  can	  consider	  the	  continuous	  deformation	  between	  a	  coffee	  mug	  and	  a	  doughnut.	  To	  an	  algebraic	  topologist,	  these	  two	  objects	  are	  topologically	  equivalent	  because	  they	  are	  both	  a	  single	  connected	  component	  with	  a	  hole	  at	  the	  center	  (Figure	  23).	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Figure	  23.	  Linking	  algebraic	  topology	  to	  evolution.	  A	  coffee	  mug	  and	  a	  doughnut	  are	  topologically	  equivalent	  
because	  they	  can	  be	  continuously	  deformed	  into	  one	  another	  without	  destroying	  the	  important	  properties	  that	  
they	  are	  both	  a	  single	  connected	  component	  with	  a	  hole	  at	  the	  center.	  A	  phylogenetic	  tree	  can	  be	  compressed	  into	  
a	  point.	  The	  same	  cannot	  be	  done	  for	  a	  reticulate	  tree	  without	  destroying	  the	  hole	  at	  the	  center.	  	  We	  want	  to	  apply	  the	  same	  concepts	  to	  characterize	  the	  topology	  of	  evolution.	  In	  settings	  of	  vertical	  evolution,	  a	  phylogenetic	  tree	  can	  be	  continuously	  deformed	  into	  a	  single	  point	  or	  connected	  component.	  The	  same	  action	  cannot	  be	  performed	  for	  a	  reticulate	  tree	  without	  destroying	   the	   loops	   or	   cycles	   in	   the	   structure.	   The	   active	   hypothesis	   then	   is	   that	   the	  presence	  of	  these	  holes	  results	  directly	  from	  reassortment	  events	  (Figure	  23).	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border	   can	  be	   glued	   together	   at	   the	   top	   to	   create	   a	   hollow	   sphere.	   The	   two-­‐dimensional	  hole	  then	  corresponds	  to	  a	  void	  or	  cavity.	  Such	  holes	  can	  be	  constructed	  in	  similar	  manners	  in	  even	  higher	  dimensions.	  To	  be	  precise,	  we	  are	  interested	  in	  holes	  that	  are	  “irreducible”	  cycles,	   that	   is,	   a	   cycle	   in	   dimension	   k	   that	   does	   not	   serve	   as	   the	   boundary	   of	   a	   (k+1)-­‐dimensional	  object.	  We	  can	  then	  define	  a	  topological	  invariant	  called	  the	  “homology	  group”	  Hk	   as	   an	   algebraic	   structure	   that	   encompasses	   all	   holes	   in	   dimension	   k,	   and	   the	   “Betti	  number”	  bk	  is	  the	  count	  of	  these	  holes.	  Again,	  the	  mathematical	  term	  homology	  here	  should	  not	   be	   confused	  with	   the	   evolutionary	   term	   referring	   to	   traits	   inherited	   from	  a	   common	  ancestor.	   Since	   no	   single	   point	   can	   be	   the	   boundary	   of	   a	   one-­‐dimensional	   line,	   no	   zero-­‐dimensional	   hole	   exists.	   The	   H0	   group	   therefore	   addresses	   how	   many	   independent,	  unconnected	  components	  comprise	  a	  space.	  
	  
Figure	  24.	  Constructing	  holes	  from	  the	  simple	  objects	  of	  different	  dimensions.	  	  For	  our	  purposes,	  we	  can	  assume	  the	  evolution	  forms	  some	  topological	  space	  E.	  We	  never	  directly	   observe	  E;	   instead,	  we	   observe	   a	   sample	   of	   data	   points	   in	   E.	   This	   point	   cloud	   is	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specifically	   genomic	   sequences	   separated	   from	  each	  other	  by	   some	  genetic	  distance.	  The	  set	   of	   these	   data	   points	   and	   space	   E	   do	   not	   share	   the	   same	   topology.	   However,	   we	   can	  estimate	  the	  topology	  of	  E	  by	  defining	  a	  function	  B(x,ε),	  which	  is	  the	  ball	  centered	  at	  data	  point	  x	  with	  a	  radius	  of	  genetic	  distance	  ε.	  We	  can	  show	  that	  at	  some	  particular	  value	  of	  ε,	  the	  union	  of	  the	  balls	  centered	  at	  all	  data	  points	  shares	  the	  same	  topology	  as	  E	  (Figure	  25).	  	  
	  
Figure	  25.	  Approximating	  the	  unobserved	  topological	  space	  of	  evolution	  E.	  We	  observe	  a	  sample	  of	  data	  points.	  A	  
way	  to	  approximate	  topology	  of	  E	  is	  to	  consider	  the	  union	  of	  balls	  centered	  at	  each	  data	  point	  with	  a	  radius	  of	  ε.	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However,	  the	  topology	  of	  the	  union	  of	  balls	  is	  difficult	  to	  compute	  but	  can	  be	  estimated	  by	  constructing	   a	   corresponding	   topological	   space	   called	   a	   simplicial	   complex.	   In	   short,	   the	  simplicial	   complex	   is	   a	   set	   of	   points,	   lines,	   triangles,	   tetrahedra,	   and	   higher-­‐dimensional	  ‘’simplicies’’.	  The	  simplicial	  complex,	  like	  any	  topological	  space,	  can	  have	  holes	  of	  different	  dimensions	   in	   it	   (Figure	   26).	   There	   are	  many	   different	   ways	   to	   construct	   the	   simplicial	  complex.	  The	  simplest	  way	  is	  to	  create	  a	  Čech	  simplicial	  complex,	  where	  one	  constructs	  a	  line	  if	  any	  pair	  of	  balls	  intersects,	  a	  triangle	  if	  any	  triplet	  of	  balls	  intersects,	  etc.	  Therefore,	  at	  some	  value	  of	  ε,	  the	  resulting	  simplicial	  complex	  shares	  the	  same	  topology	  as	  the	  union	  of	  balls,	  and	  that	  of	  E	  as	  well	  (Figure	  25).	  	  
	  
Figure	  27.	  No	  single	  value	  of	  ε	  captures	  both	  small	  and	  big	  holes.	  As	  the	  radius	  of	  genetic	  distance	  ε	  increases,	  a	  
smaller	  hole	  is	  created	  to	  the	  left	  of	  the	  geometric	  object.	  This	  smaller	  hole	  is	  destroyed	  at	  the	  same	  value	  of	  ε	  as	  
another	  larger	  hole	  is	  created	  to	  the	  right	  of	  the	  object.	  Figure	  adopted	  from	  Dr.	  Michael	  Lesnick.	  	  
However, different scales of ε create different simplicial complexes and reveal different 
topological features, such as irreducible cycles. As	  shown	  in	  Figure	  27,	  no	  single	  value	  of	  ε	  can	  capture	   the	   small	   hole	   and	   the	   big	   hole	   at	   once.	   A more comprehensive approach would 
consider the set of all simplicial complexes over the entire parameter space of ε. For irreducible 
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cycle C, we can track when C exists over a filtration (subset) of simplicial complexes over a 
particular interval [aC,bC] of genetic distance ε. Here, aC and bC are defined as the birth and death 
of feature C. We can then perform persistent homology, which computes the homology groups 
of dimension k at all scales ε. This process can be depicted in a barcode plot, which shows a 
horizontal bar between ε=[aC,bC] for every independent object C in the homology group. 
Generally, bars that persist over a large interval of ε are not likely to derive from topological 
noise.	  Figure	  28	  presents	  examples	  of	  such	  barcode	  plots	  in	  dimension	  one	  and	  two.	  	  
	  
Figure	  28.	  Example	  of	  barcode	  plots	  in	  dimension	  0	  and	  1.	  Adopted	  from	  Dr.	  Michael	  Lesnick.	  	  Our	  aim	  then	  is	  to	  apply	  persistent	  homology	  to	  the	  study	  of	  evolution.	  We	  consider	  a	  set	  of	  genomic	   sequences	   and	   calculate	   the	   genetic	   distance	   between	   each	   pair	   of	   sequences.	  With	   a	   pairwise	   distance	   matirx,	   we	   can	   then	   calculate	   the	   homology	   groups	   across	   all	  genetic	  distances	  ε	  in	  different	  dimensions.	  We	  can	  refine	  our	  original	  hypothesis	  now	  and	  assert	   that	  zero-­‐dimensional	   topology	  provides	   information	  about	  vertical	  evolution.	  At	  a	  particular	  scale	  ε	  for	  example,	  b0	  represents	  the	  number	  of	  different	  strains	  or	  subclades.	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On	   the	   other	   hand,	   one-­‐dimensional	   topology	   provides	   information	   about	   horizontal	  evolution,	  since	  reticulate	  structures	  are	  characterized	  by	  loops.	  We	  also	  hypothesize	  that	  even	  higher-­‐dimensional	  homology	  groups	  Hi≥2	  result	  from	  multiple	  horizontal	  exchanges	  or	  complex	  reticulate	  events	  involving	  multiple	  parental	  strains.	  	  
We	  shall	  test	  this	  hypothesis	  with	  both	  experimental	  and	  simulated	  viral	  genomic	  data	  and	  find	   that	   we	   can	   uncover	   both	   known	   and	   novel	   evolutionary	   patterns	   of	   influenza.	  We	  shall	   see	   that	   zero-­‐dimensional	   topology	   recapitulates	   vertical	   evolutionary	   patterns,	  particularly	   the	  known	  evolutionary	   relationships	  of	  different	  HA	  subtypes.	  On	   the	  other	  hand,	   one-­‐dimensional	   holes	   capture	   horizontal	   evolutionary	   events,	   particularly	  reassortments	   in	   influenza.	   We	   can	   indeed	   capture	   particular	   reassortment	   events	   and	  identify	   the	   parental	   strains	   that	   contribute	   to	   the	   genomic	   exchange,	   as	   in	   H3N2	   and	  H1N1pdm	  influenza.	  Two-­‐	  and	  three-­‐dimensional	  topology	  capture	  complex	  reassortments	  between	   multiple	   parental	   viral	   strains,	   which	   cannot	   be	   directly	   represented	   with	   any	  single	   phylogenetic	   structure.	   For	   example,	   we	   directly	   infer	   the	   triple	   reassortment	  history	  of	  H7N9	  avian	  influenza	  from	  a	  two-­‐dimensional	  hole	  detected	  within	  the	  simplicial	  complex.	   Beyond	   simple	   detection,	   we	   can	   also	   elucidate	   the	   broad,	   global	   patterns	   of	  reassortment,	  such	  as	  whether	  there	  is	  a	  non-­‐random	  segregation	  of	  segments	  during	  any	  reassormtent	  event.	  We	  find	  that	  in	  the	  pool	  of	  avian	  influenza,	  the	  polymerase	  subunit	  and	  NP	   are	   significantly	   likely	   to	   cosegregate	   together.	   	   Finally,	   we	   can	   estimate	   the	   lower	  bounds	  of	  reassortment	  rates	  in	  influenza,	  as	  well	  as	  the	  rate	  of	  reticulate	  events	  in	  other	  viruses.	  We	  find	  that	   the	  reassortment	  rate	   in	  avian	   influenza	   is	  exceedingly	  high	  and	  far	  outstrips	   that	   of	   other	   influenza	   strains,	   and	   even	   other	   viral	   reticulate	   rates.	   These	  findings	   will	   be	   detailed	   in	   the	   following	   part	   of	   this	   chapter,	   “The	   Topology	   of	   Viral	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Section	  2.2:	  The	  Topology	  of	  Viral	  Evolution	  
	  
Summary	  
Horizontal genomic exchange, termed reticulate evolution, can confound phylogenetic 
construction from genomic data. Drawing from algebraic topology, we present a novel 
evolutionary analysis independent of phylogeny. We show that while clonal evolution can be 
summarized as a tree, reticulate evolution exhibits non-trivial topology of dimension greater than 
zero. Our method effectively characterizes RNA viruses undergoing clonal evolution, 
reassortment or recombination. Beyond simply detecting reticulation, we succinctly recapitulate 
the history of complex genetic exchanges involving more than two parental strains, such as the 
triple reassortment of H7N9 avian influenza and the formation of circulating HIV-1 
recombinants. In addition, we identify global patterns of reticulate evolution, including frequent 
PB2-PB1-PA-NP co-segregation during avian influenza reassortment. Finally, we bound the rate 
of reticulate events (i.e. twenty reassortments per year in avian influenza). Our method not only 
captures reticulate events precluding phylogeny, but also indicates the evolutionary scales where 
phylogenetic inference could be accurate. In sum,  
1. Topological data analysis can assess the validity of phylogenetic representations. 
2. Topological data analysis captures vertical and horizontal evolutionary events. 
3. We identify recombination of multiple parental strains and co-reassorting segments. 
4. Topological data analysis can estimate lower bounds of reticulate rates.	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Introduction	  In	  On	  the	  Origin	  of	   the	  Species	   in	   1859,	  Darwin	   first	   proposed	   the	   phylogenetic	   tree	   as	   a	  structure	   to	   describe	   the	   evolution	   of	   phenotypic	   attributes.	   Since	   then,	   the	   advent	   of	  modern	  sequencing	  technologies	  has	  spurred	  the	  development	  of	  a	  number	  of	  phylogenetic	  inference	   methods91-­‐93.	   Strictly	   speaking,	   the	   tree	   model	   assumes	   that	   ancestors	   of	  observed	   organisms	   undergo	   vertical,	   clonal	   evolution	   over	   a	   number	   of	   reproductive	  cycles.	   In	   nature	   however,	   horizontal,	   dubbed	   “reticulate”	   evolution,	   disobey	   this	  assumption.	   Examples of reticulate evolution include	   species	   hybridization	   in	   eukaryotes;	  lateral	   gene	   transfer	   in	   bacteria;	   recombination	   and	   reassortment	   in	   viruses;	   viral	  integration	  in	  eukaryotes;	  and	  fusion	  of	  genomes	  of	  symbiotic	  species	  (e.g.	  mitochondria).	  These	   horizontal	   genetic	   exchanges	   can	   create	   incompatibilities	   that	  mischaracterize	   the	  species	  tree94.	  Doolittle90	  argued	  that	  molecular	  phylogeneticists	  have	  failed	  to	  identify	  the	  “true	  tree	  of	   life”	  because	  the	  history	  of	   living	  organisms	  cannot	  be	  understood	  as	  a	   tree.	  One	  may	  then	  wonder	  what	  other	  mathematical	  structures	  beyond	  phylogeny	  can	  capture	  the	  richness	  of	  evolutionary	  processes.	  	  
Current	  techniques	  of	  detecting	  reticulate	  events	  can	  be	  roughly	  divided	  into	  phylogenetic	  and	   non-­‐phylogenetic	   methodologies.	   Phylogenetic	   methods	   detect	   incongruence	   in	   the	  tree	  structure	  of	  different	  segments,95,96	  often	  using	  a	  sliding	  window	  as	  in	  bootscan97	  and	  TOPAL98,99.	   Non-­‐phylogenetic	   methods	   probe	   for	   homoplasies	   (shared	   character	   traits	  independently	  arising	  in	  different	  lineages	  by	  convergent	  or	  parallel	  evolution) or	  similar	  inconsistencies	   in	   sequence	   alignment	   (e.g	   the	   Index	   of	   Association100,	   the	   homoplasy	  test101,	   the	   pairwise	   homoplasy	   index	   (PHI)102,	   neighbor	   similarity	   score	   (NSS)103,	   and	  MaxChi104).	   Although	  many	   of	   these	  methods	   are	   designed	   for	   sensitive	   identification	   of	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viral	  recombination	  and	  bacterial	  lateral	  gene	  transfer	  in	  particular,	  they	  do	  not	  provide	  a	  complete	  representation	  of	  the	  evolutionary	  process.	  	  
Perhaps	   phylogenetic	   networks	   exemplify	   the	   largest	   departure	   from	   trees, allowing 
multiple paths between any two leaves. These	   methods	   visualize	   incompatibilities	   of	  sequence	  patterns	  or	  tree	  topologies	  as	  reticulate	  cycles	  in	  a	  network105-­‐107.	  Only	  a	  subset	  of	  the	  field,	  evolutionary	  networks,	  is	  amenable	  to	  detection	  of	  reticulate	  events.	  However,	  major	   stumbling	   blocks	   abound	   for	   such	   methods.	   Although	   phylogenetic	   network	  structure	   is	   not	   necessarily	   unique,	   all	   current	   computational	   implementations	   produce	  only	  one	  network	  that	  may	  represent	  a	  sub-­‐optimal	  solution;	  results	  may	  even	  depend	  on	  factors	   as	   arbitrary	   as	   the	   ordering	   of	   samples	   in	   the	   data	  matrix107,108.	  Moreover,	  many	  methods	  have	  impractical	  running	  times	  for	  even	  small	  datasets,	  oftentimes	  due	  to	  the	  NP-­‐hard	  problem	  of	  determining	  the	  existence	  of	  a	  tree	  within	  the	  evolutionary	  network109.	  To	  account	   for	   these	   practical	   considerations,	   ad	   hoc	  methods	   simplify	   the	   search	   space	   of	  network	   structures:	   galled	   trees,	   k-­‐level	   networks,	   galled	   networks,	   tree-­‐child	   networks,	  and	   tree-­‐sibling	   networks.	   While	   some	   of	   these	   methods	   cease	   to	   be	   NP-­‐hard110,	   all	  prioritize	   computational	   tractability	  over	  biological	  modeling111.	   For	  example,	   galled	   tree	  networks	   minimize	   the	   number	   of	   inferred	   recombination	   events	   by	   ensuring	   that	  reticulation	   cycles	   share	   no	   nodes112.	   This	   ad	   hoc	   heuristic	   is	   appropriate	   only	   for	   low	  recombination	  rates	  and	  is	  not	  universally	  applicable.	  
Here,	  we	  propose	  a	  comprehensive	  and	  fast	  method	  of	  extracting	  large-­‐scale	  patterns	  from	  genomic	   data.	   The	   structure	  we	   propose	   is	   not	   a	   tree	   or	   a	   network,	   but	   a	   set	   of	   higher-­‐dimensional	   complexes	   with	   well-­‐defined	   topological	   properties.	   Using	   the	   recently	  developed	  branch	  of	  topological	  data	  analysis	  called	  persistent	  homology	  (throughout	  this	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paper,	  we	  will	   refer	   to	   the	  mathematical	   term	  of	   homology,	   not	   the	   notion	   of	   genetic	   or	  structural	   similarity),	   we	   extract	   robust	   global	   features	   from	   these	   high-­‐dimensional	  complexes.	  Unlike	  phylogenetic	  methods	  that	  produce	  a	  single,	  possibly	  suboptimal	  tree	  or	  network,	   persistent	   homology	   considers	   all	   topologies	   and	   their	   relationships	   across	   the	  entire	   parameter	   space	   of	   genetic	   distance.	   Through	   analysis	   of	   viral	   and	   simulated	  genomic	  datasets,	  we	  show	  how	  persistent	  homology	  captures	  fundamental	  aspects	  of	  the	  evolutionary	  process	  that	  are	  not	  directly	  inferred	  from	  phylogeny.	  In	  addition	  to	  providing	  an	   evolutionary	   representation	   even	   in	   cases	   of	   reticulations,	   persistent	   homology	   can	  determine	  the	  rate	  of	  horizontal	  genomic	  events,	  complex	  exchanges	  involving	  more	  than	  two	   organisms,	   and	   statistical	   patterns	   of	   co-­‐segregation	   (genes	   more	   likely	   to	   be	  exchanged	   as	   a	   set).	  We	   calibrate	   our	  method	   using	   viral	   genomes	   since	   they	   are	   richly	  sampled	   and	   annotated,	   with	   a	   wide	   range	   of	   reticulate	   events;	   however,	   we	   foresee	   a	  broader	  application	  of	  persistent	  homology	  to	  bacteria,	  eukaryotes,	  and	  other	  datasets.	  	  
Results	  
Persistent	  homology	  in	  evolution	  
Topology	  is	  a	  mathematical	  field	  that	  characterizes	  the	  global,	  robust	  properties	  of	  spaces	  that	  are	  preserved	  during	  continuous	  deformation.	  Such	  properties	  include	  connectedness	  and	  the	  presence	  of	  holes;	  for	  instance,	  a	  donut	  can	  be	  stretched	  into	  the	  shape	  of	  a	  coffee	  cup	  without	  destroying	   their	  common	  topological	  characteristic	  of	  a	  hole.	  The	  subfield	  of	  algebraic	  topology	  in	  particular	  computes	  a	  set	  of	  algebraic	  structures,	  such	  as	  groups,	  that	  captures	  the	  essential	  aspects	  of	  a	  shape.	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Figure	  29.	  Building	   simplicial	   complexes	   in	   two-­‐dimensional	   and	   three-­‐dimensional	   space.	  A,	  B,	   and	  C	   refer	   to	  
two	  dimensions,	  and	  D,	  E,	  and	  F	  refer	  to	  three.	  A,	  D)	  Data	  points	  plotted	  in	  space.	  B,	  E)	  The	  distance	  ε	  from	  each	  
data	  point	  is	  considered	  and	  steadily	  increased.	  These	  distances	  can	  be	  visualized	  as	  circles	  of	  radius	  ε.	  ε	  =	  0.5,	  1,	  
and	  1.5	  is	  shown.	  C,	  F)	  Simplicial	  complexes	  are	  constructed	  based	  on	  the	  rule	  that	  two	  points	  within	  ε	  form	  a	  line	  
(1-­‐simplex),	  three	  points	  within	  ε	  of	  each	  other	  form	  a	  triangle	  (2-­‐simplex),	  and	  four	  points	  form	  a	  tetrahedron	  
(3-­‐simplex).	   In	  C,	  a	  one-­‐dimensional	   loop	  (b1	  =	  1)	   is	  created	  when	  ε	  =	  1	  and	  disappears	  by	  ε	  =	  1.5.	   In	  F,	  a	   two-­‐
dimensional	  cavity	  (b2	  =	  1)	  is	  created	  when	  ε	  =	  1	  and	  disappears	  (cavity	  is	  filled	  in)	  by	  ε	  =	  1.5.	  
	  	   82	  
In practical situations, we often observe only a sample of data points with some relationship 
between them. We can approximate the topology of the true space by constructing a topological 
space called a “simplicial complex” from the sample of observed data points113-­‐115.	  These	  data	  points	   in	   a	   metric	   space	   can	   be	   represented	   by	   a	   topological	   space	   called	   a	   “simplicial	  complex.”	  At	  a	  particular	  scale	  parameter	  ε	   (filtration	  distance),	  a	   simplicial	   complex	   is	  a	  set	  of	  objects:	  points,	  lines,	  triangles,	  tetrahedrons,	  etc.	  where	  two	  points	  form	  a	  line	  if	  they	  are	  closer	  than	  ε,	  three	  points	  form	  a	  triangle	  if	  all	  pairwise	  distances	  are	  less	  than	  ε,	  etc.	  From	   this	   complex,	   we	   can	   compute	   topological	   invariants	   called	   “homology	   groups”	   at	  different	  dimensions.	  The	  homology	  group	  in	  dimension	  i	  can	  be	  intuitively	  understood	  as	  the	   count	   of	   independent	   objects	   of	   dimension	   i	   that	   are	   irreducible—i.e.,	   cannot	   be	  connected	   through	   an	   (i+1)-­‐dimensional	   object	   embedded	   in	   the	   topological	   space.	   For	  instance,	  the	  zero-­‐dimensional	  homology	  group	  is	  generated	  by	  points	  (0-­‐D)	  that	  cannot	  be	  connected	   by	   lines	   (1-­‐D),	   such	   as	   with	   unconnected	   clusters	   of	   connected	   points.	   One-­‐dimensional	  homology	  is	  generated	  by	  lines	  that	  cannot	  be	  connected	  or	  filled	  in	  by	  a	  two-­‐dimensional	  surface,	  such	  as	  with	  loops	  or	  holes	  in	  the	  space	  (Figure	  29A).	  Two-­‐dimensional	  homology	   is	   generated	   by	   triangles	   bounding	   a	   void/cavity	   that	   cannot	   be	   filled	   in,	  producing	  a	  two-­‐dimensional	  hole	  (Figure	  29).	  	  	  	  
The	  count	  of	   the	   independent	  objects	   in	  each	  homology	  group	  of	  dimension	   i	   is	   the	  Betti	  number	   bi.	   These	   Betti	   numbers	   represent	   the	   global	   structure	   of	   point	   cloud	   data	   by	  counting	   trivially	   (i=0)	   the	   number	   of	   connected	   components	   and	   non-­‐trivially	   (i>0)	   the	  topological	   i-­‐dimensional	   holes	   in	   the	   data	   at	   a	   particular	   scale	   ε.	   The	   main	   goal	   of	  “persistent	  homology”	  then	  is	  to	  capture	  the	  topology	  of	  the	  data	  through	  Betti	  numbers	  not	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at	  a	  particular	  filtration	  value,	  but	  at	  all	  scales	  ε.	  This	  process	  can	  be	  depicted	  in	  a	  barcode	  plot,	  which	  shows	  a	  bar	  for	  every	  independent	  object	  at	  a	  given	  ε	  in	  dimension	  i115.	  	  
	  
Figure	   30.	   Barcoding	   characterizes	   topological	   features	   of	   vertical	   and	   horizontal	   evolution.	   Evolution	   was	  
simulated	  with	  and	  without	  reassortment	  (see	  Methods).	  A)	  A	  metric	  space	  of	  pairwise	  genetic	  distances	  can	  be	  
calculated	   for	   a	   given	   population	   of	   sequences.	   We	   visualize	   these	   data	   points	   using	   principal	   coordinate	  
analysis.	  B)	  For	  a	  given	  genetic	  distance	  ε,	   simplicial	   complexes	  can	  be	  constructed	   from	  the	  sequence	  dataset	  
(see	  Methods).	   The	   Betti	   number	   at	   different	   dimensions	   captures	   the	   topological	   features	   of	   these	   simplicial	  
complexes	  at	  different	  ε.	  A	  loop	  (red	  highlight)	  exists	  at	  ε	  =	  [0.13,	  0.16	  Hamming	  distance]	  and	  corresponds	  to	  a	  
reticulate	   event.	   The	   evolutionary	   scales	   I	   where	   b1	   =	   0	   are	   highlighted	   in	   grey.	   C)	   Valid	   only	   under	   clonal	  
evolution,	   phylogenetic	   trees	   are	   continuously	   deformable	   to	   a	   point	   where	   only	   b0	   is	   one	   and	   no	   higher-­‐
dimensional	   topology	   exists.	   Reticulate	   structures	   that	   incorporate	   horizontal	   evolutionary	   events	   are	  
continuously	  deformable	  into	  at	  least	  one	  loop,	  in	  which	  b1	  >	  0.	  	  How	   can	   we	   apply	   these	   principles	   to	   find	   global	   features	   in	   genomic	   data	   without	  imposing	   phylogenetic	   representation?	   Figure	   30	   depicts	   the	   application	   of	   our	  method	   to	  two	  populations	  of	  closely	  related	  organisms,	  one	  that	  only	  undergoes	  clonal	  evolution	  and	  another	   that	   exhibits	   recombination	   as	   well.	   The	   genomes	   of	   these	   organisms	   can	   be	  visualized	  as	  points	  in	  a	  high-­‐dimensional	  space	  (A).	  Persistent	  homology	  accepts	  as	  input	  a	   pairwise	   distance	   matrix.	   At	   different	   scales,	   these	   distances	   can	   be	   translated	   into	   a	  filtration	  (set)	  of	   simplicial	   complexes	  whose	   irreducible	  components	  are	  represented	  by	  barcodes	   (B).	   In	   the	   construction	   of	   simplicial	   complexes,	   two	   genomes	   are	   considered	  related	  (joined	  by	  a	  line),	  if	  the	  genetic	  distance	  between	  them	  is	  smaller	  than	  the	  scale	  ε.	  	  From	  there,	  we	  can	  calculate	  the	  homology	  at	  different	  genetic	  scales.	  At	  a	  particular	  scale	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ε,	   the	   zero-­‐dimensional	   Betti	   number	   represents	   the	   number	   of	   different	   strains	   or	  subclades;	   the	   one-­‐dimensional	   represents	   reticulate	   exchanges	  between	   two	  organisms;	  and	  higher-­‐dimensional	  numbers	  represent	  multiple	  or	  complex	  exchanges.	  For	  example,	  a	  reassortment	  manifests	  as	   the	  highlighted	  red	   loop	  corresponding	  to	  b1	  =	  1	   for	  ε	  =	  [0.13,	  0.16]	  in	  Figure	  30B.	  If	  the	  set	  of	  genomes	  permits	  a	  phylogenetic	  representation	  as	  in	  clonal	  evolution,	   then	   higher-­‐dimensional	   Betti	   numbers	   should	   vanish,	   since	   the	   topology	   of	   a	  tree	  can	  be	  compressed	  into	  a	  point.	  On	  the	  other	  hand,	  non-­‐zero	  higher-­‐dimensional	  Betti	  numbers	  indicate	  the	  existence	  of	  “irreducible	  cycle”	  created	  by	  reticulate	  evolution;	  these	  loops	   cannot	   be	   continuously	   deformed	   into	   a	   point	   without	   changing	   the	   topological	  structure,	  i.e.	  destroying	  the	  hole	  (C).	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Table	  2.	  Dictionary	  between	  persistent	  homology	  and	  evolutionary	  concepts.	  
Persistent	  homology	   Viral	  evolution	  Filtration	  value	  ε	   Genetic	  distance	  (evolutionary	  scale)	  0-­‐dimensional	  Betti	  number	  at	  filtration	  value	  ε	   Number	  of	  clusters	  at	  scale	  ε	  Generators	  of	  0-­‐dimensional	  homology	   A	  representative	  element	  of	  the	  cluster	  Hierarchical	  relationship	  among	  generators	  of	  0-­‐	  dimensional	  homology	   Hierarchical	  clustering	  1-­‐dimensional	  Betti	  number	   Number	  of	  irreducible	  recombination/reassortment	  events	  Generators	  of	  1-­‐dimensional	  homology	   Recombinant/reassortant	  events	  Generators	  of	  2-­‐dimensional	  homology	  	   Complex	  horizontal	  genomic	  exchange	  Non-­‐zero	  high-­‐dimensional	  homology	  (topological	  obstruction	  to	  phylogeny,	  or	  TOP)	   No	  phylogenetic	  representation	  Number	  of	  higher-­‐dimensional	  generators	  in	  a	  given	  time	  frame	  (irreducible	  cycle	  rate,	  or	  ICR)	   Lower	  bound	  on	  recombination/reassortment	  rate	  
	  
Topological	  obstruction	  to	  phylogeny	  
By	   definition,	   phylogenetic	   trees	   cannot	   contain	   cycles;	   therefore,	   higher-­‐dimensional	  irreducible	   cycles	   in	   a	   simplicial	   complex	   constructed	   from	   genomic	   data	   preclude	  phylogenetic	   construction	   at	   a	   given	   filtration	   ε.	   This	   intuition	   can	   be	   mathematically	  proven	  for	  irreducible	  cycles	  in	  dimension	  1	  and	  higher	  (see	  Supplementary	  Theorem	  2.1	  in	   publication).	  We define an additive tree as a phylogeny where the distance between two 
leaves is the sum of the branch lengths connecting them. If there exists a non-zero Betti	  number	  
of dimension greater than zero then no additive tree exists that can appropriately represent the 
genomic data. 
In the same way that bi>0 serves as a measure of deviation from tree additivity for a single 
simplicial complex, it would be useful to have some quantity that indicates how much a filtration 
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of simplicial complexes deviates from additivity. One possibility is to consider the distribution B 
of bar lengths of k-dimensional irreducible cycles for some k>0. A measure of deviation from 
additivity then could be an L-norm of B. We define the topological obstruction to phylogeny 
(TOP) to be the L-∞ norm, or maximum, of B. If TOP does not equal zero, then no additive tree 
exists that can appropriately represent the data. Other possible measures include the L-1 norm 
(the summation of B) and L-0 norm (the number of bars). In simulations of evolutionary data 
that we discuss later, we find that L-0 and L-1 are most proportional to the rate of reticulate 
events.  
A related concept is the set of genetic distances I where non-zero topology vanishes. I reflects 
the evolutionary scales at which there is no evidence of reticulate exchange that can confound 
phylogenetic construction (Figure	  30B). 
Another important	   concept	   is	   stability:	   the	   amount	   of	   fluctuation	   in	   the	   results	   stemming	  from	   small	   perturbations	   in	   the	   original	   data	   resulting	   from	   statistical	   noise,	   sequencing	  errors	   or	   incomplete	   sampling.	   We	   show	   that	   TOP	   is	   indeed	   a	   stable	   measure	   that	   is	  bounded	   by	   the	   Gromov-­‐Hausdorff	   distance	   to	   the	   additive	   tree	   (see	   Supplementary	  Theorem	   2.2	   in	   publication).	   As	   additive	   structures	   have	   vanishing	   higher-­‐dimensional	  homology,	   small	   deviations	   from	   additivity	   can	   only	   generate	   small	   bars	   in	   the	   barcode	  plot.	  	  
Topological	  estimates	  of	  recombination/reassortment	  rates	  
Most	  approaches	  to	  estimating	  recombination	  rates	  are	  based	  on	  observed	  variance	  in	  site	  differences	  between	  pairs	  of	  haplotypes116	  or	  maximum	  likelihood	  estimators117.	  Typically,	  these	   estimators	   assume	   constant	   population	   size,	   panmictic	   populations,	   and	   constant	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rates.	  Persistent	  homology,	  on	  the	  other	  hand,	  provides	  a	   lower	  bound	  for	   these	  rates	  by	  counting	   the	   number	   of	   independent	   irreducible	   cycles	   for	   all	   ε	   in	   the	   period	   of	   time	  considered.	  The	  irreducible	  cycle	  rate	  ICR	   then	  is	  defined	  as	  the	  average	  number	  of	  these	  irreducible	  cycles	  per	  unit	  of	  time,	  
	  ICR	  =	  (total	  number	  of	  one-­‐dimensional	  bars	  for	  all	  ε)	  /	  (time	  frame)	  
The numerator of this quantity is the same as the L-0 norm of higher dimensional bars. We	  normalized	  ICR	  based	  on	  the	  time	  interval	  between	  the	  earliest	  5%	  and	  most	  recent	  5%	  of	  the	  sequence	  dataset.	  We	  will	  see	  from	  simulations	  that	  ICR	  is	  proportional	  to	  and	  provides	  a	  lower	  bound	  for	  the	  rate	  of	  recombination/reassortment.	  In	  this	  way,	  sequence	  data	  adds	  a	   temporal	   dimension	   to	   our	   methodology,	   a	   unique	   aspect	   not	   shared	   by	   other	  applications	  of	  algebraic	  topology.	  
Detection of simulated reticulate events To	   evaluate	   the	   sensitivity	   and	   specificity	   of	   persistent	   homology	   to	   capture	   complex	  evolutionary	   processes,	   we	   simulated	   four	   scenarios:	   clonal	   evolution,	   population	  admixture,	   reassortment,	   and	   homologous	   recombination.	   Each	   simulation	   represents	   a	  population	  of	  constant	  size	  that	  evolves	  with	  each	  generation	  under	  a	  Wright-­‐Fisher	  model	  with	  a	  substitution	  rate	  μ	  and	  reassortment/recombination	  rate	  r	  (see	  Methods).	  We	  tested	  a	   variety	   of	   population	   sizes,	   substitution	   rates	   μ,	   recombination/reassortment	   rates	   r,	  numbers	  of	  reassorting	  segments	  S,	  and	  subsamples	  with	  or	  without	  ancestral	  sequences.	  
To	   illustrate	   how	   persistent	   homology	   captures	   reticulate	   events,	   we	   first	   modeled	   a	  population	  undergoing	  clonal	  evolution	  for	  30	  generations	  with	  random	  admixture	  through	  reassortment	  at	  time	  step	  15.	  Figure	  31A-­‐B	  shows	  a	  representative	  simulation	  and	  highlights	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the	   ancestral	   lineages	   of	   reassorting	   sequences	   as	   well	   as	   their	   closely	   related	   isolates.	  When	  we	  apply	  persistent	  homology	  to	  cumulative	  datasets	  from	  time	  steps	  1	  to	  t	  such	  that	  ancestral	   sequences	   are	   included	   (from	   100	   to	   3000	   sequences),	   no	   higher-­‐dimensional	  structure	  (b1	  >	  0)	  can	  be	  observed	  until	  the	  reassortment	  at	  t=15	  (Figure	  31C).	  However,	  2-­‐D	  topology	  remains	  trivial	  over	  the	  entire	  time	  and	  genome	  (not	  shown).	  We	  can	  also	  detect	  the	  admixture	  event	  by	  analyzing	  sequences	  at	  time	  step	  15	  without	  ancestral	  sequences.	  In	  this	  example,	  the	  one-­‐dimensional	  generator	  positively	  identifies	  all	  reassortants	  (Figure	  




	  	   89	  
	  
Figure	  31.	  Representative	  simulation	  of	  a	  single	  admixture	  event.	  The	  simulation	  followed	  a	  Wright-­‐Fisher	  model	  
with	  a	  constant	  population	  size	  of	  30	  sequences	  of	  1,000	  nucleotides	  each	  for	  15	  generations	  with	  μ=0.005	  
substitutions	  per	  site	  per	  generation.	  In	  addition,	  we	  simulated	  a	  single	  recombination	  event	  at	  time	  step	  15	  such	  
that	  four	  random	  sequences	  exchanged	  half	  their	  genomes	  between	  themselves	  randomly.	  A)	  Representation	  of	  
the	  evolutionary	  model	  of	  a	  single	  admixture	  across	  generations.	  The	  ancestral	  lineages	  of	  the	  four	  reassortants	  
and	  two	  closely	  related	  isolates	  are	  highlighted.	  B)	  An	  equivalent	  depiction	  of	  these	  lineages.	  C)	  Persistent	  
homology	  analysis	  for	  cumulative	  datasets	  from	  time	  step	  1	  to	  t	  (including	  ancestral	  sequences)	  reveals	  no	  one-­‐
dimensional	  topological	  structure	  until	  t=15.	  D)	  Persistent	  homology	  of	  generation	  15	  (without	  ancestral	  
sequences)	  identified	  a	  one-­‐dimensional	  generator	  [96.0,	  126.0):	  [3,6]	  +	  [3,4]	  +	  [5,6]	  +	  [1,4]	  +	  [1,2]	  +	  -­‐[5,2].	  This	  
generator	  of	  sequences	  represents	  an	  irreducible	  cycle	  of	  reassortants	  1,	  3,	  4,	  and	  5,	  as	  well	  as	  closely	  related	  
isolates	  2	  and	  6.	  This	  generator	  is	  depicted	  via	  principal	  coordinate	  analysis.	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Figure	  32.	  Topological	  obstruction	  (TOP)	  and	  irreducible	  cycle	  rate	  (ICR)	  of	  simulated	  reticulate	  events.	  TOP	  and	  
ICR	  during	  simulated	  reassortment	  and	  recombination.	  Simulations	  were	  performed	  at	  different	  mutation	  and	  
reassortment/recombination	  rates.	  TOP	  was	  calculated	  as	  the	  maximum	  barcode	  length	  in	  both	  dimension	  1	  and	  
2.	   ICR	   was	   calculated	   as	   the	   number	   of	   barcodes	   in	   either	   dimension	   1	   and	   2,	   normalized	   by	   the	   maximum	  
genetic	   distance	   creating	   a	   barcode.	   A)	   TOP	   during	   reassortment.	   B)	   ICR	   during	   reassortment.	   C)	   TOP	   during	  
recombination.	  D)	  ICR	  during	  recombination.	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We	  next	  considered	  evolution	  over	  a	  range	  of	  values	  for	  μ	  and	  r.	  Here,	  we	  considered	  two	  different	   indicators	   of	   high-­‐dimensional	   homology:	   the	   size	   of	   the	   longest	   non-­‐zero	  dimensional	  bar	  (TOP)	  (Figure	  32A-­‐B,	  E-­‐F),	  and	  the	  rate	  of	  non-­‐trivial	  homology	  generators	  in	  a	  higher	  dimension	  (ICR)	  (Figure	  32C-­‐D,	  G-­‐H).	  	  The	  simulations	  clearly	  show	  that	  (1)	  non-­‐trivial	  homology	  appears	  when	  r	   is	  non-­‐zero;	  (2)	  one-­‐dimensional	   ICR	  increases	   in	  direct	  proportion	   to	   r;	   and	   (3)	   multiple	   reassortment/recombinant	   events	   can	   produce	   two-­‐dimensional	  topology.	  	  
	  
Figure	   33.	   Comparative	   analysis	   of	   methods	   detecting	   reticulate	   evolution	   for	   a	   single	   admixture	   event.	   We	  
investigated	   the	   performance	   of	   persistent	   homology	   compared	   to	   NSS,	   PHI,	   and	   MaxChi.	   Simulation	   was	  
performed	  with	  a	  single	  reassortment	  event	  occurring	  at	  t=15.	  For	  comparison,	  we	  normalized	  1-­‐D	  TOP	  and	  ICR	  
to	  one.	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Figure	   34.	   Persistent	   homology	   of	   reassortments	   between	   multiple	   parental	   strains.	   We	   consider	   different	  
populations	   of	   dinucleotide	   genomes	   of	   5000	   bases	   comprised	   of	   S	   number	   of	   segments.	   We	   evolve	   these	  
sequences	  at	  a	  constant	  mutation	  rate	  of	  0.03	  substitutions	  per	  site	  per	  time	  step.	  At	  time	  step	  15,	  we	  performed	  
a	  complex	  reassortment	  such	  that	  for	  half	  the	  population,	  each	  segment	  reassorts	  independently.	  We	  performed	  
1000	   trials	   for	   each	   number	   of	   segments	   S	   from	   1	   to	   4.	   We	   plotted	   the	   average	   TOP	   and	   ICR	   for	   sequences	  
isolated	  from	  time	  steps	  14	  and	  15.	  In	  nature,	  complex	  reassortments	  may	  arise	  between	  multiple	  parental	  strains.	  To	  simulate	  this	  phenomenon,	  we	  considered	  populations	  with	  a	  variable	  number	  of	  segments	  S	  in	  their	  genomes	  evolving	  under	  a	  constant	  molecular	  clock.	  At	  time	  step	  15,	  we	  performed	  a	  single	  reassortment	  such	  that	  each	  segment	  reassorts	  independently	  among	  half	  the	  population.	  We	   plotted	   the	   average	   higher-­‐dimensional	   TOP	   and	   ICR	   as	   the	   number	   of	   segments	   S	  increases	   (Figure	   34).	   Once	   again,	   we	   see	   substantial	   one-­‐dimensional	   structure	   for	   any	  type	   of	   reassortment	   (S>1).	   Interestingly,	   we	   see	   two-­‐dimensional,	   and	   at	   times	   three-­‐dimensional,	   topology	   only	   for	   more	   complex	   reassortments	   of	   S>2.	   This	   result	  demonstrates	   persistent	   homology’s	   ability	   to	   detect	   reassortments	   between	   multiple	  parental	  strains,	  a	  feature	  not	  shared	  by	  NSS,	  PHI,	  MaxChi,	  or	  any	  other	  method.	  As	  we	  will	  see,	  determining	  the	  generators	  that	  produce	  these	  2-­‐D	  and	  3-­‐D	  holes	  promises	  to	  identify	  the	  different	  strains	  involved	  in	  these	  complex	  reassortments.	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Figure	   35.	   Reconstructing	   phylogeny	   from	   persistent	   homology	   of	   avian	   influenza	   HA.	   A)	   Barcoding	   plot	   in	  
dimension	   0	   of	   avian	   influenza	  HA	   of	   all	   subtypes.	   Each	   bar	   represents	   a	   connected	   0-­‐dimensional	   simplex	   of	  
sequences	  given	  a	  filtration	  Hamming	  distance	  of	  ε.	  When	  a	  bar	  ends	  at	  a	  given	  ε,	  it	  merges	  with	  another	  simplex.	  
Grey	  bars	  indicate	  that	  two	  simplices	  of	  the	  same	  HA	  subtype	  directly	  merged	  together	  at	  a	  given	  filtration.	  Solid	  
color	  bars	  indicate	  that	  two	  simplices	  of	  different	  HA	  subtypes	  within	  the	  same	  major	  clade	  of	  the	  corresponding	  
phylogeny	  merged	  together.	  Interpolated	  color	  bars	  indicate	  that	  two	  simplices	  of	  different	  major	  clades	  merged	  
together.	  Colors	  correspond	  to	  major	  clades	  in	  the	  reconstructed	  phylogeny.	  Barcoding	  was	  performed	  using	  lazy	  
witness	  complexes	  (see	  methods)	  with	  20%	  of	  the	  dataset	  serving	  as	  landmarks	  and	  a	  maximum	  scale	  ε	  of	  1000	  
nucleotides.	  B)	  The	  phylogeny	  of	  avian	  influenza	  HA	  reconstructed	  from	  the	  barcoding	  plot	  in	  A.	  Major	  clades	  are	  
color-­‐coded.	  C)	  Phylogenetic	  tree	  of	  avian	  influenza	  HA	  constructed	  using	  neighbor-­‐joining,	  ignoring	  all	  gap	  sites	  
using	  SeaView,	  version	  4.3.3.	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Vertical	  evolution	  in	  influenza	  
The	   evolution	   of	   influenza,	   a	   segmented	   single-­‐stranded	   RNA	   orthomyxovirus,	   is	  punctuated	   by	   frequent	   reassortment.	   To	   characterize	   influenza	   A	   evolution,	  we	   applied	  persistent	   homology	   techniques	   to	   four	   influenza	  datasets	   from	  avian,	   swine	   and	  human	  hosts	   each	   numbering	   as	   many	   as	   1,000	   genomic	   sequences.	   When	   applied	   to	   a	   single	  segment	   of	   the	   virus	   unaffected	   by	   reassortment,	   higher-­‐dimensional	   homology	   groups	  largely	  vanish,	  suggesting	  that	  no	  significant	  reticulate	  events	  have	  taken	  place	  (Figure	  36A-­‐B).	  Alignments	  of	  single	  segments	  are	  therefore	  more	  suitable	  for	  phylogenetic	  analysis.	  	  
In settings of vertical evolution, we can directly transform a filtration of simplicial complexes of 
dimension zero into an equivalent distance-based dendrogram. Figure	  35A	  represents	  the	  zero-­‐dimensional	   topology	  of	   the	  hemagglutinin	   segment	  of	  avian	   influenza	  viruses.	  The	  zero-­‐dimensional	  generators	  at	  higher	  genetic	  distances	  ε	  indicate	  the	  major	  clusters,	  coinciding	  with	  the	  major	  antigenic	  subtypes	  (H1-­‐H16).	  From	  the	  bar	  sizes	  of	  the	  barcode	  plot	  (Figure	  35A),	   we	   can	   create	   a	   dendrogram	   (Figure	   35B)	   that	   recapitulates	   classic	   phylogenetic	  analyses118,119,	   depicted	   in	   Figure	   35C.	   Importantly,	   our	   method	   deduces	   the	   two	  major	  groups	  of	  HA	  and	  in	  particular,	  tight	  clusters	  of	  H3	  and	  H4;	  H7,	  H10	  and	  H15;	  H8,	  H9	  and	  H12;	  and	  H13	  and	  H16.	  
Reassortment	  in	  influenza	  evolution	  
Persistent	   homology	   of	   concatenated	   segments	   demonstrates	   evidence	   of	   reassortment	  that	   precludes	   phylogenetic	   analysis.	   For	   avian	   influenza,	   individual	   segments	   of	  hemagglutinin	   (HA)	   (Figure	   36A)	   and	   neuraminidase	   (NA)	   (Figure	   36B)	   independently	  produce	  only	  zero-­‐dimensional	  homology	  groups.	  However,	  concatenating	  these	  segments	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reveals	   a	   complex	   high-­‐dimensional	   topology	   (Figure	   36C).	   These	   results	   confirm	   that	  persistent	  homology	  can	  detect	  pervasive	  reassortment	  in	  influenza.	  
	  
Figure	  36.	  Persistent	  homology	  analysis	  of	  reassortment	  in	  avian	  influenza.	  Analysis	  of	  A)	  HA,	  B)	  NA,	  and	  other	  
segments	  (not	  shown)	  reveal	  no	  significant	  one-­‐dimensional	  topological	  structure.	   	  C)	  When	  all	  segments	  were	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concatenated,	  however,	  substantial	  structure	  is	  present,	  revealing	  non-­‐clonal	  evolutionary	  events	  with	  the	  whole	  
genome,	   but	   not	   individual	   segments.	   Barcoding	   was	   performed	   using	   lazy	   witness	   complexes	   (see	  methods)	  
with	  20%	  of	  the	  dataset	  serving	  as	  landmarks,	  a	  maximum	  scale	  ε	  of	  500	  nucleotides,	  and	  a	  maximum	  dimension	  
of	  two.	  D)	  Network	  visualization	  constructed	  using	  the	  IRIS	  implementation	  of	  the	  algorithms	  discussed	  in	  Singh,	  
et	   al.45	   and	   Carlsson46.	  	  The	   labels	   for	   the	   regions	   in	   the	   networks	   include	   the	   genotypes	   most	   heavily	  
overrepresented	   in	   the	   region.	  E)	   Network	   representing	   the	   reassortment	   pattern	   of	   avian	   influenza	   deduced	  
from	   high-­‐dimensional	   topology.	   Line	   width	   is	   determined	   by	   the	   probability	   that	   two	   segments	   reassort	  
together	  (see	  Methods).	  Node	  color	  ranges	  from	  blue	  to	  red,	  correlating	  with	  the	  sum	  of	  connected	  line	  weights	  
for	   a	   given	  node.	  Barcoding	  was	  performed	  using	   lazy	  witness	   complexes	   (see	  methods)	  with	  one	   third	  of	   the	  
dataset	  serving	  as	  landmarks,	  a	  maximum	  scale	  ε	  of	  1000	  nucleotides,	  and	  a	  maximum	  dimension	  of	  one.	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Figure	   37.	   Persistent	   homology	   prediction	   of	   an	   H3N2	   reassortment	   supported	   by	   phylogenetic	   analysis.	  
Barcoding	  analysis	  was	  performed	  for	  concatenated	  PB2	  and	  HA	  segments	  of	  H3N2.	  A	  one-­‐dimensional	  generator	  
G3	   indicated	   an	   H3N2	   reassortment	   defined	   by	   sequences	   ABG80094,	   ABI21430,	   AFG72106,	   AFG72679,	  
AFH00097,	   AFH00229,	   AFH00427,	   AFH00801,	   and	   AFJ74406.	   Phylogenetic	   analysis	   for	   A)	   PB2	   and	   B)	   HA	  
separately	  produced	  incongruent	  tree	  structures,	  corroborating	  the	  occurrence	  of	  a	  reassortment.	  C)	  Reticulate	  
cycles	   in	   the	   NeighborNet	   phylogenetic	   network	   of	   concatenated	   PB2	   and	   HA	   confirms	   the	   existence	   of	  
incompatibilities.	  Network	  was	  created	  using	  SplitsTree	  v.	  4.12.6.	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Figure	   38.	   Persistent	   homology	   prediction	   of	   an	   H1N1pdm	   reassortment	   supported	   by	   informative	   sites.	  
Barcoding	  analysis	  was	  performed	  for	  the	  concatenated	  genome	  of	  H1N1pdm.	  A	  one-­‐dimensional	  generator	  G2	  
nominates	   a	   candidate	   H1N1pdm	   reassortment	   defined	   by	   sequences	   ADA86070,	   ADD75067,	   ADH01927,	  
ADI99739,	  ADK33740,	  ADM31737,	  and	  AFN18786.	  A)	  Informative	  sites	  in	  which	  at	  least	  two	  sequences	  differed	  
from	  the	  major	  allele	  are	  depicted.	  Two	  sets	  of	  segments	  display	  two	  allelic	  patterns.	  Given	  two	  alleles	  A	  and	  B,	  
PB2,	  M1,	  and	  NS1	  conform	  to	  the	  allelic	  pattern	  AABBBBB.	  PB1,	  PA,	  and	  HA,	  on	  the	  other	  hand,	  follow	  AAAABBA,	  
with	   only	   a	   few	   exceptions	   for	   HA.	   B)	   NeighborNet	   phylogenetic	   network	   of	   these	   informative	   sites	   confirms	  
these	   incompatibilities	   through	   two	   reticulate	   cycles.	   Network	   was	   created	   using	   SplitsTree	   v.	   4.12.6.	   These	  
results	  support	  a	  potential	  reassortment	  pattern	  that	  occurred	  during	  H1N1pdm	  evolution.	  
	  	   99	  
Our	   analysis	   of	   the	   concatenated	  H1N1pdm	   genome	   indicates	   the	   existence	   of	   two	   non-­‐trivial	   cycles,	   nominating	   candidate	   reassortments	   in	   H1N1pdm	   viruses	   in	   humans.	   One	  particular	   generator	   [G10]	   forms	   an	   irreducible	   cycle	   whose	   vertices	   represent	   isolates	  
A/Athens/INS336/2009, A/Brussels/INS243/2009, A/Netherlands/2143/2009, 
A/Boston/154/2009], A/Aarhus/INS82/2009, A/Orenburg/IIV2974/2009, and 
A/Singapore/ON2009/2009]. Given	  the	  greater	  homogeneity	  of	  the	  H1N1pdm	  dataset	  due	  to	  increased	  sampling,	  the	  number	  of	  informative	  sites	  among	  G2	  sequences	  was	  too	  small	  to	  perform	  phylogenetic	  analysis	  by	  maximum	  likelihood.	  We	  therefore	  visually	  inspected	  the	  informative	   sites,	   which	   suggested	   a	   potential	   reassortment	   of	   two	   viral	   strains	   each	  contributing	   [PB2,	   M1,	   NS1]	   and	   [PB1,	   PA,	   HA]	   (Figure	   38A).	   Phylogenetic	   network	  reconstruction	  supported	  the	  existence	  of	  these	  incompatibilities	  (Figure	  38B).	  
One-dimensional homology provides a lower-bound estimate of reassortment rate in avian 
influenza by estimating ICR (Figure	  41B).	  We calculate an ICR of <1 event per year for classic 
H1N1 swine and H3N2 human influenza viruses, supported by previous phylogenetic 
estimates120,121. In contrast, we calculate a high reassortment rate of 22.16 events per year for 
avian influenza A (Table S15). This difference could be explained by the high diversity and 
frequent co-infection of avian viruses122 and correlates with the high proportion of potential 
avian reassortants reported in previous studies123. 
	  
Non-­‐random	  reassortment	  pattern	  in	  avian	  influenza	  
While previous phylogenetic studies confirmed a high reassortment rate in avian influenza, none 
have determined a clear pattern of gene segment association123.	   To answer the question of 
whether any	  segments	   co-­‐segregate	  more	   than	  expected	  by	  chance,	  we	  applied	  persistent	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homology	  to	  avian	   influenza.	  We	   first	  considered	  all	  pairs	  of	  segments	  and	  estimated	  the	  number	   of	   reassortments	   by	   b1.	   We	   then	   ascertained	   the	   significance	   of	   observing	   a	  number	   of	   reassortments	   between	   each	   pair	   of	   segments	   given	   the	   total	   estimate	   of	  reassortments	  in	  the	  whole	  genome	  (see	  Methods).	  The	  analysis	  of	  avian	  influenza	  viruses	  reveals	   a	   statistically	   significant	   reassortment	   structure	  of	   four	   co-­‐segregating	   segments:	  PB2,	  PB1,	  PA	  and	  NP	  (Figure	  36D).	  Interestingly,	  this	  pattern	  mimics	  previous	  in	  vitro	  results	  that	   suggest	   that	   effective	   protein-­‐protein	   interaction	   between	   the	   polymerase	   complex	  and	  the	  NP	  protein	  constrain	  reassortment124.	  
Recapitulating the triple reassortment in H7N9 avian influenza 
In April 2013, an outbreak of H7N9 avian influenza in humans and poultry began in the Jiangsu 
province of China and spread to kill 32 out of 131 positive cases as of May 8th, 2013125. By 
constructing a series of phylogenetic trees per gene and observing conflicting structure by eye, 
Gao, et al. determined that the novel virus was created from a triple reassortment of an H7N3 
A/duck/Zhejiang/12/2011-like (subtype ZJ12) lineage donating HA, an H7N9 A/wild 
bird/Korea/A14/2011-like (subtype K014) lineage donating NA, and an H9N2 
A/brambling/Beijing/16/2012-like lineage donating internal segments88. Persistent homology 
analysis of concatenated H7N9 genomes and the avian influenza dataset identified a two-
dimensional irreducible cycle representing the triple reassortment of H7N9. The two-
dimensional cavity is enclosed by a six-sided b2 polytope formed by joining two tetrahedra at the 
top and bottom (Figure	  36E). The top tetrahedron is formed at the apex by the H7N9 reassortants 
A/Shanghai/1/2013 and A/Hangzhou/2/2013, and at the base by members of the three parental 
lineages. The polytope is closed at the bottom by members of a separate but related H9N2 clade. 
	  	   101	  
This finding recapitulates the finding of Gao, et al. of a triple reassortment in a succinct and 
visually interpretable manner.   	  
Rare	  recombination	  in	  influenza	  evolution	  	  
Despite	  sporadic	  reports126,	  homologous	  recombination	  in	  influenza	  plays	  a	  much	  smaller	  role	   in	   the	   evolution	   of	   the	   virus	   compared	   to	   reassortment127.	   Again,	   our	   results	   reflect	  this	   notion;	   one-­‐dimensional	   topology	   of	   the	   concatenated	   genome	   outstrips	   those	   of	  individual	  segments.	  In	  support,	  b1	  =	  0	  in	  H3N2	  and	  H1N1pdm	  (ignoring	  homoplasy	  events	  at	   ε	   ≤	   2).	   However,	   some	   small	   one-­‐dimensional	   intervals	   in	   swine	   H1N1	   and	   avian	  influenza	  do	  exist.	  Swine	  H1N1	  displays	  irreducible	  cycles	  in	  PB1	  and	  NS1	  alignments.	  To	  a	  greater	  extent,	  non-­‐homoplasy	  events	  in	  avian	  influenza	  number	  5,	  5,	  2,	  2,	  4,	  and	  1	  for	  PB2,	  PB1,	   PA,	   NP,	  M1,	   and	  NS1	   respectively.	   Two	   of	   these	   recombination	   events	   in	   PB2	   have	  been	  detected	   in	  previous	   studies,	  while	   two	   irreducible	   cycles	   in	  PB1	  most	   likely	   result	  from	   poor	   annotation	   or	   sequencing	   error31.	   Our	   analysis	   therefore	   indicates	   little	  homologous	  recombination	  in	  influenza,	  with	  most	  events	  explained	  by	  homoplasy	  (small	  bars)	  and	  sequence	  errors.	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Figure	   39.	   Barcoding	   plots	   of	   HIV1	   reveal	   evidence	   of	   recombination	   in	   A)	   env,	   B),	   gag,	   C)	   pol,	   and	   D)	   the	  
concatenated	  sequences	  of	  all	   three	  genes.	  One-­‐dimensional	  Betti	  number	  greater	  than	  one	  denotes	  non-­‐clonal	  
evolution.	  Non-­‐clonal	  patterns	  present	  for	  alignments	  of	  individual	  genes	  as	  well	  as	  the	  concatenated	  sequences	  
suggest	  recombination	  events.	  Barcoding	  was	  performed	  using	   lazy	  witness	  complexes	  (see	  methods)	  with	  one	  
third	  of	  the	  dataset	  serving	  as	  landmarks,	  a	  maximum	  scale	  ε	  of	  1000	  nucleotides,	  and	  a	  max	  dimension	  of	  one.	  E)	  
b2	  polytope	  representing	  a	  complex	  recombination	  event	  with	  multiple	  parental	  strains.	  Sequences	  of	   the	   [G4]	  
generator	  of	  concatenated	  HIV1	  gag,	  pol,	  and	  env	  were	  transformed	  into	  three-­‐dimensional	  space	  using	  principal	  
coordinate	  analysis	  of	  the	  Nei-­‐Tamura	  pairwise	  genetic	  distances.	  2-­‐simplices	  from	  the	  [G4]	  generator	  defined	  a	  
polytope	   whose	   cavity	   represents	   a	   complex	   recombination	   event.	   Each	   vertex	   of	   the	   polytope	   represents	   a	  
sequence	   that	   is	   color-­‐coded	   by	  HIV1	   subtype.	   Two-­‐dimensional	   barcoding	  was	   performed	   using	   lazy	  witness	  
complexes	   (see	   methods)	   with	   one-­‐fifth	   of	   the	   dataset	   serving	   as	   landmarks	   and	   a	   maximum	   scale	   ε	   of	   150	  
nucleotides.	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Comparing	  the	  topology	  of	  HIV,	  HEPC1,	  dengue,	  and	  other	  viruses	  
After	   showing	   that	   persistent	   homology	   recapitulates	   both	   reassortment	   and	   limited	  recombination	   in	   influenza	   in	  different	  hosts,	  we	   investigated	  whether	  our	  method	  could	  identify	  recombination	  in	  other	  viruses.	  The	  retrovirus	  HIV	  is	  notorious	  for	  high	  diversity	  mediated	  by	  not	  only	  a	  high	  mutation	  rate,	  but	  also	  frequent	  homologous	  recombination,128	  ultimately	  leading	  to	  antiretroviral	  resistance129	  and	  immune	  evasion130.	  These	  factors	  can	  cloud	  studies	   that	   classically	   rely	  on	  phylogenetics,	   such	  as	  estimates	  of	   the	  origin	  of	   the	  HIV	   pandemic131,	   underscoring	   the	   need	   for	   non-­‐phylogenetic	   approaches.	   We	   apply	   a	  similar	  barcoding	  methodology	  to	  the	  independent	  and	  concatenated	  alignments	  of	  HIV-­‐1	  gag,	  pol,	  and	  env,	   the	  three	   largest	  genes	  of	   the	  genome.	  Like	   influenza,	   the	  concatenated	  alignment	   reproduces	   one-­‐dimensional	   topology,	   indicative	   of	   non-­‐clonal	   evolution.	  However,	   individual	   gene	   alignments	   also	   reveal	   one-­‐dimensional	   homology	   groups,	  suggesting	   that	   recombination	   breakpoints	   exist	   within	   as	   well	   as	   between	   individual	  genes	  (Figure	  39A-­‐D).	  	  
Similar to the analysis of the H7N9 avian influenza triple reassortment, persistent homology of	  the	  concatenated	  HIV	  gag,	  pol,	  and	  env	  produced	  two-­‐dimensional	  topology	  derived	  from	  complex	  recombination	  events.	  One	  example	  is	  the	  [G4]	  generator	  depicted	  by	  the	  b2	  polytope	  in	  Figure	  39E.	  This	  two-­‐dimensional	  cavity	  identifies	  CRF13_cpx	  and	  CRF0209,	  two	  complex	  circulating	  recombinant	  forms	  (CRFs)	  that	  result	  from	  recombination	  between	  viruses	  of	  different	  subtypes.	  CRF13_cpx	  is	  a	  recombinant	  derived	  from	  subtypes	  A,	  G,	  J,	  U,	  and	  CRF01_AE.	  CRF0209	  is	  a	  recombinant	  between	  CRF02_AG	  and	  CRF09_cpx	  (subtypes	  A,	  G,	  and	  U).	  The	  b2	  polytope	  includes	  other	  viruses	  of	  subtype	  A,	  B,	  C,	  D,	  and	  F,	  as	  well.	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Figure	  40.	  Barcoding	  plots	  of	  dengue	  virus	  polyprotein	  show	  no	  evidence	  of	  recombination.	  Analyzing	  A)	  DENV-­‐1,	  
B)	  DENV-­‐2,	  C)	  DENV-­‐3,	  and	  D)	  DENV-­‐4	  subtypes	  uncovered	  topological	  structure	  at	  dimension	  0	  only.	  Barcoding	  
was	   performed	  using	   lazy	  witness	   complexes	  with	   one-­‐third	   of	   the	   dataset	   serving	   as	   landmarks,	   a	  maximum	  
filtration	  value	  of	  1000	  nucleotides,	  and	  a	  maximum	  dimension	  of	  one	  (see	  Methods).	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Figure	  41.	  Quantifying	  topological	  features.	  A)	  Topological	  obstruction	  is	  calculated	  using	  the	  maximum	  barcode	  
length	   in	   non-­‐zero	   dimensions.	   B)	   The	   irreducible	   cycle	   rate	   is	   the	   number	   of	   higher-­‐dimensional	   barcodes	  
normalized	  by	   the	   time	  span	  of	   sequence	   collection	   (see	  Methods).	   For	  A	  and	  B,	  one-­‐third	  of	  data	  points	  were	  
chosen	   to	   be	   landmarks,	   with	   a	   maximum	   scale	   ε	   of	   1000	   nucleotides,	   and	   a	   maximum	   dimension	   of	   one	  
considered.	  	  Flaviviruses	  are	  a	  genus	  of	  positive	  single-­‐stranded	  RNA	  viruses,	  whose	  ability	  to	  perform	  homologous	   recombination	   through	   RNA	   polymerase	   template	   switching	   has	   been	  debated.	   Sporadic	   recombinant	   strains	   have	   been	   detected	   for	   flaviviruses	   like	   hepatitis	  C132,133,	  dengue	  virus134,135,	   and	  West	  Nile	  virus136.	  However,	   some	  of	   these	   reports,	   as	   in	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dengue,	   have	   been	   shown	   to	   be	   the	   product	   of	   sequencing	   error137,	   and	   it	   is	   generally	  agreed	  that	  if	  recombination	  occurs,	  it	  is	  a	  rare	  event.	  To	  assay	  the	  extent	  of	  recombination	  in	   flaviviruses,	  we	  applied	  our	  methodology	   to	   the	  polyproteins	  of	  hepatitis	  C	   subtype	  1,	  dengue	   subtypes	   1-­‐4,	   and	   West	   Nile	   virus.	   We	   found	   high-­‐dimensional	   topology	   for	  hepatitis	  C	  virus,	  though	  at	  a	  lower	  TOP	  and	  ICR	  than	  in	  HIV.	  However,	  we	  found	  little	  to	  no	  high-­‐dimensional	   structure	   for	   dengue	   (Figure	   40)	   and	   absolutely	   no	   evidence	   of	  recombination	   for	  West	   Nile	   virus,	   suggesting	   that	   recombination	   rarely	   occurs	   in	   these	  viruses.	  	  
Recombination	   is	   considered	   to	  be	  even	   less	   frequent	   in	  negative-­‐sense	  RNA	  viruses	   like	  Newcastle	   virus,	   with	   only	   scattered	   studies	   reporting	   positive	   findings138.	   Interestingly,	  persistent	  homology	  analysis	  of	  Newcastle	  virus	  confirmed	  a	  low	  ICR	  but	  a	  non-­‐vanishing	  TOP.	  Figure	  41	  and	  Tables	  S14-­‐S15	  summarize	  the	  TOP	  and	  ICR	  calculations	   for	  all	  viruses	  examined	  in	  this	  paper.	  	  
	  
Comparative	  analysis	  with	  other	  methods	  for	  detecting	  recombination	  
To	   benchmark	   the	   performance	   of	   persistent	   homology,	  we	   also	   investigated	   alternative	  non-­‐phylogenetic	   methods	   that	   are	   specifically	   tailored	   towards	   the	   detection	   of	  recombination:	   the	   pairwise	   homoplasy	   index	   (PHI)10,	   neighbor	   similarity	   score	   (NSS)11,	  and	  MaxChi,12	  all	  of	  which	  produce	  p-­‐values	   for	   the	  significance	  of	  observing	  a	   reticulate	  event	  (see	  Methods).	  We	  first	  considered	  the	  simulation	  of	  a	  single	  population	  admixture	  at	  time	  step	  15	  following	  the	  procedure	  described	  above	  (Figure	  33).	  Interestingly,	  TOP	  and	  ICR	  remain	  zero	  prior	   to	   t=15	  when	  only	  clonal	  evolution	  has	   taken	  place;	  all	  other	  methods	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vacillate	  between	  0	  and	  1,	  with	  PHI	  even	  reaching	  significance	  level	  <	  0.05	  during	  t=[3,5].	  For	   t>15,	   both	   TOP	   and	   ICR	   become	   non-­‐zero	   and	   detect	   reassortment	   correctly.	   Of	   the	  other	  methods,	  only	  MaxChi	  detects	  reassortment.	  NSS	  and	  PHI	  have	  low	  sensitivity	  when	  analyzing	   a	   large	   number	   of	   sequences	   (>100	   of	   sequences).	   These	   results	   indicate	   that	  TOP	   and	   ICR	  have	  higher	   specificity	   than	   all	   other	  methods	   to	   detect	   a	   single	   admixture	  event.	  This	   finding	   relates	   to	  Supplementary	  Theorem	  2.1	   (see	  publication),	  which	  states	  that	  non-­‐zero	  TOP	  implies	  a	  non-­‐additive	  tree.	  
We	   next	   compared	   the	   statistical	   power	   of	   persistent	   homology	   and	   other	   methods	   to	  detect	  reticulate	  events	  under	  1)	  variable	  μ;	  2)	  variable	  r;	  and	  3)	  including	  and	  excluding	  ancestral	  sequences	  (300	  and	  100	  sequences	  respectively)	  (Figure	  42).	  Here,	  we	  show	  that	  overall	  the	  sensitivity	  of	  persistent	  homology	  is	  higher	  than	  that	  of	  NSS	  and	  PHI,	  and	  nearly	  as	   high	   as	   MaxChi.	   It	   should	   be	   noted	   that	   sensitivity	   of	   persistent	   homology	   can	   be	  increased	   even	   further	   with	   a	   greater	   number	   of	   “witness	   points”	   at	   the	   expense	   of	  increasing	  computational	  cost	  (see	  Methods).	  Moreover,	  persistent	  homology	  has	  very	  high	  specificity	  at	  r=0	  except	  in	  settings	  of	  high	  μ	  (>0.025	  substitutions	  per	  site	  per	  generation),	  leading	  to	  homoplasy.	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Figure	  42.	  Power	  plots	  comparing	  methods	  for	  detecting	  reticulate	  evolution.	  We	  investigated	  the	  performance	  of	  
persistent	  homology	  compared	  to	  NSS,	  PHI,	  and	  MaxChi	  after	  fifty	  trials	  for	  a	  given	  mutation	  rate	  and	  a	  given	  (A,	  
B)	   reassortment	   rate	   or	   (C,	   D)	   recombination	   rate	   throughout	   generations.	   These	   simulations	   were	   also	  
performed	  with	   (A,	   C)	   and	  without	   (B,	   D)	   ancestral	   sequences.	   Datasets	  with	   ancestral	   sequences	   spanned	   10	  
generations	  of	  30	   sequences	  each.	  Datasets	  without	  ancestral	   sequences	   comprised	  a	   single	   generation	  of	  100	  
sequences.	  For	  each	  method	  tested,	  red	  indicates	  greater	  confidence	  in	  detecting	  horizontal	  evolution.	  
C	  
D	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Discussion	  Persistent	  homology	  provides	  a	  fast	  method	  to	  determine	  robust,	  large-­‐scale	  properties	  of	  evolution	  from	  large	  sets	  of	  related	  genomes.	  Barcodes	  generated	  by	  persistent	  homology	  represent	   the	   structure	  of	   these	  properties	   at	  different	   evolutionary	   scales.	  The	  unveiled	  structure	   can	   be	   equivalent	   to	   phylogenetic	   representation	   in	   cases	   where	   only	   vertical	  genetic	   exchange	   takes	   place,	   as	   can	   generally	   be	   seen	   in	   single	   segment	   analysis	   in	  influenza	   A,	   dengue,	   WNV,	   and	   rabies.	   Moreover,	   persistent	   homology	   can	   capture	  horizontal	   evolution,	   particularly	   viral	   recombination	   and	   reassortment.	   Generators	   of	  non-­‐trivial	  homology	  can	  identify	  specific	  reticulate	  events,	  and	  the	  normalized	  count	  can	  provide	  a	  lower	  bound	  for	  the	  recombination/reassortment	  rate.	  Employing	  this	  strategy,	  we	   estimated	   these	   rates	   in	   influenza	   in	   several	   hosts,	   HIV,	   flaviviruses,	   rabies,	   and	  Newcastle	   virus.	   Moreover,	   we	   can	   use	   the	   higher-­‐dimensional	   topology	   to	   uncover	  complex	   evolutionary	   patterns,	   such	   as	   co-­‐segregating	   segments	   during	   influenza	  reassortment.	   To	   link	   evolutionary	   concepts	   to	   the	   principles	   of	   algebraic	   topology,	   we	  provide	  a	  dictionary	  that	  translates	  familiar	  terms	  in	  both	  fields	  (Table	  1).	  	  
Persistent	   homology	   proposes	   the	   first	   complete	   departure	   from	   the	   tree	   paradigm	   of	  evolution.	  Where	  many	  phylogenetic	  methods	  produce	  a	  single,	  possibly	  suboptimal	  tree	  or	  network,	   persistent	   homology	   analyzes	   the	   invariant	   topological	   characteristics	   of	   all	  simplicial	   complexes	   across	   the	   entire	   parameter	   space	   of	   genetic	   distance.	   Moreover,	  persistent	  homology	  presents	  a	  stable	  methodology	  in	  which	  small	  fluctuations	  in	  the	  data	  do	  not	  translate	  into	  large	  deviations	  in	  results.	  	  
In	   this	   manuscript,	   we	   propose	   a	   phenomenological	   approach	   to	   study	   evolution	   by	  capturing	  topological	  features	  of	  the	  relationships	  between	  genomes	  without	  imposing	  any	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preconceived	   structure.	   These	   relationships	   could	   be	   phylogenetic	   or	   not,	   between	  organisms	  of	   the	   same	  or	   different	   species.	   By	   unveiling	   global,	   topological	   features	   that	  cannot	   be	   represented	   by	   either	   phylogenetic	   trees	   or	   networks,	   persistent	   homology	  analyzes	  viral	  genomic	  datasets	  to	  (1)	  represent	  general	  evolutionary	  processes	  that	  may	  include	  reticulate	  events,	  (2)	  estimate	  the	  reticulate	  rates,	  and	  (3)	  extract	  complex	  patterns	  in	   these	   processes.	   In	   the	   future,	   we	   foresee	   even	   wider	   applicability	   of	   persistent	  homology	   to	   the	   analysis	   of	   other	   non-­‐viral	   taxa	   and	   to	   addressing	   the	   species	   problem	  from	  genomic	  data.	  
Methods	  
Sequence	   collection,	   annotation,	   and	   alignment.	   Complete	   coding	   sequences	   of	  influenza	  segments	  were	  collected	  from	  NCBI48,	  downloaded	  as	  of	  August	  2012.	  Complete	  coding	  sequences	  of	  env,	  gag,	  and	  pol	  were	  downloaded	  from	  the	  LANL	  HIV	  database122	  as	  of	   September	  2012.	   Complete	   coding	   sequences	   of	   hepatitis	   C,	   dengue,	  WNV,	   rabies,	   and	  Newcastle	  virus	  were	  downloaded	  from	  the	  ViPR	  database139	  as	  of	  September	  2012	  (Table	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Table	  3.	  Total	  number	  of	  sequences	  per	  virus	  studied	  and	  number	  of	  sequences	  with	  date	  information.	  Date	  
information	  was	  used	  to	  normalize	  our	  calculations	  of	  ICR.	  
	  
Strain	   #Seq	   #SeqWithDateInfo	  Avian	  influenza	   1000	   1000	  H3N2	  influenza	   1000	   1000	  H1N1pdm	  influenza	   1000	   1000	  H1N1	  swine	  influenza	   429	   429	  HIV1	   1088	   1030	  DENV1	   1372	   1261	  DENV2	   965	   910	  DENV3	   691	   633	  DENV4	   114	   95	  HEPC1	   827	   495	  WNV	   602	   409	  Enterovirus	  A	   258	   157	  Newcastle	   162	   88	  Rabies	   152	   102	  
	  
Implementation	   of	   persistent	   homology.	   To	   characterize	   vertical	   and	   horizontal	  evolution	   of	   viral	   genomes,	   we	   employed	   a	   persistent	   homology	   technique	   called	  barcoding45:	  a	  method	  of	  identifying	  topological	   invariants	  in	  cloud	  data.	  First,	  sequenced	  isolates	   are	   transformed	   in	   high-­‐dimensional	   space	   using	   pairwise	   genetic	   distance.	   All	  analysis	   was	   performed	   using	   Nei-­‐Tamura	   (shown	   in	   this	   paper)	   and	   Hamming	   genetic	  distance,	  with	  both	  producing	   similar	   results.	   From	   this	   cloud	  data,	   points	   can	  be	   linked	  based	  on	  certain	  criteria	  to	  form	  a	  simplicial	  complex:	  a	  structure	  of	  points,	  line	  segments,	  triangles,	  and	  even	  n-­‐dimensional	  counterparts.	  When	  this	  criterion	  is	  a	  distance	  less	  than	  some	  ε,	  a	  filtered	  simplicial	  complex	  called	  a	  Vietoris-­‐Rips	  stream	  is	  created.	  
An	  objective	  in	  the	  study	  of	  topology	  is	  to	  identify	  features	  of	  filtered	  simplicial	  complexes	  that	   persist	   across	   all	   values	   of	   ε.	   A	   useful	   characteristic	   is	   the	   Betti	   number,	   which	   in	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dimension	  0	  is	  b0,	  the	  number	  of	  connected	  components	  in	  a	  particular	  simplicial	  complex.	  In	   the	   context	   of	   viral	   genomics,	   b0	   at	   a	   given	   ε	   can	   define	   the	   number	   of	   clades	   or	  subspecies	   in	   a	   viral	   population.	   In	   addition,	   the	   minimum	   ε	   that	   produces	   b0	   can	   be	   a	  measure	   of	   surveillance	   completeness140.	   On	   the	   other	   hand,	   higher-­‐dimensional	   Betti	  number	  can	  detect	  reticulate	  evolution,	  such	  as	  recombination	  or	  reassortment.	  
Calculating	  Vietoris-­‐Rips	  streams	  for	  large	  datasets	  can	  be	  computationally	  expensive,	  and	  an	   alternative	   method	   called	   lazy	   witness	   streams	   can	   be	   used	   that	   produces	   a	   smaller	  number	  of	  simplicial	  complexes	  from	  a	  subset	  of	  “landmark”	  points51.	  Indeed,	  de	  Silva	  et	  al.	  assert	  that	   in	  many	  cases,	   these	  “witness	  complexes”	  are	  capable	  of	  robustly	  reproducing	  the	   homology	   groups	   of	   the	   Vietoris-­‐Rips	   stream	   with	   even	   less	   noise50.	   Suppose	   a	  landmark	  subset	  of	  points	  L	  is	  pre-­‐selected	  from	  point	  cloud	  data	  either	  at	  random	  or	  using	  a	  max-­‐min	  scheme.	  Let	  d(S,p)	  be	  the	  vector	  of	  distances	  between	  point	  p	  and	  all	  points	  in	  set	  S.	  In	  dimension	  0,	  a	  pair	  of	  points	  a	  and	  b	  is	  then	  linked	  if	  there	  exists	  a	  witness	  point	  z	  such	  that	  the	  maximum	  of	  d(a,z)	  and	  d(b,z)	  is	  less	  than	  the	  sum	  of	  ε	  and	  the	  υ’th	  smallest	  element	  in	  d(L,z).	  In	  this	  study,	  we	  used	  υ=	  2.	  Higher-­‐dimensional	  simplices	  exist	  if	  all	  pairs	  of	  points	  are	  linked	  as	  well.	  	  
Using	   the	   Javaplex	   software	   package	   at	   http://code.google.com/p/javaplex,	   we	  implemented	   a	   lazy	  witness	   stream	   to	   filter	   different	   viral	   strains	  with	   one	   third	   of	   the	  sequences	  serving	  as	  landmark	  points	  (except	  for	  Figures	  3,	  4,	  and	  5	  and	  Table	  S1,	  S3	  and	  S11,	  which	  used	  20%	  of	  sequences	  as	  landmarks).	  	  
While	  lazy	  witness	  streams	  can	  largely	  recapitulate	  the	  homology	  groups	  of	  Vietoris-­‐Rips	  at	  a	   lower	   computational	   cost,	   the	   sensitivity	   to	   detect	   irreducible	   cycles	   can	   drop	   if	   the	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number	  of	  landmark	  points	  is	  insufficient.	  However,	  through	  our	  evolutionary	  simulations,	  we	  show	  that	  even	  with	  a	  landmark	  set	  of	  20%	  of	  the	  sequences,	  our	  sensitivity	  surpasses	  other	  popular	  methods	  of	  recombinant	  detection	  (see	  Simulations).	  
Mathematical	  underpinnings	  of	  persistence	  homology.	  For	  ordinary	  topological	  spaces	  X,	   the	  (mod-­‐2)	  homology	  of	  X	   in	  dimension	  k	   is	  a	  Boolean	  vector	  space	  whose	  dimension	  counts	   the	   number	   of	   independent	   occurrences	   of	   certain	   patterns	   thought	   of	   as	   k-­‐
dimensional	   holes.	   It	   is	   computed	   using	   matrix	   operations	   applied	   to	   a	   k-­‐dimensional	  
boundary	  matrix.	  	  Elements	  in	  this	  vector	  space	  can	  be	  represented	  by	  cycles,	  by	  which	  we	  mean	  formal	  sums	  of	  k-­‐dimensional	  simplices,	  i.e.	  (k+1)-­‐tuples	  of	  points	  spanning	  a	  higher	  dimensional	  analogue	  of	  segments,	  triangles,	  tetrahedra,	  etc.	  	  We	  are	  dealing	  with	  Boolean	  vector	  spaces,	  so	  we	  may	  think	  of	   the	  sums	  as	  exclusive	  unions	  of	  k-­‐simplices.	   	  The	  cycle	  condition	  means	   that	   if	  we	   take	   the	  exclusive	  unions	  of	  all	  boundary	   faces	  we	  obtain	   the	  empty	   collection	   of	   (k-­‐1)-­‐simplices.	   	   In	   dimension	   one,	   for	   example,	   this	  means	   that	   we	  have	  a	  collection	  of	  edges	  that	  form	  a	  closed	  loop.	  	  The	  choice	  of	  cycle	  representative	  is	  not	  unique,	   but	   can	   be	   varied	   by	   any	   cycle,	   which	   is	   the	   boundary	   of	   a	   collection	   of	   (k+1)-­‐dimensional	  simplices.	  	  	  
Persistent	  homology	  is	  a	  methodology	  that	  adapts	  homology	  to	  the	  study	  of	  point	  clouds	  or	  finite	  metric	  spaces.	  	  It	  produces	  a	  nested	  family	  of	  simplicial	  complexes,	  by	  applying	  the	  k-­‐dimensional	  homology	  to	  a	   family	  of	  vector	  spaces,	  parametrized	  by	  the	  scale	  parameter,	  equipped	   with	   linear	   transformations	   from	   each	   vector	   space	   to	   any	   other	   with	   higher	  value	  of	  the	  scale	  parameter.	   	  Just	  as	  vector	  spaces	  are	  determined	  up	  to	  isomorphism	  by	  their	  dimension,	  so	  these	  algebraic	  structures	  can	  be	  determined	  up	  to	  isomorphism	  by	  a	  barcode,	   a	   collection	   of	   intervals,	   each	   one	   specified	   by	   a	   left	   hand	   and	   a	   right	   hand	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endpoint.	  Each	  interval	  in	  a	  barcode	  will	  be	  called	  a	  “bar”.	   	  A	  bar	  with	  left	  and	  right	  hand	  endpoints	   (l,r)	   corresponds	   to	   a	   homology	   element	   which	   first	   occurs	   at	   the	   scale	  parameter	  value	   r,	   and	  which	  becomes	  zero	  exactly	  when	   the	   scale	  parameter	   reaches	   r.	  	  Such	  a	  homology	  element	  can	  also	  be	  represented	  by	  a	  cycle	  as	  above,	   in	   this	  case	   in	   the	  complex	  with	  scale	  parameter	  value	  l.	  	  	  
Evolutionary	  Simulations.	  Stochastic	  evolution	  through	  antigenic	  drift	  was	  modeled	  as	  a	  neutral	  Wright-­‐Fisher	  model	  with	  a	   constant	  haploid	  population	  size	  of	  100	  dinucleotide	  sequences	  of	  genomic	  length	  L	  base	  pairs,	  with	  each	  sequence	  evolving	  at	  a	  mutation	  rate	  of	  μ	  nucleotides	  per	  site	  per	  generation.	  Each	  simulation	  began	  with	  an	  initial	  population	  of	  40%	  nucleotide	  diversity.	  We	  also	  performed	  reassortment	  for	  S	  number	  of	  segments	  each	  of	  500	  nucleotides	  at	  a	  given	  rate	  r,	  which	  governs	  the	  proportion	  of	  individuals	  exchanging	  segments	   at	   each	   generation.	   To	   simulate	   recombination,	  we	   randomized	   the	   length	   and	  coordinates	   of	   the	   genomic	   segment	   exchanged	   among	   a	   proportion	   of	   individuals	  parameterized	  by	  r	  for	  each	  generation.	  
To	   characterize	   the	   evolutionary	   topology	   for	   a	   given	   set	   of	   conditions,	   we	   considered	  datasets	  that	  either	   included	  or	  excluded	  ancestral	  sequences.	  To	  simulate	  with	  ancestral	  sequences,	  we	   analyzed	   cumulative	   datasets	  with	  multiple	   time	   steps,	   or	   generations,	   of	  evolved	  sequences.	  Otherwise,	  we	  analyzed	  only	  a	  single	  generation	  of	  sequences.	  For	  each	  dataset,	  we	   then	  determined	  a	  metric	   space	  of	  pairwise	  genetic	  distances	   (Jukes-­‐Cantor).	  Based	  on	   these	  distances,	  we	  applied	   Javaplex	   to	  perform	  barcoding	  analysis	   at	  different	  dimensions	  based	  on	  a	  lazy	  witness	  complex	  constructed	  with	  20%	  of	  sequences	  serving	  as	  landmarks.	   Such	   analysis	   can	   determine	   the	   Betti	   number	   across	   all	   filtration	   genetic	  distances	  and	  generations.	  Alternatively,	   for	  a	  given	  time	  step	  t,	  we	  can	  examine	  how	  the	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topological	   properties—topological	   obstruction	   (TOP)	   and	   irreducible	   cycle	   rate	   (ICR)—change	  as	  we	  modulate	  μ	   and	   r.	  Of	   course,	   sensitivity	   to	  detect	   irreducible	   cycles	   can	  be	  improved	  by	  increasing	  the	  number	  of	  landmark	  points.	  	  
One	   consideration	   is	   the	   ability	   of	   persistent	   homology	   to	   differentiate	   between	   real	  reticulate	   events	   and	   homoplasies.	   When	   r=0,	   evolution	   is	   purely	   clonal;	   therefore,	   any	  deviations	   from	   trivial	   homology	   derive	   from	   homoplasy.	   By	   estimating	   the	   bar	   length	  distribution	  in	  simulations	  with	  r=0,	  we	  found	  that	  all	  non-­‐trivial	  homology	  is	  represented	  by	  bars	  within	  1-­‐D	  or	  2-­‐D	  TOP	  ≤	  4	  (99%	  of	  simulations).	  For	  analysis	  of	  statistical	  power	  during	  simulations,	  we	   therefore	  considered	  1-­‐D	  or	  2-­‐D	  TOP	  >	  4	  genetic	  distance	   to	  be	  a	  reticulate	  event.	  
Reassortment	   patterns.	   To	   determine	   patterns	   of	   reassortment,	   we	   calculate	   the	  probability	  pij	  that	  two	  segments	  co-­‐segregate	  given	  that	  we	  observe	  #b1ij	  events	  in	  a	  total	  of	  #b1,	  where	  #b1ij	  is	  the	  number	  of	  non-­‐trivial	  cycles	  between	  segments	  i	  and	  j,	  and	  #b1	  is	  the	   number	   of	   non-­‐trivial	   cycles	   in	   all	   genomes.	   Assuming	   that	   segments	   do	   not	   have	  preferential	  co-­‐segregation,	  pij	  follows	  a	  binomial	  ~	  bino	  (#b1ij,	  #b1,1/2).	  Network	  figures	  were	  generated	  using	  Cytoscape	  v2.8.3141.	  	  
Phylogenetic analysis. Phylogenies for H3N2 and H1N1pdm influenza were constructed using 
maximum likelihood using the generalized time-reversible (GTR) model with an across site rate 
variation model of four different rate classes using the nearest-neighbor interchange (NNI) tree 
searching with bootstrap values calculated after 100 replicates using SeaView. 
Comparison to methods for detecting recombination. NSS, PHI, and MaxChi are examples of 
methods for detecting recombination. NSS considers neighboring pairs of sites and detects 
regions where incompatibilities cluster together103. PHI scores the likelihood of observing the 
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minimum number of homoplasies for every pair of sites in the alignment based on a parsimony 
criterion102. For each position in an alignment, MaxChi compares the distribution of polymorphic 
sites to the left and right of a putative breakpoint and scores the site based on the chi-squared 
test104. Calculation of NSS, PHI, and MaxChi was performed using the PhiPack software 
package provided by Bruen, et al.142 using default parameters. We used a window size of 100 
base pairs for PHI and 2/3 the number of polymorphic sites for MaxChi. All p-values were 
assessed using a permutation test of 1000 permutations. P-values less than 0.05 were considered 
significant for detecting recombination. 
Computation time and scalability. The memory required by Javaplex for the computation of 
persistent homology depended on several factors beyond the input dataset itself, particularly the 
number of dimensions analyzed, the number of landmarks chosen (when using lazy witness 
stream), and the maximum filtration value, all of which influence the number of possible 
simplices. For this reason, we optimized these parameters such that analysis was completed 
within computational limits. As the input into the specific persistent homology program is a 
pairwise distance matrix, genome length does not affect computation time. On a single 
computational node, for analyzing simulation data of 300 sequences with variable mutation and 
recombination rate, computational time for a Javaplex-implemented lazy witness stream with 
20% of the dataset as landmarks took on average 70.58±50.66 seconds standard deviation, 
compared to PhiPack taking 689.63±24.78 seconds on the same datasets. For a fixed number of 
landmark points, the computation of the witness complexes can in principle be parallelized 
readily.  This feature is not built into existing software but can readily be carried out, and will be 
a focus of future software development. 
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Conclusion	  In	   my	   thesis,	   I	   have	   presented	   novel	   computational	   methodologies	   aimed	   at	   dissecting	  evolutionary	   principles	   at	   a	   mega-­‐Darwin	   scale,	   through	   the	   study	   of	   the	   fast-­‐evolving	  systems	   of	   influenza.	   First,	   I	   have	   presented	   extensive	   analysis	   of	   the	   spatiotemporal	  evolution	   of	   seasonal	   influenza.	   I	   introduce	   two	   new	   computational	   methods:	   the	   q2-­‐coefficient	   and	  FluGraph.	  The	  q2-­‐coefficient	   is	   a	   readily	   computable	  measure	   of	   genomic	  surveillance	   that	   identifies	   sources	   of	   sampling	   bias	   across	   space	   and	   time	   for	   different	  strains	   of	   influenza.	   FluGraph	   counters	   these	   data	   biases	   by	   two	   strategies—spatiotemporal	   clustering	   and	   modeling	   transmission	   as	   a	   multinomial	   process—and	  constructs	   a	   network	   that	   represents	   the	   global	   spread	   of	   seasonal	   influenza.	   Having	  resolved	   these	  statistical	  biases,	   a	  network	  can	  be	  constructed	   that	  uncovers	   the	  seeding	  patterns	   of	   seasonal	   influenza	   between	   different	   regions	   (even	   at	   the	   high	   resolution	   of	  countries)	  across	  seasons.	  	  
In	   the	   second	  part	  of	  my	   thesis,	   I	   focused	  on	   the	  biological	  mechanisms	  of	  mutation	  and	  reassortment,	  particularly	  how	  they	  combine	  to	  give	  rise	  to	  pandemic	  influenza	  strains.	  To	  capture	   this	   process,	   I	   presented	   a	   new	   mathematical	   structure	   based	   on	   algebraic	  topology	   that	   captures	   both	   vertical	   and	   horizontal	   evolution.	   I	   applied	   this	   method	   to	  viruses	   with	   a	   particular	   emphasis	   on	   influenza	   to	   detect	   specific	   instances	   and	   broad	  patterns	  of	  reticulate	  evolution.	  The	  current	  implementation	  of	  persistent	  homology	  offers	  a	  novel	  alternative	  to	  the	  phylogenetic	  paradigm	  that	  is	  oftentimes	  a	  cumbersome	  or	  even	  inappropriate	  characterization	  of	  horizontal	  evolution.	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One	   possible	   pitfall	   common	   to	   the	   methods	   I	   have	   presented	   is	   the	   choice	   of	   genetic	  distance.	   Genetic	   distances	   represent	   the	   evolutionary	   divergence	   that	   has	   taken	   place	  between	   different	   individuals	   based	   on	   the	   particular	   differences	   in	   their	   genomes.	  Different	   genetic	   distance	   methods	   vary	   based	   on	   a	   number	   of	   factors.	   The	   simplest	  measure,	  Hamming	  distance,	  calculates	  the	  proportion	  of	  nucleotide	  differences	  along	  the	  entire	  genome.	  The	  Jukes-­‐Cantor	  method	  is	  a	  maximum	  likelihood	  estimate	  of	  the	  number	  of	   substitutions	   between	   two	   sequences,	   and	   takes	   into	   consideration	   the	   likelihood	   of	  back-­‐mutations	   over	   a	   long	   period	   of	   time.	  While	   Jukes-­‐Cantor	   assumes	   equal	   mutation	  rates	   between	   all	   nucleotides,	   the	   Kimura	   distance	   considers	   different	   rates	   of	  transversions	   versus	   transitions.	   And	   while	   Jukes-­‐Cantor	   assumes	   equal	   background	  nucleotide	   frequencies,	   the	   Tajima-­‐Nei	   distance	   does	   not.	   The	   Tamura	   distance	   not	   only	  differentiates	   between	   transversions	   versus	   transitions,	   but	   also	   incorporates	   the	   GC	  content.	   Hasegawa	   distance	   combines	   transversion	   versus	   transition	   rates	   with	  background	   nucleotide	   frequencies.	   Nei-­‐Tamura	   not	   only	   considers	   the	   background	  nucleotide	  frequencies,	  but	  also	  makes	  a	  distinction	  between	  transitions	  between	  purines	  and	   between	   pyrimidines,	   as	   well	   as	   transversions.	   The	   more	   elaborate	   the	   distance	  method,	  the	  longer	  the	  computation	  time,	  and	  it	   is	  not	  clear	  necessarily	  which	  distance	  is	  more	  appropriate	  in	  which	  context.	  	  
For	  the	  q2-­‐coefficient,	   I	  used	  a	  vast	  array	  of	  genetic	  distances,	   including	  Hamming,	   Jukes-­‐Cantor,	  Tajima-­‐Nei,	  Kimura,	  Tamura,	  Hasegawa,	  and	  Nei-­‐Tamura.	  Our	  results	  show	  that	  the	  choice	  of	  method	  affected	  our	  analysis	   little,	  changing	  the	  q2-­‐coefficient	  by	  no	  more	  than	  0.035,	   0.118,	   and	   0.094	   for	   influenza,	   dengue,	   and	   WNV	   respectively.	   For	   algebraic	  topology	   of	   evolution,	   I	   considered	   both	  Nei-­‐Tamura	   and	  Hamming	   distances	   and	   found	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little	   difference	   in	   topology.	   Moreover,	   as	   proven	   in	   the	   supplementary	   theorem,	   our	  method	   is	   statistically	   stable	   to	   small	   deviations	   in	   the	   data	   that	   could	   potentially	   result	  from	  choice	  of	  distance	  method.	  	  
One	  may	  wonder	  whether	  other	  assumptions	  made	  may	  affect	  analysis.	  For	  example,	   the	  q2-­‐coefficient	  assumes	  no	  site	  or	  rate	  heterogeneity	  in	  mutation	  rate.	  To	  see	  whether	  these	  assumptions	   affected	   our	   results,	   I	   calculated	   a	   phylogenetic	   analogue	   called	   the	   p2-­‐coefficient	  that	  accounts	  for	  site	  heterogeneity	  using	  the	  gamma	  model44,	  and	  reconstructs	  trees	   under	   both	   a	   strict	   and	   relaxed	   molecular	   clock.	   The	   results	   of	   the	   p2-­‐coefficient	  corresponded	   very	   strongly	   to	   those	   of	   q2-­‐coefficient.	   However,	   computation	   of	   p2	  required	  days	  compared	  to	  the	  seconds	  needed	  for	  q2	  for	  the	  same	  sequence	  dataset.	  
With	  the	  findings	  from	  the	  novel	  methodologies	  introduced	  in	  this	  thesis,	  there	  still	  remain	  many	   questions.	   Does	   H3N2	   still	   display	   the	   same	   pattern	   of	   global	   spread	   since	   post-­‐pandemic	   swine-­‐origin	  H1N1	   replaced	   seasonal	  H1N1	   in	  2009?	  How	  do	   the	  dynamics	   of	  swine-­‐origin	  H1N1	  differ	  from	  seasonal	  H1N1?	  FluGraph	  requires	  a	  dataset	  to	  span	  a	  large	  number	  of	  seasons	  to	  assess	  statistical	  significance,	  making	  the	  examination	  of	  only	  recent	  dynamics	  with	  the	  current	  framework	  difficult.	  Moreover,	  while	  FluGraph	  is	  very	  effective	  at	  countering	  regional	  and	  seasonal	  data	  bias,	  it	  makes	  two	  assumptions.	  First,	  it	  makes	  the	  parsimonious	   assumption	   that	   the	   closest	   ancestor	   of	   a	   particular	   isolate	   is	   the	   past	  sequence	  with	   the	   highest	   similarity.	   Second,	   FluGraph	   can	   only	   analyze	   sequences	  with	  complete	  date	  annotation.	  
Instead	   of	   detecting	   seeding	   events	   on	   a	   sequence-­‐by-­‐sequence	   basis,	   a	   modification	   to	  FluGraph	   that	   considers	   transmission	   between	   sets	   of	   sequences	  may	   bear	   promise.	  We	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call	  this	  lambda-­‐flow,	  a	  symmetrisized	  version	  of	  the	  Kulback-­‐Leibler	  divergence	  (KL).	  We	  define	  lambda-­‐flow	  as	  













(Q ||M ) 	  
where	  M=(P+Q)/2.	  Since	  JS	  divergence	  measures	  the	  likelihood	  that	  the	  state	  described	  by	  P	  and	  the	  state	  described	  by	  Q	  have	  a	  common	  evolutionary	  ancestor	  it	  is	  an	  apt	  metric	  for	  measuring	   the	   similarity	  between	   the	  nucleotide	   frequencies	  of	   two	   clusters	  of	   influenza	  sequences	  P	  and	  Q.	  This	  strategy	  is	  a	  promising	  direction	  to	  follow	  in	  the	  future.	  	  
Another	   interesting	   question	   is	   whether	   other	   factors,	   such	   as	   transportation,	   livestock	  trade,	   or	   avian	  migratory	   routes,	   impact	   the	   spread	   of	   seasonal	   influenza?	   These	   factors	  often	   can	   be	   represented	   by	   networks,	   as	  well.	   For	   example,	   flight	   information	   obtained	  from	   the	   International	   Air	   Transport	   Association	   database—which	   contains	   a	   list	   of	   all	  airport	  routes	  with	  corresponding	  volume	  of	  passengers—can	  readily	  be	  reformulated	  as	  a	  directed	  network	  of	   flights	  plotted	  on	   the	  global	  map.	  Network	  comparison	  methods	   can	  identify	  common	  features	  and	  differences	  between	  such	  networks	  as	  the	  aviation	  network	  with	  that	  of	  seasonal	  influenza143.	  There	  are	  two	  main	  types	  of	  network	  comparison.	  Local	  network	   comparison	   finds	   multiple,	   unrelated	   regions	   with	   similar	   graph	   structure	  between	  two	  networks,	  each	  region	  mapped	  independently	  of	   the	  others.	  Global	  network	  comparison,	  on	   the	  other	  hand,	  determines	   the	  best	  overall	  alignment	  between	  the	   input	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networks;	   each	  node	   in	  an	   input	  network	   is	  either	  matched	   to	  one	  or	  more	  nodes	   in	   the	  other	  network	  or	  explicitly	  marked	  as	  a	  gap	  node,	  i.e.,	  with	  no	  match	  in	  another	  network.	  Such	  methods	  may	  shed	  light	  upon	  the	  factors	  influencing	  the	  patterns	  of	  influenza	  spread	  we	  observed	  using	  FluGraph.	  
Given	  the	  novelty	  of	  the	  method,	  there	  are	  still	  a	  number	  of	  potential	  areas	  of	  development	  for	   the	  application	  of	   algebraic	   topology	   to	  evolution.	  For	  example,	   in	   the	   same	  way	   that	  bi>0	   serves	   as	   a	   measure	   of	   how	   much	   a	   single	   simplicial	   complex	   deviates	   from	   tree	  additivity,	   it	  would	   be	   useful	   to	   have	   some	   quantity	   that	   indicates	   how	  much	   a	   barcode	  (filtration	  of	  simplicial	  complexes)	  deviates	  from	  additivity.	  In	  the	  paper,	  we	  consider	  the	  distribution	  B	  of	  bar	  lengths	  of	  k-­‐dimensional	  cycles	  for	  some	  k>0	  and	  measure	  the	  L-­‐norm	  of	   B.	  We	   define	   the	   topological	   obstruction	   to	   phylogeny	   (TOP)	   to	   be	   the	   L-­‐∞	   norm,	   or	  maximum,	  of	  B	  and	  prove	  that	  a	  filtration	  of	  non-­‐zero	  TOP	  implies	  non-­‐additivity	  for	  some	  ε.	  However,	  other	  possible	  L-­‐norms	  can	  be	  used.	  In	  simulations	  of	  evolutionary	  data	  where	  we	   initially	  set	  a	  rate	  r	  of	  horizontal	  evolution,	  we	   find	   that	  of	  all	  L-­‐norms,	   the	  L-­‐1	  norm	  (summation	  of	  B)	  and	  L-­‐0	  norm	  (number	  of	  bars)	  are	  most	  proportional	  to	  r.	  	  
Another	   open	   question	   is	   whether	   we	   can	   further	   improve	   the	   differentiation	   between	  topological	   noise	   and	   signal?	   To	   account	   for	   this	   problem,	   we	   first	   simulated	   vertical	  evolution	   without	   any	   reassortment	   and	   calculated	   the	   topology	   of	   the	   datasets.	   Any	  higher-­‐dimensional	  holes	  detected	  were	  considered	  to	  be	  false	  positives	  due	  to	  topological	  noise	   or	   homoplasy.	   We	   then	   used	   the	   length	   of	   these	   small	   bars	   as	   a	   threshold	   for	  nominating	   candidates	   for	   reassortment.	   A	   more	   rigorous	  means	   of	   filtering	   topological	  noise	   might	   entail	   bootstrapping	   sequences	   to	   construct	   a	   confidence	   interval	   for	   TOP,	  similar	  to	  the	  method	  proposed	  by	  Balakrishnan,	  et	  al.	  144	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It	  is	  important	  to	  consider	  situations	  in	  which	  algebraic	  topology	  may	  encounter	  difficulty	  in	   the	  detection	  of	   reassortment.	  Such	   instances	  may	   include	  reassortment	  during	  strong	  frequency-­‐dependent	  selective	  sweeps.	  It	  is	  also	  likely	  that	  influenza	  viruses	  that	  are	  closer	  together	   in	   genetic	   distance	   are	  more	   likely	   to	   reassort.	   In	   both	   examples,	   the	   resulting	  higher-­‐dimensional	  holes	  may	  be	  small	  and	  difficult	  to	  distinguish	  from	  topological	  noise.	  	  Importantly,	  such	  cases	  would	  be	  difficult	  to	  detect	  for	  any	  method	  anyway.	  	  
	  
Figure	  43.	  Detecting	  reassortment	  using	  algebraic	  topology	  in	  settings	  of	  strong	  selection	  of	  reassortant	  strains.	  Here,	  we	  use	  
different	  measures	  of	  deviation	  from	  additivity	  (L-­‐0,	  L-­‐1,	  and	  L-­‐infinity,	  and	  find	  that	  L-­‐0	  is	  the	  most	  robust	  to	  the	  selective	  
sweep.	  	  To	   consider	   the	   topological	   behavior	   in	   settings	   of	   strong	   selection,	   I	   conducted	  evolutionary	   simulations	   with	   increased	   fitness	   of	   recombinant	   strains.	   I	   simulated	   20	  generations	  of	   evolution	  undergoing	  a	   constant	  mutation	  and	   recombination	   rate,	  with	   a	  selective	   sweep	   at	   generation	   10.	   Although	   the	   selective	   sweep	   produced	   a	   dramatic	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reduction	   in	   L-­‐1	   and	   L-­‐infinity,	   L-­‐0	   is	   more	   robust	   (Figure	   43).	   In	   other	   words,	   new	  irreducible	  cycles	  are	  born	  at	  the	  expected	  rate	  but	  consist	  of	  reassortments	  between	  very	  similar	  sequences	  (descendants	  of	  the	  selected	  sweep).	  	  
These	   observations	   can	   be	   explained	   as	   follows.	   The	   quick	   fixation	   of	   the	   selected	  recombinant	  has	  a	  double	  effect.	  Selective	  sweeps	  reduce	  diversity	  and	  inhibit	  the	  ability	  to	  identify	   large	   recombinations	   by	   any	   computational	  means	   (by	   persistent	   homology	   and	  any	  other).	  Moreover,	  as	   the	  diversity	  decreases,	   the	  non-­‐selected	  recombinants	  between	  similar	   parental	   genomes	   correspond	   to	   smaller	   bars.	   The	   total	   number	   of	   bars	   (L0	  measure)	   is	   robust,	   but	   all	   other	   functions	   (L1,	   etc.)	   are	   extremely	   sensitive	   to	   selective	  sweeps.	  In	  the	  paper	  we	  only	  deal	  with	  L0	  (total	  number	  of	  bars	  independent	  of	  size)	  and	  L-­‐infinity	  (TOP,	  or	  the	  size	  of	  the	  longest	  bar).	  Future	  work	  could	  tailor	  algebraic	  topology	  to	  the	  identification	  of	  selective	  sweeps	  in	  a	  highly	  reassortant	  population.	  	  
Other	  questions	  about	  algebraic	  topology	  remain.	  Can	  we	  incorporate	  other	  metric	  spaces	  and	  parameters	  like	  time	  to	  apply	  our	  current	  implementation	  or	  even	  a	  multi-­‐dimensional	  version	  of	  persistent	  homology?	  Can	  we	  further	  formalize	  the	  relationship	  of	  additive	  trees	  as	  a	  subset	  of	  simplicial	  complexes?	  Can	  we	  optimize	  local	  irreducible	  cycle	  identification	  in	  the	   generation	   of	   topological	   features?	   What	   other	   fields	   of	   inquiry	   can	   be	   explored	  through	  the	  application	  of	  persistent	  homology?	  
We	  are	  currently	  in	  the	  midst	  of	  a	  revolution	  in	  high-­‐throughput	  sequencing	  that	  promises	  the	   perfect	   opportunity	   to	   answer	   these	   questions.	   Though	   systematic	   errors	   in	   these	  technologies	   remain,	   new	   improvements	   have	   taken	   place	   even	   in	   the	   span	   of	  my	   Ph.D.,	  typified	  by	  lower	  cost,	  higher	  depth,	   longer	  reads,	  and	  paired-­‐end	  reads.	  Although	  whole-­‐
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exome	   remains	   the	  most	   popular	   form	  of	   sequencing,	   the	   introduction	   of	  whole-­‐genome	  DNA	  and	  whole-­‐transcriptome	  RNA	  sequencing	  have	  expanded	  the	  biological	  questions	  we	  can	   ask.	   Soon,	   limitations	   stemming	   from	   sample	   purity	   will	   be	   eliminated	   with	   the	  developments	  of	  single-­‐cell	  and	  single-­‐molecule	  real	  time	  sequencing.	  Future	  work	  on	  the	  methods	   I	  have	  presented	   in	   this	   thesis	   combined	  with	  advancements	   in	   sequencing	  will	  further	  contribute	  to	  our	  understanding	  of	  influenza	  evolution.	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Supplementary	  Chapter	  3:	  Gene	  
fusions	  in	  glioblastoma	  
multiforme	  	  
Section	  3.1:	  Introduction	  In	   addition	   to	   parasites	   like	   influenza,	   cancer	   provides	   an	   informative	   model	   of	   rapid	  evolution.	  For	  this	  reason,	  I	  include	  as	  a	  supplement	  to	  my	  thesis	  the	  work	  I	  have	  done	  in	  studying	   evolution	   through	   cancer,	   particularly	   the	   aggressive	   disease	   glioblastoma	  multiforme.	  	  
One	   might	   wonder	   what	   influenza	   and	   glioblastoma	   have	   in	   common.	   However,	   the	  parallels	  between	  cancer	  and	  parasites	  are	  not	  trivial;	  recently,	  researchers	  identified	  devil	  facial	   tumor	  disease,	  a	  specific	   type	  of	  parasitic	  cancer	   transmissible	  between	  Tazmanian	  devils145.	   This	   discovery	   supports	   the	   idea	   that	   in	   all	   cancers,	   tumorgenesis	   is	   an	  evolutionary	  process146	  mediated	  by	  the	  genetic	  and	  epigenetic	  derangement	  of	  an	   initial	  group	  of	  normal	  cells.	  These	  mutations	  include	  SNVs,	  indels,	  CNVs,	  translocations,	  and	  viral	  integration,	  and	  lead	  to	  phenotypic	  changes	  of	  increased	  cell	  growth,	  loss	  of	  differentiation,	  and	   increased	   proliferation	   through	   clonal	   expansion	   to	   the	   detriment	   of	   the	   host	  organism.	   Merlo,	   et	   al.	   aptly	   describe	   neoplasms	   as	   “microcosms	   of	   evolution”	   where	  mutant	   cells	   compete	   for	   space	   and	   resources,	   evade	   predation	   by	   immune	   system	   and	  chemotherapy,	   and	   cooperate	   to	   colonize	   other	   parts	   of	   the	   body	   through	  metastasis147.	  Though	   not	   as	   fast	   as	   influenza,	   the	   estimated	   doubling	   time	   of	   aggressive	   cancers,	   like	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glioblastoma,	   can	   be	   as	   short	   as	   17	   days148.	   The	   range	   of	   evolutionary	   rates	   can	   run	   the	  gamut,	   from	   indolent	   to	   acute	   cancers,	   based	  on	   the	   status	   of	   telomeres	   and	  DNA	   repair	  enzymes	   in	   the	   cell	   or	   presence	   of	   extrinsic	   factors	   like	   smoking	   or	   UV	   radiation.	   For	  example,	  while	  the	  somatic	  mutation	  rate	  of	  normal	  human	  cells	  is	  estimated	  at	  10.6*10-­‐7	  mutations	   per	   cell	   division,	   the	   same	   rate	   in	   individuals	  with	   Fanconi	   anemia—a	   cancer	  predisposition	   syndrome	   resulting	   from	   mutations	   in	   a	   family	   of	   DNA	   repair	   genes—increases	  to	  411*10-­‐7,	  by	  nearly	   forty-­‐fold149.	  One	  particular	   type	  of	  mutation	  called	  gene	  fusions	  achieves	  an	  especially	   rapid	  shift	   in	   the	  cancer	  cell’s	  phenotype.	  Typified	  by	  such	  cancers	  as	  chronic	  myelogenous	   leukemia,	   the	  survival	  of	   the	  tumor	  cell	  becomes	  heavily	  dependent	   on	   the	   continuing	   function	   of	   the	   fusion,	   a	   property	   known	   as	   oncogenic	  addiction.	  	  
PC	  Nowell	  first	  formalized	  the	  notion	  of	  cancer	  as	  an	  evolutionary	  process	  in	  which	  genetic	  instability	   creates	   genetic	   variation	   that	   is	   sieved	   by	   natural	   selection150.	   This	   instability	  leads	   to	   a	  menagerie	   of	   somatic	  mutations,	   including	   substitutions,	   indels,	   copy	   number	  variants,	  methylation	  aberrations,	  translocations,	  and	  gene	  fusions.	  Unlike	  the	  proliferation	  of	  viruses	  that	  can	  be	  complicated	  by	  reticulate	  events,	  cancer	  evolution	  is	  largely	  a	  clonal	  process,	   where	   an	   initial	   tumor	   cell	   population	   proliferates	   often	   through	   abnormal	  mitosis,	  and	  different	  cell	  lineages	  are	  created	  by	  sequential	  mutations	  that	  confer	  greater	  or	   lesser	   fitness.	   Fitness	   is	   determined	   by	   the	   “hallmarks	   of	   cancer”:	   the	   tumor	   cell’s	  abilities	   for	   evasion	   of	   apoptosis,	   self-­‐sufficiency	   in	   growth	   signals,	   insensitivity	   to	   anti-­‐growth	   signals,	   sustained	   angiogenesis,	   limitless	   replicative	   potential,	   and	   tissue	  invasion/metastasis151.	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There	  are	   two	  general	   theories	   for	   the	  creation	  of	   tumor	  heterogeneity:	   the	  cancer	  stem-­‐cell	   (CSC)	  and	  clonal	  evolution	  model152.	   	  The	   tumor	   is	  akin	   to	  an	  abnormal	  organ	   in	   the	  body.	  And	  much	  like	  stem	  cells	  of	  any	  organ,	  there	  is	  evidence	  that	  for	  many	  cancers,	  there	  exists	  only	  a	  small	  subset	  of	  the	  tumor	  capable	  of	  indefinite	  proliferation	  through	  acquired	  mutations.	   These	   CSCs	   can	   create	   from	   scratch	   a	   tumor	  mass	   of	   differentiated	   cells	  with	  limited	   proliferation	   capacity153.	   Such	   CSCs	   have	   been	   isolated	   in	   a	   number	   of	   cancers,	  including	  leukemia,	  breast	  cancer,	  and	  lung	  cancer.	  In	  the	  second	  clonal	  evolution	  scenario,	  each	   cancer	   cell	   can	   produce	   any	   number	   of	   lineages	   with	   potentially	   unlimited	  proliferation	  ability.	  Natural	  selection	  then	  sifts	  through	  the	  resulting	  variation,	  expanding	  or	  contracting	  different	  lineages.	  These	  theories	  are	  not	  mutually	  exclusive	  and	  may	  apply	  to	  certain	  cancers	  to	  different	  degrees.	  	  
The	   mutations	   at	   each	   step	   of	   a	   clonal	   expansion	   endow	   the	   cancer	   cell	   with	   variable	  fitness.	   Indeed,	   these	   mutations	   can	   be	   divided	   into	   driver	   lesions	   that	   further	   tumor	  progression	   and	  passenger	   lesions	   that	   are	   byproducts	   of	   the	  mutagenic	   environment	   of	  the	   cancer154.	  Driver	   genes	  provide	  potential	   candidates	   of	   oncogene	   addiction,	   in	  which	  the	  survival	  of	  a	  tumor	  cell	  becomes	  increasingly	  dependent	  on	  the	  continuing	  function	  of	  a	  lesion155.	  	  
One	  particular	  type	  of	  mutation—gene	  fusions—has	  been	  shown	  to	  display	  both	  features	  of	  driver	  gene	  and	  oncogene	  addiction.	  Fusion	  transcripts	  result	  when	  two	  or	  more	  genes	  are	  stitched	  together,	  often	  through	  some	  combination	  of	  translocation,	  amplification,	  deletion,	  or	   inversion.	   Such	   fusions	   can	   even	   arise	   without	   DNA	   rearrangements	   in	   read-­‐through	  events,	  where	  the	  RNA	  polymerase	  switches	  to	  one	  gene	  halfway	  through	  transcription	  of	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its	  neighboring	  gene.	  In	  general,	  gene	  fusions	  may	  result	  in	  1)	  an	  oncogene	  stitched	  to	  the	  promoter	   of	   a	   highly	   expressed	   gene,	   2)	   the	   disruption	   of	   a	   tumor	   suppressor,	   or	   3)	   a	  completely	  novel	  hybrid	  protein.	  	  
The	  prototypic	  example	  of	  a	  driver	  gene	  fusion	  conferring	  oncogene	  addiction	  is	  BCR-­‐ABL,	  implicated	   in	   chronic	   myelogenous	   leukemia	   and	   gastrointestinal	   stromal	   tumors.	   This	  lesion	  creates	  a	  novel	  hybrid	  tyrosine	  kinase	  with	  constitutive	  activation.	  Blockade	  of	  the	  gene	  fusion	  with	  the	  blockbuster	  drug	  imatinib	  results	  in	  significant	  remission,	  making	  this	  blockbuster	  drug	  the	  most	  successful	  chemotherapy	  on	  the	  market.	  	  
Because	  early	   fusion	  discovery	   techniques	   included	   low-­‐throughput	   cytogenetic	  methods	  like	   FISH	   and	   SKY	   that	   were	   dependent	   on	   tumor	   purity,	   many	   researchers	   initially	  believed	   that	   gene	   fusions	   occurred	   only	   in	   leukemias	   and	   lymphomas.	   With	   the	  development	   of	   deep	   sequencing	   and	   computational	   discovery	   tools,	   gene	   fusions	   have	  been	  discovered	  in	  an	  increasing	  number	  of	  solid	  tumors	  as	  well.	  
One	  particular	  solid	  tumor	  that	  has	  yet	  to	  be	  fully	  characterized	  is	  glioblastoma	  multiforme	  (GBM),	  the	  most	  common	  and	  aggressive	  brain	  cancer	  in	  adults.	  Based	  on	  expression	  data,	  GBM	  can	  be	  subdivided	  into	  several	  subtypes	  prognostic	  of	  survival.	  The	  classical	  subtype	  is	   characterized	   by	   frequent	   EGFR	   amplification,	   fewer	   TP53	   mutations,	   and	   longest	  survival	  following	  aggressive	  treatment.	  In	  contrast,	  the	  proneural	  subtype	  is	  recurrent	  in	  TP53,	   PDGFRA,	   and	   IDH1	   SNVs.	   Moreover,	   this	   subgroup	   tends	   to	   affect	   younger	  individuals	   with	   better	   prognosis,	   though	   aggressive	   treatment	   does	   not	   significantly	  impact	  outcome.	  The	  mesenchymal	  subtype	  contains	  less	  EGFR	  amplification	  and	  frequent	  SNVs	   in	   PTEN,	   P53,	   and	   particularly	   NF1.	   Patients	   in	   this	   category	   respond	   well	   to	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aggressive	   treatment.	   Finally,	   although	   the	   neural	   subtype	   does	   not	   have	   significantly	  higher	   or	   lower	   rates	   of	  mutation	   than	   other	   subtypes,	   the	   expression	   profile	   of	   several	  gene	   types	  mirrored	   that	  of	  normal,	  non-­‐cancerous	  neurons.	  These	  patients	   tended	  to	  be	  the	   oldest	   on	   average	   and	   showed	  mild	   response	   to	   aggressive	   treatment156.	   In	   all	   these	  subtypes,	   however,	   no	   driver	   gene	   fusions	   have	   been	   identified	   until	   now.	   In	   addition,	  glioma	   stemlike	   cell	   lines	   (GSCs)	   have	   been	   isolated	   from	   glioblastomas.	   This	  subpopulation	   harbors	   the	   same	   mutations	   including	   EGFR	   amplification	   and	   displays	  multipotency,	  clonogenicity,	  and	  an	  ability	  to	  promote	  angiogenesis157.	  	  
In	  the	  following	  appendix,	  we	  will	  see	  how	  both	  RNA	  and	  DNA	  sequencing	  can	  be	  harnessed	  to	  search	  for	  gene	  fusions.	  I	  developed	  and	  applied	  gene	  fusion	  discovery	  tools,	  TX-­‐fuse	  and	  EXomeFuse,	  	  to	  identify	  a	  number	  of	  gene	  fusions	  in	  both	  GSCs	  and	  patient	  tumors.	  In	  the	  first	  part	  of	  the	  chapter,	  “Transforming	  Fusions	  of	  FGFR	  and	  TACC	  Genes	  in	  Human	  Glioblastoma”	  published	  in	  Science,	  I	  will	  detail	  the	  discovery	  of	  the	  FGFR-­‐TACC	  fusion	  found	  in	  a	  subset	  of	  GBM	  patients.	  These	  lesions	  play	  a	  major	  role	  in	  delaying	  mitotic	  progression	  and	  inducing	  aneuploidy	  in	  the	  tumor,	  thus	  marking	  a	  major	  driving	  event	  in	  the	  evolution	  of	  the	  cancer.	  Moreover,	  this	  finding	  informs	  the	  debate	  over	  whether	  aneuploidy	  in	  cancer	  is	  a	  driver	  or	  passenger	  aberration158.	  Notably,	  FGFR	  inhibitors	  exist	  that	  significantly	  prolong	  survival,	  suggesting	  signs	  of	  oncogene	  addiction.	  	  
In	  an	  excerpt	  of	  “The	  integrated	  landscape	  of	  driver	  genomic	  alterations	  in	  glioblastoma,”	  published	  in	  Nature	  Genetics,	  we	  will	  delve	  into	  additional	  gene	  fusions	  discovered	  in	  GBM,	  particularly	  fusions	  involving	  either	  EGFR	  or	  NTRK1.	  Similar	  to	  FGFR-­‐TACC,	  mice	  with	  EGFR-­‐SEPT14	  xenografts	  respond	  to	  EGFR	  inhibitors.	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Section	  3.2:	  Transforming	  fusions	  of	  FGFR	  and	  
TACC	  genes	  in	  glioblastoma	  	  
Summary	  The	  brain	  tumor	  glioblastoma	  multiforme	  (GBM)	  is	  among	  the	  most	  lethal	  forms	  of	  human	  cancer.	   Here,	   we	   report	   that	   a	   small	   subset	   of	   GBMs	   (3.1%;	   3	   of	   97	   tumors	   examined)	  harbors	   oncogenic	   chromosomal	   translocations	   that	   fuse	   in-­‐frame	   the	   tyrosine	   kinase	  coding	  domains	  of	  fibroblast	  growth	  factor	  receptor	  (FGFR)	  genes	  (FGFR1	  or	  FGFR3)	  to	  the	  transforming	   acidic	   coiled-­‐coil	   (TACC)	   coding	   domains	   of	  TACC1	  or	  TACC3,	   respectively.	  The	  FGFR-­‐TACC	  fusion	  protein	  displays	  oncogenic	  activity	  when	  introduced	  into	  astrocytes	  or	   stereotactically	   transduced	   in	   the	  mouse	   brain.	   The	   fusion	   protein,	  which	   localizes	   to	  mitotic	  spindle	  poles,	  has	  constitutive	  kinase	  activity	  and	  induces	  mitotic	  and	  chromosomal	  segregation	   defects	   and	   triggers	   aneuploidy.	   Inhibition	   of	   FGFR	  kinase	   corrects	   the	  aneuploidy,	   and	   oral	   administration	   of	   an	  FGFR	  inhibitor	   prolongs	   survival	   of	   mice	  harboring	   intracranial	  FGFR3-­‐TACC3–initiated	   glioma.	  FGFR-­‐TACC	  fusions	   could	  potentially	  identify	  a	  subset	  of	  GBM	  patients	  who	  would	  benefit	  from	  targeted	  FGFR	  kinase	  inhibition.	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Main	  Text	  Chromosomal	  translocations	  leading	  to	  production	  of	  oncogenic	  fusion	  proteins	  are	  critical	  events	   in	   the	  pathogenesis	  of	  human	  cancer	   159-­‐161.	  To	  examine	  whether	   such	  alterations	  are	   present	   in	   the	   tumor	   glioblastoma	   multiforme	   (GBM),	   we	   used	   massively	   parallel,	  paired-­‐end	  sequencing	  of	  expressed	  transcripts	  (RNA-­‐seq)	  to	  detect	  gene	  fusions	  in	  short-­‐term	   cultures	   of	   glioma	   stemlike	   cells	   (GSCs)	   freshly	   isolated	   from	   nine	   patients	   with	  primary	  GBMs.	  Using	  TX-­‐Fuse,	  a	  methodology	  that	  detects	  split	  reads	  and	  split	  inserts	  (see	  Appendix	   A	   and	   Figure	   44A),	   we	   discovered	   six	   rearrangements	   (all	   of	   which	   were	  intrachromosomal)	   that	  gave	  rise	   to	   in-­‐frame	  fusion	  transcripts	  (Supplementary	  Table	  G-­‐1).	  We	  validated	  five	  in-­‐frame	  fusion	  predictions	  by	  direct	  sequencing	  of	  polymerase	  chain	  reaction	  (PCR)	  products	  spanning	  the	  fusion	  breakpoint	  (Figure	  44B	  to	  E	  and	  Figure	  46).	  
In	  Figure	  46,	  A	  and	  B,	  we	  show	  the	  prediction	  and	  cDNA	  sequence	  validation,	  respectively,	  for	   the	   fusion	   with	   the	   highest	   read	   support	   involving	  fibroblast	   growth	   factor	   receptor	  3	  (FGFR3)	  fused	  in-­‐frame	  with	  transforming	  acidic	  coiled-­‐coil	  3	  (TACC3)	  in	  GSC-­‐1123	  and	  GBM-­‐1123	  primary	  tumor.	  The	  cDNA	  contained	  an	  open	  reading	  frame	  coding	  for	  a	  protein	  of	  1048	  amino	  acids	  resulting	  from	  the	  in-­‐frame	  fusion	  of	  the	  FGFR3	  N	  terminus	  (residues	  1	   to	   758)	   with	   the	  TACC3	   C	   terminus	   (residues	   549	   to	   838)	   (Figure	   45A	   and	   Figure	  46C).	  FGFR3	   is	   a	   member	   of	   the	  FGFR	  receptor	   tyrosine	   kinase	   (TK)	   family	   162,	  whereas	  TACC3	   belongs	   to	   the	   evolutionarily	   conserved	  TACC	  gene	   family,	   which	   also	  includesTACC1	  and	  TACC2.	  The	  distinctive	  feature	  of	  TACC	  proteins	  is	  a	  coiled-­‐coil	  domain	  at	   the	  C	   terminus,	  known	  as	   the	  TACC	  domain,	  which	  mediates	   localization	   to	   the	  mitotic	  spindle	   163,164.	  TACC	  proteins	  are	  hypothesized	   to	  be	  oncogenic	   in	  several	  human	  tumors,	  including	  GBMs	  165,166.	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Figure	   44.	   Identification	   and	   validation	   of	   gene	   fusions	   in	   GBM.	   (A)	   TX-­‐Fuse	   pipeline	   for	   the	   identification	   of	  
fusion	   transcripts	   from	   RNA-­‐Seq	   data.	   (B)	   RT-­‐PCR	   for	   POLR2A-­‐WRAP53	   (left	   panel).	   Sanger	   sequencing	  
chromatograms	  show	  the	  reading	  frames	  at	  the	  breakpoint	  and	  putative	  translation	  of	  the	  fusion	  proteins	  in	  the	  
positive	  sample	  (right	  panel).	  (C)	  RT-­‐PCR	  for	  CAPZB-­‐	  UBR4	  (left	  panel).	  Sanger	  sequencing	  chromatograms	  show	  
the	  reading	  frames	  at	  the	  breakpoint	  and	  putative	  translation	  of	  the	  fusion	  proteins	  in	  the	  positive	  sample	  (right	  
panel).	  (D)	  RT-­‐PCR	  for	  ST8SIA4-­‐PAM	  (left	  panel).	  Sanger	  sequencing	  chromatograms	  show	  the	  reading	  frames	  at	  
the	  breakpoint	  and	  putative	  translation	  of	  the	  fusion	  proteins	  in	  the	  positive	  sample	  (right	  panel).	  (E)	  RT-­‐PCR	  for	  
PIGU-­‐NCOA6	   (right	   panel).	   Sanger	   sequencing	   chromatograms	   show	   the	   reading	   frames	   at	   the	  breakpoint	   and	  
putative	  translation	  of	  the	  fusion	  proteins	  in	  the	  positive	  sample	  (right	  panel).	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Figure	  45.	  Analysis	  and	  validation	  of	  the	  expression	  of	  FGFR3-­‐TACC3	  fused	  transcripts	  in	  GSCs	  and	  GBM	  samples.	  
(A)	  Amino	  acid	  sequence	  of	  the	  FGFR3-­‐TACC3	  protein	  in	  GSC-­‐1123.	  Residues	  corresponding	  to	  FGFR3	  and	  TACC3	  
are	  shown	  in	  red	  and	  blue,	  respectively.	  The	  fusion	  protein	  joins	  the	  TK	  domain	  of	  FGFR3	  to	  the	  TACC	  domain	  of	  
TACC3.	  (B)	  Expression	  measured	  by	  read	  depth	  from	  RNA-­‐seq	  data.	  Grey	  arcs	  indicate	  predicted	  components	  of	  
transcripts	  fused	  together.	  Overall	  read	  depth	  (blue)	  and	  split	  insert	  depth	  (red)	  are	  depicted	  in	  the	  graph,	  with	  a	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50-­‐read	  increment	  and	  a	  maximum	  range	  of	  1800	  reads.	  Note	  the	  very	  high	  level	  of	  expression	  in	  the	  regions	  of	  
the	  genes	  implicated	  in	  the	  fusion	  events,	  particularly	  for	  FGFR3-­‐TACC3.	  (C)	  qRT-­‐PCR	  shows	  very	  high	  expression	  
of	  FGFR3	  and	  TACC3	  mRNA	  sequences	  included	  in	  the	  FGFR3-­‐TACC3	  fusion	  transcript	  in	  GSC-­‐1123.	  (D)	  Western	  
blot	   analysis	   with	   a	   monoclonal	   antibody,	   which	   recognizes	   the	   N-­‐terminal	   region	   of	   human	   FGFR3,	   shows	  
expression	   of	   a	   ~150	   kD	   protein	   in	   GSC-­‐1123	   but	   not	   in	   GSC-­‐0331	   and	   GSC-­‐0114	   that	   lack	   the	   FGFR3-­‐TACC3	  
rearrangement.	   (E)	   Immunostaining	   analysis	  with	   the	   FGFR3	   antibody	   of	   the	   GBM-­‐1123	   (upper	   panels)	   and	   a	  
GBM	   sample	   lacking	   the	   FGFR3-­‐TACC3	   rearrangement	   (lower	   panels).	   FGFR3	   (red),	   DNA	   (DAPI,	   blue).	   The	  
pictures	  were	   taken	  at	   low	  (left)	  and	  high	   (right)	  magnification.	   (F)	  MS/MS	  analysis	  of	  ~150	  kD	   fusion	  protein	  
immunoprecipitated	   by	   the	  monoclonal	   anti-­‐FGFR3	   antibody	   from	   GSC-­‐1123	   identifies	   three	   unique	   peptides	  
mapping	   to	   the	   FGFR3	   (upper	   panels)	   and	   three	   peptides	  mapping	   to	   the	   C-­‐terminal	   region	   of	   TACC3	   (lower	  
panels).	  
	  
Figure	  46.	   FGFR3-­‐TACC3	  gene	   fusion	   identified	  by	  whole-­‐transcriptome	   sequencing	  of	  GSCs.	   (A)	  Here,	   76	   split-­‐
reads	  are	  shown	  aligning	  on	  the	  breakpoint.	  The	  predicted	  reading	  frame	  at	  the	  breakpoint	  is	  shown	  at	  the	  top	  
with	  FGFR3	  sequences	  in	  red	  and	  TACC3	  in	  blue.	  (B)	  (Left)	  FGFR3-­‐TACC3–specific	  PCR	  from	  cDNA	  derived	  from	  
GSCs	  and	  GBMs.	  M,	  1-­‐kb	  DNA	  ladder.	  (Right)	  Sanger	  sequencing	  chromatogram	  showing	  the	  reading	  frame	  at	  the	  
breakpoint	   and	   putative	   translation	   of	   the	   fusion	   protein	   in	   the	   positive	   samples.	   T,	   threonine;	   S,	   serine;	   D,	  
aspartic	   acid;	   F,	   phenylalanine;	   E,	   glutamic	   acid.	   (C)	   Schematics	   of	   the	   FGFR3-­‐TACC3	   protein.	   Regions	  
corresponding	   to	  FGFR3	  orTACC3	  are	  shown	   in	  red	  or	  blue,	   respectively.	  The	   fusion	  protein	   joins	   the	   tyrosine	  
kinase	   domain	   of	   FGFR3	   to	   the	   TACC	   domain	   of	   TACC3.	   (D)	   Genomic	   fusion	   of	   FGFR3	   exon	   17	   with	   intron	   7	  
ofTACC3.	  In	  the	  fused	  mRNA,	  exon	  16	  of	  FGFR3	  is	  spliced	  5′	  to	  exon	  8	  of	  TACC3.	  Solid	  black	  arrows	  indicate	  the	  
position	  of	  the	  fusion-­‐genome	  primers,	  which	  generate	  fusion-­‐specific	  PCR	  products	  in	  GSC-­‐1123	  and	  GBM-­‐1123.	  	  
In	  the	  predicted	  fusion	  protein,	  the	  intracellular	  TK	  domain	  of	  FGFR3	  is	  fused	  upstream	  of	  the	  TACC	  domain	  of	  TACC3	  (Figure	  46C).	  Exon-­‐specific	  gene	  expression	  analysis	   from	  the	  RNA-­‐seq	  coverage	  in	  GSC-­‐1123	  and	  quantitative	  reverse	  transcription	  PCR	  showed	  that	  the	  expression	  of	   the	   fused	  FGFR3-­‐TACC3	  exons	   is	  higher	   in	  GSC-­‐1123	   than	   in	  other	  GSCs	  or	  the	  normal	  brain	   (80-­‐	   to	  130-­‐fold)	   (Figure	  45B	  and	  C).	  The	  FGFR3-­‐TACC3	   fusion	  protein	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was	  abundantly	  expressed	  in	  GSC-­‐1123	  and	  GBM-­‐1123,	  and	  immunoprecipitation	  followed	  by	  mass	  spectrometry	  revealed	  the	  presence	  of	  FGFR3	  and	  TACC3	  peptides,	  consistent	  with	  the	   cDNA	   translation	   prediction	   (Figure	   45D	   to	   F).	   We	   used	   PCR	   to	   map	   the	   genomic	  breakpoint	   coordinates	   to	   chromosome	  4	   (1,808,966	   for	  FGFR3	  and	  1,737,080	   forTACC3,	  genome	   build	   GRCh37/hg19),	   falling	   within	  FGFR3	  exon	   17	   and	  TACC3	  intron	   7,	   which	  gives	  rise	   to	  a	   transcript	   in	  which	  the	  5′	  FGFR3	  exon	  16	   is	  spliced	  to	   the	  3′	  TACC3	  exon	  8	  (Figure	  46D).	  The	  DNA	   junctions	  of	  FGFR3	  and	  TACC3	  show	  microhomology	  within	   a	  10-­‐base	   region,	   an	   observation	   consistent	   with	   results	   previously	   reported	   for	   other	  chromosomal	  rearrangements	  in	  human	  cancer	  (Figure	  46D)	  167,168.	  
We	  next	  investigated	  whether	  FGFR3-­‐TACC3	  fusions	  are	  recurrent	  in	  GBMs.	  The	  analysis	  of	  the	   GBM	   data	   set	   from	   the	   Cancer	   Genome	   Atlas	   (TCGA)	   169	   revealed	   that	   four	   tumors	  display	   marked	   co-­‐outlier	   expression	   of	  FGFR3	  and	  TACC3	  (Figure	   47A).	   The	   same	   four	  tumors	  harbor	  microamplification	  events	  of	  the	  FGFR3	  and	  TACC3	  genes	  (Figure	  47B).	  We	  modified	  the	  gene-­‐fusion	  discovery	  method	  as	  a	  package	  called	  EXome-­‐Fuse	  to	  detect	  split	  reads	  and	  split	  inserts	  from	  exome	  DNA	  sequences	  of	  the	  available	  GBM	  cases	  and	  matched	  constitutional	  DNA	  in	  TCGA	  (Figure	  47C).	  From	  this	  analysis,	  FGFR3-­‐TACC3	  emerged	  as	  the	  sole	  recurrent	  somatic	  genomic	  rearrangement	  among	  the	  six	  fusions	  detected	  in	  GSCs.	  We	  found	  split	  reads	  and	  split	   inserts	   joining	  FGFR3	  and	  TACC3	  exons	  in	  the	  four	  GBM	  tumor	  DNAs	  carrying	  co-­‐outlier	  expression	  and	  microamplification	  of	  the	  FGFR3	  and	  TACC3genes	  (Figure	  48A	  and	  Supplementary	  Table	  G-­‐2	  and	  G-­‐3).	  Among	   the	   four	  positive	  TCGA	  GBM	  specimens,	   two	   were	   available	   for	   molecular	   analysis,	   and	   we	   confirmed	   the	   predicted	  fusion	  transcripts	  by	  Sanger	  sequencing	  (Figure	  48B	  and	  C).	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Figure	  47.	  Analysis	  of	  expression	  and	  CNV	  for	  the	  FGFR3	  and	  TACC3	  genes	  in	  TCGA	  derived	  GBM	  samples.	  (A)	  Co-­‐
outlier	  expression	  of	  FGFR3	  and	  TACC3	  in	  four	  GBM	  harboring	  FGFR3-­‐	  TACC3	  gene	  fusions.	  (B)	  CNV	  analysis	  
showing	  micro-­‐amplifications	  of	  the	  rearranged	  portions	  of	  the	  FGFR3	  and	  TACC3	  genes	  in	  all	  four	  GBM	  samples	  
harboring	  FGFR3-­‐TACC3	  gene	  fusions.	  (C)	  Exome-­‐Fuse	  pipeline	  for	  the	  identification	  of	  gene	  fusion	  
rearrangements	  from	  DNA	  exome	  sequences.	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Figure	   48.	   FGFR-­‐TACC	   gene	   fusions	   identified	   by	   exome	   sequencing	   analysis.	   (A)	   Split-­‐reads	   aligning	   to	   the	  
genomic	   breakpoints	   of	   FGFR3	   and	   TACC3	   genes	   in	   four	   TCGA-­‐GBM	   samples	   carrying	   gene	   fusions	   between	  
FGFR3	   and	   TACC3	   genes.	   (B-­‐C)	   FGFR3-­‐TACC3-­‐specific	   RT-­‐PCR	   (left	   panel).	   Sanger	   sequencing	   chromatograms	  
showing	  the	  reading	  frame	  at	  the	  breakpoint	  and	  putative	  translation	  of	  the	  fusion	  protein	  in	  the	  positive	  sample	  
(right	   panel).	   (D)	   FGFR1-­‐TACC1-­‐	   specific	   RT-­‐PCR	   from	   GBM	   samples	   (left	   panel).	   Sanger	   sequencing	  
chromatograms	  showing	  the	  reading	  frame	  at	  the	  breakpoint	  and	  putative	  translation	  of	  the	  fusion	  protein	  in	  the	  
positive	  samples	  (right	  panel).	  (E)	  FGFR3-­‐TACC3-­‐specific	  RT-­‐PCR	  (left	  panel).	  Sanger	  sequencing	  chromatograms	  
showing	   the	   reading	   frame	   at	   the	   breakpoint	   and	   putative	   translation	   of	   the	   fusion	   protein	   in	   the	   positive	  
samples	  (right	  panel).	  The	  FGFR3	  and	  TACC3	  genes	   are	   located	   48	   kb	   apart	   on	   human	   chromosome	   4p16.	   The	  other	   members	   of	   the	  FGFR	  and	  TACC	  families	   retain	   the	   close	   physical	   association,	  with	  FGFR1	  and	  TACC1	   paired	   on	   chromosome	   8p11	   and	  FGFR2	  and	  TACC2	  paired	   on	  chromosome	  10q26	  170.	  To	  determine	  whether	  other	  intrachromosomal	  FGFR-­‐TACC	  fusion	  combinations	   exist	   in	   human	  GBM,	  we	   screened	   cDNA	   from	   an	   independent	   panel	   of	   88	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primary	   GBMs	   and	   discovered	   two	   additional	   cases	   (one	   harboring	  FGFR1-­‐TACC1	  and	  one	  FGFR3-­‐TACC3),	  corresponding	  to	  3	  of	  97	  total	  GBMs	  (3.1%),	   including	  the	  GBM-­‐1123	  case	  (Figure	  48D	  and	  E).	  None	  of	  the	  tumors	  harboring	  FGFR-­‐TACC	  fusions	  had	  mutations	  in	  IDH1	  or	  IDH2	  genes	   (Supplementary	   Table	   G-­‐4).	   In	   all	   seven	   GBMs	   harboring	  FGFR-­‐TACC	  rearrangements	  (four	  from	  TCGA	  and	  three	  from	  our	  tumor	  collection),	  the	  FGFR-­‐TK	  domain	  is	  fused	  upstream	  of	  the	  TACC	  domain.	  
	  
Figure	   49.	   Analysis	   of	   FGFR3-­‐TACC3	   fusion	   protein	   in	   cell	   lines	   and	   tumors	   (A)	   Rat1A	   cells	   transduced	   with	  
control	  lentivirus	  or	  lentivirus	  expressing	  FGFR3,	  TACC3	  or	  FGFR3-­‐TACC3	  were	  analyzed	  by	  Western	  blot	  with	  an	  
antibody	  recognizing	  the	  N-­‐terminus	  of	  FGFR3	  (included	  in	  the	  FGFR3-­‐	  TACC3	  fusion	  protein)	  or	  the	  N-­‐terminus	  
of	  TACC3	  (not	  included	  in	  the	  FGFR3-­‐TACC3	  fusion	  protein).	  (B)	  Quantitative	  Western	  blot	  of	  endogenous	  FGFR3-­‐
TACC3	  in	  GSC-­‐1123	  compared	  with	  lentivirally	  expressed	  FGFR3-­‐TACC3	  in	  Rat1A.	  (C)	  Quantitative	  Western	  blot	  
of	  ectopic	  FGFR3-­‐TACC3	  fusion	  protein	  in	  mouse	  Ink4A;Arf-­‐/-­‐	  astrocytes	  and	  mouse	  GBM	  (mGBM-­‐15	  and	  mGBM-­‐
17)	   compared	   with	   the	   endogenous	   expression	   in	   GSC-­‐1123.	   (D)	   Western	   blot	   analysis	   of	   FGFR3-­‐TACC3	   and	  
FGFR3-­‐TACC3-­‐K508M	   in	   Rat1A.	   (E)	   Subcutaneous	   tumors	   are	   generated	   by	   Ink4A;Arf-­‐/-­‐	   astrocytes	   expressing	  
FGFR-­‐TACC	   fusions.	   Immunostaining	   of	   tumors	   from	   mice	   injected	   with	   Ink4A;Arf-­‐/-­‐	   astrocytes	   expressing	  
FGFR3-­‐TACC3	  shows	  positivity	   for	  glioma-­‐specific	   (Nestin,	  Olig2	  and	  GFAP)	  and	  proliferation	   (Ki67	  and	  pHH3)	  
markers.	   (F)	  FGFR3	  immunostaining	  of	  GBM-­‐1123,	  GSC-­‐1123,	  mouse	  GBM	  induced	  by	  FGFR3-­‐TACC3	  expressing	  
lentivirus	  and	  subcutaneous	  xenograft	  of	  mouse	  astrocytes	  transformed	  by	  FGFR3-­‐T	  ACC3	  fusion.	  FGFR3-­‐T	  ACC3,	  
red;	  DNA	  (DAPI),	  blue.	  (G)	  Quantification	  of	  FGFR3-­‐TACC3	  positive	  cells	  in	  the	  tumors	  and	  cultures	  of	  cells	  shown	  
in	  panel	   F.	  α-­‐tubulin	  or	  β-­‐actin	   are	   shown	  as	   control	   for	   loading.	   F3-­‐T3:	   FGFR3-­‐TACC3;	   F3-­‐T3-­‐	  K508M:	  FGFR3-­‐
TACC3-­‐K508M.	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Figure	   50.	   Transforming	   activity	   of	  FGFR-­‐TACC	  fusion	   proteins.	   (A)	   FGFR1-­‐TACC1	   and	   FGFR3-­‐TACC3	   induce	  
anchorage-­‐independent	   growth	   in	   Rat1A	   fibroblasts.	   F1-­‐T1,	   FGFR1-­‐TACC1;	   F3-­‐T3,	   FGFR3-­‐TACC3.	   (B)	   Kaplan-­‐
Meier	   survival	   curves	   of	   mice	   injected	   intracranially	   with	   pTomo-­‐shp53	   (n	   =	   8	   animals)	   or	   pTomo-­‐EGFRvIII-­‐
shp53	  (n	  =	  7)	  (green	  line)	  and	  pTomo-­‐FGFR3-­‐TACC3-­‐shp53	  (n=	  8)	  (red	  line).	  Points	  on	  the	  curves	  indicate	  deaths	  
(log-­‐rank	   test,	   P	   =	   0.00001,	   pTomo-­‐shp53	   versus	   pTomo-­‐FGFR3-­‐TACC3-­‐shp53).	   (C)	   Representative	  
microphotographs	   of	   hematoxylin	   and	   eosin	   staining	   of	   advanced	   FGFR3-­‐TACC3-­‐shp53–generated	   tumors	  
showing	  histological	  features	  of	  high-­‐grade	  glioma.	  Note	  the	  high	  degree	  of	  infiltration	  of	  the	  normal	  brain	  by	  the	  
tumor	   cells.	   Immunofluorescence	   staining	   shows	   that	   glioma	  and	   stem	  cell	  markers	   (Nestin,	  Olig2,	   and	  GFAP),	  
proliferation	   markers	   (Ki67	   and	   pHH3),	   and	   the	   FGFR3-­‐TACC3	   protein	   are	   widely	   expressed	   in	   the	   FGFR3-­‐
TACC3-­‐shp53	  brain	  tumors.	  To	   explore	   whether	  FGFR-­‐TACC	  fusions	   are	   oncogenic,	   we	   transduced	   Rat1A	   fibroblasts	  andInk4A;	  Arf−/−	  astrocytes	  with	  a	  lentivirus	  expressing	  FGFR3-­‐TACC3,	  which	  resulted	  in	  the	   expression	   of	   the	   fusion	   protein	   at	   levels	   comparable	   to	   those	   present	   in	   GSC-­‐1123	  (Figure	  49A	   to	  D).	  Rat1A	  cells	  expressing	  FGFR3-­‐TACC3	  (or	  FGFR1-­‐TACC1)	  but	  not	   those	  expressing	  a	  kinase-­‐dead	  FGFR3-­‐TACC3	  protein	  (FGFR3-­‐TACC3-­‐K508M),	  FGFR3,	  TACC3,	  or	  the	  empty	   lentivirus	  acquired	  the	  ability	  to	  grow	  in	  anchorage-­‐independent	  conditions	   in	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soft	  agar	  (Figure	  50A	  and	  Supplementary	  Table	  G-­‐5).	  Transduction	  of	  the	  same	  lentiviruses	  in	   primary	  Ink4A;Arf−/−	  astrocytes	   followed	   by	   subcutaneous	   injection	   into	  immunodeficient	  mice	   revealed	   that	   only	   astrocytes	   expressing	  FGFR3-­‐TACC3	   or	  FGFR1-­‐TACC1	   formed	   tumors	   (Supplementary	   Table	   G-­‐5).	   The	   tumors	  were	   glioma-­‐like	   lesions	  with	   strong	   positivity	   for	   Ki67,	   phospho-­‐histone	  H3,	   nestin,	   glial	   fibrillary	   acidic	   protein	  (GFAP),	  and	  Olig2	  (Figure	  49E).	  To	  target	  a	  small	  number	  of	  cells	  with	  the	  fusion	  protein	  into	   the	   brain	   of	   immunocompetent	   animals,	   we	   stereotactically	   transduced	   the	   adult	  mouse	   hippocampus	   with	   purified	   lentivirus	   expressingFGFR3-­‐TACC3	   and	   short	   hairpin	  RNA	  (shRNA)	  against	  p53	  (pTomo-­‐FGFR3-­‐TACC3-­‐shp53)	  171.	  Seven	  of	  eight	  mice	  (87.5%)	  transduced	  with	  FGFR3-­‐TACC3	  succumbed	   from	  malignant	  brain	   tumors	  within	  240	  days	  (Figure	  50B).	  None	  of	  the	  mice	  transduced	  with	  a	  lentivirus	  expressing	  epidermal	  growth	  factor	   receptor	   version	   III	   (EGFRvIII)/shp53	   or	   the	   shp53	   control	   lentivirus	   developed	  clinical	   signs	   of	   brain	   tumors	   or	   died.	   The	  FGFR3-­‐TACC3	   tumors	   were	   invasive,	   rapidly	  growing	  high-­‐grade	  gliomas	   that	  stained	  positive	   for	   the	  glioma	  stem	  cell	  markers	  nestin	  and	   Olig2,	   the	   glial	   marker	   GFAP,	   and	   Ki67	   and	   phospho-­‐histone	   H3	   (Figure	   50C).	  The	  FGFR3-­‐TACC3	   fusion	   protein	  was	   expressed	   in	   the	   xenograft	   and	   intracranial	   tumor	  models	  at	  levels	  comparable	  to	  those	  seen	  in	  human	  GSCs	  and	  GBMs	  (Figure	  49C,	  F,	  and	  G).	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Figure	   51.	   Analysis	   of	   FGFR	   signaling	   by	   FGFR3-­‐TACC3	   fusion	   protein.	   (A-­‐C)	   Ink4A;Arf-­‐/-­‐	   mouse	   astrocytes	  
transduced	  with	  different	  constructs	  were	  starved	  of	  mitogens	  and	  left	  untreated	  or	  treated	  with	  (A)	  FGF-­‐2	  (50	  
ng/ml)	  for	  the	  indicated	  times,	  (B)	  FGF-­‐1	  for	  10	  min	  at	  the	  indicated	  concentrations	  and	  (C)	  FGF-­‐8	  for	  10	  min	  at	  
the	  indicated	  concentrations.	  Phospho-­‐proteins	  and	  total	  proteins	  were	  analyzed	  by	  Western	  blot.	  β-­‐actin	  and	  α-­‐
tubulin	  are	  shown	  as	  a	  control	  for	  loading.	  (D)	  Constitutive	  auto-­‐phosphorylation	  of	  FGFR3-­‐TACC3	  fusion.	  Human	  
astrocytes	   transduced	  with	  empty	   lentivirus	  or	  a	   lentivirus	  expressing	  FGFR3-­‐TACC3	  or	  FGFR3-­‐TACC3-­‐	  K508M	  
were	   left	   untreated	   (0)	   or	   treated	   with	   100	   nM	   of	   the	   FGFR	   TK	   inhibitor	   PD173074	   for	   the	   indicated	   times.	  
Phospho-­‐proteins	  and	   total	  proteins	  were	  analyzed	  by	  Western	  blot	  using	   the	   indicated	  antibodies.	   (E)	  Mouse	  
GSCs	  derived	   from	  FGFR3-­‐TACC3	  or	  RasV12	   induced	  glioma	  were	   left	  untreated	   (0)	  or	   treated	  with	  100	  nM	  of	  
PD173074	  for	  the	  indicated	  times.	  Phospho-­‐proteins	  and	  total	  proteins	  were	  analyzed	  by	  Western	  blot	  using	  the	  
indicated	  antibodies.	  F3-­‐T3:	  FGFR3-­‐TACC3;	  F3-­‐T3-­‐K508M:	  FGFR3-­‐TACC3-­‐K508M.	  To	   investigate	   the	   mechanism	   by	   which	   the	  FGFR-­‐TACC	  fusion	   drives	   oncogenesis,	   we	  explored	   whether	   it	   activates	   downstream	  FGFR	  signaling.	  FGFR3-­‐TACC3	   failed	   to	  hyperactivate	  the	  canonical	  signaling	  events	  downstream	  of	  FGFR	  (pERK	  and	  pAKT)	  in	  the	  presence	   or	   absence	   of	   the	   ligands	   FGF-­‐1,	   FGF-­‐2,	   or	   FGF-­‐8	   (Figure	   51A	   to	   C)	   172.	  However,	  FGFR3-­‐TACC3	  displayed	  constitutive	  phosphorylation	  of	   its	  TK	  domain	  and	   the	  adaptor	  protein	  FRS2,	  both	  of	  which	  were	  abolished	  by	  PD173074,	  a	  compound	  that	   is	  a	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specific	   inhibitor	   of	  FGFR-­‐associated	  TK	   activity	   173,	   or	   by	   the	   Lys508→Met508	  (K508M)	  mutation	  (Figure	  51D	  and	  E).	  Thus,	  FGFR3-­‐TACC3	  gains	  constitutive	  kinase	  activity	  that	  is	  essential	   for	   oncogenic	   transformation,	   but	   the	   downstream	   signaling	   of	   this	   aberrant	  activity	   is	   distinct	   from	   the	   canonical	   signaling	   events	   downstream	   to	  FGFR.	   We	  hypothesized	  that	  by	  driving	  the	  localization	  of	  the	  fusion	  protein,	  the	  TACC	  domain	  might	  create	   TK-­‐dependent	   functions.	   Confocal	   imaging	   showed	   that	  FGFR3-­‐TACC3	   painted	   an	  arc-­‐shaped	  structure,	  bending	  over	  and	  encasing	  the	  metaphase	  spindle	  poles,	   frequently	  displaying	  asymmetry	  toward	  one	  of	  the	  two	  poles	  and	  relocating	  to	  the	  midbody	  as	  cells	  progressed	  into	  the	  late	  stages	  of	  mitosis	  (telophase	  and	  cytokinesis)	  (Figure	  52	  and	  Figure	  53A	  and	  B	  and	  Figure	  54A).	  Conversely,	  the	  localization	  of	  TACC3	  was	  restricted	  to	  spindle	  microtubules;	  TACC3	   did	   not	   relocalize	   to	   the	   midbody	   (Figure	   53C).	   Wild-­‐type	   FGFR3	  lacked	  discrete	  localization	  patterns	  in	  mitosis	  (Figure	  53D).	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Figure	   52.	   Z-­‐stacked	   confocal	   images	   of	   the	   representative	   FGFR3-­‐TACC3	   expressing	   Ink4A;Arf-­‐/-­‐	   mouse	  
astrocyte	  shown	  as	  a	  maximum	  intensity	  projection	  in	  Figure	  3A.	  Cells	  were	  immunostained	  using	  FGFR3	  (red)	  
and	  α-­‐tubulin	  (green).	  DNA	  was	  counterstained	  with	  DAPI	  (blue).	  Images	  were	  acquired	  at	  0.250	  μm	  intervals.	  
Coordinates	  of	  the	  image	  series	  are	  indicated.	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Figure	   53.	   Localization	   of	   FGFR3,	   TACC3	   and	   FGFR3-­‐TACC3	   fusion	   in	   mitotic	   cells.	   (A)	   Maximum	   intensity	  
projection	  confocal	  image	  of	  a	  representative	  FGFR3-­‐TACC3	  expressing	  Ink4A;Arf-­‐/-­‐	  mouse	  astrocyte	  at	  
metaphase,	  immunostained	  using	  the	  FGFR3	  antibody	  (red).	  FGFR3-­‐	  TACC3	  displays	  asymmetric	  localization	  on	  
top	  of	  one	  spindle	  pole.	  (B)	  In	  telophase	  FGFR3-­‐	  TACC3	  localizes	  to	  the	  mid-­‐body.	  (C)	  Maximum	  intensity	  
projection	  confocal	  image	  of	  a	  representative	  TACC3	  expressing	  Ink4A;Arf-­‐/-­‐	  mouse	  astrocyte	  at	  metaphase	  
immunostained	  with	  the	  TACC3	  antibody	  (red).	  TACC3	  staining	  coincides	  with	  the	  spindle	  microtubules.	  (D)	  
Maximum	  intensity	  projection	  confocal	  image	  of	  a	  representative	  FGFR3	  expressing	  Ink4A;Arf-­‐	  /-­‐	  mouse	  
astrocyte	  at	  metaphase	  immunostained	  with	  the	  FGFR3	  antibody	  (red).	  FGFR3	  does	  not	  show	  a	  distinct	  staining	  
pattern	  in	  mitosis.	  Cells	  were	  co-­‐immunostained	  using	  α-­‐tubulin	  (green)	  to	  visualize	  the	  mitotic	  spindle.	  DNA	  was	  
counterstained	  with	  DAPI	  (blue).	  Images	  were	  acquired	  at	  0.250	  μm	  intervals.	  Endogenous	  levels	  of	  FGFR3	  or	  
TACC3	  were	  undetectable	  under	  the	  applied	  experimental	  conditions.	  F3-­‐T3:	  FGFR3-­‐TACC3.	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Figure	   54.	   FGFR3-­‐TACC3	   localizes	   to	   spindle	   poles,	   delays	   mitotic	   progression,	   and	   induces	   chromosome	  
segregation	  defects	  and	  aneuploidy.	  (A)	  Confocal	  microscopy	  analysis	  of	  FGFR3-­‐TACC3	  (red)	  covering	  the	  spindle	  
poles	  of	  a	  representative	  mitotic	  cell.	  α-­‐tubulin,	  green;	  DNA	  [stained	  with	  4′,6-­‐diamidino-­‐2-­‐phenylindole	  (DAPI)],	  
blue.	   (B)	   Representative	   fluorescence	   video	  microscopy	   for	   cells	   transduced	  with	   vector	   or	   FGFR3-­‐TACC3.	   (C)	  
Box-­‐and-­‐whisker	  plot	  representing	  the	  analysis	  of	  the	  time	  from	  nuclear	  envelope	  breakdown	  (NEB)	  to	  anaphase	  
onset	   and	   from	   NEB	   to	   nuclear	   envelope	   reconstitution	   (NER).	   The	   duration	   of	   mitosis	   was	   measured	   by	  
following	   50	   mitoses	   for	   each	   condition	   by	   time-­‐lapse	   microscopy.	   (D)	   Representative	   images	   of	   cells	   with	  
chromosome	   missegregation.	   Arrows	   point	   to	   chromosome	   misalignments,	   lagging	   chromosomes,	   and	  
chromosome	  bridges.	   (E)	  Distribution	   of	   chromosome	   counts	   of	   human	   astrocytes	   transduced	  with	   control	   or	  
FGFR3-­‐TACC3–expressing	   lentivirus.	   Chromosomes	  were	   counted	   in	  100	  metaphase	   cells	   for	   each	   condition	   to	  
determine	  the	  ploidy	  and	  diversity	  of	  chromosome	  counts	  within	  the	  cell	  population.	  The	  mitotic	   localization	  of	  FGFR3-­‐TACC3	  suggests	  that	  the	  fusion	  protein	  might	  affect	  the	  fidelity	   of	   mitosis	   and	   generate	   aneuploidy.	   Time-­‐lapse	   microscopy	   revealed	   that	   the	  average	  time	  from	  nuclear	  envelope	  breakdown	  to	  anaphase	  onset	  was	   increased	   in	  cells	  expressing	  FGFR3-­‐TACC3	   in	   comparison	   with	   control	   cells.	   The	   mitotic	   delay	   was	  exacerbated	  by	  delays	   in	   the	  completion	  of	  cytokinesis	  (Figure	  54,	  B	  and	  C).	  Quantitative	  analyses	   of	  mitoses	   revealed	   that	   cells	   expressingFGFR3-­‐TACC3	   or	  FGFR1-­‐TACC1	   exhibit	  three	  to	   five	  times	  more	  errors	   in	  chromosomal	  segregation	  compared	  with	  control	  cells.	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The	  most	   frequent	  mitotic	   aberrations	   triggered	   by	   the	   fusion	   proteins	  were	  misaligned	  chromosomes	   during	   metaphase,	   lagging	   chromosomes	   at	   anaphase,	   and	   chromosome	  bridges	  that	  impaired	  cytokinesis	  and	  generated	  micronuclei	  in	  the	  daughter	  cells	  (Figure	  54D,	  Figure	  55A,	  and	  Supplementary	  Table	  G-­‐6).	  After	   treatment	  with	   the	  spindle	  poison	  colcemid,	   more	   than	   18%	   of	   cells	   expressing	  FGFR3-­‐TACC3	   displayed	   prematurely	  separated	   sister	   chromatids,	   in	   contrast	  with	   less	   than	  3%	  of	   control,	  FGFR3-­‐,	   or	  TACC3-­‐expressing	  cells	  (Figure	  55B	  and	  C).	  Accordingly,	  the	  fusion	  protein	  induced	  resistance	  to	  metaphase	   arrest	   after	   nocodazole	   treatment	   (Figure	   55D).	   These	   findings	   suggest	   that	  the	  FGFR3-­‐TACC3	   fusion	   protein	   may	   induce	   aneuploidy.	   Karyotype	   analysis	   revealed	  that	  FGFR3-­‐TACC3	  increased	  the	  percentage	  of	  aneuploidy	  by	  more	  than	  2.5-­‐fold	  and	  led	  to	  the	  accumulation	  of	  cells	  with	  broad	  distribution	  of	  chromosome	  counts	  when	  compared	  with	  cells	  transduced	  with	  empty	  vector,	  FGFR3,	  or	  TACC3	  (Figure	  55E	  and	  Supplementary	  Table	  G-­‐7).	  Hence,	  GSC-­‐1123	  contained	  an	  aneuploid	  modal	  number	  of	  chromosomes	  (49)	  with	  broad	  distribution	  of	  chromosome	  counts	  (Supplementary	  Table	  G-­‐8).
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Figure	   55.	   FGFR3-­‐TACC3	   expression	   induces	   chromosome	   missegregation,	   chromatid	   cohesion	   defects,	  
aneuploidy	  and	  defective	  spindle	  checkpoint.	  (A)	  Representative	  microphotographs	  of	  metaphase	  spreads	  from	  
Ink4A;Arf-­‐/-­‐	   astrocytes	   expressing	   the	   empty	   vector	   or	   FGFR3-­‐TACC3	   fusion.	   Arrows	   indicate	   chromosome	  
misalignments,	   lagging	   chromosomes	   and	   chromosome	   bridges.	   (B)	   Representative	   metaphase	   spreads	   show	  
premature	  sister	  chromatid	  separation	  (PMSCS)	  in	  Ink4A;Arf-­‐/-­‐	  astrocytes	  expressing	  FGFR3-­‐TACC3	  (left	  panel).	  
The	   number	   of	   mitosis	   with	   PMSCS	   was	   scored	   in	   at	   least	   100	   metaphases	   for	   each	   condition	   in	   three	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independent	   experiments	   (right	   panel).	   Data	   are	   presented	   as	   the	   means±standard	   deviation,	   (n=3).	   (C)	  
Representative	  metaphase	  spreads	  show	  PMSCS	  in	  Rat1A	  cells	  expressing	  FGFR3-­‐	  TACC3	  fusion	  (left	  panel);	  the	  
number	   of	   mitosis	   with	   PMSCS	   was	   scored	   in	   triplicate	   samples	   (right	   panel).	   Data	   are	   presented	   as	   the	  
means±standard	   deviation,	   (n=3).	   (D)	   Nocodazole	   was	   added	   for	   the	   indicated	   times	   to	   Rat1A-­‐H2B-­‐GFP	   cells	  
transduced	  with	  the	  specified	  lentiviruses.	  The	  mitotic	  index	  at	  each	  time	  point	  was	  determined	  by	  scoring	  the	  
number	  of	  H2B-­‐GFP-­‐positive	  cells	  in	  mitosis	  at	  each	  time	  point.	  Data	  are	  presented	  as	  means±standard	  deviation,	  
(n=3).	  (E)	  Karyotype	  analysis	  of	  Rat1A	  cells	  transduced	  with	  control,	  FGFR3,	  TACC3	  or	  FGFR3-­‐TACC3	  expressing	  
lentiviruses.	   Distribution	   of	   chromosome	   counts	   of	   cells	   arrested	   in	   mitosis	   and	   analyzed	   using	   DAPI.	  
Chromosomes	  were	  counted	  in	  100	  metaphase	  cells	  for	  each	  condition	  to	  determine	  the	  ploidy	  and	  the	  diversity	  
of	   chromosome	  counts	  within	   the	   cell	  population.	   (F)	  Representative	  karyotypes	  of	  primary	  human	  astrocytes	  
transduced	  with	  control	  or	  FGFR3-­‐TACC3	  expressing	  lentivirus.	  F3-­‐T3:	  FGFR3-­‐TACC3.	  To	  explore	  whether	  aneuploidy	  is	  a	  direct	  consequence	  of	  FGFR3-­‐TACC3	  expression	  and	  is	  induced	   in	   diploid	   neural	   cells,	   we	   analyzed	   primary	   human	   astrocytes	   6	   days	   after	  transduction	  with	   the	   FGFR3-­‐TACC3	   lentivirus.	   The	   transduced	   cells	   exhibited	   a	   fivefold	  increase	   of	   the	   rate	   of	   aneuploidy	   and	   a	  wider	   distribution	   of	   chromosome	   counts	   than	  controls	   (Figure	   54E,	   Figure	   55F,	   and	   Supplementary	   Table	   G-­‐7).	   Consistent	   with	   the	  notion	  that	  aneuploidy	  is	  detrimental	  to	  cellular	  fitness,	  acute	  expression	  of	  FGFR3-­‐TACC3	  inhibited	   the	   proliferation	   of	   human	   astrocytes.	   However,	   continuous	   culture	   of	   FGFR3-­‐TACC3–expressing	   astrocytes	   led	   to	   progressive	   gain	   of	   proliferative	   capacity	   that	  overrode	  that	  of	  control	  cells	  (Figure	  56A	  and	  B).	  Thus,	  acute	  expression	  of	  FGFR3-­‐TACC3	  in	  normal	  cells	  from	  the	  central	  nervous	  system	  causes	  chromosomal	  instability	  (CIN)	  and	  aneuploidy	  with	  an	  acute	  fitness	  cost	  manifested	  by	  slower	  proliferation.	  
Next,	  we	  determined	  whether	  the	  CIN	  and	  aneuploidy	  caused	  by	  FGFR3-­‐TACC3	  requires	  TK	  activity	  and	  can	  be	  corrected.	  Treatment	  of	  Rat1A	  cells	  with	  PD173074	  corrected	  FGFR3-­‐TACC3–induced	   aneuploidy	   by	   more	   than	   80%,	   restored	   the	   narrow	   distribution	   of	  chromosome	   counts	   typical	   of	   control	   cells,	   and	   largely	   corrected	   the	   cohesion	   defect	  (Figure	   57,	   A	   to	   C,	   and	   Supplementary	   Table	   G-­‐9).	   To	   determine	   whether	  FGFR-­‐TACC–expressing	  Rat1A	  and	  GSC-­‐1123	  cells	  are	  dependent	  on	  FGFR-­‐TK	  activity	  for	  their	  growth,	  we	   studied	   the	   effect	   of	   PD173074,	  AZD4547,	   or	  BGJ398.	   The	   latter	   two	   compounds	   are	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highly	   specific	   inhibitors	  of	  FGFR-­‐TK	  under	   clinical	   investigation	   174,175.	  Each	  of	   the	   three	  drugs	   inhibited	   the	   growth	   of	   cells	   expressing	  FGFR3-­‐TACC3	   and	  FGFR1-­‐TACC1	   at	  concentrations	  <10	  nM,	  whereas	  they	  were	  ineffective	  at	  concentrations	  as	  high	  as	  1	  μM	  in	  cells	  transduced	  with	  vector,FGFR3,	  TACC3,	  and	  the	  FGFR3-­‐TACC3-­‐K508M	  mutant	  (Figure	  56C	   and	   D	   and	   Figure	   57D).	   The	   growth	   of	   GSC-­‐1123	   was	   also	   abolished	   by	   nanomolar	  concentrations	   of	   these	  FGFR-­‐TK	   inhibitors	   (Figure	   57E).	   Targeting	   of	   the	   fusion	   gene	  by	  FGFR3	   shRNA	   inhibited	   the	   growth	   of	   cells	   ectopically	   expressing	   FGFR3-­‐TACC3	   and	  GSC-­‐1123	  in	  proportion	  to	  the	  silencing	  efficiency	  of	  FGFR3-­‐TACC3	  (Figure	  56E	  and	  F).	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Figure	   56.	   Analysis	   of	   FGFR3-­‐TACC3	   fusion	   mediated	   growth	   alteration	   and	   specificity	   of	   FGFR	   TK	   inhibitor	  
effects	   on	   cells	   carrying	   FGFR-­‐TACC	   fusions.	   (A)	   Decreased	   proliferation	   is	   an	   early	   effect	   of	   FGFR3-­‐TACC3	  
expression	   in	   human	   primary	   astrocytes	   (7	   days	   after	   infection,	   passage	   1).	   Values	   are	   the	   means±standard	  
deviation,	   (n=4).	   (B)	   Enhanced	   proliferation	   rate	   of	   human	   primary	   astrocytes	   transduced	   with	   lentivirus	  
expressing	  FGFR3-­‐TACC3	  fusion	  six	  weeks	  after	  infection	  (passage	  10).	  Values	  are	  the	  means±standard	  deviation,	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(n=4).	  (C-­‐D)	  Cell	  growth	  as	  determined	  by	  MTT	  assay	  for	  Rat1A	  cells	  transduced	  with	  the	  specified	  lentiviruses	  
and	   subsequently	   treated	   for	   three	   days	   with	   vehicle	   or	   BGJ398	   (C)	   or	   AZD4547	   (D)	   at	   the	   indicated	  
concentration.	  Values	  are	  the	  means±standard	  error	  of	   the	  ratio	  between	  inhibitor	  treated	  and	  vehicle	  treated	  
cells,	   (n=4).	   (E)	  Rat1A	  cells	  expressing	  FGFR3-­‐TACC3	   fusion	  were	   transduced	  with	   lentivirus	  expressing	  a	  non-­‐
targeting	  shRNA	  (sh-­‐Ctr)	  or	  shRNA	  sequences	  targeting	  FGFR3.	  Five	  days	  after	  infection,	  cell	  lysates	  were	  assayed	  
by	  Western	   blot	   (left	   panel).	   The	   proliferation	   rate	   of	   parallel	   cultures	  was	   analyzed	   by	   the	  MTT	   assay	   at	   the	  
indicated	  times.	  Infection	  with	  lentivirus	  expressing	  the	  most	  efficient	  FGFR3	  silencing	  sequences	  (sh-­‐3	  and	  sh-­‐
4),	   reverted	   the	  growth	  of	  FGFR3-­‐TACC3	  expressing	  cultures	   to	  a	  rate	  comparable	   to	   that	  of	  Rat1A	   transduced	  
with	   empty	   vector	   (right	   panel).	   Values	   are	   the	   means±standard	   deviation,	   (n=4).	   (F)	   GSC-­‐1123	   cells	   were	  
transduced	   with	   lentivirus	   expressing	   a	   non-­‐targeting	   shRNA	   (sh-­‐Ctr)	   or	   lentivirus	   expressing	   sh-­‐3	   and	   sh-­‐4	  
sequences	  targeting	  FGFR3.	  Western	  Blot	  analysis	  was	  performed	  using	  the	  FGFR3	  antibody	  to	  the	  detect	  FGFT3-­‐
TACC3	   fusion	   protein	   (left	   panel).	   Parallel	   cultures	   of	   GSC-­‐1123	   cells	  were	   transduced	   in	   triplicate.	   Five	   days	  
after	   infection	   cells	   were	   plated	   at	   density	   of	   2X104	   cells/well	   in	   triplicate	   and	   the	   number	   of	   trypan	   blue	  
excluding	  cells	  was	  scored	  at	  the	  indicated	  times	  (right	  panel).	  Values	  are	  the	  means±	  standard	  deviation,	  (n=3).	  
(G)	  The	  FGFR	  TK	  inhibitor	  PD173074	  suppresses	  tumor	  growth	  of	  subcutaneous	  tumors	  generated	  by	  Ink4A;Arf-­‐
/-­‐	  astrocytes	  expressing	  FGFR3-­‐TACC3.	  After	  tumor	  establishment	  (200-­‐300	  mm3,	  arrow)	  mice	  were	  treated	  with	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Figure	   57.	   Inhibition	   of	  FGFR-­‐TK	   activity	   corrects	   the	   aneuploidy	   and	   suppresses	   tumor	   growth	   initiated	  
by	  FGFR3-­‐TACC3.	  (A)	  Karyotype	  analysis	  of	  Rat1A	  cells	  transduced	  with	  control	  or	  FGFR3-­‐TACC3	  lentivirus	  and	  
treated	  with	  vehicle	  [dimethyl	  sulfoxide	  (DMSO)]	  or	  PD173470	  (100	  nM)	  for	  5	  days.	  (B)	  Correction	  of	  premature	  
sister	  chromatid	  separation	  (PMSCS)	  by	  PD173470	  in	  cells	  expressingFGFR3-­‐TACC3.	  Panels	  show	  representative	  
metaphase	   spreads.	   (C)	   Quantitative	   analysis	   of	   metaphases	   with	   loss	   of	   sister	   chromatid	   cohesion	   (FGFR3-­‐
TACC3	   treated	  with	  DMSO	  versus	  FGFR3-­‐TACC3	   treated	  with	  PD173470).	  P	  =	  0.001;	  error	  bars	   indicate	  SD.	   (D	  
and	   E)	   Growth-­‐inhibition	   assays	   of	   Rat1A	   cells	   transduced	  with	   the	   indicated	   lentivirus	   (D)	   and	  GSC-­‐1123	   (E)	  
treated	  with	  PD173470	  at	  the	  indicated	  concentrations.	  Cells	  were	  treated	  for	  3	  days	  (D)	  or	  for	  the	  indicated	  time	  
(E).	   Cell	   viability	   was	   determined	   by	   the	   MTT	   assay.	   Error	   bars	   show	   means	   ±	   SE	   (n	   =	   4	   culture	   wells).	   AU,	  
arbitrary	  units.	  (F)	  Survival	  of	  glioma-­‐bearing	  mice	  was	  tracked	  after	  intracranial	  implantation	  of	  Ink4A;Arf−/−	  
astrocytes	  transduced	  with	  FGFR3-­‐TACC3.	  After	  tumor	  engraftment,	  mice	  were	  treated	  with	  vehicle	  or	  AZD4547	  
(50	  mg/kg)	  for	  20	  days	  (vehicle,	  n	  =	  7	  animals;	  AZD4547,	  n	  =	  6;	  P	  =	  0.001).	  Finally,	   we	   studied	   mice	   bearing	   glioma	   xenografts	   of	  FGFR3-­‐TACC3–transformed	  astrocytes	  and	  investigated	  whether	  PD173074	  affected	  tumor	  growth.	  Twelve	  days	  after	  injection	  of	  tumor	  cells,	  mice	  were	  treated	  with	  PD173074	  or	  vehicle	  (lactate	  buffer).	  Only	  the	   group	   treated	  with	   PD173074	   showed	   inhibition	   of	   tumor	   growth	   (Figure	   56G).	  We	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also	  tested	  a	  more	  clinically	  relevant	  FGFR	  inhibitor,	  AZD4547,	  in	  mice	  bearing	  intracranial	  luciferase-­‐expressing	   glioma	   xenografts.	   Oral	   administration	   of	   AZD4547	   prolonged	  survival	  of	  the	  mice	  by	  28	  days	  compared	  with	  mice	  treated	  with	  the	  vehicle	  control	  (Figure	  
57F).	  
In	   summary,	   our	   functional	   characterization	   of	   the	  FGFR-­‐TACC	  fusion	   genes	   found	   in	   a	  small	   subset	   of	   GBM	   patients	   indicates	   that	   the	   constitutively	   active	  FGFR-­‐TK	   and	  the	  TACC	  domain	  are	  both	  essential	  for	  oncogenesis.	  It	  has	  long	  been	  thought	  that	  mutation	  of	  the	  genes	  that	  control	  chromosome	  segregation	  during	  mitosis	  may	  explain	  the	  high	  rate	  of	   CIN	   and	   aneuploidy,	  which	   is	   typical	   of	  most	   solid	   tumors,	   including	   GBMs	   158.	   A	   few	  examples	   of	   mutational	   inactivation	   of	   candidate	   genes	   have	   been	   reported	   in	   human	  cancer	   176,177.	   However,	   gain-­‐of-­‐function	   mutations	   causally	   implicated	   in	   the	   control	   of	  mitotic	  fidelity	  have	  not	  been	  described.	  The	  absence	  of	  dominant	  mutations	  of	  CIN	  genes	  in	  human	  cancer	  clashes	  with	  the	  classic	  observation	  from	  cell-­‐fusion	  experiments	  that	  the	  underlying	  mechanisms	  that	  cause	  CIN	  behave	  as	  dominant	  traits,	   indicating	  that	  the	  CIN	  phenotype	   results	   from	   gain-­‐of-­‐function	   events	   rather	   than	   gene	   inactivation	   178,179.	   The	  FGFR-­‐TACC	  gene	   fusion	   is	  a	  mechanism	   for	   the	   initiation	  of	  CIN	  and	  provides	  a	  potential	  clue	  to	  the	  nature	  of	  dominant	  mutations	  responsible	  for	  aneuploidy	  in	  human	  cancer.	  
In	   itself,	   induction	   of	   aneuploidy	   is	   detrimental	   to	   cellular	   fitness	   180.	   Oncogenic	  transformation	   requires	   cooperation	  between	   aneuploidy	   and	   genetic	   lesions	   that	   confer	  growth	  advantage	  and	  protect	  cells	  against	  the	  detrimental	  effects	  of	  aneuploidy	  181-­‐183.	  The	  tumor-­‐initiating	   activity	   of	   the	   FGFR3-­‐TACC3	   fusion	   protein	   suggests	   that	   it	   has	   growth-­‐promoting	  signaling	  functions	  that	  complement	  the	  loss	  of	  mitotic	  fidelity	  and	  aneuploidy	  to	  induce	  full-­‐blown	  tumorigenesis	  180.	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There	   are	   now	   several	   well-­‐known	   examples	   in	   which	   kinase	   inhibitors	   have	   been	  developed	  into	  effective	  therapies	  for	  patients	  whose	  tumors	  carry	  functional	  gene	  fusions	  that	   deregulate	   kinase	   activity	   184,185.	   The	   antitumor	   effects	   in	   mouse	   models	   and	   the	  correction	   of	   aneuploidy	   precipitated	   by	  FGFR-­‐TK	   inhibition	   of	   glioma	   cells	   driven	  by	  FGFR-­‐TACC	  fusions	   provide	   a	   strong	   rationale	   for	   clinical	   investigation	  of	  FGFR	  inhibitors	  in	  GBM	  patients	  whose	  tumors	  exhibit	  FGFR-­‐TACC	  rearrangements.	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Section	  3.3:	  The	  integrated	  landscape	  of	  driver	  
genomic	  alterations	  in	  glioblastoma	  	  
Summary	  Glioblastoma,	   the	   most	   common	   malignant	   brain	   tumor,	   remains	   one	   of	   the	   most	  challenging	   forms	   of	   cancer	   to	   treat.	  We	   identified	   recurrent	   translocations	   that	   fuse	   in-­‐
frame	   the	   coding	   sequence	   of	   EGFR	   to	   several	   partners	   in	   7.6%	   of	   tumors,	   with	   EGFR-­‐
SEPT14	  as	  the	  most	  frequent	  functional	  gene	  fusion	  in	  human	  glioblastoma.	  EGFR-­‐SEPT14	  fusions	  constitutively	  activated	  Stat3	  signaling,	  and	  conferred	  both	  mitogen	  independency	  for	  growth	  and	  sensitivity	  to	  EGFR	  inhibition.	  These	  results	  provide	  important	  insights	  into	  the	  pathogenesis	  of	  glioblastoma	  and	  highlight	  new	  targets	  for	  therapeutic	  intervention.	  
Introduction	  Glioblastoma	  (GBM)	  is	  the	  most	  common	  primary	  intrinsic	  malignant	  brain	  tumor	  affecting	  ~10,000	  new	  patients	  each	  year	  with	  a	  median	  survival	   rate	  of	  only	  12-­‐15	  months186,187.	  Identifying	   and	   understanding	   the	   functional	   significance	   of	   the	   genetic	   alterations	   that	  drive	   initiation	   and	   progression	   of	   GBM	   is	   crucial	   to	   develop	   more	   effective	   therapies.	  Previous	   efforts	   in	   GBM	   genome	   characterization	   included	   array-­‐based	   profiling	   of	   copy	  number	   changes,	  methylation	  and	  gene	  expression	  and	   targeted	   sequencing	  of	   candidate	  genes169,188-­‐190.	  These	  studies	  identified	  somatic	  changes	  in	  well-­‐known	  GBM	  genes	  (EGFR,	  
PTEN,	  IDH1,	  TP53,	  NF1,	  etc.)	  and	  nominated	  putative	  cancer	  genes	  with	  somatic	  mutations,	  but	  the	  functional	  consequences	  of	  most	  alterations	  is	  unknown.	  	  
Chromosomal	   rearrangements	   resulting	   in	   recurrent	   and	   oncogenic	   gene	   fusions	   are	  hallmarks	   of	   hematological	  malignancies,	   and	   recently	   they	  have	   also	   been	  uncovered	   in	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solid	  tumors	  (breast,	  prostate,	  lung	  and	  colorectal	  carcinoma)167,191.	  Recently,	  we	  reported	  that	  a	  small	  subset	  of	  GBM	  harbor	  FGFR-­‐TACC	  gene	   fusions	  and	  provided	  data	   to	  suggest	  that	  the	  patients	  with	  FGFR-­‐TACC-­‐positive	  tumors	  would	  benefit	  from	  targeted	  FGFR	  kinase	  inhibition192.	  It	  remains	  unknown	  whether	  gene	  fusions	  involving	  other	  RTK-­‐coding	  genes	  exist	   in	  GBM	  to	  create	  different	  oncogene	  addicting	  states.	  Here,	  we	  analyze	  a	   large	  RNA-­‐sequencing	   dataset	   of	   primary	   GBM	   and	   Glioma	   Sphere	   Cultures	   (GSCs)	   and	   report	   the	  global	  landscape	  of	  in-­‐frame	  gene	  fusions	  in	  human	  GBM.	  
	  
Figure	  58.	  Amplification	  surrounding	  the	  genomic	  neighborhood	  of	  EGFR,	  SEPT14,	  and	  PSPH	  among	  samples	  
harboring	  EGFR	  fusions.	  We	  plot	  copy	  number	  log2	  ratio	  across	  the	  genomic	  region	  of	  chr7:55000000-­‐56500000	  
for	  samples	  with	  EGFR-­‐PSPH	  (top	  three	  rows)	  and	  EGFR-­‐SEPT14	  (bottom	  six	  rows).	  Genomic	  coordinates	  are	  also	  
plotted	  for	  EGFR	  (blue),	  SEPT14	  (yellow),	  and	  PSPH	  (cyan).	  
Recurrent	  EGFR	  fusions	  in	  GBM	  To	   identify	   gene	   fusions	   in	   GBM,	   we	   analyzed	   RNA-­‐seq	   data	   from	   a	   total	   of	   185	   GBM	  samples	   (161	   primary	   GBM	   plus	   24	   short-­‐term	   glioma	   sphere	   cultures	   freshly	   isolated	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from	   patients	   carrying	   primary	   GBM).	   The	   analysis	   of	   the	   RNA-­‐seq	   dataset	   led	   to	   the	  discovery	   of	   92	   candidate	   rearrangements	   that	   give	   rise	   to	   in-­‐frame	   fusion	   transcripts	  (Supplementary	   Table	   I-­‐1).	   Beside	   the	   previously	   reported	   FGFR3-­‐TACC3	   fusions	   events,	  the	  most	  frequent	  recurrent	  in-­‐frame	  fusions	  involved	  EGFR	  in	  7.6%	  of	  samples	  (14/185,	  3.8%-­‐11.3%	   CI).	   Nine	   of	   the	   14	   EGFR	   fusions	   included	   the	   recurrent	   partners	   SEPT14	  (6/185,	  3.2%)	  and	  PSPH	  (3/185,	  1.6%)	  as	  the	  3’	  gene	  segment	  in	  the	  fusion.	  All	  the	  EGFR-­‐
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Table	  4.	  Relative	  expression	  of	  EGFR	  fusion	  and	  wild-­‐type	  transcripts.	  Expression	  is	  estimated	  using	  the	  depth	  of	  
reads	  covering	  the	  fusion	  breakpoint	  or	  wild-­‐type	  exon	  junctions	  excluded	  from	  the	  fusion	  transcript.	  These	  
wild-­‐type	  exons	  include	  exons	  25-­‐26,	  26-­‐27,	  and	  27-­‐28.	  
	  
EGFR-­‐SEPT14	   	   	   	  
Sample	   FusionBp	   Exon25-­‐26	   Exon26-­‐27	   Exon27-­‐28	  
TCGA-­‐28-­‐2513	   1464	   21	   12	   25	  
TCGA-­‐27-­‐1837	   796	   6	   5	   6	  
TCGA-­‐06-­‐0750	   414	   69	   61	   101	  
TCGA-­‐32-­‐5222	   495	   256	   190	   348	  
TCGA-­‐28-­‐1747	   142	   426	   300	   502	  
TCGA-­‐06-­‐2557	   13	   1031	   657	   1254	  
	   	   	   	   	  
EGFR-­‐PSPH	   	   	   	  
Sample	   FusionBp	   Exon25-­‐26	   Exon26-­‐27	   Exon27-­‐28	  
TCGA-­‐28-­‐5209	   5648	   216	   122	   232	  
TCGA-­‐06-­‐5408	   37	   232	   200	   292	  
TCGA-­‐28-­‐5215	   28	   29	   26	   44	  
	  
	  
Figure	   59.	   EGFR-­‐SEPT14	   gene	   fusion	   identified	   by	   whole	   transcriptome	   sequencing.	   a,	   Split	   reads	   are	   shown	  
aligning	   on	   the	   breakpoint.	   The	   predicted	   reading	   frame	   at	   the	   breakpoint	   is	   shown	   at	   the	   top	   with	   EGFR	  
sequences	  in	  blue	  and	  SEPT14	  in	  red.	  b,	  (left	  panel),	  EGFR-­‐SEPT14-­‐specific	  PCR	  from	  cDNA	  derived	  from	  GBMs.	  
Marker,	   1kb	   ladder.	   (right	   panel),	   Sanger	   sequencing	   chromatogram	   showing	   the	   reading	   frame	   at	   the	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sequence	  and	  schematics.	  Regions	  corresponding	  to	  EGFR	  an*d	  Septin14	  are	  shown	  in	  blue	  and	  red,	  respectively.	  
The	  fusion	  joins	  the	  tyrosine	  kinase	  domain	  of	  EGFR	  and	  the	  Coiled-­‐coil	  domain	  of	  Septin14.	  d,	  	  Genomic	  fusion	  of	  
EGFR	  exon	  25	  with	  intron	  9	  of	  SEPT14.	  In	  the	  fuse	  mRNA	  exon	  24	  of	  EGFR	  is	  spliced	  5’	  to	  exon	  10	  of	  SEPT14.	  Solid	  






Figure	   60.	   EGFR-­‐PSPH	   gene	   fusion	   identified	   by	   whole	   transcriptome	   sequencing.	   a,	   Split	   reads	   are	   shown	  
aligning	  on	  the	  breakpoint.	  The	  predicted	  reading	  frame	  at	  the	  breakpoint	  is	  shown	  at	  the	  top	  with	  EGFR	  
sequences	  in	  blue	  and	  PSPH	  in	  red.	  b,	  (left	  panel),	  EGFR-­‐PSHP	  specific	  PCR	  from	  cDNA	  derived	  from	  GBMs.	  
Marker,	  1kb	  ladder.	  (right	  panel),	  Sanger	  sequencing	  chromatogram	  showing	  the	  reading	  frame	  at	  the	  
breakpoint	  and	  putative	  translation	  of	  the	  fusion	  protein	  in	  the	  positive	  sample.	  c,	  	  EGFR-­‐PSPH	  fusion	  protein	  
sequence	  and	  schematics.	  Regions	  corresponding	  to	  EGFR	  and	  PSPH	  are	  shown	  in	  blue	  and	  red,	  respectively.	  The	  
fusion	  includes	  the	  tyrosine	  kinase	  domain	  of	  EGFR	  and	  the	  last	  35	  amino	  acids	  of	  PSPH.	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Figure	  61.	  NFASC-­‐NTRK1	  gene	  fusion	  identified	  by	  whole	  transcriptome	  sequencing.	  a,	  Split	  reads	  are	  shown	  
aligning	   on	   the	   breakpoint.	   The	   predicted	   reading	   frame	   at	   the	   breakpoint	   is	   shown	   at	   the	   top	   with	   NFASC	  
sequences	   in	  blue	  and	  NTRK1	   in	  red.	  b,	   (left	  panel),	  NFASC-­‐NTRK1	  specific	  PCR	   from	  cDNA	  derived	   from	  GBMs.	  
Marker,	   1kb	   ladder.	   (right	   panel),	   Sanger	   sequencing	   chromatogram	   showing	   the	   reading	   frame	   at	   the	  
breakpoint	  and	  putative	  translation	  of	  the	  fusion	  protein	  in	  the	  positive	  sample.	  c,	  	  NFASC-­‐NTRK1	  fusion	  protein	  
sequence	  and	  schematics.	  Regions	  corresponding	  to	  NFASC	  and	  NTRK1	  are	  shown	  in	  blue	  and	  red,	  respectively.	  
The	  fusion	  includes	  two	  of	  the	  five	  fibronectin-­‐type	  III	  domain	  of	  neurofascin	  and	  	  the	  protein	  kinase	  domain	  of	  
NTRK1.	   d,	   	   Genomic	   fusion	   of	  NFASC	   intron	  9	  with	   intron	  21	   of	  NTRK1.	   In	   the	   fuse	  mRNA	  exon	  21	   of	  NFASC	   is	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structure	  of	  the	  EGFR-­‐Septin14	  fusion	  proteins	  involves	  EGFR	  at	  the	  N-­‐terminus,	  providing	  a	   receptor	   tyrosine	   kinase	   domain	   fused	   to	   a	   coiled-­‐coil	   domain	   from	   Septin14.	   Exon-­‐specific	   gene	   expression	   analysis	   from	   the	   RNA-­‐seq	   coverage	   in	   TCGA-­‐27-­‐1837	  demonstrated	   that	   the	   EGFR	   and	   SEPT14	   exons	   implicated	   in	   the	   fusion	   are	   highly	  overexpressed	   compared	   with	   the	   mRNA	   sequences	   not	   included	   in	   the	   fusion	   event	  (Figure	  62).	  Using	  PCR,	  the	  genomic	  breakpoint	  coordinates	  were	  mapped	  to	  chromosome	  7	   (#55,268,937	   for	   EGFR	   and	   #	   55,870,909	   for	   SEPT14,	   genome	   build	   GRCh37/hg19)	  falling	  within	  EGFR	  exon	  25	  and	  SEPT14	  intron	  9,	  which	  gives	  rise	  to	  a	  transcript	  in	  which	  the	  5’	  EGFR	  exon	  24	  is	  spliced	  to	  the	  3’	  SEPT14	  exon	  10	  (Figure	  59d).	  Interestingly,	  the	  fused	  
EGFR-­‐PSPH	  cDNA	  and	  predicted	  fusion	  protein	  in	  the	  GBM	  sample	  TCGA-­‐06-­‐5408	  involves	  the	   same	  EGFR	  N-­‐terminal	   region	   implicated	   in	   the	  EGFR-­‐SEPT14	  with	  PSPH	   providing	   a	  carboxy-­‐terminal	  portion	  of	  35	  amino	  acids	  (Figure	  60).	  An	  example	  of	  a	  fusion	  in	  which	  the	  EGFR-­‐TK	   region	   is	   the	  3’	  partner	   is	   the	  CAND1-­‐EGFR	   fusion	   in	   the	  glioma	   sphere	   culture	  #16	  (Figure	  63).	  Thus,	  either	  in	  the	  more	  frequent	  fusions	  in	  which	  EGFR	  is	  the	  5’	  partner	  or	  in	  those	  with	  EGFR	  as	  the	  3’	  gene,	  the	  region	  of	  the	  EGFR	  mRNA	  coding	  for	  the	  TK	  domain	  is	  invariably	  retained	  in	  each	  of	  the	  fusion	  transcripts	  (Supplementary	  Table	  I-­‐1).	  RT-­‐PCR	  and	  genomic	  PCR	  followed	  by	  Sanger	  sequencing	  from	  GBM	  TCGA-­‐06-­‐5411	  were	  also	  used	  to	  successfully	   validate	   the	   NFASC-­‐NTRK1	   fusions	   in	   which	   the	   predicted	   fusion	   protein	  includes	  the	  TK	  domain	  of	  the	  high-­‐affinity	  NGF	  receptor	  (TrkA)	  fused	  downstream	  to	  the	  immunoglobulin-­‐like	  region	  of	  the	  cell	  adhesion	  and	  ankyrin-­‐binding	  region	  of	  neurofascin	  (Figure	  61).	  
	  	   163	  
	  
Figure	  62.	  Expression	  of	  thee	  fusion	  genes	  measured	  by	  read	  depth	  from	  RNA-­‐seq	  data.	  Note	  the	  very	  high	  level	  of	  
expression	  in	  the	  regions	  of	  the	  genes	  implicated	  in	  the	  fusion	  events.	  	  To	   confirm	   that	   GBM	  harbor	   recurrent	  EGFR	   fusions	   and	   determine	   the	   frequency	   in	   an	  independent	   dataset,	   we	   screened	   cDNA	   from	   a	   panel	   of	   248	   GBMs	   and	   discovered	   10	  additional	   cases	  harboring	  EGFR-­‐SEPT14	   fusions	   (4%).	  Conversely,	  NFASC-­‐NTRK1	   fusions	  were	   not	   detected	   in	   this	   dataset.	  We	   also	   determined	   that	   the	   frequency	   of	  EGFR-­‐PSPH	  fusions	  was	  2.2%	  (3/135).	  	  
Table	   5.	   Analysis	   of	   the	   incidence	   of	   EGFR-­‐SEPT14	   and	   EGFR-­‐PSPH	   gene	   fusions	   in	   GBM	   harboring	   or	   not	   the	  
EGFRvIII	  rearrangement.	  	  
Isoform	   EGFR-­‐SEPT14	   EGFR-­‐PSPH	   Non-­‐
Fusion	  
Total	  
EGFRvIII	   1	   1	   14	   16	  
No	  EGFRvIII	   5	   2	   64	   71	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Figure	   63.	   CAND1-­‐EGFR	   gene	   fusion	   identified	   by	   whole	   transcriptome	   sequencing.	   a,	   Split	   reads	   are	   shown	  
aligning	   on	   the	   breakpoint.	   The	   predicted	   reading	   frame	   at	   the	   breakpoint	   is	   shown	   at	   the	   top	   with	   CAND1	  
sequences	   in	   blue	   and	   EGFR	   in	   red.	   b,	   (left	   panel),	   CAND1-­‐EGFR	   specific	   PCR	   from	   cDNA	   derived	   from	   GBMs.	  
Marker,	   1kb	   ladder;	   (right	   panel),	   Sanger	   sequencing	   chromatogram	   showing	   the	   reading	   frame	   at	   the	  
breakpoint	  and	  putative	  translation	  of	  the	  fusion	  protein	  in	  the	  positive	  sample.	  c,	   	  CAND1-­‐EGFR	  fusion	  protein	  
sequence.	  Regions	  corresponding	  to	  CAND1	  and	  EGFR	  are	  shown	  in	  blue	  and	  red,	  respectively.	  d,	  	  Genomic	  fusion	  
of	  CAND1	  intron	  4	  with	  intron	  15	  of	  EGFR.	  In	  the	  fuse	  mRNA	  exon	  4	  of	  CAND1	  is	  spliced	  5’	  to	  exon	  16	  of	  EGFR.	  The	  discovery	  of	  recurrent	  EGFR	  fusions	  in	  GBM	  is	  of	  particular	  interest.	  EGFR	  is	  activated	  in	   a	   significant	   fraction	   of	   primary	   GBM	   (~25%)	   by	   an	   in-­‐frame	   deletion	   of	   exons	   2-­‐7	  (EGFRvIII)194.	  However,	  seven	  of	  the	  nine	  tumors	  harboring	  EGFR-­‐SEPT14	  and	  EGFR-­‐PSPH	  
CAND1 EGFR a!
TTACAAGTGCAATAGCAAAACAGGAAGATGTCTCTGTTCAGCTAGAAGCCTTGGATATTATGGCTGATATGTTGAGCAG !ATGCACTGGGCCAGGTCTTGAAGGCTGTCCAACGAATGGGCCTAAGATCCCGTCCATCGCCACTGGGATGGTGGGGGC !


















































Ex16   Exon 4 





Exon 17 Exon 3 Ex16 
















Chr12 q14 Chr7 p12 
Suppl mentary Figure 13 
	  	   165	  
gene	   fusions	   lacked	   the	   EGFRvIII	   rearrangement	   (Table	   5).	   To	   establish	   the	   functional	  relevance	  of	  EGFR	  fusions,	  we	  determined	  whether	  the	  most	  frequent	  EGFR	  fusion	  in	  GBM	  (EGFR-­‐SEPT14)	   provides	   an	   alternative	   mechanism	   of	   EGFR	   activation	   and	   confers	  sensitivity	  to	  EGFR	  inhibition.	  First,	  we	  asked	  whether	  EGFR	  gene	  fusions	  cluster	  into	  any	  of	   the	   known	   gene	   expression	   subtypes	   of	   GBM	   (proneural,	   neural,	   classical,	  mesenchymal).	   Although	   no	   individual	   subtype	   displayed	   a	   statistically	   significant	  enrichment	  of	  EGFR	   fusions,	  we	   found	  that	  8	  of	  9	  GBM	  harboring	  EGFR-­‐SEPT14	  or	  EGFR-­‐
PSPH	   belong	   to	   the	   classical	   or	   mesenchymal	   subtype	   (Fisher’s	   P	   value	   =	   0.05	   for	  classical/mesenchymal	  enrichment,	  Table	  6).	  Next,	  we	  cloned	  the	  EGFR-­‐SEPT14	  cDNA	  and	  prepared	  lentiviruses	  expressing	  EGFR-­‐SEPT14,	  EGFRvIII	  or	  EGFR	  wild	  type.	  Transduction	  of	  the	  #48	  human	  glioma	  sphere	  culture	  (which	  lacks	  genomic	  alteration	  of	  EGFR)	  with	  the	  recombinant	   lentiviruses	   showed	   that	   cells	   expressing	  EGFR-­‐SEPT14	   or	  EGFRvIII	   but	   not	  those	  expressing	  wild	   type	  EGFR	  or	  vector	  controls	   retained	   the	  ability	   to	  grow	  and	  self-­‐renew	  as	   spheres	   in	   the	   absence	  of	   the	  mitogens	  EGF	  and	  bFGF	   (Figure	  64a).	  Accordingly,	  established	   glioma	   cell	   lines	   transduced	   with	   EGFR-­‐SEPT14	   or	   EGFRvIII	   lentiviruses	  proliferated	  at	  higher	  rate	  than	  control	  cells	  or	  cells	  expressing	  wild	  type	  EGFR	  (Figure	  65a,	  b).	  Furthermore,	  EGFR-­‐SEPT14	  and	  EGFRvIII	  markedly	  enhanced	  the	  ability	  of	  glioma	  cells	  to	  migrate	   in	   a	  wound	  assay	   (Figure	  65c).	  The	  above	   findings	   suggest	   that	  EGFR-­‐SEPT14	  might	  constitutively	  activate	  signaling	  events	  downstream	  of	  EGFR.	  When	  analyzed	  in	  the	  presence	   and	   absence	   of	   mitogens,	   the	   expression	   of	   EGFR-­‐SEPT14	   (or	   EGFRvIII)	   in	   the	  glioma	   sphere	   cultures	   #48	   invariably	   triggered	   constitutive	   activation	   of	   phospho-­‐Stat3	  but	  had	  no	  effects	  on	  phospho-­‐ERK	  and	  phospho-­‐AKT	  (Figure	  64b,	  c).	  The	  differential	  gene	  expression	   analysis	   between	   GBM	   harboring	   EGFR-­‐SEPT14	   versus	   those	   positive	   for	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EGFRvIII	  identified	  a	  set	  of	  9	  genes	  markedly	  up-­‐regulated	  in	  EGFR-­‐SEPT14	   tumors	  (Figure	  
66).	  These	  genes	  broadly	  belong	   to	   inflammatory/immune	  response	   functional	  categories	  and	   some	   of	   them	   code	   for	   chemokines	   (CXCL9,	   10,	   11)	   that	   have	   been	   associated	  with	  more	  aggressive	  glioma	  phenotypes195.	  	  
	  
Table	  6.	  Enrichment	  of	  classical/mesenchymal	  subtype	  among	  samples	  with	  EGFR-­‐SEPT14	  or	  EGFR-­‐PSPH.	  	  
	   Classical	   Mesenchymal	   Proneural	   Neural	  
EGFR	  Fusion	   3	   5	   1	   0	  
No	  Fusion	   37	   47	   38	   0	  
Total	   40	   52	   39	   28	  	  
Fisher’s p-value = 0.0500 for the enrichment of classical/mesenchymal subtype.  	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Figure	  64.	  Functional	  analysis	  of	  EGFR-­‐SEPT14	  fusion	  and	  effect	  of	  inhibition	  of	  EGFR	  kinase	  on	  glioma	  growth.	  a,	  
Sphere	   forming	   assay	   in	   the	   absence	   of	   EGF	  of	  GBM-­‐derived	  primary	   cells	   (#48)	   expressing	   vector,	   EGFR	  wild	  
type,	  EGFR	  Viii	  or	  EGFR-­‐SEP14	  fusion.	  Data	  are	  Mean±SD	  of	   triplicate	  samples	  (p	  =	  0.0051	  and	  0.027	  for	  EGFR-­‐
SEP14	   fusion	   and	   EGFR	   Viii	   compared	   with	   vector,	   respectively).	   b,	   Western	   blot	   analysis	   of	   GBM-­‐derived	  
primary	  cells	  (#48)	  expressing	  vector,	  EGFR	  Viii	  or	  EGFR-­‐SEP14	  fusion	  cultured	  in	  the	  presence	  of	  EGF.	  c,	  GBM-­‐
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derived	  cells	  (#48)	  expressing	  vector,	  EGFR	  Viii	  or	  EGFR-­‐SEP14	  fusion	  were	  cultured	  in	  the	  absence	  of	  EGF	  for	  48	  
h	   and	   then	   stimulated	  with	  EGF	  20ng/ml	   for	   the	   indicated	   time.	   Cells	  were	   assayed	  by	  western	  blot	   using	   the	  
indicated	  antibodies.	  d,	  Survival	  of	  GBM-­‐derived	  cells	  (#48)	  expressing	  vector,	  EGFR	  wild	  type,	  EGFR	  Viii	  or	  EGFR-­‐
SEP14	   fusion	   after	   treatment	   with	   lapatinib	   for	   48	   h	   at	   the	   indicated	   concentrations.	   Data	   are	   Mean±SD	   of	  
triplicate	  samples.	  e,	  Survival	  of	  GBM-­‐derived	  cells	  (#48)	  expressing	  vector,	  EGFR	  wild	  type,	  EGFR	  Viii	  or	  EGFR-­‐
SEP14	   fusion	   after	   treatment	   with	   erlotinib	   for	   48	   h	   at	   the	   indicated	   concentrations.	   Data	   are	   Mean±SD	   of	  
triplicate	  samples.	  Experiments	  were	  repeated	  three	  times.	  f,	  In	  vivo	  inhibition	  of	  tumor	  growth	  by	  EGFR	  kinase	  
inhibitors	   in	   glioma	   patient	   derived	   xenografts	   carrying	   EGFR-­‐SEPT14	   fusion	   but	   not	   wild	   type	   EGFR.	   T-­‐C	  
indicates	  the	  median	  difference	  in	  survival	  between	  drug	  treated	  and	  vehicle	  (control)	  treated	  mice.	  
	  
Figure	  65.	  Expression	  of	  EGFR-­‐SEPT14	   fusion	  promotes	  an	  aggressive	  phenotype	  and	   inhibition	  of	  EGFR	  kinase	  
delays	   GBM	   growth	   in	   vivo.	   a,	   Growth	   rate	   of	   U87	   glioma	   cells	   transduced	  with	   a	   lentivirus	   expressing	   EGFR-­‐
SEPT14,	  EGFR	  Viii,	  EGFR	  WT	  or	  the	  empty	  vector	  (average	  of	  triplicate	  cultures).	  b,	  Growth	  rate	  of	  SNB19	  glioma	  
cells	  transduced	  with	  a	  lentivirus	  expressing	  EGFR-­‐SEPT14,	  EGFR	  Viii,	  EGFR	  WT	  or	  the	  empty	  vector	  (average	  of	  
triplicate	  cultures).	  c,	  (Left	  panels)	  Migration	  assay	  in	  SNB19	  glioma	  cells	  transduced	  with	  a	  lentivirus	  expressing	  
EGFR-­‐SEPT14,	  EGFR	  Viii,	  EGFR	  WT	  or	  the	  empty	  vector.	  (Right	  panels)	  Quantification	  of	  the	  cell	  covered	  area	  
(average	  of	  triplicate	  cultures).	  Error	  bars	  are	  SD.	  d,	  Kinetics	  of	  tumor	  growth	  for	  glioma	  patient-­‐derived	  
xenografts	  carrying	  the	  EGFR-­‐SEPT14	  fusion	  (D08-­‐0537	  MG,	  left	  panel)	  or	  wild	  type	  EGFR	  (D08-­‐0714,	  right	  panel)	  
treated	  with	  Lapatinib	  or	  vehicle	  (control).	  Error	  bars	  are	  SD.	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Figure	   66.	   Differential	   expression	   of	   GBM	   tumor	   samples	   harboring	   EGFR-­‐SEPT14	   fusions	   and	   EGFRvIII	  
rearrangements.	   After	   filtering	   for	   statistical	   significance	   for	   differential	   expression,	   ten	   genes	   remained	   that	  
characterized	  the	  EGFR-­‐SEPT14	  phenotype	  from	  the	  EGFRvIII	  phenotype.	  Log2	  expression	  was	  plotted	  as	  a	  heat	  
map.	   Samples	   were	   hierarchically	   clustered	   by	   Euclidean	   distance	   using	   average	   linkage.	   This	   clustering	  
demonstrates	  clear	  separation	  between	  EGFR-­‐SEPT14	  samples	   (red)	  and	  EGFRvIII	   samples	   (green),	   confirming	  
the	  unique	  molecular	  signature	  of	  gene	  fusion.	  Finally,	   we	   sought	   to	   investigate	   whether	   the	  EGFR-­‐SEPT14	   fusion	   confers	   sensitivity	   to	  inhibition	   of	   EGFR-­‐TK.	   Treatment	   of	   #48-­‐derived	   isogenic	   cell	   lines	   expressing	   EGFR-­‐
SEPT14,	  EGFRvIII,	   wild	   type	  EGFR	   or	   vector	   control	  with	   lapatinib,	   an	   irreversible	   EGFR	  inhibitor	   recently	   proposed	   to	   target	   EGFR	   alterations	   in	   GBM196,	   revealed	   that	   EGFR-­‐Sept14	   and	   EGFRvIII	   but	   not	   wild-­‐type	   EGFR	   sensitized	   glioma	   cells	   to	   pharmaceutical	  EGFR	   inhibition	   (Figure	   64d).	   Similar	   effects	   were	   obtained	   following	   treatment	   of	   #48-­‐derivatives	   with	   erlotinib,	   another	   inhibitor	   of	   EGFR-­‐TK	   (Figure	   64e).	   To	   ask	   whether	  sensitivity	   to	   EGFR-­‐TK	   inhibition	   is	   retained	   in	   un-­‐manipulated	   human	   glioma	   cells	  spontaneously	   harboring	   EGFR-­‐SEPT14	   in	   vivo,	   we	   screened	   a	   collection	   of	   30	   GBM	  xenografts	   directly	   established	   in	   the	   mouse	   from	   human	   GBM	   for	   the	   presence	   of	   the	  
EGFR-­‐SEPT14	  fusion	  gene.	  The	  screen	  identified	  one	  xenograft	  (D08-­‐0537	  MG),	  which	  had	  been	   established	   from	   a	   heavily	   pretreated	   GBM,	   harboring	   the	   EGFR-­‐SEPT14	   fusion.	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Treatment	  of	  D08-­‐0537	  MG	  tumors	  with	  lapatinib	  or	  erlotinib	  showed	  that	  each	  of	  the	  two	  drugs	   significantly	   delayed	   the	   rate	   of	   tumor	   growth,	   with	   lapatinib	   displaying	   the	  strongest	  anti-­‐tumor	  effects.	  Conversely,	  EGFR	  inhibitors	  were	  ineffective	  against	  the	  GBM	  xenograft	   D08-­‐0714	   MG,	   which	   lacks	   genomic	   alterations	   of	   the	   EGFR	   gene	   (Figure	   64f,	  Figure	   65d).	   Taken	   together,	   these	   data	   determine	   that	   the	  EGFR-­‐SEPT14	   fusion	   confers	  mitogen	   independency	   for	   growth,	   constitutively	   activates	   Stat3	   signaling	   and	   imparts	  sensitivity	  to	  EGFR	  kinase	  inhibition	  to	  glioma	  cells	  harboring	  the	  fusion	  gene.	  	  	  
Discussion	  In	   this	   study,	  we	   also	   report	   the	   landscape	   of	   gene	   fusions	   from	   a	   large	   dataset	   of	   GBM	  analyzed	  by	  RNA-­‐Sequencing.	   In-­‐frame	   gene	   fusions	   retaining	   the	  RTK-­‐coding	  domain	   of	  
EGFR	   emerged	   as	   the	   most	   frequent	   gene	   fusion	   events	   in	   GBM.	   In	   this	   tumor,	   EGFR	   is	  frequently	   targeted	   by	   focal	   amplications	   and	   our	   finding	   underscores	   the	   strong	  recombinogenic	   probability	   of	   focally	   amplified	   genes,	   as	   recently	   reported	   for	   the	  myc	  locus	   in	   medulloblastoma197.	   Resembling	   intragenic	   rearrangements	   that	   generate	   the	  
EGFRvIII	  allele,	  we	  found	  that	  EGFR-­‐SEPT14	  fusions	  impart	  to	  glioma	  cells	  the	  ability	  to	  self-­‐renew	   and	   grow	   in	   the	   absence	   of	   mitogens,	   constitutively	   activate	   Stat3	   signaling	   and	  confer	  sensitivity	  to	  EGFR	  inhibition.	  These	  findings	  highlight	  the	  relevance	  of	  gene	  fusions	  implicating	  RTK-­‐coding	   genes	   in	   the	  pathogenesis	   of	  GBM192.	   They	   also	  provide	   a	   strong	  rationale	  for	  the	  inclusion	  of	  GBM	  patients	  harboring	  EGFR	  fusions	  in	  clinical	  trials	  based	  on	  EGFR	  inhibitors.	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Supplementary	  Figure	  A-­‐1.	   Influenza	  A	  surveillance	  by	  q2-­‐coefficient	   in	  different	   transmission	  zones.	  Depicted	  
strains	  include	  A)	  human	  H3N2,	  B)	  human	  seasonal	  H1N1	  (pre-­‐2009	  lineage),	  C)	  human	  H1N1pdm	  (post-­‐2009	  
lineage),	  D)	  swine	  H1N1,	  E)	  human	  H5N1,	  F)	  avian	  H5N1,	  and	  G)	  avian	  non-­‐H5N1.	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Supplementary	  Figure	  A-­‐2.	  Global	  map	  of	  influenza	  A	  surveillance	  by	  transmission	  zone.	  Depicted	  strains	  include	  
A)	  human	  H3N2,	  B)	  human	  seasonal	  H1N1	  (pre-­‐2009	  lineage),	  C)	  human	  H1N1pdm	  (post-­‐2009	  lineage),	  D)	  
human	  H5N1,	  and	  E)	  avian	  H5N1.	  Each	  zone	  is	  colored	  on	  the	  spectrum	  from	  blue	  to	  red	  by	  q2-­‐coefficient.	  Gray	  
areas	  denote	  regions	  with	  viruses	  isolated	  over	  the	  span	  of	  no	  more	  than	  one	  month.	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  B.	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Tables	  to	  “Quantifying	  Pathogen	  
Surveillance	  Using	  Temporal	  
Genomic	  Data”	  
	  
Supplementary	  Table	  B-­‐1.	  Current	  q2-­‐coefficients	  of	  influenza.	  Intervals	  based	  on	  the	  95%	  HPD	  of	  evolutionary	  
rate	  are	  also	  provided.	  
Hamming	  	  	   PB2	   PB1	   PA	   HA	   NP	   NA	   M1	   NS1	  H3N2	  human	   0.993	  (0.990-­‐0.996)	   0.995	  (0.993-­‐0.996)	   0.997	  (0.996-­‐0.998)	   0.997	  (0.996-­‐0.998)	   0.996	  (0.993-­‐0.997)	   0.997	  (0.997-­‐0.998)	   0.998	  (0.997-­‐0.999)	   0.996	  (0.992-­‐0.997)	  H1N1	  seasonal	  human	   0.975	  (0.969-­‐0.979)	   0.979	  (0.976-­‐0.980)	   0.979	  (0.974-­‐0.981)	   0.990	  (0.988-­‐0.990)	   0.974	  (0.971-­‐0.977)	   0.993	  (0.991-­‐0.994)	   0.989	  (0.989-­‐0.992)	   0.979	  (0.972-­‐0.981)	  H1N1pdm	  human	   0.998	  (0.998-­‐0.998)	   0.998	  (0.998-­‐0.998)	   0.997	  (0.997-­‐0.998)	   1.000	  (0.999-­‐1.000)	   0.999	  (0.999-­‐0.999)	   0.999	  (0.999-­‐0.999)	   0.999	  (0.999-­‐1.000)	   0.999	  (0.998-­‐0.999)	  H1N1	  swine	   0.647	  (0.601-­‐0.662)	   0.679	  (0.634-­‐0.716)	   0.696	  (0.664-­‐0.715)	   0.804	  (0.787-­‐0.821)	   0.732	  (0.691-­‐0.778)	   0.809	  (0.785-­‐0.821)	   0.895	  (0.873-­‐0.926)	   0.709	  (0.660-­‐0.781)	  H5N1	  human	   0.703	  (0.652-­‐0.729)	   0.776	  (0.743-­‐0.816)	   0.790	  (0.745-­‐0.822)	   0.821	  (0.795-­‐0.848)	   0.803	  (0.743-­‐0.829)	   0.821	  (0.780-­‐0.827)	   0.908	  (0.851-­‐0.943)	   0.853	  (0.806-­‐0.894)	  non-­‐H5N1	  avian	   0.633	  (0.606-­‐0.650)	   0.665	  (0.637-­‐0.692)	   0.702	  (0.665-­‐0.730)	   0.686	  (0.658-­‐0.707)	   0.663	  (0.624-­‐0.683)	   0.666	  (0.632-­‐0.682)	   0.788	  (0.745-­‐0.855)	   0.837	  (0.744-­‐0.864)	  H5N1	  avian	   0.785	  (0.753-­‐0.798)	   0.857	  (0.841-­‐0.872)	   0.863	  (0.849-­‐0.882)	   0.909	  (0.895-­‐0.921)	   0.854	  (0.827-­‐0.888)	   0.854	  (0.827-­‐0.861)	   0.923	  (0.905-­‐0.940)	   0.848	  (0.813-­‐0.895)	  
Nei-­‐Tamura	  	  	   PB2	   PB1	   PA	   HA	   NP	   NA	   M1	   NS1	  H3N2	  human	   0.990	  (0.989-­‐0.993)	   0.994	  (0.992-­‐0.995)	   0.996	  (0.994-­‐0.997)	   0.995	  (0.994-­‐0.997)	   0.994	  (0.993-­‐0.996)	   0.997	  (0.996-­‐0.997)	   0.998	  (0.996-­‐0.999)	   0.996	  (0.991-­‐0.997)	  H1N1	  seasonal	  human	   0.972	  (0.963-­‐0.977)	   0.977	  (0.974-­‐0.979)	   0.976	  (0.973-­‐0.979)	   0.988	  (0.986-­‐0.989)	   0.973	  (0.971-­‐0.975)	   0.991	  (0.991-­‐0.993)	   0.989	  (0.989-­‐0.990)	   0.971	  (0.968-­‐0.980)	  H1N1pdm	  human	   0.998	  (0.997-­‐0.998)	   0.998	  (0.997-­‐0.998)	   0.998	  (0.998-­‐0.999)	   1.000	  (0.999-­‐1.000)	   0.999	  (0.999-­‐0.999)	   1.000	  (1.000-­‐1.000)	   0.999	  (0.999-­‐0.999)	   0.999	  (0.998-­‐0.999)	  H1N1	  swine	   0.603	  (0.586-­‐ 0.660	  (0.631-­‐ 0.672	  (0.637-­‐ 0.787	  (0.767-­‐ 0.706	  (0.678-­‐ 0.792	  (0.768-­‐ 0.887	  (0.868-­‐ 0.690	  (0.640-­‐
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0.641)	   0.695)	   0.696)	   0.804)	   0.735)	   0.809)	   0.910)	   0.739)	  H5N1	  human	   0.665	  (0.606-­‐0.697)	   0.763	  (0.730-­‐0.783)	   0.745	  (0.694-­‐0.758)	   0.795	  (0.762-­‐0.834)	   0.763	  (0.711-­‐0.809)	   0.809	  (0.751-­‐0.821)	   0.894	  (0.837-­‐0.936)	   0.829	  (0.729-­‐0.865)	  non-­‐H5N1	  avian	   0.619	  (0.594-­‐0.638)	   0.653	  (0.624-­‐0.683)	   0.672	  (0.635-­‐0.705)	   0.671	  (0.638-­‐0.689)	   0.643	  (0.605-­‐0.671)	   0.643	  (0.615-­‐0.674)	   0.779	  (0.739-­‐0.836)	   0.785	  (0.735-­‐0.846)	  H5N1	  avian	   0.759	  (0.732-­‐0.780)	   0.848	  (0.826-­‐0.868)	   0.842	  (0.799-­‐0.865)	   0.904	  (0.880-­‐0.915)	   0.843	  (0.822-­‐0.856)	   0.842	  (0.822-­‐0.859)	   0.919	  (0.896-­‐0.928)	   0.844	  (0.809-­‐0.883)	  
	  
Supplementary	  Table	  B-­‐2.	  Current	  q2-­‐coefficients	  of	  influenza	  HA	  by	  transmission	  zone.	  Entries	  assigned	  NaN	  
represent	  transmission	  zones	  that	  were	  not	  sampled	  for	  longer	  than	  the	  span	  of	  a	  month.	  Intervals	  based	  on	  the	  
95%	  HPD	  of	  evolutionary	  rate	  are	  also	  provided.	  
Hamming	   	   	   	   	   	   	   	  
	  	   H3N2	  human	   H1N1	  seasonal	  human	   H1N1pdm	  human	   H1N1	  swine	   H5N1	  human	   non-­‐H5N1	  avian	   H5N1	  avian	  Central	  America	  Caribbean	  	   0.969	  (0.958-­‐0.979)	   0.975	  (0.975-­‐0.975)	   0.992	  (0.992-­‐0.992)	   0.545	  (0.545-­‐0.545)	   0.000	  (0.000-­‐0.000)	   0.529	  (0.529-­‐0.529)	   0.000	  (0.000-­‐0.000)	  
Central	  Asia	   0.545	  (0.545-­‐0.545)	   0.500	  (0.000-­‐0.500)	   0.846	  (0.846-­‐0.923)	   0.000	  (0.000-­‐0.000)	   0.000	  (0.000-­‐0.000)	   0.000	  (0.000-­‐0.000)	   0.000	  (0.000-­‐0.000)	  
Eastern	  Africa	   0.946	  (0.946-­‐0.959)	   0.931	  (0.931-­‐0.931)	   0.983	  (0.983-­‐0.992)	   0.000	  (0.000-­‐0.000)	   0.000	  (0.000-­‐0.000)	   0.385	  (0.385-­‐0.385)	   0.000	  (0.000-­‐0.000)	  
Eastern	  Asia	   0.986	  (0.980-­‐0.992)	   0.952	  (0.948-­‐0.952)	   0.999	  (0.999-­‐0.999)	   0.753	  (0.733-­‐0.773)	   0.711	  (0.684-­‐0.737)	   0.726	  (0.699-­‐0.742)	   0.874	  (0.868-­‐0.880)	  Eastern	  Europe	   0.979	  (0.979-­‐0.979)	   0.889	  (0.889-­‐0.889)	   0.997	  (0.997-­‐0.997)	   0.333	  (0.333-­‐0.333)	   0.000	  (0.000-­‐0.000)	   0.191	  (0.170-­‐0.213)	   0.936	  (0.936-­‐0.936)	  
Middle	  Africa	   0.923	  (0.923-­‐0.923)	   0.000	  (0.000-­‐0.000)	   0.950	  (0.950-­‐0.950)	   0.000	  (0.000-­‐0.000)	   0.000	  (0.000-­‐0.000)	   0.000	  (0.000-­‐0.000)	   0.000	  (0.000-­‐0.000)	  North	  America	   0.997	  (0.995-­‐0.997)	   0.989	  (0.988-­‐0.989)	   1.000	  (0.999-­‐1.000)	   0.877	  (0.862-­‐0.889)	   0.000	  (0.000-­‐0.000)	   0.685	  (0.652-­‐0.709)	   0.500	  (0.500-­‐0.500)	  Northern	  Africa	   0.967	  (0.934-­‐0.967)	   0.800	  (0.800-­‐0.800)	   0.986	  (0.986-­‐0.986)	   0.000	  (0.000-­‐0.000)	   0.964	  (0.929-­‐0.964)	   0.636	  (0.636-­‐0.636)	   0.963	  (0.947-­‐0.967)	  Northern	  Europe	   0.982	  (0.975-­‐0.984)	   0.909	  (0.909-­‐0.909)	   0.999	  (0.999-­‐0.999)	   0.368	  (0.342-­‐0.421)	   0.000	  (0.000-­‐0.000)	   0.189	  (0.162-­‐0.189)	   NaN	  
Oceania	   0.989	  (0.985-­‐0.989)	   0.971	  (0.971-­‐0.975)	   0.998	  (0.998-­‐0.998)	   NaN	   0.000	  (0.000-­‐0.000)	   0.240	  (0.200-­‐0.240)	   0.000	  (0.000-­‐0.000)	  South	  East	  Asia	   0.987	  (0.985-­‐0.989)	   0.950	  (0.945-­‐0.950)	   0.999	  (0.998-­‐0.999)	   0.632	  (0.632-­‐0.632)	   0.764	  (0.745-­‐0.800)	   0.391	  (0.391-­‐0.435)	   0.862	  (0.843-­‐0.886)	  South	  West	  Europe	   0.944	  (0.918-­‐0.966)	   0.650	  (0.650-­‐0.650)	   0.998	  (0.998-­‐0.998)	   0.455	  (0.455-­‐0.455)	   0.000	  (0.000-­‐0.000)	   0.764	  (0.750-­‐0.778)	   0.792	  (0.792-­‐0.792)	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Southern	  Africa	   0.895	  (0.895-­‐0.895)	   0.714	  (0.714-­‐0.714)	   0.900	  (0.900-­‐0.900)	   0.000	  (0.000-­‐0.000)	   0.000	  (0.000-­‐0.000)	   NaN	   0.000	  (0.000-­‐0.000)	  
Southern	  Asia	   0.952	  (0.952-­‐0.952)	   0.932	  (0.932-­‐0.949)	   0.989	  (0.989-­‐0.989)	   0.000	  (0.000-­‐0.000)	   0.000	  (0.000-­‐0.000)	   0.417	  (0.400-­‐0.417)	   0.771	  (0.729-­‐0.833)	  Temperate	  South	  America	   0.970	  (0.970-­‐0.970)	   0.912	  (0.912-­‐0.912)	   0.993	  (0.987-­‐0.993)	   0.000	  (0.000-­‐0.000)	   0.000	  (0.000-­‐0.000)	   0.400	  (0.400-­‐0.400)	   0.000	  (0.000-­‐0.000)	  Tropical	  South	  America	   0.966	  (0.898-­‐0.983)	   0.917	  (0.917-­‐0.917)	   0.987	  (0.983-­‐0.996)	   0.600	  (0.600-­‐0.600)	   0.000	  (0.000-­‐0.000)	   0.000	  (0.000-­‐0.000)	   0.000	  (0.000-­‐0.000)	  Western	  Africa	   0.982	  (0.982-­‐0.982)	   0.750	  (0.750-­‐0.750)	   0.987	  (0.987-­‐0.987)	   0.000	  (0.000-­‐0.000)	   0.000	  (0.000-­‐0.000)	   NaN	   0.978	  (0.978-­‐0.978)	  
Western	  Asia	   0.964	  (0.952-­‐0.964)	   0.727	  (0.727-­‐0.727)	   0.991	  (0.982-­‐0.991)	   0.000	  (0.000-­‐0.000)	   0.000	  (0.000-­‐0.000)	   0.694	  (0.694-­‐0.750)	   0.125	  (0.125-­‐0.250)	  	   	  	   	   	   	   	   	   	  
Nei-­‐Tamura	   	   	   	   	   	   	   	  
	  	   H3N2	  human	   H1N1	  seasonal	  human	   H1N1pdm	  human	   H1N1	  swine	   H5N1	  human	   non-­‐H5N1	  avian	   H5N1	  avian	  Central	  America	  Caribbean	  	   0.958	  (0.958-­‐0.958)	   0.975	  (0.975-­‐0.975)	   0.996	  (0.988-­‐0.996)	   0.545	  (0.455-­‐0.545)	   0.000	  (0.000-­‐0.000)	   0.529	  (0.529-­‐0.529)	   0.000	  (0.000-­‐0.000)	  
Central	  Asia	   0.545	  (0.545-­‐0.545)	   0.000	  (0.000-­‐0.500)	   0.923	  (0.923-­‐0.923)	   0.000	  (0.000-­‐0.000)	   0.000	  (0.000-­‐0.000)	   0.000	  (0.000-­‐0.000)	   0.000	  (0.000-­‐0.000)	  
Eastern	  Africa	   0.946	  (0.939-­‐0.946)	   0.931	  (0.931-­‐0.931)	   0.975	  (0.949-­‐0.983)	   0.000	  (0.000-­‐0.000)	   0.000	  (0.000-­‐0.000)	   0.385	  (0.385-­‐0.385)	   0.000	  (0.000-­‐0.000)	  
Eastern	  Asia	   0.977	  (0.965-­‐0.985)	   0.948	  (0.944-­‐0.952)	   0.998	  (0.998-­‐0.999)	   0.749	  (0.710-­‐0.753)	   0.684	  (0.658-­‐0.711)	   0.706	  (0.671-­‐0.723)	   0.862	  (0.850-­‐0.868)	  Eastern	  Europe	   0.973	  (0.932-­‐0.979)	   0.889	  (0.889-­‐0.889)	   0.997	  (0.997-­‐0.997)	   0.333	  (0.333-­‐0.333)	   0.000	  (0.000-­‐0.000)	   0.170	  (0.128-­‐0.191)	   0.936	  (0.915-­‐0.936)	  
Middle	  Africa	   0.923	  (0.846-­‐0.923)	   0.000	  (0.000-­‐0.000)	   0.950	  (0.900-­‐0.950)	   0.000	  (0.000-­‐0.000)	   0.000	  (0.000-­‐0.000)	   0.000	  (0.000-­‐0.000)	   0.000	  (0.000-­‐0.000)	  North	  America	   0.995	  (0.992-­‐0.996)	   0.988	  (0.985-­‐0.989)	   0.999	  (0.999-­‐1.000)	   0.853	  (0.845-­‐0.880)	   0.000	  (0.000-­‐0.000)	   0.668	  (0.636-­‐0.691)	   0.500	  (0.375-­‐0.500)	  Northern	  Africa	   0.918	  (0.902-­‐0.951)	   0.800	  (0.800-­‐0.800)	   0.986	  (0.986-­‐0.986)	   0.000	  (0.000-­‐0.000)	   0.929	  (0.911-­‐0.964)	   0.636	  (0.636-­‐0.636)	   0.957	  (0.927-­‐0.967)	  Northern	  Europe	   0.977	  (0.975-­‐0.982)	   0.909	  (0.879-­‐0.909)	   0.999	  (0.998-­‐0.999)	   0.342	  (0.342-­‐0.368)	   0.000	  (0.000-­‐0.000)	   0.162	  (0.162-­‐0.189)	   NaN	  
Oceania	   0.985	  (0.980-­‐0.985)	   0.971	  (0.951-­‐0.971)	   0.998	  (0.998-­‐0.998)	   NaN	   0.000	  (0.000-­‐0.000)	   0.240	  (0.200-­‐0.240)	   0.000	  (0.000-­‐0.000)	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South	  East	  Asia	   0.984	  (0.982-­‐0.987)	   0.945	  (0.940-­‐0.950)	   0.998	  (0.998-­‐0.998)	   0.632	  (0.632-­‐0.632)	   0.745	  (0.691-­‐0.800)	   0.391	  (0.348-­‐0.391)	   0.864	  (0.838-­‐0.875)	  South	  West	  Europe	   0.924	  (0.910-­‐0.935)	   0.650	  (0.650-­‐0.650)	   0.998	  (0.998-­‐0.998)	   0.455	  (0.455-­‐0.455)	   0.000	  (0.000-­‐0.000)	   0.769	  (0.745-­‐0.769)	   0.792	  (0.792-­‐0.792)	  Southern	  Africa	   0.895	  (0.842-­‐0.895)	   0.714	  (0.714-­‐0.714)	   0.900	  (0.800-­‐0.900)	   0.000	  (0.000-­‐0.000)	   0.000	  (0.000-­‐0.000)	   NaN	   0.000	  (0.000-­‐0.000)	  
Southern	  Asia	   0.952	  (0.935-­‐0.952)	   0.932	  (0.915-­‐0.932)	   0.983	  (0.977-­‐0.989)	   0.000	  (0.000-­‐0.000)	   0.000	  (0.000-­‐0.000)	   0.383	  (0.317-­‐0.400)	   0.729	  (0.729-­‐0.854)	  Temperate	  South	  America	   0.960	  (0.949-­‐0.970)	   0.912	  (0.912-­‐0.912)	   0.987	  (0.987-­‐0.993)	   0.000	  (0.000-­‐0.000)	   0.000	  (0.000-­‐0.000)	   0.400	  (0.200-­‐0.400)	   0.000	  (0.000-­‐0.000)	  Tropical	  South	  America	   0.898	  (0.847-­‐0.932)	   0.917	  (0.917-­‐0.917)	   0.987	  (0.975-­‐0.987)	   0.600	  (0.400-­‐0.600)	   0.000	  (0.000-­‐0.000)	   0.000	  (0.000-­‐0.000)	   0.000	  (0.000-­‐0.000)	  Western	  Africa	   0.982	  (0.982-­‐0.982)	   0.500	  (0.500-­‐0.750)	   0.987	  (0.975-­‐0.987)	   0.000	  (0.000-­‐0.000)	   0.000	  (0.000-­‐0.000)	   NaN	   0.978	  (0.956-­‐0.978)	  
Western	  Asia	   0.952	  (0.904-­‐0.952)	   0.727	  (0.727-­‐0.727)	   0.991	  (0.991-­‐0.991)	   0.000	  (0.000-­‐0.000)	   0.000	  (0.000-­‐0.000)	   0.694	  (0.694-­‐0.694)	   0.125	  (0.125-­‐0.125)	  
	  
Supplementary	  Table	  B-­‐3.	  Current	  q2-­‐coefficients	  of	  dengue	  by	  country.	  Intervals	  based	  on	  the	  95%	  HPD	  of	  
evolutionary	  rate	  are	  also	  provided.	  
	  
Hamming	   	   	   	  	  	   DENV1	   DENV2	   DENV3	  Brazil	   0.200	  (0.200-­‐0.200)	   0.000	  (0.000-­‐0.000)	   0.410	  (0.410-­‐0.410)	  Cambodia	   0.485	  (0.485-­‐0.485)	   0.412	  (0.412-­‐0.412)	   0.327	  (0.327-­‐0.327)	  Colombia	   0.231	  (0.231-­‐0.231)	   0.235	  (0.235-­‐0.235)	   0.294	  (0.294-­‐0.294)	  Mexico	   0.545	  (0.545-­‐0.545)	   0.100	  (0.100-­‐0.100)	   nan	  	  Nicaragua	   0.474	  (0.474-­‐0.474)	   0.763	  (0.763-­‐0.763)	   0.844	  (0.844-­‐0.844)	  Thailand	   0.400	  (0.400-­‐0.400)	   0.425	  (0.425-­‐0.425)	   0.263	  (0.263-­‐0.263)	  USA	   0.345	  (0.345-­‐0.345)	   0.512	  (0.512-­‐0.512)	   0.566	  (0.566-­‐0.566)	  Venezuela	   0.380	  (0.380-­‐0.380)	   0.320	  (0.320-­‐0.320)	   0.511	  (0.511-­‐0.511)	  Vietnam	   0.688	  (0.688-­‐0.688)	   0.367	  (0.367-­‐0.367)	   0.389	  (0.389-­‐0.389)	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Nei-­‐
Tamura	   	   	   	  	  	   DENV1	   DENV2	   DENV3	  Brazil	   0.200	  (0.200-­‐0.200)	   0.000	  (0.000-­‐0.000)	   0.410	  (0.359-­‐0.410)	  Cambodia	   0.485	  (0.471-­‐0.485)	   0.412	  (0.382-­‐0.412)	   0.327	  (0.327-­‐0.327)	  Colombia	   0.231	  (0.231-­‐0.231)	   0.235	  (0.176-­‐0.235)	   0.294	  (0.294-­‐0.294)	  Mexico	   0.545	  (0.527-­‐0.545)	   0.100	  (0.100-­‐0.100)	   nan	  Nicaragua	   0.447	  (0.447-­‐0.447)	   0.763	  (0.748-­‐0.763)	   0.844	  (0.828-­‐0.844)	  Thailand	   0.400	  (0.400-­‐0.400)	   0.425	  (0.425-­‐0.425)	   0.263	  (0.263-­‐0.263)	  USA	   0.345	  (0.345-­‐0.345)	   0.512	  (0.446-­‐0.512)	   0.566	  (0.566-­‐0.566)	  Venezuela	   0.380	  (0.380-­‐0.380)	   0.320	  (0.280-­‐0.320)	   0.511	  (0.457-­‐0.511)	  Vietnam	   0.686	  (0.666-­‐0.686)	   0.367	  (0.367-­‐0.367)	   0.389	  (0.389-­‐0.389)	  
	  
Supplementary	  Table	  B-­‐4.	  Current	  q2-­‐coefficients	  of	  West	  Nile	  virus	  by	  host.	  Intervals	  based	  on	  the	  95%	  HPD	  of	  
evolutionary	  rate	  are	  also	  provided.	  
	  
Hamming	   	  Mosquito	   0.775	  (0.625-­‐0.869)	  Bird	   0.617	  (0.411-­‐0.776)	  
	  
Nei-­‐
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Supplementary	  Table	  B-­‐5.	  Number	  of	  sequences	  for	  each	  viral	  gene.	  
Influenza	   	   	   	   	   	   	   	   	  	  	   PB2	   PB1	   PA	   HA	   NP	   NA	   M1	   NS1	  H1N1	   1042	   1065	   1042	   2567	   1068	   3123	   2245	   1087	  H1N1pdm	   4757	   4127	   4322	   11626	   4484	   9457	   7067	   4885	  H1N1swine	   421	   468	   464	   878	   485	   1090	   951	   544	  H3N2	   3058	   3023	   2989	   7083	   3066	   7839	   5726	   3151	  H5N1	   438	   509	   533	   1193	   444	   640	   672	   660	  H5N1human	   162	   179	   190	   158	   166	   189	   166	   198	  non_H5N1	   2880	   2832	   2892	   3418	   2565	   2879	   2911	   2944	  	   	   	   	   	   	   	   	   	  
Dengue	   	   	   	   	   	   	   	   	  Strain	   ENV	   	   	   	   	   	   	   	  DENV1	   1082	   	   	   	   	   	   	   	  DENV2	   676	   	   	   	   	   	   	   	  DENV3	   473	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Appendix	  C.	  Supplementary	  Text	  
to	  “Network	  Analysis	  of	  Global	  
Influenza	  Spread”	  
	  
Evaluation	  of	  Clustering	  One	  way	  of	  assessing	  the	  ability	  to	  differentiate	  variants	  for	  a	  given	  influenza	  segment	  and	  regional	  clustering	  method	  is	  to	  count	  the	  non-­‐unique	  solutions,	  defined	  as	  the	  instances	  in	  which	  a	  given	   isolate	  has	  multiple	  closest	  ancestors	   from	  different	  geographical	  zones	  or	  seasons.	   Generally,	   the	   number	   of	   non-­‐unique	   solutions	   is	   a	   function	   of	   the	   genetic	  diversity	  and	  the	  length	  of	  a	  given	  sequence.	  For	  instance,	  the	  resolution	  tends	  to	  decrease	  in	   highly	   conserved	   segments,	   such	   as	   segments	   M1/M2,	   and	   in	   sequences	   of	   smaller	  length,	   such	  as	   the	  HA1	  domain63.	  Additionally,	   low	  geographic	  or	  seasonal	  diversity	   in	  a	  dataset	   can	   reduce	   the	  number	  of	  non-­‐unique	   solutions	  by	   increasing	   the	   likelihood	   that	  equally	  close	  ancestors	  are	  from	  the	  same	  location,	  allowing	  inference	  of	  a	  unique	  seeding	  region	  and	  season.	  For	  reference,	  non-­‐unique	  solutions	  were	  measured	  for	  all	  segments	  of	  the	   influenza	   virus	   as	   well	   as	   for	   the	   HA1	   domain	   (Figure	   19).	   HA	   and	   NA	   incurred	   only	  modest	  numbers	  of	  non-­‐unique	  solutions	  in	  both	  H3N2	  and	  H1N1.	  Interestingly,	  H1N1	  in	  general	   possessed	   fewer	   non-­‐unique	   solutions	   than	   H3N2.	   This	   observation	   most	   likely	  derives	  from	  H1N1’s	  greater	  genetic	  diversity	  due	  to	  fewer	  seasonal	  bottlenecks29.	  	  	  
Most	   likely	   due	   to	   increased	   positive	   selection,	   the	   HA1	   epitope	   has	   the	   greatest	  evolutionary	  rate	  of	  mutation	   in	   the	   influenza	  genome,	  estimated	  at	  6.7	  x	  10–3	  nucleotide	  substitutions	   per	   site	   per	   year63,199.	   Resolution	   of	   the	   HA1	   domain,	   however,	   was	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comparable	   to	   the	   M1	   segment,	   indicating	   that	   the	   resolution	   gained	   from	   its	   high	  evolutionary	   rate	   was	   offset	   by	   its	   greater	   geographic/seasonal	   coverage	   and	   shorter	  length,	  which	   is	  half	   that	   of	   the	   entire	  HA	   coding	   region.	  Therefore,	   any	  discrepancies	   in	  findings	  were	  resolved	   in	   favor	  of	   the	  complete	  coding	  sequences	  of	  HA	  and	  NA	  over	   the	  HA1	   domain.	   Despite	   the	   large	   number	   of	   non-­‐unique	   solutions,	   we	   considered	   any	  findings	  from	  the	  HA1	  domain	  that	  were	  corroborated	  by	  the	  complete	  coding	  sequences	  to	  be	  convincing.	  	  
Determining	  Flu	  Seasons	  The	  influenza	  season	  in	  the	  northern	  and	  southern	  temperate	  zones	  is	  well-­‐defined,	  lasting	  November	  to	  April,	  and	  May	  to	  September	  respectively200.	  Defining	  tropical	  flu	  seasons,	  on	  the	  other	  hand,	  is	  particularly	  difficult	  since	  epidemics	  persist	  at	  low	  levels	  year-­‐round,	  often	  with	  two	  ill-­‐defined	  annual	  and	  semi-­‐annual	  peaks	  that	  occur	  usually,	  but	  not	  always,	  during	  the	  rainy	  season	  and	  the	  winter	  season,	  respectively201-­‐203.	  For	  our	  analysis,	  accuracy	  in	  defining	  the	  endpoints	  of	  these	  seasons	  is	  important	  in	  order	  not	  to	  falsely	  increase	  the	  number	  of	  internal	  seeding	  events	  (a	  given	  region	  seeding	  itself).	  	  
To	  account	  for	  this	  problem,	  we	  compiled	  from	  literature	  a	  list	  of	  all	  known	  flu	  time	  frames	  for	  all	   tropical	  countries	   in	  our	  database	  (Supplementary	  Table	  D-­‐1).	  When	  clustering	  by	  climate	   zone	   and	   continent,	   we	   defined	   a	   general	   tropical	   flu	   season,	   from	  October	   1	   to	  September	   30th	   of	   the	   next	   year,	   to	   minimize	   overlap	   between	   our	   defined	   seasonal	  endpoints	   and	   epidemic	   peaks.	   Generalizing	   tropical	   flu	   seasons,	   however,	   was	   not	  necessary	  for	  clustered	  country	  analysis;	  we	  therefore	  defined	  flu	  seasons	  specific	  to	  each	  country,	  beginning	  before	  the	  larger	  annual	  peak	  and	  ending	  after	  the	  smaller	  semiannual	  peak.	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Timing	  of	  Observed	  Seeding	  Events	  In	  constructing	  the	  network	  of	  seeding	  events,	  we	  also	  investigated	  the	  time	  frame	  between	  each	   pair	   of	   seeded	   and	   seeding	   sequences.	   We	   found	   that	   no	   matter	   the	   method	   of	  clustering	  or	  segment	  analyzed,	  the	  overwhelming	  majority	  (>90%)	  of	  seeding	  sequences	  came	   from	  within	  one	  year	  of	   the	  seeded	  sequence.	  This	   finding	  suggested	   that	  placing	  a	  temporal	  threshold	  on	  which	  isolates	  to	  consider	  as	  seeding	  candidates	  to	  be	  unnecessary.	  	  	  
Randomization	  of	  Networks	  As	   a	   comparison	   to	   experimental	   data,	   randomized	  networks	  must	   control	   for	  particular	  epidemiological	   principles	   that	   constrain	   the	   data.	   One	   philosophical	   question	   that	   such	  networks	  must	   address	   is	   to	   what	   extent	   are	   seeding	   events	   independent.	   One	   possible	  argument	  is	  that	  all	  seeding	  events	  are	  universally	  independent	  of	  each	  other.	  This	  makes	  sense	   to	  a	   certain	  extent;	   an	   influenza	   carrier	   in	   the	  northern	  hemisphere	  does	  not	  have	  any	  direct	  effect	  on	  a	  carrier	  in	  the	  south.	  Even	  carriers	  in	  the	  same	  region	  and	  season	  are	  independent	  agents	  of	  free	  will	  and	  can	  make	  choices	  to	  travel	  to	  any	  random	  place.	  In	  the	  context	   of	   our	   network	  model,	   this	   argument	   asserts	   that	   each	   unit	   of	   a	   weighted	   edge	  represents	  a	  seeding	  event	  independent	  of	  all	  others,	  even	  those	  in	  the	  same	  edge.	  	  
A	   randomized	   network	   that	   reflects	   transmission	   of	   complete	   independence	   would	   mix	  seeding	  events	  irrespective	  of	  their	  origin	  or	  target	  while	  preserving	  the	  number	  of	  seeding	  events	   into	   and	   out	   of	   each	   region.	   To	   this	   end,	   we	   implemented	   a	   Markov	   chain	   that	  iteratively	  samples	  a	  pair	  of	  seeding	  regions	  (x1,	  x2)	  and	  a	  pair	  of	  seeded	  regions	  (y1,	  y2)	  at	  random.	  Given	  that	  xi-­‐>yj	   	   is	  the	  number	  of	  seeding	  events	  from	  region	  xi	  to	  region	  yi,	  the	  counts	  for	  seeding	  events	  were	  randomly	  mixed	  such	  that	  	   𝑥! → 𝑦!! 	  and	   𝑥! → 𝑦!! 	  remain	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constant.	  We	   ran	   this	   procedure	  10,000	   times	  with	   a	  mixing	   time	  of	   100,000	   steps.	   This	  methodology	  is	  akin	  to	  Markov	  sampling	  to	  randomize	  an	  NxN	  contingency	  table204.	  	  
Of	   course,	   complete	   independence	   cannot	   totally	   describe	   what	   occurs	   in	   reality.	   For	  example,	   a	   northern	   hemisphere	   carrier	   of	   influenza	   can	   indirectly	   suppress	   a	   southern	  carrier’s	  ability	  to	  transmit	  to	  the	  north	  through	  herd	  immunity.	  Moreover,	  one	  could	  argue	  that	  carriers	  in	  the	  same	  region	  and	  season	  are	  more	  likely	  to	  travel	  to	  the	  same	  places	  due	  to	   similar	   backgrounds.	   This	   is	   even	   truer	   if	   one	   also	   considers	   that	   available	  transportation	   routes	   may	   discretize	   the	   number	   of	   travel	   destinations	   from	   a	   given	  location.	   One	   can	   imagine	   that	   seeding	   patterns	   may	   largely	   mirror	   the	   topology	   of	   the	  international	  aviation	  network59,82,83,199.	  In	  this	  way,	  the	  seeding	  events	  of	  a	  weighted	  edge	  are	  interdependent	  and	  cannot	  be	  fractionized.	  
A	  natural	  way	  of	  simulating	  such	  local	  interdependence	  and	  interregional	  independence	  is	  to	  shuffle	  edges	  such	  that	  topological	  indegree	  and	  outdegree	  is	  preserved.	  In	  this	  process,	  two	   links	   at	   a	   time,	   x1-­‐y1	   and	   x2-­‐y2,	   are	   chosen	   from	   the	   observed	   graph	   and	   rewired	   to	  form	   x1-­‐y2	   and	   x2-­‐y1205.	   We	   ran	   this	   procedure	   10,000	   times,	   with	   100,000	   shuffling	  iterations.	  This	  is	  a	  process	  often	  used	  to	  analyze	  protein-­‐protein	  interaction	  networks.	  	  
Our	  choice	   for	  a	  random	  network	  depended	  on	  the	  specific	  metrics	  of	  network	  centrality	  we	  were	  testing.	  Degree	  flow,	  defined	  as	  the	  difference	  between	  seeding	  events	  out	  of	  and	  into	  a	  region,	  is	  invariant	  to	  mixing	  by	  complete	  independence.	  Therefore,	  we	  randomized	  degree	  flow	  by	  rewiring	  edges.	  On	  the	  other	  hand,	  PageRank	  and	  betweenness	  are	  metrics	  dependent	   on	   topology	   and	  were	  more	   effectively	   randomized	   by	  mixing	   the	  weights	   of	  seeding	  events.	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These	   techniques	   worked	   effectively	   for	   clustering	   by	   continent	   and	   country,	   but	   were	  unable	   to	  randomize	   the	  3x3	  matrix	  produced	  by	  climate	  zone	  clustering	  without	  mixing	  internal	  seeding	  events	  along	  the	  matrix	  diagonal.	  To	  test	  only	  external	  seeding	  events,	  we	  used	   a	   variant	   of	   an	   Erdos-­‐Reyni	   random	   graph	   with	   preserved	   number	   of	   edges	   for	  clustering	  by	  climate	  zone.	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Appendix	  D.	  Supplementary	  
Tables	  to	  “Network	  Analysis	  of	  
Global	  Influenza	  Spread”	  
	  
Supplementary	   Table	   D-­‐1.	   Timing	   of	   tropical	   flu	   seasons	   used	   in	   the	   dataset.	   This	   data	   was	   used	   to	   create	   a	  
consensus	  tropical	  season	  for	  clustering	  by	  climate	  zone,	  starting	  from	  October	  1st	  to	  September	  30th	  of	  the	  next	  
year.	  For	  clustering	  by	  country,	  a	  unique	  season	  was	  assigned	  to	  each	  tropical	  country	  that	  encompasses	  both	  the	  
annual	  and	  semi-­‐annual	  peaks.	  
	  
Country	   Annual	  Peak	   Semi-­‐Annual	  
Peak	  
References	  
Brazil	   Jun	   Jan	   6,206	  
Cambodia	   Jun-­‐Dec	  	   -­‐	   207,208	  
Guam	   Sept	   	   209	  
Hong	  Kong	   Jan-­‐Feb	  	  	   Jul-­‐Aug	   64,210-­‐212	  
India	   Jul-­‐Aug	   -­‐	   203,213	  
Indonesia	   Dec-­‐Jan	   -­‐	   214	  
Madagascar	   Jul-­‐Aug	   -­‐	   215	  
Malaysia	   Jun-­‐Jul	   -­‐	   216	  
New	  
Caledonia	  
Feb-­‐Jun	  (H3N2),	  May-­‐Sept	  (H1N1)	   -­‐	   217	  
Nicaragua	   Jun-­‐Jul	   Nov-­‐Dec	   218	  
Philippines	   Jul-­‐Sep	  	   Dec-­‐Jan	   203	  
Singapore	  	   Apr-­‐Jun	   Nov-­‐Jan	   203	  
Thailand	   Jun-­‐Sep	   Jan-­‐Mar	   203,219	  
Vietnam	   May-­‐Sep	   -­‐	   203	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Supplementary	   Table	   D-­‐2.	   Top	   seeding	   countries	   after	   clustering	   by	   country	   for	   the	   H3N2	   HA1	   domain.	   A	  
distinction	  is	  made	  between	  externally	  and	  locally	  seeding	  countries.	  Note	  that	  the	  total	  number	  of	  significant	  























USA	   USA	   *	   -­‐	   4	   40	   2146	  
	   Argentina	   *	   *	   3	   	   	  
	   Japan	   -­‐	   -­‐	   2	   	   	  
	   Kenya	   *	   *	   2	   	   	  
	   New	  Zealand	   -­‐	   -­‐	   2	   	   	  
	   Norway	   *	   *	   2	   	   	  
	   Austria	   *	   *	   1	   	   	  
	   Bangladesh	   *	   *	   1	   	   	  
	   Brazil	   *	   *	   1	   	   	  
	   Bulgaria	   *	   *	   1	   	   	  
	   Chile	   -­‐	   -­‐	   1	   	   	  
	   China	   -­‐	   -­‐	   1	   	   	  
	   Ecuador	   *	   *	   1	   	   	  
	   Egypt	   *	   *	   1	   	   	  
	   Germany	   *	   *	   1	   	   	  
	   Honduras	   *	   *	   1	   	   	  
	   Italy	   *	   *	   1	   	   	  
	   Kuwait	   *	   *	   1	   	   	  
	   Malaysia	   -­‐	   -­‐	   1	   	   	  
	   Mexico	   *	   *	   1	   	   	  
	   Nepal	   *	   *	   1	   	   	  
	   Netherlands	   *	   *	   1	   	   	  
	   New	  Caledonia	   *	   *	   1	   	   	  
	   Northern	  Mariana	  Islands	   *	   *	   1	   	   	  
	   Philippines	   -­‐	   -­‐	   1	   	   	  
	   Qatar	   *	   *	   1	   	   	  
	   Russia	   *	   *	   1	   	   	  
	   Sri	  Lanka	   *	   *	   1	   	   	  
	   Ukraine	   *	   *	   1	   	   	  
	   Uruguay	   *	   *	   1	   	   	  
	   Venezuela	   *	   *	   1	   	   	  
Hong	  Kong	   Hong	  Kong	   *	   -­‐	   8	   37	   361	  
	   Australia	   -­‐	   -­‐	   3	   	   	  
	   China	   -­‐	   -­‐	   3	   	   	  
	   Malaysia	   *	   *	   3	   	   	  
	   Singapore	   *	   *	   3	   	   	  
	   USA	   -­‐	   -­‐	   3	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   Chile	   *	   *	   2	   	   	  
	   Philippines	   *	   *	   2	   	   	  
	   Thailand	   *	   *	   2	   	   	  
	   Finland	   *	   *	   1	   	   	  
	   Japan	   -­‐	   -­‐	   1	   	   	  
	   New	  Caledonia	   *	   *	   1	   	   	  
	   Northern	  Mariana	  Islands	   *	   *	   1	   	   	  
	   Norway	   -­‐	   -­‐	   1	   	   	  
	   Peru	   *	   *	   1	   	   	  
	   South	  Africa	   *	   *	   1	   	   	  
	   Taiwan	   -­‐	   -­‐	   1	   	   	  
China	   Hong	  Kong	   -­‐	   *	   5	   27	   133	  
	   China	   *	   -­‐	   4	   	   	  
	   USA	   *	   *	   4	   	   	  
	   South	  Korea	   -­‐	   *	   3	   	   	  
	   Taiwan	   *	   *	   2	   	   	  
	   Argentina	   -­‐	   -­‐	   1	   	   	  
	   Australia	   -­‐	   -­‐	   1	   	   	  
	   Canada	   *	   *	   1	   	   	  
	   Denmark	   *	   *	   1	   	   	  
	   Indonesia	   *	   *	   1	   	   	  
	   Japan	   -­‐	   -­‐	   1	   	   	  
	   New	  Zealand	   -­‐	   -­‐	   1	   	   	  
	   Thailand	   -­‐	   -­‐	   1	   	   	  
	   United	  Kingdom	   *	   *	   1	   	   	  
Australia	   USA	   *	   *	   4	   25	   339	  
	   France	   *	   *	   2	   	   	  
	   Hong	  Kong	   -­‐	   -­‐	   2	   	   	  
	   New	  Zealand	   -­‐	   *	   2	   	   	  
	   Singapore	   -­‐	   -­‐	   2	   	   	  
	   Austria	   *	   *	   1	   	   	  
	   Canada	   *	   *	   1	   	   	  
	   Czech	  Republic	   *	   *	   1	   	   	  
	   Egypt	   *	   *	   1	   	   	  
	   Ireland	   *	   *	   1	   	   	  
	   Malaysia	   -­‐	   -­‐	   1	   	   	  
	   New	  Caledonia	   *	   *	   1	   	   	  
	   Philippines	   -­‐	   -­‐	   1	   	   	  
	   Spain	   *	   *	   1	   	   	  
	   Sweden	   *	   *	   1	   	   	  
	   Taiwan	   -­‐	   -­‐	   1	   	   	  
	   Turkey	   *	   *	   1	   	   	  
	   United	  Kingdom	   *	   *	   1	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Japan	   China	   -­‐	   -­‐	   2	   24	   429	  
	   Taiwan	   *	   *	   2	   	   	  
	   Argentina	   -­‐	   -­‐	   1	   	   	  
	   Australia	   -­‐	   -­‐	   1	   	   	  
	   Austria	   *	   *	   1	   	   	  
	   Canada	   *	   *	   1	   	   	  
	   Chile	   -­‐	   -­‐	   1	   	   	  
	   Germany	   *	   *	   1	   	   	  
	   Honduras	   *	   *	   1	   	   	  
	   Hungary	   *	   *	   1	   	   	  
	   India	   *	   *	   1	   	   	  
	   Japan	   -­‐	   -­‐	   1	   	   	  
	   Macau	   *	   *	   1	   	   	  
	   Mongolia	   *	   *	   1	   	   	  
	   Paraguay	   *	   *	   1	   	   	  
	   Peru	   *	   *	   1	   	   	  
	   Russia	   *	   *	   1	   	   	  
	   Solomon	  Islands	   *	   *	   1	   	   	  
	   South	  Korea	   -­‐	   -­‐	   1	   	   	  
	   Sri	  Lanka	   *	   *	   1	   	   	  
	   USA	   -­‐	   -­‐	   1	   	   	  
	   Viet	  Nam	   *	   *	   1	   	   	  
South	  
Korea	  
Japan	   *	   *	   4	   14	   126	  
	   South	  Korea	   *	   -­‐	   4	   	   	  
	   USA	   -­‐	   -­‐	   3	   	   	  
	   French	  Guiana	   *	   *	   1	   	   	  
	   Guatemala	   *	   *	   1	   	   	  
	   Hong	  Kong	   -­‐	   -­‐	   1	   	   	  
New	  
Zealand	  
New	  Zealand	   *	   -­‐	   6	   13	   523	  
	   Australia	   *	   *	   4	   	   	  
	   Brazil	   *	   *	   1	   	   	  
	   Bulgaria	   *	   *	   1	   	   	  
	   India	   *	   *	   1	   	   	  
Taiwan	   China	   -­‐	   -­‐	   3	   13	   31	  
	   Australia	   -­‐	   -­‐	   1	   	   	  
	   Germany	   *	   *	   1	   	   	  
	   Hong	  Kong	   -­‐	   -­‐	   1	   	   	  
	   Macau	   *	   *	   1	   	   	  
	   Nepal	   *	   *	   1	   	   	  
	   New	  Zealand	   -­‐	   -­‐	   1	   	   	  
	   Singapore	   -­‐	   -­‐	   1	   	   	  
	   Taiwan	   -­‐	   -­‐	   1	   	   	  
	   Thailand	   -­‐	   -­‐	   1	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   USA	   -­‐	   -­‐	   1	   	   	  
Thailand	   Australia	   -­‐	   -­‐	   2	   11	   76	  
	   Japan	   -­‐	   -­‐	   2	   	   	  
	   Thailand	   *	   -­‐	   2	   	   	  
	   Bangladesh	   *	   *	   1	   	   	  
	   Canada	   *	   *	   1	   	   	  
	   Hong	  Kong	   -­‐	   -­‐	   1	   	   	  
	   New	  Zealand	   -­‐	   -­‐	   1	   	   	  
	   South	  Korea	   -­‐	   -­‐	   1	   	   	  
Russia	   Australia	   -­‐	   -­‐	   1	   8	   17	  
	   Austria	   *	   *	   1	   	   	  
	   France	   -­‐	   -­‐	   1	   	   	  
	   Malaysia	   -­‐	   -­‐	   1	   	   	  
	   Saudi	  Arabia	   *	   *	   1	   	   	  
	   Taiwan	   -­‐	   -­‐	   1	   	   	  
	   USA	   -­‐	   -­‐	   1	   	   	  
	   Ukraine	   *	   *	   1	   	   	  
Nepal	   China	   -­‐	   -­‐	   1	   7	   14	  
	   Hong	  Kong	   -­‐	   -­‐	   1	   	   	  
	   Hungary	   *	   *	   1	   	   	  
	   Japan	   -­‐	   -­‐	   1	   	   	  
	   Malaysia	   -­‐	   -­‐	   1	   	   	  
	   Thailand	   -­‐	   -­‐	   1	   	   	  
	   USA	   -­‐	   -­‐	   1	   	   	  
Norway	   USA	   *	   *	   4	   7	   14	  
	   New	  Zealand	   -­‐	   -­‐	   1	   	   	  
	   Peru	   *	   *	   1	   	   	  
	   Philippines	   -­‐	   -­‐	   1	   	   	  
Austria	   Greece	   *	   *	   1	   6	   105	  
	   Iceland	   *	   *	   1	   	   	  
	   Italy	   *	   *	   1	   	   	  
	   Japan	   -­‐	   -­‐	   1	   	   	  
	   Mexico	   *	   *	   1	   	   	  
	   USA	   -­‐	   -­‐	   1	   	   	  
Germany	   USA	   -­‐	   -­‐	   2	   6	   31	  
	   Australia	   -­‐	   -­‐	   1	   	   	  
	   Japan	   -­‐	   -­‐	   1	   	   	  
	   Norway	   -­‐	   -­‐	   1	   	   	  
	   Thailand	   -­‐	   -­‐	   1	   	   	  
Philippines	   USA	   -­‐	   -­‐	   2	   6	   20	  
	   Australia	   -­‐	   -­‐	   1	   	   	  
	   Canada	   *	   *	   1	   	   	  
	   New	  Zealand	   -­‐	   -­‐	   1	   	   	  
	   Singapore	   -­‐	   -­‐	   1	   	   	  
Brazil	   Brazil	   *	   -­‐	   1	   5	   14	  
	   Chile	   -­‐	   -­‐	   1	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   China	   -­‐	   -­‐	   1	   	   	  
	   New	  Zealand	   -­‐	   -­‐	   1	   	   	  
	   USA	   -­‐	   -­‐	   1	   	   	  
Singapore	   Japan	   -­‐	   -­‐	   1	   5	   32	  
	   New	  Zealand	   -­‐	   -­‐	   1	   	   	  
	   Singapore	   -­‐	   -­‐	   1	   	   	  
	   South	  Korea	   -­‐	   -­‐	   1	   	   	  
	   Thailand	   -­‐	   -­‐	   1	   	   	  
France	   Austria	   *	   *	   1	   4	   25	  
	   Hong	  Kong	   -­‐	   -­‐	   1	   	   	  
	   Thailand	   -­‐	   -­‐	   1	   	   	  
	   USA	   -­‐	   -­‐	   1	   	   	  
Ireland	   Australia	   -­‐	   -­‐	   1	   4	   3	  
	   Norway	   -­‐	   -­‐	   1	   	   	  
	   Russia	   *	   *	   1	   	   	  
	   USA	   -­‐	   -­‐	   1	   	   	  
Sweden	   France	   -­‐	   -­‐	   1	   4	   5	  
	   French	  Guiana	   *	   *	   1	   	   	  
	   Romania	   *	   *	   1	   	   	  
	   USA	   -­‐	   -­‐	   1	   	   	  
Italy	   Italy	   *	   -­‐	   1	   3	   15	  
	   Latvia	   *	   *	   1	   	   	  
	   USA	   -­‐	   -­‐	   1	   	   	  
Kenya	   Kenya	   *	   -­‐	   2	   3	   63	  
	   USA	   -­‐	   -­‐	   1	   	   	  
Algeria	   Norway	   -­‐	   -­‐	   1	   2	   1	  
	   USA	   -­‐	   -­‐	   1	   	   	  
Canada	   Macau	   *	   *	   1	   2	   16	  
	   USA	   -­‐	   -­‐	   1	   	   	  
Croatia	   Australia	   -­‐	   -­‐	   1	   2	   1	  
	   Madagascar	   *	   *	   1	   	   	  
Kuwait	   Iraq	   *	   *	   1	   2	   16	  
	   USA	   -­‐	   -­‐	   1	   	   	  
Latvia	   Austria	   *	   *	   1	   2	   3	  
	   Romania	   *	   *	   1	   	   	  
Mexico	   France	   -­‐	   -­‐	   1	   2	   12	  
	   Honduras	   *	   *	   1	   	   	  
Peru	   Germany	   *	   *	   1	   2	   5	  
	   USA	   -­‐	   -­‐	   1	   	   	  
Switzerlan
d	  
Hong	  Kong	   -­‐	   -­‐	   1	   2	   1	  
	   South	  Africa	   *	   *	   1	   	   	  
United	  
Kingdom	  
Italy	   *	   *	   1	   2	   15	  
	   South	  Korea	   -­‐	   -­‐	   1	   	   	  
Argentina	   Philippines	   -­‐	   -­‐	   1	   1	   16	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Bulgaria	   Japan	   -­‐	   -­‐	   1	   1	   4	  
Fiji	   Macau	   *	   *	   1	   1	   1	  
Guam	   Japan	   -­‐	   -­‐	   1	   1	   3	  
Malaysia	   Japan	   -­‐	   -­‐	   1	   1	   26	  
Mongolia	   Japan	   -­‐	   -­‐	   1	   1	   7	  
New	  
Caledonia	  
Australia	   -­‐	   -­‐	   1	   1	   17	  




USA	   -­‐	   -­‐	   1	   1	   5	  
Slovenia	   Austria	   *	   *	   1	   1	   1	  
Spain	   Austria	   *	   *	   1	   1	   1	  
Turkey	   Germany	   *	   *	   1	   1	   1	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Appendix	  E:	  Background	  in	  
algebraic	  topology	  	  A	  main	  goal	   in	   the	   field	  of	  algebraic	   topology	   is	   to	   characterize	   the	  properties	  of	  a	   set	  of	  points	   or	   topological	   space	   X	   that	   are	   invariant	   to	   continuous	   deformation,	   such	   as	  stretching	   or	   bending	   without	   tearing	   or	   gluing.	   Such	   properties	   include	   the	   number	   of	  connected	  components	  or	  the	  number	  of	  holes	  that	  comprise	  X.	  Intuitively,	  we	  can	  see	  that	  a	   donut	   can	   be	   continuously	   deformed	   to	   assume	   the	   shape	   of	   a	   coffee	   mug	   without	  destroying	   the	   topological	   features	   of	   a	   single	   connected	   component	   with	   a	   single	   hole.	  	  Similarly,	  a	  football	  can	  be	  deformed	  into	  the	  shape	  of	  a	  basketball,	  as	  they	  are	  each	  a	  single	  connected	  component	  with	  a	  void	  or	  cavity.	  Algebraic	   topology	   formalizes	   these	   intuitive	  notions.	   It	   asserts	   that	   the	   equivalence	   classes	   of	   the	   donut-­‐coffee	   mug	   and	   football-­‐basketball	   are	   examples	   of	   homeomorphisms	   and	   share	   the	   same	   homology	   groups.	  Algebraic	  topology	  provides	  the	  language	  to	  describe	  and	  compute	  topological	  features	  of	  more	   complex	   topological	   spaces,	   as	  well.	  We	  will	   review	   the	  mathematical	   background	  necessary	  to	  grasp	  these	  notions.	  	  
Abstract	  algebra	  
Algebraic	  topology	  is	  based	  on	  the	  field	  of	  abstract	  algebra,	  which	  is	  the	  study	  of	  algebraic	  structures	  that	  include	  groups,	  rings,	  fields,	  modules,	  vector	  spaces,	  and	  algebras.	  For	  our	  purposes,	  we	  will	   frame	  evolution	  as	  a	   topological	   space	  whose	   topological	  properties	   in	  different	  dimensions	  can	  be	  mathematically	  represented	  as	  groups.	  Groups	  are	  defined	  as	  a	  set	  of	  elements	  G	  combined	  with	  a	  binary	  operation	  *	  that	  satisfies	  four	  conditions:	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1. Closure:	  For	  a	  and	  b	  in	  G,	  a*b	  is	  also	  in	  G.	  2. Associativity:	  	  For	  a,	  b,	  and	  c	  in	  G,	  a*(b*c)	  =	  (a*b)*c	  3. Identity:	  There	  is	  an	  identity	  element	  e	  in	  G	  such	  that	  for	  a	  in	  G,	  e*a	  =	  a*e	  =	  a.	  4. Invertibility:	  For	  a	  in	  G,	  there	  exists	  another	  b	  in	  G	  such	  that	  a*b	  =	  b*a	  =	  e.	  b	  is	  thus	  the	  inverse	  of	  a,	  or	  a-­‐1.	  	  
In	  addition,	  groups	  may	  or	  may	  not	  be	  abelian	  (commutative),	  where	  a*b	  =	  b*a	  for	  a	  and	  b	  in	   G.	   	   An	   illustrative	   example	   obeying	   all	   the	   above	   properties	   is	   the	   abelian	   group	   of	  integers	  under	  the	  addition	  operation	  (ℤ,+)	  with	  an	  identity	  element	  of	  0.	  	  
It	   will	   be	   important	   to	   establish	   relationships	   between	   different	   groups	   in	   a	   topological	  space.	  We	  introduce	  the	  idea	  of	  a	  homomorphism	  Φ,	  a	  structure-­‐preserving	  map	  between	  two	  algebraic	   structures,	   such	   as	   groups.	   Formally,	   for	   groups	   (G,+)	   and	   (H,*),	   the	   group	  homomorphism	  Φ	  is	  a	  mapping	  function	  Φ:	  G→H	  that	  preserves	  the	  algebraic	  structure	  of	  both	   G	   and	   H	   such	   that	   for	   all	   a	   and	   b	   in	   G,	   Φ(a+b)	   =	  Φ(a)*	  Φ(b).	   As	  with	   all	  mapping	  functions,	   we	   can	   define	   the	   kernel	   and	   image	   under	  Φ.	   The	   image	   of	   G	   under	  Φ	   is	   the	  subset	  of	  H	  that	  is	  mapped	  from	  G	  onto	  H.	  	  The	  kernel	  is	  the	  subset	  of	  G	  under	  Φ	  that	  maps	  to	  the	  identity	  element	  of	  H.	  When	  homomorphism	  Φ	  is	  bijective	  (one-­‐to-­‐one	  and	  onto),	  we	  refer	   to	  Φ	   as	   an	   isomorphism.	  Moreover,	   the	   first	   isomorphism	   theorem	   states	   that	   the	  image	  of	  a	  group	  G	  under	  a	  homomorphism	  Φ	  is	  always	  isomorphic	  to	  the	  quotient	  group	  G/ker(Φ),	  where	  ker(Φ)	   is	   the	  kernel	  of	  Φ.	   	  We	  will	  discuss	  quotient	  groups	   later.	  These	  notions	  are	  illustrated	  in	  Supplementary	  Table	  E-­‐1	  and	  will	  prove	  useful	  in	  our	  discussion	  of	  homology.	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A	  subset	  H	  of	  a	  group	  (G,*)	  is	  considered	  a	  subgroup	  of	  G	  if	  it	  also	  forms	  a	  group	  under	  the	  operation	  *	  induced	  by	  G.	  Now	  suppose	  given	  an	  element	  a	  in	  group	  G,	  we	  want	  to	  build	  a	  subgroup	  H	  of	  G	  containing	  only	  the	  element	  a.	  For	  H	  to	  be	  closed	  under	  the	  operation	  *	  as	  a	  group,	  we	  must	  also	  include	  aa,	  aaa,	  etc.,	  as	  well	  as	  a-­‐1a-­‐1,	  a-­‐1a-­‐1a-­‐1,	  etc.	  Here,	  the	  operator	  *	  between	   elements	   is	   understood	   but	   omitted	   for	   visual	   simplicity.	   Such	   a	   group	   can	   be	  expressed	  as	   𝑎! n  𝜖  ℤ 	  and	  is	  denoted	  as	  <a>.	  <a>	  is	  called	  a	  cyclic	  group	  that	  is	  generated	  by	   element	   a,	   the	   generator.	   We	   will	   see	   that	   each	   generator	   corresponds	   to	   a	   unique	  topological	  feature	  in	  a	  space.	  
	  
Supplementary	  Table	  E-­‐1.	  Homomorphism	  Φ	  between	  groups	  G	  and	  H.	  The	  kernel	  ker(Φ)	  and	  image	  img(Φ)	  are	  
depicted	  as	  subgroups	  of	  G	  and	  H,	  respectively.	  The	  left	  and	  right	  cosets	  aN	  and	  Na	  of	  the	  kernel	  N	  are	  depicted,	  as	  
well.	   Since	   they	   are	   equivalent,	   the	   kernel	   is	   a	   normal	   subgroup	  N	   of	   G.	   In	   fact,	   img(Φ)	   is	   the	   quotient	   group	  
G/ker(Φ).	  We	  can	  further	  define	  two	  other	  special	  subgroups,	  called	  cosets.	  Let	  H	  be	  a	  subgroup	  of	  G	  and	  a	  be	  an	  element	  of	  G.	  The	  left	  coset	  aH	  is	   𝑎ℎ h  𝜖  𝐻 ,	  and	  the	  right	  coset	  is	   ℎ𝑎 h  𝜖  𝐻 .	  A	  subgroup	  N	  is	  said	  to	  be	  normal	  its	  left	  and	  right	  cosets	  are	  the	  same,	  or	  aN	  =	  Na.	  If	  there	  exists	  a	  normal	  subgroup	  N	  of	  group	  G,	  then	  we	  can	  construct	  the	  quotient	  group,	  which	  is	  a	  subgroup	  Q	  that	  aggregates	  similar	  elements	  within	  a	  larger	  group	  G	  together	  given	  some	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equivalence	   relation.	   In	   other	   words,	   Q	   is	   a	   subgroup	   whose	   elements	   are	   equivalence	  classes	  and	  partitions	  of	  the	  group	  G.	  In	  the	  quotient	  of	  a	  group,	  the	  equivalence	  class	  of	  the	  identity	  element	  is	  the	  normal	  subgroup	  N,	  and	  all	  other	  equivalence	  classes	  are	  cosets	  of	  N.	  This	  idea	  can	  be	  concisely	  expressed	  as	  Q	  =	  G/N	  or	  G	  modulo	  N.	  Importantly,	   it	  can	  be	  proved	  that	  a	  quotient	  group	  is	  always	  a	  cyclic	  group.	  
Algebraic	  topology	  and	  homology	  
Algebraic	  topology	  draws	  from	  abstract	  algebra	  to	  study	  topological	  spaces.	  A	  topological	  space	   can	   be	   defined	   as	   a	   set	   of	   points	   coupled	   with	   the	   notion	   of	   neighborhoods	  surrounding	  these	  points.	  Given	  a	  set	  of	  points	  X,	  a	  neighborhood	  of	  point	  x  𝜖	  X	  is	  a	  subset	  of	   X	   that	   also	   contains	   x	   such	   that,	   intuitively,	   x	   can	   be	   moved	   without	   leaving	   the	  neighborhood.	  We	  define	  a	  subset	  U	  of	  X	  to	  be	  open	  if	  every	  point	  in	  U	  has	  a	  neighborhood	  in	  X	  also	  contained	  in	  U.	  X	  is	  then	  a	  topological	  space	  if:	  
1. The	  empty	  set	  and	  X	  are	  open	  2. The	  union	  of	  any	  combination	  of	  open	  sets	  is	  open	  3. The	  intersection	  of	  any	  finite	  number	  of	  open	  sets	  is	  open.	  	  
We	  can	   introduce	   ideas	  of	  algebraic	  structure	   to	   topological	  spaces	  X.	   Indeed,	   topological	  groups	  can	  be	  formed	  given	  a	  set	  of	  topological	  spaces	  X	  and	  a	  binary	  operation	  f	  and	  its	  inverse	   function,	   both	  of	  which	  are	   continuous.	  That	   is,	   f:	   X→Y	   is	   continuous	   if	   for	   every	  subset	  U	  of	  Y,	  f-­‐1(U)	  is	  an	  open	  subset	  of	  X.	  Analogous	  to	  isomorphisms	  in	  the	  group	  setting,	  we	  can	  define	  continuous	  isomorphisms	  between	  topological	  spaces.	  We	  call	  such	  mapping	  functions	   homeomorphisms.	   From	   a	   topological	   perspective,	   topological	   spaces	   that	   are	  homeomorphic	  are	  equivalent.	  Thus,	  a	  coffee	  mug	  and	  a	  donut	  are	  homeomorphic.	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For	   two	   topological	   spaces	   to	   be	   homeomorphic,	   the	   mapping	   function	   must	   preserve	  algebraic	   structure	   and,	   subsequently,	   topological	   features	   as	  well.	  Homology	   theory	   is	   a	  method	   that	   quantifies	   these	   features,	   particularly	   the	   number	   of	   irreducible	   cycles	   that	  exist	   in	   a	   topological	   space.	   These	   irreducible	   cycles	   at	   different	   dimensions	   provide	  information	  about	   the	  connectedness	   (zero	  dimension)	  and	   the	  holes	   (higher	  dimension)	  within	  the	  topological	  space.	  	  
In	  particular,	  given	  a	  topological	  space	  X,	  each	  homology	  group	  Hk(X)	   is	  an	  abelian	  group	  generated	  by	  the	  k-­‐dimensional	  holes	  in	  a	  topological	  space.	  The	  construction	  of	  homology	  groups	   can	   proceed	   by	   defining	   a	   chain	   complex:	   a	   sequence	   of	   homology	   groups	  associated	   with	   chain	   complexes	   C0,	   C1,	   C2,	   etc.	   connected	   by	   homomorphisms	   called	  boundary	  operators	  ∂n:	  Cn→Cn-­‐1:	  …	  !!!!  	  Cn	        !!      	  Cn-­‐1	  !!!!  	  …	        !!      	  Cn	        !!      	  Cn-­‐1	      !!      	  0	  
	  where	  0	  is	  the	  trivial	  group.	  It	  can	  also	  be	  shown	  that	  two	  consecutive	  ∂n∂n+1	  is	  trivial	  and	  equal	  to	  zero.	  We	  will	  elaborate	  on	  the	  construction	  of	  homology	  groups	  in	  the	  context	  of	  simplicial	  complexes.	  
The	  Betti	  number	  bk	  is	  the	  rank	  of	  the	  homology	  group	  Hk(X).	  Specifically	  the	  Betti	  number	  of	   dimension	   k	   is	   the	   number	   of	   irreducible	   k-­‐dimensional	   cycles.	   b0	   is	   the	   number	   of	  unconnected	  components	  or	  clusters,	  b1	  is	  the	  number	  of	  one-­‐dimensional	  loops/holes,	  b2	  is	  the	  number	  of	  voids/cavities,	  etc.	  	  	  
Simplicial	  homology	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Suppose	   we	   want	   to	   estimate	   the	   topological	   space	   M.	   However,	   instead	   of	   the	   true	  topological	   space,	   we	   observe	   a	   sample	   of	   data	   points	   Sn	   =	   𝑋!,… ,𝑋! 	  within	   M.	   The	  topological	  spaces	  of	  Sn	  and	  M	  are	  not	  homeomorphic	  and,	  therefore,	  their	  homologies	  are	  not	  equal.	  However,	  we	  can	  consider	  a	  set	  Sε  = 𝐵(𝑋! , ε)!!!! ,	  where	  B(x,ε)	  is	  a	  ball	  of	  radius	  ε	  centered	  at	  x,	  that	  shares	  the	  same	  homology	  as	  M	  for	  a	  range	  of	  ε	  (Figure	  25).	  Computing	  the	   homology	   of	   Sε	   is	   difficult	   but	   can	   be	   approximated	   through	   the	   construction	   of	   a	  special	   type	   of	   typological	   space	   called	   the	   simplicial	   complex	   K.	   K	   is	   a	   set	   of	   simplices,	  where	  a	  0-­‐simplex	  is	  a	  point,	  a	  1-­‐simplex	  is	  a	  line,	  a	  2-­‐simplex	  is	  a	  triangle	  with	  a	  filled-­‐in	  face,	   a	   3-­‐simplex	   is	   a	   tetrahedron	  with	   a	   	   filled-­‐in	   interior,	   etc.	   Two	   conditions	  must	   be	  satisfied	  for	  simplicial	  complex	  K:	  
1. Any	  face	  of	  a	  simplex	  in	  K	  is	  also	  in	  K	  2. The	  intersection	  of	  any	  two	  simplices	  σ1,	  σ2	  𝜖	  K	  is	  a	  face	  of	  both	  σ1	  and	  σ2.	  	  One	  way	  of	  constructing	  K	  given	  a	  point	  cloud	  of	  data	  Sn	  is	  to	  build	  a	  Vietoris-­‐Rips	  complex	  V(Sn,	   ε),	   in	  which	   a	   simplex	   σ	   is	   included	   if	   each	   pair	   of	   vertices	   in	   σ	   is	   no	  more	   than	   a	  filtration	   distance	   ε	   apart.	   The	   series	   of	   Vietoris-­‐Rips	   complexes	   created	   by	   gradually	  increasing	  ε	  is	  a	  sequence	  of	  inclusions	  called	  a	  filtration,	  where	  K1 	  K2 … Kn.	  	  We	   can	   employ	   simplicial	   homology	   using	  ℤ2	   coefficients	   (0	   and	   1)	   to	   analyze	   the	  homology	   of	   a	   Vietoris-­‐Rips	   complex	   K	   built	   from	   a	   finite	   set	   of	   points	   S.	  We	   define	   the	  simplicial	   k-­‐chain	  Ck	   to	  be	   a	   linear	   combination	  of	   k-­‐simplices.	  With	  ℤ2	   coefficients,	   Ck	   =	  𝑎!𝜎!! 	  in	   dimension	   k,	   where	  𝑗  𝜖   0,1 	  with	   the	   addition	   modulo	   2	   operator.	   So,	   the	  addition	  of	  two	  different	  k-­‐chains	  C1	  and	  C2	  is	  the	  set	  difference	  of	  the	  two	  k-­‐chains.	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Let	  σ	  be	  a	  simplex	  comprised	  of	  vertices	   𝑥!,… , 𝑥! .	  The	  boundary	  of	  σ	  can	  be	  defined	  as	  ∂k(σ)= σ(!!)!!!! ,	  where	  ∂	   is	   the	  boundary	  operator	  and	  σ !! 	  is	   the	  simplex	  derived	   from	  removing	  vertex	  xi.	  The	  boundary	  of	  a	  k-­‐chain	  is	  a	  (k-­‐1)-­‐chain	  that	  is	  the	  linear	  combination	  of	   boundaries	   of	   the	   simplices	  within	   the	   k-­‐chain,	   expressed	   as	   ∂k(Ck)= 𝑎! ∂!σ!! .	   From	  these	   definitions,	  we	   can	   also	   confirm	   that	   two	   consecutive	   ∂k∂k+1	   is	   trivial	   and	   equal	   to	  zero.	  	  
	  
Supplementary	  Table	  E-­‐2.	  Homology	  group	  construction.	  Groups	  Cp,	  Zp,	  and	  Bp	  are	  related	  by	  a	  mapping	  function,	  the	  
boundary	  operator	  ∂p.	  The	  homology	  group	  of	  	  Hp	  associated	  with	  the	  chain	  complex	  Cp	  is	  equivalent	  to	  the	  
quotient	  group	  Zp/Bp.	  Figure	  taken	  from	  Balakrishnan,	  et	  al.144	  A	   k-­‐chain	   Ck	   is	   a	   cycle	   if	   its	   boundary	   ∂k(Ck)	   =	   0.	   Zk	   denotes	   the	   set	   of	   all	   cycles	   C	   in	  dimension	  k	  and	  can	  be	  equivalently	  defined	  as	  Zk	  =	  ker(∂n).	  Some	  elements	  of	  Zk	  are	  called	  boundary	   cycles	   if	   they	   serve	   as	   boundaries	   of	   (k+1)-­‐chains.	   Such	   elements	   form	   a	  subgroup	  of	  Zk,	  represented	  by	  Bk,	  which	  can	  be	  thought	  of	  as	  the	  image	  of	  ∂n+1.	  Finally,	  we	  can	  define	  the	  homology	  group	  of	  the	  simplicial	  complex	  K	  as	  the	  quotient	  group	  Hk(K)	  =	  Zk/Bk	   (Supplementary	   Table	   E-­‐2).	   Identically,	   Hk	   is	   the	   cyclic	   group	   generated	   by	   the	  equivalence	  classes	  of	  Zk.	  Two	  cycles	  are	  considered	  to	  be	  in	  the	  same	  equivalence	  class	  if	  they	  differ	  only	  by	  the	  addition	  of	  boundary	  cycles.	  Moreover,	  the	  identity	  element	  of	  the	  homology	   group	   is	   the	   equivalence	   class	   of	   trivial	   cycles	   [Bk]	   =	   [0].	   The	  Betti	   number	   of	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dimension	  k	  is,	  again,	  the	  rank	  of	  the	  homology	  group	  and	  is	  then	  a	  count	  of	  irreducible	  k-­‐dimensional	  cycles:	  the	  number	  of	  non-­‐trivial	  equivalence	  classes	  in	  Zk.	  	  	  
Persistent	  homology	  
Recall	   the	   notion	   of	   filtrations,	   a	   sequence	   of	   simplicial	   complex	   inclusions	   created	   by	  gradually	   increasing	   a	   filtration	   distance	   ε.	   Persistent	   homology	   computes	   the	   homology	  groups	  and	  Betti	  numbers	  associated	  to	  each	  simplicial	  complex	  within	  the	  filtration	  over	  the	  entire	  parameter	  space	  ε220.	  As	  ε	  increases,	  non-­‐trivial	  topological	  features	  appear	  and	  disappear.	   The	   interval	   of	   ε	   over	  which	   the	   equivalence	   class	   of	   the	   feature	   exists	   is	   the	  persistence,	  bounded	  by	  values	  of	  ε	  representing	  the	  birth	  and	  the	  death	  of	  the	  irreducible	  cycle.	  These	  non-­‐trivial	  features	  for	  each	  dimension	  can	  be	  represented	  in	  a	  barcode	  plot,	  in	   which	   each	   bar	   denotes	   an	   irreducible	   cycle	   that	   is	   drawn	   between	   the	   values	   of	   ε	  corresponding	   to	   its	   birth	   and	   death.	   Equivalently,	   each	   bar	   of	   a	   barcode	   plot	   can	   be	  represented	  as	  a	  point	  (x,y)	  in	  a	  coordinate	  system	  known	  as	  a	  persistence	  diagram,	  where	  x	  and	  y	  represent	  the	  birth	  and	  death	  of	  the	  irreducible	  cycle,	  respectively.	  Points	  that	  are	  close	   to	   the	  diagonal	  Y=X	  corresond	   to	   short-­‐lived	  bars.	  Persistent	  or	   long-­‐lived	  bars	  are	  represented	  by	  points	  far	  from	  the	  diagonal144.	  
	  
Persistent	  homology	  of	  additive	  and	  reticulate	  trees	  
Evolutionary	   study	   has	   classically	   been	   described	   according	   to	   the	   tree	   paradigm.	  Mathematically,	   a	   tree	   is	   an	   undirected	   acyclic	   graph.	   Many	   methods	   of	   phylogenetic	  construction	  depend	  on	  creating	  a	  matrix	  of	  genetic	  distances	  between	  pairs	  of	  sequences.	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The	   most	   general	   form	   of	   distance-­‐based	   trees	   is	   the	   additive	   tree,	   which	   for	   any	   four	  nodes	   x,	   y,	   u,	   and	   v	   in	   the	   tree	   must	   obey	   the	   four-­‐point	   condition:	  𝑑 𝑥,𝑦 + 𝑑 𝑢, 𝑣 ≤𝑚𝑎𝑥 𝑑 𝑥,𝑢 + 𝑑 𝑦, 𝑣 ,𝑑 𝑥, 𝑣 + 𝑑(𝑦,𝑢) .	  
In	   general,	   additive	   trees	   adequately	   describe	   vertical	   evolution	   governed	   strictly	   by	   the	  mutation	  rate	  across	  multiple	  generations.	  In	  the	  presence	  of	  horizontal	  evolution	  in	  which	  large	  segments	  of	  genomic	  material	  are	  exchanged	  across	  different	  clades	  or	  lineages,	  two	  branches	  of	   the	  additive	  tree	  are	  merged	  together	  to	  create	  a	  “reticulate	  tree,”	  which	   is	  a	  misnomer,	  as	  this	  structure	  is	  a	  graph	  and	  ceases	  to	  be	  a	  tree	  in	  the	  mathematical	  sense	  at	  all.	  	  
Instead	  of	  considering	  additive	  and	  reticulate	  trees	  in	  the	  phylogenetic	  sense,	  we	  consider	  these	   structures	   in	   the	   context	   of	   simplicial	   complexes.	   This	   perspective	   allows	   us	   to	  compute	   their	   persistent	   homology.	   An	   additive	   tree	   is	   a	   single	   connected	   component	  without	  any	   loops	  and	  displays	  only	  zero-­‐dimensional	   topology.	  Reticulate	   structures,	  on	  the	   other	   hand,	   contain	   loops	   and	   therefore	   contain	   non-­‐trivial	   higher-­‐dimensional	  topology.	  The	  greater	  the	  simplicial	  complex	  deviates	  from	  an	  additive	  tree	  structure,	  the	  higher	   the	  higher-­‐dimensional	  Betti	  number	  bi>0.	   Indeed,	  we	   can	  prove	   that	   for	   any	  non-­‐zero	  bi>0,	  the	  simplicial	  complex	  cannot	  be	  an	  additive	  tree.	  	  At	  different	  filtrations	  ε,	  simplicial	  complexes	  are	  created	  that	  may	  or	  may	  not	  possess	  an	  additive	   tree	   structure.	   Therefore,	   their	   homology	   changes	   at	   different	   ε.	   This	   persistent	  homology	  can	  be	  displayed	  in	  a	  barcode	  plot	  where	  for	  a	  given	  filtration	  and	  dimension	  k,	  different	   bars	   represent	   different	   k-­‐dimensional	   irreducible	   cycles.	   In	   the	   same	  way	   that	  bi>0	  serves	  as	  a	  measure	  of	  deviation	  from	  tree	  additivity,	  it	  would	  be	  useful	  to	  have	  some	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quantity	   that	   indicates	   how	   much	   a	   filtration	   of	   simplicial	   complexes	   deviates	   from	  additivity.	  One	  possibility	  is	  to	  consider	  the	  distribution	  B	  of	  bar	  lengths	  of	  k-­‐dimensional	  cycles	  for	  some	  k>0.	  	  One	  measure	  of	  deviation	  of	  additivity	  then	  could	  be	  an	  L-­‐norm	  of	  B.	  We	   define	   the	   topological	   obstruction	   to	   phylogeny	   (TOP)	   to	   be	   the	   L-­‐∞	   norm,	   or	  maximum,	  of	  B.	  We	  prove	  that	  a	  filtration	  of	  non-­‐zero	  TOP	  implies	  non-­‐additivity	  for	  some	  ε.	  	  
Another	  possible	  measure	   is	   the	  L-­‐1	  norm,	  which	   is	  equivalent	   to	  the	  summation	  of	  B.	   In	  simulations	  of	  evolutionary	  data	  where	  we	  initially	  set	  a	  rate	  r	  of	  horizontal	  evolution,	  we	  find	  that	  of	  all	  L-­‐norms,	  the	  L-­‐1	  norm	  is	  most	  proportional	  to	  r.	  We	  can	  also	  consider	  the	  L-­‐0	   norm,	   simply	   the	   number	   of	   irreducible	   cycles,	   which	   is	   also	   proportional	   to	   r.	   To	  approximate	  r,	  we	  consider	  either	  the	  L-­‐1	  or	  L-­‐0	  norm	  normalized	  by	  time.	  We	  define	  this	  quantity	  to	  be	  the	  irreducible	  cycle	  rate	  (ICR).	  	  
	  
Stability	  of	  persistent	  homology	  metrics	  
Statistical	   stability	   alludes	   to	   how	  much	   one	   can	   trust	   results	   of	   an	   analysis	   given	   small	  perturbations	  arising	  in	  the	  input	  dataset.	  In	  the	  setting	  of	  genetic	  analysis,	  such	  noise	  can	  derive	   from	  sequencing	  or	  alignment	  errors.	  Consider	   two	  persistence	  diagrams	  A	  and	  B	  based	  on	  the	  same	  input	  data	  but	  differing	  with	  respect	  to	  some	  noise.	  We	  can	  claim	  that	  there	  is	  statistical	  stability	  if	  the	  difference	  between	  A	  and	  B	  is	  bounded	  by	  some	  quantity.	  One	   commonly	   used	   distance	   metric	   between	   persistence	   diagrams	   is	   the	   bottleneck	  distance.	  This	  metric	  depends	  on	  some	  optimal,	  unique	  pairwise	  matching	  between	  points	  in	  A	  and	  points	  in	  B.	  In	  cases	  where	  A	  and	  B	  have	  unequal	  points	  or	  are	  very	  different,	  we	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allow	  points	  to	  be	  paired	  with	  their	  orthogonal	  projection	  onto	  the	  diagonal	  Y=X.	  For	  each	  matched	  pair	  of	  points	  a	  and	  b	  in	  persistence	  diagrams	  A	  and	  B,	  let	  the	  distance	  between	  a	  and	  b	  to	  be	  the	  L-­‐∞	  distance	  𝑑! 𝑎, 𝑏 =   𝑚𝑎𝑥 𝑎! − 𝑏! , 𝑎! − 𝑏!    ,	  where	  ax,	  bx	  and	  ay,	  by	  are	  respectively	  the	  births	  and	  deaths	  of	  irreducible	  cycles	  a	  and	  b.	  The	  bottleneck	  cost	  of	  a	  given	   matching	   is	   then	   the	   maximum	  𝑑! 𝑎, 𝑏 	  for	   some	   a	   and	   b.	   Finally,	   the	   bottleneck	  distance	   is	   then	   the	  minimum	   bottleneck	   cost	   for	   all	   possible	  matchings	   between	   A	   and	  B221.	  Assuming	  we	  can	  assign	  a	  finite	  metric	  space	  to	  each	  barcode	  plot	  A	  and	  B,	  Chazal,	  et	  al.	   prove	   that	   the	   bottleneck	   distance	   between	   A	   and	   B	   is	   bounded	   by	   the	   Gromov-­‐Hausdorff	   distance	   between	   finite	   metric	   spaces	   embedded	   in	   A	   and	   B222.	   In	   short,	   the	  Gromov-­‐Hausdorff	  distance	  is,	  for	  all	  compact	  metric	  spaces,	  the	  infimum	  of	  the	  Hausdorff	  distance:	   the	   longest	   distance	   from	  a	   point	   in	   one	   set	   to	   the	   closest	   point	   in	   another	   set	  within	  a	  metric	  space.	  	  
As	  mentioned	  previously,	  we	  consider	  the	  L-­‐∞	  norm	  of	  bar	  lengths,	  TOP,	  to	  be	  a	  measure	  of	  deviation	   from	   additivity,	   where	   no	   higher-­‐dimensional	   irreducible	   cycles	   are	   produced.	  We	   can	   frame	   the	   notion	   of	   non-­‐additivity	   in	   the	   context	   of	   comparing	   non-­‐trivial	  persistence	   diagram	  A	   and	   a	   persistence	   diagram	  B	   representing	   an	   additive	   tree	  where	  there	  are	  no	  plotted	  points,	  only	  a	  diagonal	  where	  the	  birth	  equals	  the	  death.	  Each	  point	  (ax,	  ay)	   in	   A	   must	   then	   be	   optimally	   matched	   to	   its	   orthogonal	   projection	   (bx,	   by)	   on	   the	  diagonal.	  With	  simple	  algebra,	  we	  find	  that	  bx	  =	  by	  =	  (ax	  +	  ay)/2.	  The	  L-­‐∞	  distance	  between	  a	  and	  b	  is	  then:	  
𝑑! 𝑎, 𝑏 =   𝑚𝑎𝑥 𝑎! − 𝑏! , 𝑎! − 𝑏!    = (𝑎! − 𝑎!)/2	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The	  bottleneck	  distance	  is	  then	  the	  maximum	  𝑑! 𝑎, 𝑏 	  which	  is	  equivalent	  to	  TOP/2.	  TOP	  is	  bounded	  by	  two	  times	  the	  Gromov-­‐Hausdorff	  distance.	  Thus,	  TOP	  is	  a	  statistically	  stable	  measure	  of	  deviation	  from	  additivity.	  	  
	  
Geometric	  interpretation	  of	  the	  space	  of	  trees	  and	  simplicial	  complexes	  
Billera,	   et	   al.223	   first	   proposed	   a	   geometric	   interpretation	   of	   a	   metric	   space	   of	   trees,	   in	  which	   each	   point	   represents	   an	   unrooted	   binary	   tree	  with	   L	   leaves	   and	   positive	   branch	  lengths.	  Given	  that	   the	  number	  of	   interior	  edges	  r	  =	  L-­‐3,	  a	  particular	  additive	  tree	  can	  be	  plotted	  as	  point	  in	  a	  positive	  open	  orthant	  (0,	  ∞)r	  according	  to	  the	  vector	  of	  interior	  edge	  lengths	  (l1,…,lr).	  One	  can	  traverse	  this	  orthant	  by	  varying	  the	  branch	  lengths	  of	  the	  tree.	  A	  single	  orthant	  corresponds	  to	  a	  single	  tree	  topology.	  However,	  multiple	  tree	  topologies	  and	  therefore	  multiple	   orthants	   can	   exist.	   In	   particular,	   the	   number	   of	   different	   binary	   trees	  with	  L	  leaves	  is	  (2*L-­‐3)!!	  The	  multiple	  orthants	  are	  joined	  at	  boundaries	  at	  which	  at	  least	  one	  coordinate	  equals	  zero.	  In	  other	  words,	  one	  can	  switch	  between	  orthants	  representing	  different	  tree	  topologies	  by	  shrinking	  an	  interior	  branch	  length	  to	  zero.	  When	  the	  interior	  edge	  reaches	  zero,	  degeneracy	  occurs.	  	  
The	  space	  of	  trees	  described	  by	  gluing	  together	  (2*L-­‐3)!!	  orthants	  is	  embedded	  in	  a	  higher-­‐dimensional	   metric	   space	   of	   non-­‐additive	   trees	   and	   simplicial	   complexes	   of	   non-­‐trivial	  higher-­‐dimensional	  homology.	  Non-­‐additive	  trees	  lie	  close	  to	  the	  domain	  of	  additive	  trees,	  while	   simplicial	   complexes	   with	   irreducible	   cycles	   lie	   further	   away.	   Within	   this	   metric	  space,	  we	  can	  describe	  two	  domains	  in	  which	  TOP	  is	  zero	  and	  non-­‐zero.	  The	  domain	  of	  zero	  TOP	  contains	  all	  additive	   trees.	  All	   structures	  within	   the	  domain	  of	  non-­‐zero	  TOP	  cannot	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contain	   additive	   trees.	   Furthermore,	   the	   domain	   where	   TOP	   is	   0	   is	   a	   subspace	   of	   the	  domain	  in	  which	  the	  Gromov-­‐Hausdorff	  distance	  is	  zero	  (Supplementary	  Table	  E-­‐3).	  	  
	  
	  
Supplementary	  Table	  E-­‐3.	  The	  geometric	  space	  of	  trees	  and	  simplicial	  complexes.	  For	  L	  leaves	  or	  genetic	  sequences,	  
the	  dimension	  of	  the	  space	  of	  all	  simplicial	  complexes	  is	  the	  number	  of	  possible	  branches	  between	  sequences	  D	  =	  
L	  choose	  2.	  Embedded	  within	   the	  space	  of	  simplicial	  complexes	   is	   the	  space	  of	  additive	   trees	  of	  dimension	  T	  =	  
(2*L-­‐5)!!.	   The	  metric	   space	   can	   be	   traversed	   by	   shrinking	   or	   enlarging	   different	   branches	   within	   the	   tree	   or	  
simplicial	  complex.	  	  
	  
	  
	  	   220	  
Appendix	  F.	  Methods	  for	  
“Transforming	  Fusions	  of	  FGFR	  
and	  TACC	  Genes	  in	  Human	  
Glioblastoma”	  
	  
Identification	   of	   gene	   fusions	   from	   whole	   transcriptome	   (RNA-­‐seq)	   and	   exome	  
sequencing	  
RNA-­‐Sequencing	  was	  performed	  from	  total	  RNA	  extracted	  from	  GSC	  cultures	  isolated	  from	  nine	  GBM	  patients	  using	  Illumina	  HiSeq	  2000,	  producing	  roughly	  60.3	  million	  paired	  reads	  per	  sample.	  Using	  the	  global	  alignment	  software	  Burrows-­‐Wheeler	  Aligner	  (BWA)	  224	  with	  modified	  Mott’s	   trimming,	  an	   initial	   seed	   length	  of	  32,	  maximum	  edit	  distance	  of	  2	  and	  a	  maximum	  gap	  number	  of	  1,	   on	   average	  43.1	  million	   reads	  were	  mapped	  properly	   to	   the	  RefSeq	  transcriptome	  and,	  of	  the	  remaining,	  8.6	  million	  were	  mapped	  to	  the	  hg19	  genome	  per	   sample.	   We	   considered	   the	   remaining	   14.3%	   of	   paired	   reads—including	   those	   that	  failed	   to	   map	   to	   either	   transcriptome	   or	   genome	   with	   proper	   forward-­‐reverse	   (F-­‐R)	  orientation,	   within	   expected	   insert	   size,	   and	   with	   minimal	   soft	   clipping	   (unmapped	  portions	  at	  the	  ends	  of	  a	  read)—to	  be	  appropriate	  for	  gene	  fusion	  analysis.	  
We	  constructed	  a	  novel	  computational	  pipeline	  called	  TX-­‐Fuse	  that	  identifies	  two	  sources	  of	  evidence	  for	  the	  presence	  of	  a	  gene	  fusion:	  1.	  Split	  inserts,	  in	  which	  each	  read	  of	  a	  mate	  pair	  maps	   entirely	   to	   one	   side	   of	   a	   breakpoint,	   and	   2.	   Individual	   split	   reads	   that	   span	   a	  breakpoint.	  Split	  inserts	  are	  readily	  detected	  from	  BWA	  mapping.	  On	  the	  other	  hand,	  split	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reads	   demand	   precision	   alignment	   of	   smaller	   nucleotide	   stretches.	   To	   that	   end,	   our	  pipeline	  employs	  the	  local	  alignment	  package	  BLAST	  with	  word	  size	  of	  20,	  identity	  cutoff	  of	  95%,	   expectation	   cutoff	   of	   10-­‐4,	   and	   soft	   filtering	   to	   map	   raw	   paired	   reads	   against	   the	  RefSeq	  transcriptome.	  From	  this	  procedure,	  we	  obtained	  a	  list	  of	  potential	  split	  reads	  that	  were	   filtered	   to	   ensure	   maintenance	   of	   coding	   frame	   in	   the	   predicted	   fusion	   transcript	  given	   the	   proper	   F-­‐R	   orientation	   in	   the	   read	   pair.	   We	   also	   screened	   out	   false	   positive	  candidates	  produced	  from	  paralogous	  gene	  pairs	  using	  the	  Duplicated	  Genes	  Database	  and	  the	   EnsemblCompara	   GeneTrees	   225.	   Pseudogenes	   in	   the	   candidate	   list	   were	   annotated	  using	   the	   list	   from	  HUGO	  Gene	  Nomenclature	  Committee	   (HGNC)	  database	   226	   and	   given	  lower	  priority.	   For	   each	   remaining	   gene	   fusion	   candidate,	  we	   created	   a	   virtual	   reference	  based	  on	  the	  predicted	  fusion	  transcript	  and	  re-­‐mapped	  all	  unmapped	  reads	  using	  BLAST	  with	   word	   size	   of	   16,	   identity	   cutoff	   of	   85%,	   query	   coverage	   greater	   than	   85%,	   and	  expectation	   cutoff	   of	   10-­‐4	   to	   obtain	   a	   final	   count	   of	   split	   reads	   and	   inserts.	   Moreover,	  sequencing	   depth	   per	   base	   of	   the	   virtual	   reference	   was	   calculated	   to	   corroborate	   that	  components	  of	  each	  gene	  participating	  in	  the	  gene	  fusion	  were	  highly	  expressed.	  
To	  establish	  the	  recurrence	  of	  our	  initial	  panel	  of	  gene	  fusion	  candidates,	  we	  modified	  our	  gene	  fusion	  discovery	  pipeline	  to	  produce	  EXome-­‐Fuse,	  which	  probes	  for	  fusions	  within	  the	  available	  dataset	  of	  paired-­‐read	  exome	  DNA	  sequencing	  of	  336	  matched	  GBM	  samples	  from	  TCGA.	  To	  increase	  sensitivity	  for	  gene	  fusion	  identification,	  we	  aligned	  reads	  unmapped	  by	  BWA	  to	  the	  gene	  pair	  participating	  in	  each	  fusion	  candidate	  using	  a	  BLAST	  word	  size	  of	  24	  for	  split	   inserts	  and	  16	  for	  split	  read	  and	  split	   insert	  discovery.	  Given	  that	  the	  breakpoint	  detected	  in	  DNA	  cannot	  directly	  indicate	  the	  resulting	  breakpoint	  in	  the	  transcribed	  RNA,	  we	  could	  not	  ensure	   fusion	  candidates	   to	  maintain	   coding	   frame.	  Moreover,	  we	  made	  no	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restriction	  on	  split	  insert	  orientation.	  For	  split	  reads,	  we	  only	  required	  that	  the	  component	  of	  the	  split	  read	  mapped	  to	  the	  same	  gene	  as	  its	  mate	  maintained	  F-­‐R	  directionality.	  
	  
Co-­‐outlier	  expression	  and	  CNV	  analysis	  from	  Atlas-­‐TCGA	  GBM	  samples	  
Tomlins	  et	  al.	  227	  reported	  that	  outlier	  gene	  expression	  from	  microarray	  datasets	  identifies	  candidate	   oncogenic	   gene	   fusions.	  Wang	   et	   al.	   228	   suggested	   a	   “breakpoint	   principle”	   for	  intragenic	   copy	   number	   aberrations	   in	   fusion	   partners.	  We	   combined	   the	   two	  principles	  (outlier	  expression	  and	  intragenic	  CNV)	  to	  identify	  candidate	  gene	  fusions	  in	  GBM	  samples	  from	  Atlas-­‐TCGA.	  Genomic	  and	  expression	  data	   sets	  were	  downloaded	   from	  TCGA	  public	  data	   portal	   as	   available	   on	   December	   1,	   2011,	   where	   a	   description	   of	   TCGA	   data	   types,	  platforms,	  and	  analyses	  is	  also	  available	  229.	  Specific	  data	  sources	  were	  (according	  to	  Data	  Levels	  and	  Data	  Types)	  as	  follows:	  Expression	  data,	  “Level	  2”	  normalized	  signals	  per	  probe	  set	   (Affymetrix	  HT_HG-­‐U133A)	  of	  526	   samples;	  Copy	  number	  data,	   “Level	  1”	   raw	  signals	  per	  probe	  (Affymetrix	  Genome-­‐Wide	  Human	  SNP	  Array	  6.0)	  of	  1070	  samples	  (tumor	  and	  matched	  normal	  control).	  
The	   gene	   expression	   analysis	  was	   performed	   first	   using	  R	   230.	  We	   calculated	   the	  median	  absolute	   deviation	   (MAD)	   and	   then	   we	   labeled	   a	   gene	   as	   an	   outlier	   according	   to	   the	  following	  formula:	  Zi,j	  =	  0.6745(xi,j	  –	  mean(xi)	  )/MADi	  >	  3.5	  231.	  Samples	  were	  identified	  as	  ECFS	   (expression	   candidate	   fusion	   sample)	   if	   both	   genes	   of	   interest	   (e.	   g.	   FGFR3	   and	  TACC3)	  displayed	  outlier	  behavior	   (co-­‐outliers).	  Next,	  ECFS	  were	  analyzed	   for	  CNV	  using	  PennCNV	  232.	  Tumors	  samples	  were	  paired	  to	  their	  normal	  controls	  to	  obtain	  the	  log	  ratio	  values	   and	   the	   VEGA	   algorithm	  was	   used	   to	   obtain	   a	  more	   accurate	   segmentation	   233.	   If	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genomic	   aberrations	   are	   revealed,	   the	   samples	   are	   identified	   as	   GECFS	   (genomic	   and	  expression	   candidate	   fusion	   sample).	   The	   GBM	   samples	   TCGA-­‐27-­‐1835,	   TCGA-­‐19-­‐5958,	  TCGA-­‐06-­‐6390,	  TCGA-­‐12-­‐0826	  were	  identified	  as	  GECFS	  for	  FGFR3-­‐TACC3.	  
Cell	  culture	  and	  isolation	  and	  culture	  of	  GSCs	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Karyotyping	  
Cultured	   cells	   were	   treated	  with	   0.02	   μg/ml	   colcemid	   for	   90	  minutes	   at	   37°C.	   The	   cells	  were	   then	   trypsinized,	   centrifuged	   for	   7	   minutes	   at	   200	   x	   g,	   and	   the	   cell	   pellet	   re-­‐suspended	   in	   warmed	   hypotonic	   solution	   and	   incubated	   at	   37°C	   for	   13	   minutes.	   The	  swollen	  cells	  were	  then	  centrifuged	  and	  the	  pellet	  re-­‐suspended	  in	  8	  ml	  of	  Carnoy’s	  fixative	  (3:1	  methanol:glacial	  acetic	  acid).	  The	  cell	  suspension	  was	  centrifuged	  and	  washed	  twice	  in	  Carnoy’s	  fixative.	  After	  the	  last	  centrifugation,	  the	  cells	  were	  resuspended	  in	  0.5	  to	  1	  ml	  of	  freshly	  prepared	   fixative	   to	  produce	  an	  opalescent	  cell	   suspension.	  Drops	  of	   the	   final	  cell	  suspension	  were	  placed	  on	  clean	  slides	  and	  air-­‐dried.	  Slides	  were	  stained	  with	  DAPI	  and	  metaphases	  were	  analyzed	  under	  a	  fluorescent	  microscope.	  At	  least	  100	  cells	  in	  metaphase	  were	  examined	  for	  chromosome	  count.	  PMSCS	  was	  scored	  in	  cells	  where	  a	  majority	  of	  the	  sister	   chromosomes	  were	  no	   longer	  associated.	  Two-­‐tailed	  unpaired	   t-­‐tests	  with	  Welch's	  correction	  were	  performed	  for	  comparison	  of	  means	  analysis.	  
Genomic	  and	  mRNA	  RT-­‐PCR	  
Total	   RNA	   was	   extracted	   from	   cells	   by	   using	   RNeasy	   Mini	   Kit	   (QIAGEN),	   following	   the	  manufacturer	   instructions.	   500	   ng	   of	   total	   RNA	   was	   retro-­‐transcribed	   by	   using	   the	  Superscript	   III	   kit	   (Invitrogen),	   following	   the	   manufacturer	   instructions.	   The	   cDNAs	  obtained	  after	  the	  retro-­‐transcription	  was	  used	  as	  templates	  for	  qPCR	  as	  described	  234,235.	  The	  reaction	  was	  performed	  with	  a	  Roche480	  thermal	  cycler,	  using	  the	  Absolute	  Blue	  QPCR	  SYBR	   Green	   Mix	   from	   Thermo	   Scientific.	   The	   relative	   amount	   of	   specific	   mRNA	   was	  normalized	  to	  18S.	  Results	  are	  presented	  as	  the	  mean±SD	  of	  triplicate	  amplifications.	  The	  validation	   of	   fusion	   transcripts	   was	   performed	   using	   both	   genomic	   and	   RT-­‐PCR	   with	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Primers	  used	  for	  the	  screening	  of	  FGFR-­‐TACC	  fusions	  are:	  
FGFR3-­‐FW1:	  5’-­‐CGTGAAGATGCTGAAAGACGATG-­‐3’;	  
TACC3-­‐REV1:	  5’-­‐	  AAACGCTTGAAGAGGTCGGAG-­‐3’;	  
FGFR1-­‐FW1:	  5’-­‐ATGCTAGCAGGGGTCTCTGA-­‐3’;	  
TACC1-­‐REV1:	  5’-­‐CCCTTCCAGAACACCTTTCA-­‐3’;	  
Primers	  used	   for	   genomic	  detection	  of	   FGFR3-­‐TACC3	   fusion	   in	  GBM-­‐1123	  and	  GSC-­‐1123	  are:	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genomicFGFR3-­‐FW1:	   5’-­‐ATGATCATGCGGGAGTGC-­‐3’;	   genomicTACC3-­‐REV1:	   5’-­‐GGGGGTCGAACTTGAGGTAT-­‐3’;	  Primers	  used	  to	  validate	  fusions	  detected	  by	  RNA-­‐seq	  are:	  POLR2A-­‐FW1:	  5’-­‐CGCAGGCTTTTTGTAGTGAG-­‐3’;	  
WRAP53-­‐REV1:	  5’-­‐TGTAGGCGCGAAAGGAAG-­‐3’;	  PIGU-­‐FW1:	  5’-­‐GAACTCATCCGGACCCCTAT-­‐3’;	   NCOA6-­‐REV1:	   5’-­‐GCTTTCCCCATTGCACTTTA-­‐3’;	   ST8SIA4-­‐FW1:	   5’-­‐GAGGAGAGAAGCACGTGGAG-­‐3’;	  PAM-­‐REV1:	  5’-­‐GGCAGACGTGTGAGGTGTAA-­‐3’;	  CAPZB-­‐FW:	  5’-­‐GTGATCAGCAGCTGGACTGT-­‐3’;	  UBR4-­‐REV1:	  5’-­‐GAGCCTGGGCATGGATCT-­‐5’;	  
Cloning	  and	  Lentiviral	  production	  
Lentiviral	  expression	  vectors,	  pLOC-­‐GFP	  (Open	  Biosystems)	  and	  pTomo-­‐shp53,	  were	  used	  to	  clone	  FGFR3,	  TACC3,	  FGFR3-­‐TACC3,	  FGFR3-­‐TACC3-­‐K508M,	  and	  FGFR1-­‐TACC1.	  pTomo-­‐shp53	   was	   a	   gift	   of	   Inder	   Verma	   and	   Dinorah	   Friedman-­‐Morvinski	   (Salk	   Institute,	   San	  Diego).	   The	   FGFR3-­‐TACC3-­‐K508M	   mutant	   was	   generated	   using	   the	   Phusion	   Site	   Direct	  Mutagenesis	  kit	  (NEB,	  USA).	  MISSION	  shRNAs	  clones	  (pLKO.1	  lentiviral	  expression	  vectors)	  against	   FGFR3	  were	   purchased	   from	   Sigma.	   The	   hairpin	   sequences	   targeting	   the	   FGFR3	  gene	  are-­‐	  
5 ′ -­‐TGCGTCGTGGAGAACAAGTTT-­‐3 ′ 	   (#TRCN0000000372;	   Sh#2);	   5 ′ -­‐GTTCCACTGCAAGGTGTACAG-­‐3 ′ 	   (#TRCN0000430673;	   Sh#3);	   5 ′ -­‐GCACAACCTCGACTACTACAA-­‐3′	  (#TRCN0000000374;	  Sh#4).	  
Subcutaneous	  xenografts	  and	  drug	  treatment	  
Rat1A	   or	   Ink4A;Arf-­‐/-­‐	   astrocytes	   (5x105)	   transduced	  with	   different	   lentiviral	   constructs	  were	   suspended	   in	   150	   μl	   of	   PBS,	   together	  with	   30	   μl	   of	  Matrigel	   (BD	  Biosciences),	   and	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injected	   subcutaneously	   in	   the	   flank	   of	   athymic	   nude	   (Nu/Nu)	   mice	   (Charles	   River	  Laboratories,	   Wilmington,	   MA).	   For	   experiments	   with	   FGFR	   inhibitors,	   mice	   carrying	  ~200-­‐300	   mm3	   subcutaneous	   tumors	   derived	   from	   Ink4A;Arf-­‐/-­‐	   astrocytes	   were	  randomized	   to	   receive	   50	  mg/kg	   PD173074	   in	   0.05	  M	   lactate	   buffer	   (pH	   5)	   or	   an	   equal	  volume	   of	   lactate	   buffer	   by	   oral	   gavage.	   Treatment	   was	   administered	   for	   three	   cycles	  consisting	  of	   four	   consecutive	  days	   followed	  by	   two	  days	  of	   rest.	  Tumor	  diameters	  were	  measured	   with	   caliper,	   and	   tumor	   volumes	   estimated	   using	   the	   formula:	   0.5	   x	   length	   x	  width2.	  Data	  are	  expressed	  as	  mean±SE.	  Mice	  were	  sacrificed	  when	  tumors	  in	  the	  control	  group	  reached	  the	  maximal	  size	  allowed	  by	  the	  IACUC	  Committee	  at	  Columbia	  University.	  
Orthotopic	  transplantation	  and	  drug	  treatment	  
Ink4A;Arf-­‐/-­‐	   astrocytes	   carrying	   a	   luciferase	   expressing	   vector	   were	   transduced	   with	  FGFR3-­‐TACC3	  lentivitus.	  1x103	  cells	  in	  2	  μl	  of	  saline	  were	  injected	  in	  the	  caudate-­‐putamen	  of	  4-­‐6	  week	  old	  male	  athymic	  nude	  (Nu/Nu)	  mice	  using	  a	  stereotaxic	   frame	  (coordinates	  relative	   to	   bregma:	   0.5	   mm	   anterior;	   1.1	   mm	   lateral;	   3.0	   mm	   ventral)	   and	   a	   26	   gauge	  Hamilton	  syringe.	  Six	  days	  after	  injection,	  mice	  underwent	  bioluminescence	  imaging	  using	  a	   Xenogen	   CCD	   apparatus	   and	   were	   randomized	   to	   receive	   50	   mg/kg	   AZD4547	   in	   1%	  Tween	  80	  (treatment	  group)	  or	  DMSO	  in	  an	  equal	  volume	  of	  vehicle	  (control	  group)	  by	  oral	  gavage.	  AZD4547	  was	  administered	  daily	  for	  two	  cycles	  of	  10	  days	  with	  a	  two	  day	  interval.	  Mice	  were	  monitored	  daily	  and	  sacrificed	  when	  neurological	  symptoms	  appeared.	  Kaplan-­‐	  Meier	   survival	   curve	   was	   generated	   using	   the	   DNA	   Statview	   software	   package	  (AbacusConcepts,	   Berkeley,	   CA).	   Log-­‐rank	   analysis	   was	   performed	   on	   the	   Kaplan-­‐Meier	  survival	  curve	  to	  determine	  statistical	  significance.	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Intracranial	  injections	  of	  lentiviruses	  
Intracranial	   injection	   of	   FGFR3-­‐TACC3-­‐shp53,	   EGFRvIII-­‐shp53	   or	   shp53	   pTomo	  lentiviruses	  was	  performed	  in	  4	  week-­‐old	  C57BL/6J	  mice	  in	  accordance	  with	  guidelines	  of	  IACUC	   Committee.	   Briefly,	   1.8	   μl	   of	   purified	   lentiviral	   particles	   in	   PBS	   (1X109/ml)	  were	  injected	  into	  the	  dentate	  gyrus	  using	  a	  stereotaxic	  frame	  (coordinates	  relative	  to	  bregma:	  1.45	  mm	  posterior;	   1.65	  mm	   lateral;	   2.4	  mm	   ventral)	   and	   a	   26	   gauge	  Hamilton	   syringe.	  Mice	  were	  monitored	  daily	  and	  sacrificed	  when	  neurological	   symptoms	  appeared.	  Mouse	  brain	  was	  analyzed	  histopathologically	  and	  by	  immunofluorescence.	  
Histology	  and	  immunostaining	  





survival curve to determine statistical significance.  
 
Intracranial injections of lentiviruses  
Intracranial injection of FGFR3-TACC3-shp53, EGFRvIII-shp53 or shp53 pTomo 
lentiviruses was performed in 4 week-old C57BL/6J mice in accordance with guidelines of 
IACUC Committee. Briefly, 1.8 µl of purified lentiviral particles in PBS (1X109/ml) were 
injected into the dentate gyrus using a stereotaxic frame (coordinates relative to bregma: 
1.45 mm posterior; 1.65 mm lateral; 2.4 mm ventral) and a 26 gauge Hamilton syringe. 
Mice were monitored daily and sacrificed when neurological symptoms appeared. Mouse 
brain was analyzed histopathologically and by immunofluorescence. 
 
Histology and immunostaining 
Tissue preparation and immunohistochemistry on brain tumors and immunofluorescence 
staining were performed as previously described (11-13). Antibodies and concentrations used 
in immunofluorescence staining are: 
Anti-Ki67 Rabbit 1:1000 Vector Labs 
Anti-pHH3 Rabbit 1:500 Millipore 
Anti-FGFR3 Mouse 1:1000 Santa Cruz 
Anti-TACC3 Goat 1:1000 USBiological 
Anti-α-tubulin Mouse 1:1000 Sigma 
Anti-Nestin Mouse 1:1000 BD Pharmingen 
Anti-Olig2 Rabbit 1:200 IBL 
Anti-GFAP Rabbit 1:200 Dako  
Anti-ERK Rabbit 1:1000 Cell Signaling 
Anti-pERK Rabbit 1:1000 Cell Signaling 
Anti-FRS Rabbit 1:250 Santa Cruz 
Anti-pFRS Rabbit 1:1000 Cell Signaling 
Anti-AKT Rabbit 1:1000 Cell Signaling 
Anti-pAKT473  Rabbit 1:1000 Cell Signaling 
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Immunofluorescence	  and	  live-­‐cell	  microscopy.	  
Immunofluorescence	  microscopy	  was	  performed	  on	  cells	  fixed	  with	  4%	  para-­‐formaldehyde	  (PFA)	   in	  PHEM	  (60	  mM	  PIPES,	  27	  mM	  HEPES,	  10	  mM	  EGTA,	  4	  mM	  MgSO4,	  pH	  7.0).	  Cells	  were	   permeabilized	   using	   1%	   Triton	   X	   100.	   Mitotic	   spindles	   were	   visualized	   by	   anti-­‐α-­‐	  tubulin	   antibodies	   (Sigma).	   Secondary	   antibodies	   conjugated	   to	   Alexa	   Fluor-­‐488/-­‐594	  (Molecular	  Probes)	  were	  used.	  All	   staining	  with	  multiple	  antibodies	  were	  performed	   in	  a	  sequential	   manner.	   DNA	   was	   stained	   by	   DAPI	   (Sigma).	   Fluorescence	   microscopy	   was	  performed	  on	  a	  Nikon	  A1R	  MP	  microscope.	  Images	  were	  recorded	  with	  a	  Z-­‐optical	  spacing	  of	  0.25	  μm	  and	  analyzed	  using	  ImageJ	  software	  (National	  Institute	  of	  Health).	  For	  live-­‐cell	  analyses,	  Rat1A	   cells	   infected	  with	  pLNCX-­‐H2B	   retrovirus	   and	   transduced	  with	   lentiviral	  vector	   or	   FGFR3-­‐TACC3	   fusion	   were	   seeded	   in	   glass	   bottom	   dishes	   in	   phenol	   red	   free	  DMEM	  and	  followed	  by	  time-­‐lapse	  microscopy	  using	  the	  Nikon	  A1R	  MP	  biostation	  at	  37°C	  and	  5%	  CO2/95%	  air.	  Images	  with	  a	  Z-­‐optical	  spacing	  of	  1	  μm	  were	  recorded	  every	  4	  min	  for	  8	  h.	  Images	  of	  unchallenged	  mitosis	  from	  early	  prophase	  until	  cytokinesis	  were	  further	  processed	   using	   ImageJ	   software.	   The	   time-­‐point	   of	   nuclear	   envelope	   breakdown	   (NEB)	  was	   defined	   as	   the	   first	   frame	   showing	   loss	   of	   smooth	   appearance	   of	   chromatin	   and	  anaphase	   was	   the	   first	   frame	   when	   chromosome	   movement	   towards	   the	   poles	   became	  apparent.	  Nuclear	   envelope	   reconstitution	   (NER)	  was	  defined	   as	   the	   first	   frame	   showing	  nuclei	  decondensation.	  Box	  and	  whisker	  plots	  were	  calculated	  from	  image	  sequences	  from	  at	   least	   50	   recorded	   cells.	   Statistical	   analysis	   was	   performed	   using	   StatView	   software	  (AbacusConcepts,	  Berkeley,	  CA).	  Two-­‐tailed	  unpaired	  t-­‐tests	  with	  Welch's	  correction	  were	  performed	  for	  comparison	  of	  means	  analysis.	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Appendix	  G.	  Supplementary	  
Tables	  for	  “Transforming	  Fusions	  
of	  FGFR	  and	  TACC	  Genes	  in	  
Human	  Glioblastoma”	  
	  
Supplementary	  Table	  G-­‐1.	  Predicted	  in-­‐frame	  fusion	  proteins	  from	  RNA-­‐Seq	  of	  nine	  GSCs.	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Supplementary	  Table	  G-­‐2.	  List	  of	  split	  inserts	  supporting	  the	  identification	  of	  FGFR3-­‐TACC3	  fusion	  genes	  in	  four	  
GBM	  samples	  from	  the	  ATLAS-­‐TCGA	  exome	  collection.	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Supplementary	  Table	  G-­‐3.	  List	  of	  split	  reads	  supporting	  the	  identification	  of	  FGFR3-­‐TACC3	  fusion	  genes	  in	  four	  GBM	  
samples	  from	  TCGA	  exomes.	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Supplementary	  Table	  G-­‐5.	  In	  vitro	  and	  in	  vivo	  transformation	  assays.	  
	  
Supplementary	  Table	  G-­‐6.	  Chromosomal	  segregation	  defects	  induced	  by	  FGFR-­‐TACC	  fusions.	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Supplementary	  Table	  G-­‐8.	  Chromosome	  analysis	  by	  SKY	  of	  20	  cells	  from	  the	  GSC-­‐1123	  culture.	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Supplementary	  Table	  G-­‐9.	  Analysis	  of	  chromosomal	  number	  in	  Rat1A	  cells	  treated	  with	  the	  FGFR3	  inhibitor	  
PD173074.	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  	   238	  
Appendix	  H.	  Supplementary	  Text	  
for	  “The	  integrated	  landscape	  of	  
driver	  genomic	  alterations	  in	  
glioblastoma”	  
	  
RNA-­‐Seq	   bioinformatics	   analysis.	  We	  analyzed	  161	  RNA-­‐Seq	  GBM	  tumor	  samples	   from	  The	   Cancer	   Genome	   Atlas	   (TCGA),	   a	   public	   repository	   containing	   large-­‐scale	   genome-­‐sequencing	  of	  different	   cancers,	  plus	  24	  patients-­‐derived	  GSCs.	  Nine	  of	   the	  GSCs	  samples	  reported	   in	  previous	  studies	  were	  kept	   in	   the	   list	   to	  evaluate	  recurrence192.	  We	  analyzed	  the	   samples	   by	  means	   of	   the	   ChimeraScan198	   algorithm	   in	   order	   to	   detect	   a	   list	   of	   gene	  fusion	   candidates.	   Briefly,	   ChimeraScan	   detects	   those	   reads	   that	   discordantly	   align	   to	  different	  transcripts	  of	  the	  same	  reference	  (split	  inserts).	  These	  reads	  provide	  an	  initial	  set	  of	  putative	  fusion	  candidates.	  Finally,	   the	  algorithm	  realigns	  the	  initially	  unmapped	  reads	  to	   the	   putative	   fusion	   candidates	   and	   detects	   those	   reads	   that	   align	   across	   the	   junction	  boundary	  (split	  reads).	  These	  reads	  provide	  the	  genomic	  coordinates	  of	  the	  breakpoint.	  	  	  RNA-­‐Seq	  analysis	  detected	  a	  total	  of	  39,329	  putative	  gene	  fusion	  events.	  In	  order	  to	  focus	  the	   experimental	   analysis	   on	   biologically	   relevant	   fused	   transcripts,	   we	   applied	   Pegasus	  annotation	   pipeline	   (http://sourceforge.net/projects/pegasus-­‐fus/).	   For	   each	   putative	  fusion,	   Pegasus	   reconstructs	   the	   entire	   fusion	   sequence	   on	   the	   base	   of	   genomic	   fusion	  breakpoint	  coordinates	  and	  gene	  annotations.	  Pegasus	  also	  annotates	  the	  reading	  frame	  of	  the	  resulting	  fusion	  sequences	  as	  either	  in-­‐frame	  or	  frame-­‐shift.	  Moreover,	  Pegasus	  detects	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the	   protein	   domains	   that	   are	   either	   conserved	   or	   lost	   in	   the	   new	   chimeric	   event	   by	  predicting	   the	  amino	  acid	   sequence	  and	  automatically	  querying	   the	  UniProt	  web	   service.	  On	  the	  basis	  of	  the	  Pegasus	  annotation	  report,	  we	  selected	  relevant	  gene	  fusions	  for	  further	  experimental	   validation	  according	   to	   the	   reading	   frame	  and	   the	   conserved/lost	  domains.	  The	  selected	  list	  (Supplementary	  Table	  7)	  was	  based	  on	  in-­‐frame	  events	  expressed	  by	  ten	  or	  more	   reads	  and	  at	   least	  one	   read	  spanning	   the	  breaking	  point.	  To	   filter	  out	   candidate	  transplicing	  events	  we	  focused	  on	  events	  with	  putative	  breakpoints	  at	  a	  distance	  of	  at	  least	  25kb.	  	  
EXome-­‐Fuse:	   Identification	   of	   Genetic	   Rearrangments	   using	   Whole-­‐Exome	   Data.	  Although	  whole-­‐exome	   sequencing	   data	   contains	   low	   intronic	   coverage	   that	   reduces	   the	  sensitivity	   for	   fusion	   discovery,	   it	   is	   readily	   available	   through	   the	   TCGA	   database.	   To	  characterize	   the	   genomic	   breakpoint	   of	   the	   chromosomal	   rearrangement,	   we	   therefore	  designed	   EXome-­‐Fuse:	   a	   novel	   gene	   fusion	   discovery	   pipeline	   particularly	   designed	   to	  analyze	  whole-­‐exome	  data.	  For	  the	  samples	  harboring	  EGFR-­‐SEPT14,	  EGFR-­‐PSPH,	  NFASC-­‐NTRK1,	   and	  BCAN-­‐NTRK1	   fusions	   in	  RNA,	  we	   applied	  EXome-­‐Fuse	   to	   the	   corresponding	  whole-­‐exome	  sequencing	  data	  deposited	  in	  TCGA.	  This	  algorithm	  can	  be	  divided	  into	  three	  stages:	  split	  insert	  identification,	  split	  read	  identification,	  and	  virtual	  reference	  alignment.	  Mapping	   against	   the	   human	   genome	   reference	   hg18	  with	  BWA,	  we	   first	   identify	   all	   split	  inserts	   to	   compile	   a	   preliminary	   list	   of	   fusion	   candidates.	  We	  prune	   this	   list	   of	   any	   false	  positives	  produced	   from	  paralogous	  gene	  pairs	  using	   the	  Duplicated	  Genes	  Database	  and	  the	   EnsemblCompara	   GeneTrees225.	   Pseudogenes	   in	   the	   candidate	   list	   were	   annotated	  using	   the	   list	   from	  HUGO	   Gene	   Nomenclature	   Committee	   (HGNC)	   database226	   and	   given	  lower	  priority.	  We	  also	  filtered	  out	  candidates	  between	  homologous	  genes,	  as	  well	  as	  those	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with	   homologous	   or	   low-­‐complexity	   regions	   around	   the	   breakpoint.	   For	   the	   remaining	  fusion	  candidates,	  we	  probed	  for	  any	  supporting	  split	  reads	  and	  their	  mates	  using	  BLAST	  with	  a	  word	  size	  of	  16,	  identity	  cutoff	  of	  90%,	  and	  an	  expectation	  cutoff	  of	  10-­‐4.	  Finally,	  we	  create	  a	  virtual	  reference	  for	  each	  fusion	  transcript	  and	  re-­‐align	  all	  reads	  to	  calculate	  a	  final	  tally	   of	   split	   inserts	   and	   split	   reads	   such	   that	   all	   aligning	   read	   pairs	   maintain	   F-­‐R	  directionality.	  
Determining	  the	  presence	  of	  EGFRvIII	  transcripts	  To	   determine	   the	   prevalence	   of	   EGFRvIII	   transcripts,	   we	   created	   an	   in-­‐house	   script	   to	  calculate	  the	  number	  of	  split	  inserts	  and	  split	  reads	  supporting	  the	  junction	  between	  EGFR	  exons	   1	   and	   8.	  We	   considered	   the	   EGFRvIII	   isoform	   to	   be	   expressed	   if	   there	  were	  more	  than	  five	  split	  reads	  or	  five	  split	  inserts	  in	  a	  sample.	  
	  
Calculating	  relative	  expression	  of	  EGFR	  fusions	  versus	  wild-­‐type	  To	   determine	   the	   functional	   relevance	   of	   EGFR-­‐SEPT14	   and	   EGFR-­‐PSPH	   fusions,	   we	  determined	   the	   relative	   expression	   between	   the	   fusion	   and	  wild-­‐type	   transcripts	  within	  each	   sample	   based	   on	   BAM	   files	   mapped	   by	   TopHat	   provided	   by	   TCGA.	   As	   a	   proxy	   to	  expression	  of	  the	  transcript,	  we	  calculated	  the	  depth	  of	  reads	  covering	  either	  a	  mutant	  or	  wild-­‐type	   junction.	   In	   particular,	   we	   considered	   the	   depth	   of	   reads	   covering	   the	   fusion	  breakpoint	   of	   EGFR-­‐SEPT14	   or	   EGFR-­‐PSPH	   to	   estimate	   the	   expression	   of	   the	   fusion	  transcript.	  Since	  all	  EGFR	  fusions	  stereotypically	  involved	  exon	  24	  joined	  to	  either	  SEPT14	  or	  PSPH,	  we	  considered	  the	  depth	  of	  reads	  covering	  the	  junctions	  between	  EGFR	  exons	  25-­‐26,	  26-­‐27,	  and	  27-­‐28	  to	  be	  a	  specific	  gauge	  of	  wild-­‐type	  EGFR	  expression.	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Enrichment	  of	  classical/mesenchymal	  subtype	  among	  samples	  with	  EGFR	  fusions	  To	  assess	  whether	  samples	  with	  EGFR	  fusions	  tended	  to	  occur	  in	  a	  particular	  GBM	  subtype,	  we	  first	  classified	  each	  TCGA	  GBM	  sample	  by	  expression	  according	  to	  Verhaak,	  et	  al190.	  We	  then	  tallied	  the	  number	  of	  classical,	  mesenchymal,	  proneural,	  and	  neural	  samples	  with	  or	  without	   EGFR	   gene	   fusions.	   We	   found	   that	   the	   combined	   class	   of	   classical	   and	  mesenchymal	   phenotype	   was	   enriched	   for	   EGFR	   fusions	   according	   to	   the	   Fisher’s	   exact	  test.	  	  
	  
Copy	  number	  variation	  in	  EGFR	  fusions	  Gene	   fusions	   often	   arise	   from	   genomic	   instability.	   Motivated	   by	   this	   observation,	   we	  downloaded	  segmented	  SNP	  array	  data	  from	  TCGA	  and	  calculated	  the	  log2	  ratio	  between	  tumor	  and	  normal	  copy	  number.	  We	  plotted	  this	  along	  the	  chromosomal	  neighborhood	  of	  EGFR,	  SEPT14,	  and	  PSPH	  (chr7:55000000-­‐56500000).	  
	  
Differential	  expression	  between	  samples	  with	  EGFR-­‐SEPT14	  and	  EGFRvIII	  	  We	   also	   performed	   in-­‐house	   differential	   expression	   analysis	   to	   determine	   a	   distinct	  molecular	   signature	   distinguishing	   EGFR-­‐SEPT14	   and	   EGFRvIII	   phenotype.	   Towards	   this	  end,	  we	  performed	  a	  t-­‐test	  comparing	  the	  expression	  of	  the	  two	  groups	  of	  samples	  for	  each	  gene.	   Correcting	   for	   multiple	   hypotheses	   using	   Benjamini-­‐Hochberg	   method,	   we	  considered	  only	  genes	  with	  FDR	  <	  0.05.	  In	  addition,	  we	  excluded	  genes	  with	  a	  variance	  less	  than	  the	  10th	  percentile	  or	  absolute	  value	  lower	  than	  two	  across	  all	  samples.	  These	  filters	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left	   a	   predictive	   set	   of	   ten	   genes.	   Finally,	   we	   performed	   hierarchical	   clustering	   on	   the	  expression	  of	  these	  ten	  genes	  using	  Euclidean	  distance	  and	  average	  linkage.	  	  
Cell	  culture	  	  U87	   cells	   were	   obtained	   from	   ATCC.	   SNB19,	   U87	   and	   HEK-­‐293T	   cells	   were	   cultured	   in	  DMEM	   supplemented	   with	   10%	   Fetal	   Bovine	   Serum.	   Growth	   rate	   was	   determined	   by	  plating	   cells	   in	   six-­‐well	   plates	   post	   3	   days	   after	   infection	  with	   the	   lentivirus	   indicated	   in	  Figure	  Legends.	   The	  number	  of	   viable	   cells	  was	  determined	  by	  Trypan	  blue	   exclusion	   in	  triplicate	  cultures	  obtained	  from	  triplicate	  independent	  infections.	  Migration	  was	  evaluated	  by	  Confluent	  cells	  were	  scratched	  with	  a	  pipette	  tip	  and	  cultured	  in	  0.25%	  FBS.	  After	  16	  h,	  images	  were	   taken	   using	   the	   Olympus	   IX70	   connected	   to	   a	   digital	   camera.	   Images	  were	  processed	  using	   the	   ImageJ64	   software.	  The	   area	  of	   the	   cell-­‐free	  wound	  was	   assessed	   in	  triplicate	  samples.	  Experiments	  were	  repeated	  twice.	  	  GBM-­‐derived	   primary	   cultures	  were	   grown	   in	   DMEM:F12	  media	   containing	  N2	   and	   B27	  supplements,	   and	   human	   recombinant	   FGF-­‐2	   and	   EGF	   (50	   ng/ml	   each;	   Peprotech).	   For	  sphere	   formation,	  cells	  were	   infected	  with	   lentiviral	  particles.	  Four	  days	   later	  single	  cells	  were	  plated	  at	  density	  of	  ≤	  1	  cells/well	  in	  triplicate	  in	  low	  attachment	  96	  well	  plates.	  The	  number	  and	  the	  size	  of	  spheres	  were	  scored	  after	  10-­‐14	  days.	  Limiting	  dilution	  assay	  was	  performed	   as	   described	   previously	   (Tropepe,	   V.,	   Sibilia,	   M	   1999).	   Spheres	   were	  dissociated	   into	   single	   cells	   and	   plated	   in	   low	   attachment	   96-­‐well	   plates	   in	   0.2	   ml	   of	  medium	   containing	   growth	   factors	   (EGF	   and	   FGF-­‐2)	   except	   for	   EGFR	   transduced	   cells,	  which	  were	  cultured	  in	  the	  absence	  of	  EGF.	  Cultures	  were	  left	  undisturbed	  for	  10	  days,	  and	  then	   the	  percentage	  of	  wells	  not	   containing	   spheres	   for	   each	   cell	   dilution	  was	   calculated	  and	  plotted	  against	  the	  number	  of	  cells	  per	  well.	  Linear	  regression	  lines	  were	  plotted,	  and	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the	  number	  of	  cells	  required	  to	  generate	  at	  least	  one	  sphere	  in	  every	  well	  (=the	  stem	  cell	  frequency)	  was	  calculated.	  The	  experiment	  was	  repeated	  twice.	  Treatment	  of	  GBM	  primary	  cultures	  with	  erlotinib	  or	   lapatinib	  was	  performed	   in	   cells	   transduced	  with	  pLOC	  vector,	  pLOC-­‐EGFR	  WT,	  EGFR-­‐Viii	  or	  EGFR-­‐SEPT14	  and	  selected	  with	  blastacydin	  for	  5	  days.	  Cells	  were	  seeded	  on	  6-­‐cm	  dishes	   in	  the	  absence	  of	  EGF	  and	  allowed	  to	  attach	  overnight.	  Cells	  were	   then	   treated	   with	   the	   indicated	   drugs	   at	   the	   indicated	   doses	   for	   48	   hours.	   Each	  treatment	  group	  was	  seeded	  in	  triplicate.	  Absolute	  viable	  cell	  counts	  were	  determined	  by	  Trypan	   blue	   exclusion	   and	   counted	   on	   a	   hemocytometer.	   EGF	   stimulation	   of	   EGFR	  transduced	  primary	  glioma	  cells	  was	  performed	  in	  cells	  deprived	  of	  growth	  factors	  for	  48	  hours.	  Cells	  were	  colleted	  at	  the	  indicated	  times	  and	  processed	  for	  western	  blot	  analysis.	  
	  
	  
Immunofluorescence	  	  Immunoflurescence	   staining	   on	   normal	  mouse	   and	   human	   brain	   and	   brain	   tumor	   tissue	  microarrays	   were	   performed	   as	   previously	   described	   (Carro	   and	   Niola	   NCB	   and	   JCI).	  Immunofluorescence	  microscopy	  was	  performed	  on	  cells	  fixed	  with	  4%	  para-­‐formaldehyde	  (PFA)	  in	  phosphate	  buffer.	  Cells	  were	  permeabilized	  using	  0.2%	  Triton	  X	  100.	  Antibodies	  and	  concentrations	  used	  in	  immunofluorescence	  staining	  are:	  B-­‐III	  Tubulin	   	   	   Mouse	  	   1:400	   	   	   Promega	  Catenin	  D2	   	   	   Guinea	  Pig	   1:500	   	   	  	  	  	  	  	  	  	  	  	  	  	  Acris	  Fibronectin	   	   	   Mouse	  	   1:1,000	   	   BD-­‐Pharmingen	  Col5A1	   	   	   Rabbit	  	   1:200	   	   	   Santa	  Cruz	  Biotech	  PSD-­‐95	   	   	   Rabbit	  	   1:500	   	   	   Invitrogen	  Smooth	  muscle	  actin	  	   Mouse	  	   1:200	   	   	   Sigma	   	   	   	  	  Secondary	  antibodies	  conjugated	  to	  Alexa	  Fluor	  594	  or	  Alexa	  488	  (Molecular	  Probes)	  were	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used.	   DNA	  was	   stained	   by	   DAPI	   (Sigma).	   Fluorescence	  microscopy	   was	   performed	   on	   a	  Nikon	  A1R	  MP	  microscope.	  Quantification	  of	  the	  fluorescence	  intensity	  staining	  in	  primary	  or	   established	   glioma	   cells	   was	   performed	   using	   NIH	   Image	   J	   software	  (http://rsb.info.nih.gov/ij/).	  The	  histogram	  of	  the	  intensity	  of	  fluorescence	  of	  each	  point	  of	  a	  representative	   field	   for	  each	  condition	  was	  generated.	  The	   fluorescence	   intensity	  of	   ten	  fields	  from	  three	  independent	  experiments	  was	  scored,	  standardized	  to	  the	  number	  of	  cells	  in	  the	  field	  and	  divided	  by	  the	  intensity	  of	  the	  vector.	  	  
Western	  Blot,	  immunoprecipitation	  and	  in	  vitro	  binding	  Western	   blot	   analysis	   and	   immunoprecipitation	  were	   performed	   as	   described	   (REF	  NCB	  2008)	  using	  the	  following	  antibodies:	  Anti-­‐Vinculin	   	   	   Mouse	  	   1:400	   	   	   SIGMA	  Anti-­‐N-­‐Cadherin	   	   Mouse	  	   1:200	   	   	   BD-­‐Pharmingen	  Cyclin	  A	   	   	   Rabbit	  	   1:500	   	   	   Santa	  Cruz	  Biotech	  p27	   	   	   Mouse	  	   1:250	   	   	   BD	  Transduction	  B-­‐III	  Tubulin	   	   	   Mouse	  	   1:400	   	   	   Promega	  Catenin	  D2	   	   	   Guinea	  Pig	   1:500	   	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  Acris	  Fibronectin	   	   	   Mouse	  	   1:1,000	   	   BD-­‐Pharmingen	  p107	   	   	   Rabbit	  	   1:1000	   	   Santa	  Cruz	  Biotech	  Nestin	   	   	   Mouse	  	   1:500	   	   	   BD-­‐Pharmingen	  CD133	   	   	   Babbit	  	   1:200	   	   	   Abcam	  	  Sox2	   	   	   Rabbit	  	   1:500	   	   	   Cell	  Signaling	  EGFR	   	   	   Mouse	  	   1:1000	   	   Millipore	  AKT	   	   	   Rabbit	  	   1:1000	   	   Cell	  Signaling	  pAKT-­‐S473	   	   	   Rabbit	  	   1:1000	   	   Cell	  Signaling	  ERK1/2	   	   	   Rabbit	  	   1:1000	   	   Cell	  Signaling	  pERK1/2	   	   	   Rabbit	  	   1:1000	   	   Cell	  Signaling	  STAT3	   	   	   Rabbit	  	   1:1000	   	   Santa	  Cruz	  Biotech	  pSTAT3-­‐Y705	   	   	   Rabbit	  	   1:1000	   	   Cell	  Signaling	  LZTR1	   	   	   Rabbit	  	   1:1000	   	   Abcam	  	  Cul3	   	   	   	   Rabbit	  	   1:1000	   	   Bethyl	  For	   the	   in	   vitro	   binding	   between	   Cul3	   and	   LZTR1	   wild	   type	   and	   mutant	   LZTR1	   was	  translated	   in	   vitro	   using	   the	   TNT	   Quick	   Coupled	   Transcription/Translation	   System	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(Promega).	  Flag-­‐Cul3	  was	  immunoprecipitated	  from	  transfected	  HEK-­‐293T	  cells	  with	  Flag-­‐M2	   beads	   (Sigma)	   using	   RIPA	   buffer.	   Binding	  was	   performed	   in	   200mM	  NaCl	   plus	   0.5%	  NP40	   for	   2hrs	   at	   4o	   degrees.	   Immunocomplexes	   were	   analyzed	   by	   SDS-­‐PAGE	  electrophoresis	  and	  immunoblot.	  	  
Cloning	  and	  Lentiviral	  production	  The	  lentiviral	  expression	  vector,	  pLOC-­‐GFP	  and	  pLOC-­‐CTNND2	  were	  purchased	  from	  Open	  Biosystems.	  The	  full	  length	  EGFR-­‐SEP14	  cDNA	  was	  amplified	  from	  tumor	  sample	  TCGA-­‐27-­‐1837.	   Primers	   used	   were:	   EGFR	   FW:	   5’-­‐agcgATGCGACCCTCCGGGA-­‐3’	   and	   PSPH	   REV:	   5’-­‐	  TCTTACGATGTTTGTCTTTCTTTGT;	   EGFR	   wild	   type,	   EGFR	   Viii	   and	   EGFR-­‐SEP14	   cDNAs	  were	   cloned	   into	   pLOC.	   pCDNA-­‐Myc-­‐Hist-­‐LZTR1	   was	   a	   kind	   gift	   from	   Prof.	   Jens	   Kroll	  (Tumor	   Biology	   Center,	   Freiburg,	   Germany)(REF	   JBC).	   pCDNA-­‐Flag-­‐Cul3	   was	   kindly	  provided	   by	   Prof.	  Michele	   Pagano,	  New	  York	  University,	  New	  York,	   USA).	  Wild	   type	   and	  mutant	  cDNAs	  for	  LZTR1	  and	  CTNND2	  obtained	  by	  site-­‐directed	  mutagenesis	  (QuikChange	  II,	   Agilent)	   were	   cloned	   into	   pLOC	   vector.	   Lentiviral	   particles	   were	   produced	   using	  published	  protocols	  (Carro,	  Zhao,	  Niola).	  	  
Genomic	  and	  mRNA	  RT-­‐PCR	  	  Total	   RNA	   was	   extracted	   from	   cells	   by	   using	   RNeasy	   Mini	   Kit	   (QIAGEN),	   following	   the	  manufacturer	   instructions.	   500	   ng	   of	   total	   RNA	   was	   retro-­‐transcribed	   by	   using	   the	  Superscript	   III	   kit	   (Invitrogen),	   following	   the	   manufacturer	   instructions.	   The	   cDNAs	  obtained	  after	  the	  retro-­‐transcription	  was	  used	  as	  templates	  for	  qPCR	  as	  described	  (Carro	  2010	  and	  Zhao	  2008).	  The	  reaction	  was	  performed	  with	  a	  Roche480	  thermal	  cycler,	  using	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the	  Absolute	  Blue	  QPCR	  SYBR	  Green	  Mix	   from	  Thermo	  Scientific.	  The	   relative	  amount	  of	  specific	   mRNA	   was	   normalized	   to	   GAPDH.	   Results	   are	   presented	   as	   the	   mean±SD	   of	  triplicate	   amplifications.	   The	   validation	   of	   fusion	   transcripts	   was	   performed	   using	   both	  genomic	  and	  RT-­‐PCR	  with	  forward	  and	  reverse	  primer	  combinations	  designed	  within	  the	  margins	   of	   the	   paired-­‐end	   read	   sequences	   detected	   by	   RNA-­‐seq.	   Expressed	   fusion	  transcript	   variants	   were	   subjected	   to	   direct	   sequencing	   to	   confirm	   sequence	   and	  translation	  frame.	  Primers	  used	  for	  the	  screening	  of	  gene	  fusions	  are:	  	  hEGFR-­‐RT-­‐FW1:	  5’-­‐	  GGGTGACTGTTTGGGAGTTGATG	  -­‐3’;	  	  hSEP14-­‐RT-­‐REV1:	  5’-­‐	  TGTTTGTCTTTCTTTGTATCGGTGC-­‐3’;	  	  hEGFR-­‐RT-­‐FW1:	  5’-­‐AGAGGTGACCACCAATCAGC-­‐3’;	  	  hPSPH-­‐RT-­‐REV1:	  5’-­‐CGTGTCCCACACAGAGACAG-­‐3’;	  hNFASC-­‐RT-­‐	  FW1:	  5’-­‐	  AGTTCCGTGTCATTGCCATCAAC-­‐3’;	  hNTRK1-­‐RT-­‐REV1:	  5’-­‐	  TGTTTCGTCCTTCTTCTCCACCG-­‐3’;	  hCAND1-­‐RT-­‐	  FW1:	  5’-­‐	  GGAAAAAATGACATCCAGCGAC-­‐3’	  hEGFR-­‐RT-­‐REV1:	  5’-­‐	  TGGGTGTAAGAGGCTCCACAAG-­‐3’	  Primers	  used	  for	  genomic	  detection	  of	  gene	  fusions	  are:	  genomic	  EGFR-­‐FW1:	  5’-­‐	  GGATGATAGACGCAGATAGTCGCC-­‐3’;	  genomic	  SEPT14-­‐REV1:	  5’-­‐	  TCCAGTTGTTTTTTCTCTTCCTCG-­‐3’;	  genomic	  NFASC-­‐FW1:	  5’-­‐	  TCCGAGTCCAGGCTGAAAATG-­‐3’;	  genomic	  NTRK1-­‐REV1:	  5’-­‐	  CTACTTCCTATCTCACCCCAAAAGG-­‐3’;	  genomic	  CAND1-­‐FW1:	  5’-­‐	  GCAATAGCAAAACAGGAAGATGTC-­‐3’;	  genomic	  EGFR-­‐REV1:	  5’-­‐	  GAACACTTACCCATTCGTTGG-­‐3’;	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Semiquantitative	  RT-­‐PCR	  to	  detect	  exogenous	  Myc-­‐LZTR1	  WT	  and	  mutant	  LZTR1-­‐R801W	  was	  performed	  using	  the	  following	  primers:	  LZTR1	  FW:	  5’-­‐	  TCCCACATCTCAGACAAGCA-­‐3’;	  His-­‐Tag	  REV:	  5’-­‐	  TCAATGGTGATGGTGATGATG-­‐3’;	  GAPDH	  FW:	  5’-­‐	  GAAGGTGAAGGTCGGAGTCAAC-­‐3’;	  GAPDH	  REV:	  5’-­‐	  CAGAGTTAAAAGCAGCCCTGGT-­‐3’;	  	  
Subcutaneous	  xenografts	  and	  drug	  treatment	  	  Female	  athymic	  mice	  (nu/nu	  genotype,	  Balb/c	  background,	  6	  to	  8	  weeks	  old)	  were	  used	  for	  all	   antitumor	   studies.	   All	   animal	   procedures	   conformed	   to	   Institutional	   Animal	   Care	   and	  Use	   Committee	   and	  National	   Institute	   of	   Health	   guidelines.	   Patient-­‐derived	   adult	   human	  glioblastoma	  xenografts	  were	  maintained	  at	  the	  Preston	  Robert	  Tisch	  Brain	  Tumor	  Center	  at	   Duke.	   Xenografts	  were	   excised	   from	   host	  mice	   under	   sterile	   conditions,	   homogenized	  with	  the	  use	  of	  a	  tissue	  press/modified	  tissue	  cytosieve	  (Biowhitter	  Inc,	  Walkersville,	  MD)	  and	  tumor	  homogenate	  was	  loaded	  into	  a	  repeating	  Hamilton	  syringe	  (Hamilton,	  Co.,	  Reno,	  NV)	   dispenser.	   Cells	   were	   injected	   sub-­‐cutaneously	   into	   the	   right	   flank	   of	   the	   athymic	  mouse	  at	  an	  inoculation	  volume	  of	  50	  µl	  with	  a	  19-­‐gauge	  needle	  237.	  Subcutaneous	  tumors	  were	  measured	  twice	  weekly	  with	  hand-­‐held	  vernier	  calipers	  (Scientific	  Products,	  McGraw,	  IL).	  	  Tumor	  volumes,	  V	  were	  calculated	  with	  the	  following	  formula:	  [(width)2	  ×	  (length)]/2	  =	  V	   (mm3).	   For	   the	   sub-­‐cutaneously	   tumor	   studies,	   groups	   of	  mice	  randomly	   selected	   by	  tumor	  volume	  were	  treated	  with	  EGFR	  kinase	  inhibitors	  when	  the	  median	  tumor	  volumes	  were	   on	   average	   150	   mm3	   and	   were	   compared	   with	   control	   animals	   receiving	   vehicle	  (saline).	  Erlotinib	  	  	  was	  administered	  at	  	  	  100mg/Kg	  orally	  	  	  daily	  for	  10	  days.	  Lapatinib	  was	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administered	   at	   	  	  75mg/Kg	  orally	  twice	   per	   day	   for	   20	  days.	  	   Response	   to	   treatment	  was	  assessed	  by	  delay	  in	  tumor	  growth	  and	  tumor	  regression.	  Growth	  delay,	  expressed	  as	  T-­‐C,	  is	  defined	  as	  the	  difference	  in	  days	  between	  the	  median	  time	  required	  for	  tumors	  in	  treated	  and	  control	  animals	  to	  reach	  a	  volume	  five	  times	  greater	  than	  that	  measured	  at	  the	  start	  of	  the	   treatment.	   	   Tumor	   regression	   is	   defined	   as	   a	   decrease	   in	   tumor	   volume	   over	   two	  successive	   measurements.	   	   Statistical	   analysis	   was	   performed	   using	   a	   SAS	   statistical	  analysis	  program,	  the	  Wilcoxon	  rank	  order	  test	  for	  growth	  delay,	  and	  Fisher’s	  exact	  test	  for	  tumor	  regression	  as	  previously	  described.	  
	  
Intracranial	  Injection	  GBM	  derived	  primary	  cells	  were	  first	   infected	  with	  a	   lentivirus	  expressing	  Luciferase	  and	  subsequently	   transduced	   with	   pLOC-­‐vector	   or	   pLOC-­‐CTNND2	   lentiviral	   particles.	  Intracranial	   injection	   was	   performed	   in	   9	   week-­‐old	   Nu/Nu	   mice	   (Charles	   River	  laboratories)	   in	  accordance	  with	  guidelines	  of	  IACUC	  Committee.	  Briefly	  5X105	  cells	  were	  resuspended	  in	  2.5	  ml	  of	  PBS	  were	  injected	  into	  the	  caudate	  putamen	  using	  a	  stereotaxic	  frame	  (coordinates	  relative	  to	  the	  bregma:	  0.6mm	  anterior;	  1.65mm	  medium-­‐lateral;	  3mm	  depth-­‐ventral).	  Tumor	  growth	  was	  monitored	  using	  IVIS	  Imaging	  system.	  Briefly	  mice	  were	  anesthetized	   with	   3%	   isofluorane	   before	   intra-­‐peritoneal	   injection	   of	   100mg/Kg	   body	  weight	   n-­‐Luciferin	   (Xenogen).	   Ten	   minutes	   after	   injection	   of	   n-­‐Luciferin,	   images	   were	  acquired	  for	  1	  min	  with	  Xenogen	  IVIS	  system	  (Xenogen)	  using	  Living	  Image	  acquisition	  and	  analysis	   software	   (Xenogen).	   The	   bioluminescent	   signal	   was	   expressed	   in	   photons	   per	  second	   and	   displayed	   as	   a	   pseudo-­‐color	   image	   representing	   the	   spatial	   distribution	   of	  photon	  counts.	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Appendix	  I.	  Supplementary	  
Tables	  to	  “The	  integrated	  
landscape	  of	  driver	  genomic	  
alterations	  in	  glioblastoma”	  	  
Supplementary	  Table	  I-­‐1.	  Gene	  fusions	  identified	  through	  RNA	  sequencing.	  
























TCGA-­‐28-­‐5209	   EGFR	   PSPH	   6849	   5648	   55268106	   56079562	   24	   6	  
TCGA-­‐06-­‐0211	   LANCL2	   SEPT14	   2619	   2078	   55479782	   55886916	   6	   7	  
TCGA-­‐28-­‐2513	   EGFR	   SEPT14	   1899	   1464	   55268106	   55863785	   24	   10	  
TCGA-­‐27-­‐1835	   FGFR3	   TACC3	   1748	   1604	   1808661	   1741429	   17	   11	  
TCGA-­‐06-­‐0211	   LANCL2	   SEPT14	   1367	   1128	   55479782	   55886916	   6	   7	  
TCGA-­‐27-­‐1837	   EGFR	   SEPT14	   989	   796	   55268106	   55863785	   24	   10	  
NYU_A	   FGFR3	   TACC3	   973	   492	   1808661	   1737458	   17	   8	  
TCGA-­‐06-­‐5411	  
KIAA0756,
NFASC	   NTRK1	   841	   751	   204951148	   156844363	   21	   10	  
TCGA-­‐06-­‐0750	   EGFR	   SEPT14	   534	   414	   55268106	   55863785	   24	   10	  
TCGA-­‐32-­‐5222	   EGFR	   SEPT14	   528	   495	   55268106	   55863785	   24	   10	  
TCGA-­‐06-­‐0138	   YEATS4	   XRCC6BP1	   328	   306	   69764755	   58339411	   6	   2	  
TCGA-­‐76-­‐4925	   FGFR3	   TACC3	   303	   203	   1808661	   1739325	   17	   10	  
NYU_B	   POLR2A	   WRAP53	   263	   240	   7388176	   7604059	   1	   5	  
TCGA-­‐28-­‐1747	   EGFR	   SEPT14	   181	   142	   55268106	   55863785	   24	   10	  
TCGA-­‐06-­‐2557	   EIF4H	   GTF2I	   180	   142	   73604248	   74173110	   4	   34	  
TCGA-­‐06-­‐5413	   AKAP6	   EGLN3	   171	   129	   32903023	   34400421	   2	   2	  
TCGA-­‐14-­‐0736	   WDR20	   ASNA1	   151	   75	   102606509	   12856191	   1	   3	  
GBM-­‐
CUMC3316_L1	   MAPK1	  
FAM119B,	  
DKFZp586
D0919	   145	   96	   22160139	   58166800	   3	   2	  
TCGA-­‐19-­‐2619	   BCAN	   NTRK1	   130	   17	   156628525	   156844698	   13	   11	  
TCGA-­‐06-­‐0211	   SEC61G	   EGFR	   129	   103	   54825188	   55224226	   2	   9	  
TCGA-­‐76-­‐4929	   ADAM17	   YWHAQ	   106	   95	   9675963	   9731644	   4	   2	  
TCGA-­‐19-­‐2624	   EGFR	   GNS	   92	   59	   55240817	   65110599	   14	   15	  




D0919	   METTL1	   29	   18	   58166911	   58163739	   2	   3	  
TCGA-­‐06-­‐5415	   TXNDC15	   ARPC2	   90	   36	   134210220	   219103387	   1	   6	  
TCGA-­‐06-­‐0158	   EML4	   CASK	   86	   63	   42396776	   41420897	   1	   17	  
TCGA-­‐06-­‐5856	  
TMEM120
B	   AVIL	   75	   56	   122150870	   58193703	   1	   18	  
NYU_B	   CAPZB	   UBR4	   72	   48	   19746155	   19433460	   3	   82	  
TCGA-­‐19-­‐1787	   TFG	   GPR128	   23	   19	   100438902	   100348442	   3	   2	  
TCGA-­‐12-­‐5295	   SDC4	   SPCS1	   68	   18	   43976965	   52740660	   1	   2	  
NYU_G	   ST8SIA4	   PAM	   60	   55	   100191807	   102260661	   4	   5	  
TCGA-­‐14-­‐2554	  
Ari2,ARIH
2	   CAMP	   59	   52	   48965246	   48265844	   1	   2	  
TCGA-­‐06-­‐0178	   AGAP2	   TMEM67	   59	   21	   58123422	   94827533	   13	   27	  
TCGA-­‐26-­‐5136	   CNN3	   ALG14	   54	   49	   95392394	   95448862	   1	   4	  
GBM-­‐
CUMC3296_L1	   VOPP1	   IL22	   48	   35	   55639964	   68645358	   1	   4	  
TCGA-­‐06-­‐0744	   EGFR	  
ERP44,	  
KIAA0573	   46	   30	   55087058	   102784508	   1	   5	  
TCGA-­‐28-­‐5204	   TBC1D14	   HTRA3	   45	   33	   6996029	   8288288	   4	   3	  
TCGA-­‐06-­‐2569	   SSR1	   DMD	   44	   33	   7310150	   32328393	   2	   42	  
TCGA-­‐06-­‐0138	   SLC35E3	   OS9	   44	   38	   69145970	   58109543	   6	   6	  
TCGA-­‐06-­‐0129	  
PCDHGC3,
PCDHGC4	   QKI	   43	   24	   140858113	   163956014	   1	   4	  
TCGA-­‐06-­‐0157	   NAT8L	  
DBNDD1,	  
DKFZp761
L2416	   39	   24	   2062889	   90075838	   2	   2	  
TCGA-­‐06-­‐0125	   ARID1A	  
hoip,RNF3
1	   39	   26	   27094490	   24624366	   11	   12	  
TCGA-­‐06-­‐5408	   EGFR	   PSPH	   38	   37	   55268106	   56079562	   24	   6	  
TCGA-­‐28-­‐2514	   ARID1A	   BEND5	   37	   29	   27024031	   49202124	   1	   5	  
TCGA-­‐41-­‐4097	   PPP2R2B	  
CCT3,	  
DKFZp667
A196	   37	   18	   146017814	   156294880	   7	   6	  
TCGA-­‐06-­‐0125	   ARID1A	  
hoip,	  
RNF31	   36	   21	   27094490	   24624366	   11	   12	  
TCGA-­‐28-­‐5204	   CLTA	   UBE2R2	   36	   31	   36204176	   33911962	   4	   4	  
TCGA-­‐19-­‐2619	   NUCKS1	   PM20D1	   34	   31	   205719085	   205811017	   1	   9	  
NYU_E	   SNTB2	   VPS4A	   14	   13	   69333677	   69349911	   6	   2	  
NYU_G	   ERF	   GSK3A	   14	   3	   42759130	   42744294	   1	   2	  
NYU_B	   SCNN1A	   TNFRSF1A	   13	   9	   6457893	   6443410	   11	   2	  
TCGA-­‐19-­‐2624	   MDM2	   PPM1H	   34	   22	   69230529	   63195940	   10	   3	  
TCGA-­‐14-­‐0787	   ASH1L	   C1orf61	   33	   30	   155385535	   156384545	   6	   4	  
TCGA-­‐28-­‐5204	   TSC22D4	   C7orf61	   12	   1	   100065175	   100061309	   4	   2	  
BT299	   EPHB2	   CPSF3L	   33	   6	   23037536	   1256473	   1	   2	  
TCGA-­‐26-­‐5134	   LNX1	   USP46	   33	   27	   54373484	   53494330	   4	   4	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GBM-­‐
CUMC3338_L1	   ADCK4	   NUMBL	   11	   4	   41198856	   41192900	   14	   2	  
TCGA-­‐19-­‐5960	   PBXIP1	   PMVK	   10	   8	   154918048	   154904891	   10	   2	  
TCGA-­‐32-­‐1970	   ZNF544	  
DKFZp586
H1320,	  
AP2A1	   31	   28	   58758160	   50285014	   3	   2	  
NYU_E	   ASL	   CRCP	   10	   8	   65557650	   65592691	   15	   2	  
TCGA-­‐28-­‐5215	   EGFR	   PSPH	   31	   28	   55268106	   56079562	   24	   6	  
TCGA-­‐28-­‐2513	   LANCL2	   SEPT14	   31	   14	   55433922	   55914330	   1	   3	  
BT308	   PIGU	   NCOA6	   30	   26	   33222419	   33303169	   6	   16	  
TCGA-­‐28-­‐2514	   EGFR	  
GASP,	  
VOPP1	   29	   23	   55268106	   55588823	   24	   2	  
TCGA-­‐12-­‐3652	   NFX1	   C9orf24	   28	   20	   33295425	   34382867	   2	   3	  
TCGA-­‐41-­‐5651	   OS9	   KIF5A	   28	   23	   58090156	   57960909	   5	   7	  
TCGA-­‐19-­‐0957	   NFIA	  
RNLS,	  
C10orf59	   27	   14	   61554352	   90122482	   2	   5	  
TCGA-­‐06-­‐5856	   PSPC1	   CRYL1	   26	   18	   20304379	   20987526	   6	   6	  
GBM-­‐
CUMC3338_L1	   SENP3	  
GPS2,	  
KIAA1787	   26	   15	   7470322	   7217040	   8	   6	  
TCGA-­‐06-­‐5856	   C12orf49	   MDM2	   26	   16	   117175595	   69229609	   1	   9	  
TCGA-­‐28-­‐5208	   COBL	   SEPT14	   23	   15	   51203855	   55886916	   7	   7	  
TCGA-­‐12-­‐0616	   EMID2	   GGCT	   22	   16	   101176424	   30536851	   4	   4	  
NYU_B	  
KIAA0642,
GIGYF2	   TRPM8	   22	   20	   233613792	   234862561	   4	   10	  
TCGA-­‐06-­‐2557	   EGFR	   SEPT14	   21	   13	   55268106	   55863785	   24	   10	  
TCGA-­‐27-­‐1830	   PSMD1	   DNER	   20	   14	   231945028	   230377652	   12	   6	  
TCGA-­‐19-­‐2625	   RBM9	   LGALS2	   20	   16	   36424288	   37967938	   1	   2	  
TCGA-­‐41-­‐4097	   SLC25A26	   IMMT	   19	   17	   66313803	   86374956	   6	   13	  
TCGA-­‐14-­‐1402	   XRN1	   SMYD3	   19	   11	   142166712	   246093239	   1	   6	  
TCGA-­‐02-­‐2483	   ASTN2	  
ARHGDIG,	  
PDIA2	   18	   6	   119976637	   332025	   3	   3	  
TCGA-­‐06-­‐1804	   TDRD3	   ESD	   18	   13	   61109367	   47345631	   12	   10	  
TCGA-­‐06-­‐5414	   CHD7	   TOX	   18	   16	   61655656	   59872567	   2	   2	  
GBM-­‐
CUMC3296_L1	   CAND1	   EGFR	   17	   14	   67688936	   55238868	   4	   16	  
TCGA-­‐06-­‐2564	   CCDC127	  
hTERT,	  
TERT	   17	   12	   216844	   1282739	   2	   3	  
TCGA-­‐32-­‐5222	   MTOR	  
KIAA0833,	  





5	   USP18	   16	   6	   24640521	   18659539	   1	   10	  
GBM-­‐
CUMC3342_L1	   FAM13C	  
DKFZp434
E2022,	  
SUFU	   15	   11	   61083748	   104375025	   4	   9	  
TCGA-­‐27-­‐1831	   FREM2	   MTRF1	   15	   14	   39438743	   41808143	   16	   7	  
TCGA-­‐06-­‐0129	   SLC22A23, TNFRSF21	   15	   11	   3410422	   47221257	   3	   4	  




CUMC3322_L1	   AGK	   WDR60	   15	   12	   141255367	   158715068	   2	   16	  
TCGA-­‐19-­‐2624	   HOXC10	   WIBG	   15	   10	   54379794	   56297264	   1	   2	  
TCGA-­‐76-­‐4925	   SRP68	   AP1M2	   14	   8	   74046509	   10694746	   9	   2	  
TCGA-­‐41-­‐5651	   TSFM	   INHBE	   14	   9	   58186856	   57849877	   6	   2	  
TCGA-­‐19-­‐2619	   WBSCR17	   PPP1R9A	   14	   10	   70800719	   94827661	   2	   5	  




7	   13	   13	   910775	   4438632	   1	   8	  
TCGA-­‐28-­‐5208	   LANCL2	   PSPH	   13	   2	   55433922	   56079562	   1	   6	  
TCGA-­‐14-­‐1402	   RHEB	  
H91620,	  
PRKAG2	   12	   11	   151216546	   151372723	   1	   4	  
NYU_E	   CTSC	   RAB38	   12	   11	   88033698	   87883123	   5	   2	  
TCGA-­‐06-­‐0129	   DIP2B	   TAF8	   12	   7	   51128913	   42019095	   34	   2	  
TCGA-­‐26-­‐5139	   ZSWIM4	   UBQLN4	   11	   9	   13920034	   156012704	   5	   7	  
TCGA-­‐19-­‐2624	  
TBC1D30,
KIAA0984	   PPM1H	   10	   6	   65232631	   63226059	   8	   2	  
TCGA-­‐06-­‐5859	   SMAD4	   RAX	   10	   10	   48586286	   56936733	   7	   2	  
TCGA-­‐28-­‐2499	   DGKD	   SPP2	   10	   10	   234299129	   234967480	   3	   3	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inserts	   gene5p	   chr5p	   gene3p	   chr3p	  
TCGA-­‐06-­‐0750	   51	   17	   EGFR	   chr7	   SEPT14	   chr7	  
TCGA-­‐27-­‐1837	   648	   505	   EGFR	   chr7	   SEPT14	   chr7	  
TCGA-­‐28-­‐2513	   378	   251	   EGFR	   chr7	   SEPT14	   chr7	  
TCGA-­‐06-­‐5411	   676	   131	   NFASC	   chr1	   NTRK1	   chr1	  
TCGA-­‐32-­‐5222	   0	   1	   EGFR	   chr7	   SEPT14	   chr7	  
TCGA-­‐28-­‐5209	   0	   1	   EGFR	   chr7	   PSPH	   chr7	  	  
